
<html lang="en"     class="pb-page"  data-request-id="702230bc-40f1-40b4-9acd-f1cf3c2d88e2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-3;article:article:10.1021/acs.jmedchem.9b01457;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Structure–Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin" /></meta><meta name="dc.Creator" content="Maryline  Kienle" /></meta><meta name="dc.Creator" content="Patrick  Eisenring" /></meta><meta name="dc.Creator" content="Barbara  Stoessel" /></meta><meta name="dc.Creator" content="Oliver P.  Horlacher" /></meta><meta name="dc.Creator" content="Samuel  Hasler" /></meta><meta name="dc.Creator" content="Gwénaëlle  van Colen" /></meta><meta name="dc.Creator" content="Ruben C.  Hartkoorn" /></meta><meta name="dc.Creator" content="Anthony  Vocat" /></meta><meta name="dc.Creator" content="Stewart T.  Cole" /></meta><meta name="dc.Creator" content="Karl-Heinz  Altmann" /></meta><meta name="dc.Description" content="A series of derivatives of the antimycobacterial natural product pyridomycin have been prepared with the C2 side chain attached to the macrocyclic core structure by a C–C single bond, in place of t..." /></meta><meta name="Description" content="A series of derivatives of the antimycobacterial natural product pyridomycin have been prepared with the C2 side chain attached to the macrocyclic core structure by a C–C single bond, in place of t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 6, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01457" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01457" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01457" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01457" /></link>
        
    
    

<title>Synthesis and Structure–Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01457" /></meta><meta property="og:title" content="Synthesis and Structure–Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0094.jpeg" /></meta><meta property="og:description" content="A series of derivatives of the antimycobacterial natural product pyridomycin have been prepared with the C2 side chain attached to the macrocyclic core structure by a C–C single bond, in place of the synthetically more demanding enol ester double bond found in the natural product. Hydrophobic C2 substituents of sufficient size generally provide for potent anti-Mtb activity of these dihydropyridomycins (minimum inhibitory concentration (MIC) values around 2.5 μM), with several analogs thus approaching the activity of natural pyridomycin. Surprisingly, some of these compounds, in contrast to pyridomycin, are insensitive to overexpression of InhA in Mycobacterium tuberculosis (Mtb). This indicates that their anti-Mtb activity does not critically depend on the inhibition of InhA and that their overall mode of action may differ from that of the original natural product lead." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01457"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01457">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01457&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01457&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01457&amp;href=/doi/10.1021/acs.jmedchem.9b01457" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1105-1131</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01427" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01458" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Structure–Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Maryline Kienle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maryline Kienle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maryline++Kienle">Maryline Kienle</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Patrick Eisenring</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick Eisenring</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Eisenring">Patrick Eisenring</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbara Stoessel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbara Stoessel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Stoessel">Barbara Stoessel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Oliver P. Horlacher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Oliver P. Horlacher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Oliver+P.++Horlacher">Oliver P. Horlacher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Samuel Hasler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Samuel Hasler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Samuel++Hasler">Samuel Hasler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gwénaëlle van Colen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gwénaëlle van Colen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gw%C3%A9na%C3%ABlle++van+Colen">Gwénaëlle van Colen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruben C. Hartkoorn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruben C. Hartkoorn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health Institute, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruben+C.++Hartkoorn">Ruben C. Hartkoorn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anthony Vocat</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anthony Vocat</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health Institute, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anthony++Vocat">Anthony Vocat</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stewart T. Cole</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stewart T. Cole</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health Institute, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stewart+T.++Cole">Stewart T. Cole</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Karl-Heinz Altmann</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karl-Heinz Altmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zurich, Switzerland</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3c575d4e50115459555246125d5048515d52527c4c545d4e515d1259485446125f54"><span class="__cf_email__" data-cfemail="751e140719581d101c1b0f5b14190118141b1b35051d140718145b10011d0f5b161d">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karl-Heinz++Altmann">Karl-Heinz Altmann</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0747-9734" title="Orcid link">http://orcid.org/0000-0002-0747-9734</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01457&amp;href=/doi/10.1021%2Facs.jmedchem.9b01457" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1105–1131</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 6, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 September 2019</li><li><span class="item_label"><b>Published</b> online</span>6 January 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 February 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01457" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01457</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1105%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaryline%2BKienle%252C%2BPatrick%2BEisenring%252C%2BBarbara%2BStoessel%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D3%26contentID%3Dacs.jmedchem.9b01457%26title%3DSynthesis%2Band%2BStructure%25E2%2580%2593Activity%2BRelationship%2BStudies%2Bof%2BC2-Modified%2BAnalogs%2Bof%2Bthe%2BAntimycobacterial%2BNatural%2BProduct%2BPyridomycin%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1131%26publicationDate%3DFebruary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01457"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1722</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01457" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Structure–Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maryline&quot;,&quot;last_name&quot;:&quot;Kienle&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Eisenring&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Stoessel&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;P. Horlacher&quot;},{&quot;first_name&quot;:&quot;Samuel&quot;,&quot;last_name&quot;:&quot;Hasler&quot;},{&quot;first_name&quot;:&quot;Gwénaëlle&quot;,&quot;last_name&quot;:&quot;van Colen&quot;},{&quot;first_name&quot;:&quot;Ruben&quot;,&quot;last_name&quot;:&quot;C. Hartkoorn&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;Vocat&quot;},{&quot;first_name&quot;:&quot;Stewart&quot;,&quot;last_name&quot;:&quot;T. Cole&quot;},{&quot;first_name&quot;:&quot;Karl-Heinz&quot;,&quot;last_name&quot;:&quot;Altmann&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;1105-1131&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01457&quot;},&quot;abstract&quot;:&quot;A series of derivatives of the antimycobacterial natural product pyridomycin have been prepared with the C2 side chain attached to the macrocyclic core structure by a C–C single bond, in place of the synthetically more demanding enol ester double bond found in the natural product. Hydrophobic C2 substituents of sufficient size generally provide for potent anti-Mtb activity of these dihydropyridomycins (minimum inhibitory concentration (MIC) values around 2.5 μM), with several analogs thus approaching the activity of natural pyridomycin. Surprisingly, some of these compounds, in contrast to pyridomycin, are insensitive to overexpression of InhA in Mycobacterium tuberculosis (Mtb). This indicates that their anti-Mtb activity does not critically depend on the inhibition of InhA and that their overall mode of action may differ from that of the original natural product lead.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01457&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01457" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01457&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01457" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01457&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01457" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01457&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01457&amp;href=/doi/10.1021/acs.jmedchem.9b01457" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01457" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01457" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01457%26sid%3Dliteratum%253Aachs%26pmid%3D31904960%26genre%3Darticle%26aulast%3DKienle%26date%3D2020%26atitle%3DSynthesis%2Band%2BStructure%25E2%2580%2593Activity%2BRelationship%2BStudies%2Bof%2BC2-Modified%2BAnalogs%2Bof%2Bthe%2BAntimycobacterial%2BNatural%2BProduct%2BPyridomycin%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D3%26spage%3D1105%26epage%3D1131%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291304" title="Organic reactions">Organic reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292330" title="Chemical synthesis">Chemical synthesis</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/jmcmar.2020.63.issue-3/20200213/jmcmar.2020.63.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0094.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0094.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of derivatives of the antimycobacterial natural product pyridomycin have been prepared with the C2 side chain attached to the macrocyclic core structure by a C–C single bond, in place of the synthetically more demanding enol ester double bond found in the natural product. Hydrophobic C2 substituents of sufficient size generally provide for potent <i>anti-Mtb</i> activity of these dihydropyridomycins (minimum inhibitory concentration (MIC) values around 2.5 μM), with several analogs thus approaching the activity of natural pyridomycin. Surprisingly, some of these compounds, in contrast to pyridomycin, are insensitive to overexpression of InhA in <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>). This indicates that their <i>anti</i>-<i>Mtb</i> activity does not critically depend on the inhibition of InhA and that their overall mode of action may differ from that of the original natural product lead.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tuberculosis (TB), while often regarded as a disease of the past, as of today is still one of the major global threats to public health. In 2017, the World Health Organization (WHO) reported an estimated 10 million new cases of infection and 1.6 million TB-related deaths.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In addition, 1.7 billion individuals globally present an asymptomatic latent tuberculosis infection and have a 5–10% lifetime risk of developing active disease.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> A particular risk for the activation of dormant bacteria exists for individuals with an impaired (or suppressed) immune system, e.g., as the result of a human immunodeficiency virus (HIV) infection. However, bacterial activation may also be triggered by malnutrition, affliction with diabetes, or unhealthy lifestyle habits (smoking, alcohol abuse).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Recently, the emergence of multidrug- and extensively drug-resistant (MDR and XDR, respectively) strains of the causative pathogen <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) has become a serious threat also in industrialized countries.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> This development has been exacerbated by the lack of development of novel <i>anti</i>-TB drugs for several decades; only two new chemical entities have been approved for TB treatment since the approval of rifampicin in 1968 (Italy; FDA approval in 1971),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> namely, bedaquiline<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> and delamanid.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Of these, only bedaquiline acts via a truly novel mechanism of action.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Therefore, to eradicate TB and eliminate resistant strains, the development of improved antimycobacterial agents, ideally equipped with novel mechanisms of action, is urgently required.</div><div class="NLM_p">Pyridomycin (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is a bacterial secondary metabolite that was first isolated in 1953 from the <i>Streptomyces</i> strain 6706 (later termed <i>Streptomyces pyridomyceticus</i>) by Maeda and co-workers.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> At the time of discovery, the compound was shown to exhibit significant antimycobacterial activity and low systemic toxicity in mice. However, little additional work on the pharmacology of pyridomycin (<b>1</b>) has been reported for several decades thereafter.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0053.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0053.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of pyridomycin (<b>1</b>) and of 2,1′-dihydropyridomycins <b>2</b> and <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As part of a comprehensive initiative directed toward the discovery of new anti-TB drugs (ERC FP7 program MM4TB), we have recently revisited <b>1</b> as a potential lead structure for <i>anti</i>-TB drug discovery and we reconfirmed its antimycobacterial activity in vitro (minimum inhibitory concentration, MIC = 0.56–1.48 μM).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Of equal importance, we determined the molecular target of pyridomycin (<b>1</b>) as the mycobacterial nicotinamide adenine dinucleotide (NADH)-dependent enoyl-[acyl-carrier-protein] reductase (InhA),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> which is also the ultimate target of the clinical TB drug isoniazid (INH). INH acts as a prodrug and requires activation by KatG, a mycobacterial catalase peroxidase, to exert its antimycobacterial activity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Resistance to INH most often results from mutations in the <i>katG</i> gene rather than in <i>inhA</i> itself.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In contrast, we have shown pyridomycin (<b>1</b>) to be a direct NADH-competitive inhibitor of the reductase; as a consequence, most INH-resistant strains remain susceptible to <b>1</b>,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> which renders the compound a promising starting point for TB drug discovery.</div><div class="NLM_p">The binding mode of <b>1</b> to InhA could be determined by X-ray crystallography, which showed that <b>1</b>, in contrast to the INH-NADH adduct formed after activation of INH by KatG<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and other previously reported direct InhA inhibitors,<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20">(12−20)</a> blocks both the NADH and the lipid-binding site of the enzyme.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This binding mode makes pyridomycin unique among InhA inhibitors and effectively defines a new mode of action.</div><div class="NLM_p last">Only one total synthesis of pyridomycin (<b>1</b>) has been reported in the literature,<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> with the most challenging and difficult step being the installation of the exocyclic C2–C1′ double bond of the unique enol ester moiety. To circumvent this problem, we have investigated analogs of <b>1</b> with a single bond between C2 and C1′, which we have termed “dihydropyridomycins”.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Prototypical examples of this family of pyridomycin analogs are the 2-<i>iso</i>-propyl derivatives <b>2</b> and <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which retain a simple branched C2 side chain. Of these two analogs, the 2<i>R</i> isomer <b>2</b> was only ca. 4-fold less active than <b>1</b>, while it was 8-fold more potent than its 2<i>S</i> isomer <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). These findings indicated that (a) the enol ester moiety in pyridomycin (<b>1</b>) is not crucial for antimycobacterial activity, while at the same time (b) highlighting the importance of the configuration of the newly created stereocenter (in comparison with <b>1</b>) at C2 for biological activity. Based on X-ray crystallography, the binding modes of dihydropyridomycin <b>2</b> and pyridomycin (<b>1</b>) to InhA are very similar, with the C2 substituent protruding into a hydrophobic pocket in both cases.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In light of these findings, we have now prepared a series of new 2<i>R</i> dihydropyridomycin derivatives with variations in the size and hydrophobicity of the C2 substituent and we have determined the effects of these variations on antimycobacterial activity. In addition, we have investigated the importance of the configuration at the C10 and C11 stereocenters of <b>1</b> for biological activity and we have assessed the effect of the replacement of the C12(O)-O1 ester group of the natural product by an amide moiety (which we thought could lead to improved metabolic stability).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">As outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the synthesis of all pyridomycin analogs was to follow the same overall strategy that we had developed previously for the synthesis of <b>2</b> and <b>3</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Thus, analogs <b>28</b> and <b>35</b> were to be obtained by the late-stage amide coupling of 3-hydroxypicolinic acid (<b>27</b>) with the corresponding macrocyclic amines, which would in turn be formed by simultaneous cleavage of the benzyl amino and benzyl ester groups by catalytic hydrogenation of amino acids <b>25</b> and <b>34</b>, respectively, followed by macrolactamization and cleavage of the BOC-protecting group.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Retrosynthesis of Pyridomycin Analogs <b>28</b> and <b>35</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Protected amino acids <b>25</b> and <b>34</b> would result from an esterification or an amide coupling reaction of acid <b>24</b> with alcohols <b>8</b> and amine <b>33</b>, respectively. Acid <b>24</b> could be accessed from aldehyde <b>20</b> by means of an <i>anti</i>-aldol reaction, as described previously,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> while alcohols <b>8</b> and amine <b>33</b> were to be prepared by esterification of acids <b>5</b>, <b>11</b>, or <b>32</b> with N<sub>α</sub>-BOC-Thr-OBn (<b>6</b>).</div><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Synthesis of Alcohols <b>8</b></h4><div class="NLM_p">The synthesis of alcohols <b>8a</b>–<b>c,f</b> departed from the commercially available hydroxy acids <b>4a</b>–<b>c,f</b>, which were converted into their <i>tert</i>-butyldimethylsilyl (TBS) ethers <b>5a</b>–<b>c,f</b> (via the bis-TBS derivative of the hydroxy acid and selective in situ cleavage of the TBS-ester group)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The Yamaguchi esterification<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> of partially protected hydroxy acids <b>5a</b>–<b>c,f</b> with N<sub>α</sub>-BOC-<span class="smallcaps smallerCapital">l</span>-Thr-OBn (<b>6</b>) (which is commercially available but was synthesized here in two steps from <span class="smallcaps smallerCapital">l</span>-Thr following literature procedures<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>) then delivered intermediates <b>7a</b>–<b>c,f</b>. Finally, TBS deprotection with HF·pyridine furnished the desired free alcohols <b>8a</b>–<b>c,f</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Alcohols <b>8a</b>–<b>c,f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) TBSCl, imidazole, DMF, room temperature (rt), 24 h, (ii) K<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (5:2), 0 °C to rt, 4 h, 79% to quant.; (b) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, toluene, rt, 5 min, then alcohol <b>6</b>, DMAP, rt, 18 h, 12–92%; (c) HF·pyridine, THF, 0 °C to rt, 17 h, 82% to quant.</p></p></figure><div class="NLM_p">Alcohols <b>8d</b> and <b>8e</b>, which serve as precursors for dihydropyridomycins with an asymmetric C2 side chain that are the specific formal hydrogenation products of pyridomycin (<b>1</b>), were obtained in six steps from <span class="smallcaps smallerCapital">d</span>-Ile (<b>9e</b>) and <span class="smallcaps smallerCapital">d</span>-<i>allo</i>-Ile (<b>9d</b>), respectively (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Diazotation of the amino acids with aq. H<sub>2</sub>SO<sub>4</sub> and NaNO<sub>2</sub> produced α-hydroxy acids <b>4d,e</b> in excellent yields with retention of configuration.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0030.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Alcohols <b>8d,e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub> (aq. 1 M), NaNO<sub>2</sub>, H<sub>2</sub>O, 0 °C, 19 h, then rt, 15 min, 97% and quant.; (b) benzyl bromide, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 0 °C to rt, 20 h, 94 and 90%; (c) TBSOTf, lutidine, DCM, −78 °C, 30 min, then rt, 15 h, 93 and 77%; (d) H<sub>2</sub> (5 bar), Pd/C (10%), EtOAc, rt, 1 h, quant. and 81%; (e) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, toluene, rt, 5 min, then alcohol <b>6</b>, DMAP, rt, 18 h, 92 and 68%; (f) HF·pyridine, THF, 0 °C to rt, 17 h, quant. The first yield given is for the respective intermediate leading to <b>8d</b>, the second for the one leading to <b>8e</b>.</p></p></figure><div class="NLM_p">Applying the conditions previously used for the conversion of <b>4a</b>–<b>c,f</b> into <b>5a</b>–<b>c,f</b> (excess TBSCl/imidazole in DMF, then K<sub>2</sub>CO<sub>3</sub>) failed to deliver the desired TBS ethers <b>5d,e</b>. Hydroxy acids <b>4d,e</b> were thus transformed into the corresponding benzyl esters with BnBr/Cs<sub>2</sub>CO<sub>3</sub> followed by reaction with TBSCl; benzyl ester cleavage by catalytic hydrogenation then furnished acids <b>5d,e</b>. Finally, the Yamaguchi esterification<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> of <b>5d,e</b> with <b>6</b> followed by TBS deprotection gave free alcohols <b>8d,e</b>.</div><div class="NLM_p">Compared to all other alcohols <b>8</b>, the synthesis of alcohol <b>8i</b> required a different protecting group regime, due to the need for a protecting group on the prospective C2 hydroxymethyl side chain. Starting from methyl ester <b>10</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> quantitative ester saponification gave carboxylic acid <b>11</b>, which was esterified with N<sub>α</sub>-BOC-Thr-OBn (<b>6</b>) under Yamaguchi conditions<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> to give <b>12</b> in 71% yield (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Acetal cleavage with <i>p</i>-TsOH in MeOH followed by selective protection of the primary hydroxy group as a TBS ether then furnished alcohol <b>8i</b> in 41% overall yield from <b>12</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Alcohol <b>8i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KOH (aq. 2 M), MeOH, rt, 1 h, 99%; (b) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, THF/DMF (2:3), rt, 5 min, then alcohol <b>6</b>, DMAP, rt, 18 h, 71%; (c) <i>p</i>-TsOH, MeOH, rt, 20 h, 69%; (d) TBSCl, imidazole, DCM, rt, 18 h, 60%.</p></p></figure><div class="NLM_p">The syntheses of the two diastereoisomeric alcohols <b>8g</b> and <b>8h</b> were more elaborate than those of all other building blocks <b>8</b>, as they required the de novo installation of two chiral centers in precursor acids <b>5g</b> and <b>5h</b>. Both syntheses proceeded through epoxide <b>14</b> as a common intermediate that was obtained by an enantioselective Sharpless epoxidation of <i>trans</i>-cinnamyl alcohol (<b>13</b>) in 74% yield.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> Epoxide <b>14</b> was opened either in an <i>anti-</i>fashion with MeLi, to furnish diol <b>15</b> in 74% yield as a single diastereoisomer,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> or in a <i>syn-</i>fashion with Me<sub>3</sub>Al,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> to provide <b>17</b> in 77% yield as an inseparable mixture of diastereoisomers (d.r. = 3.4:1). The diols <b>15</b> and <b>17</b> were doubly TBS-protected, and the primary silyl ether was selectively cleaved using camphorsulfonic acid (CSA). The resulting alcohols <b>16</b> and <b>18</b> were oxidized to the corresponding acids <b>5g</b> and <b>5h</b> in good yields (94 and 86%, respectively) following a two-stage Swern–Pinnick protocol (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33−35)</a> Yamaguchi esterification<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> of <b>5g,h</b> with <b>6</b> followed by TBS removal with HF·pyridine finally furnished the desired alcohols <b>8g</b> and <b>8h</b> in 73 and 77% yields, respectively. Importantly, while the undesired <i>anti</i>-isomer could not be completely removed from the various intermediates en route from <b>17</b> to <b>8h</b> (ca. 5–10% of the <i>anti</i>-product present), <b>8h</b> was obtained as a single diastereoisomer.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Alcohols <b>8g,h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <span class="smallcaps smallerCapital">l</span>-(+)-DET, TTIP, <i>t</i>-BuOOH, DCM, −20 °C, 16 h, 74%; (b) for <b>15</b>, CuCN, MeLi, Et<sub>2</sub>O, −78 °C to 0 °C, 3 h, 74%; for <b>17</b>, Me<sub>3</sub>Al, toluene, 0 °C, 2 h, 77% (3.4:1 mixture of diastereoisomers); (c) TBSCl, imidazole, DMF, 0 °C to rt, 12–15 h, 93 and 88% (7.73:1 mixture of diastereoisomers); (d) CSA, DCM/MeOH 1:1, 0 °C, 3–5 h, 60 and 48%; (e) (i) (COCl)<sub>2</sub>, DMSO, Et<sub>3</sub>N, DCM, −78 °C to rt; (ii) NaClO<sub>2</sub>, NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O, <i>t</i>-BuOH/THF/H<sub>2</sub>O (4.5:3:1), rt, 2 h, 94 and 86%; (f) <b>6</b>, 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, DMAP, toluene, 0 °C to rt, 2 h, 75 and 60%; (g) HF·pyridine, THF, pyridine, 0 °C to rt, 16 h, 73 and 77%. The first yield is for the respective intermediate leading to <b>8g</b>; the second is for the one leading to <b>8h</b>.</p></p></figure></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Synthesis of Acids <b>24</b> and bis-<i>epi</i>-<b>24</b></h4><div class="NLM_p">Acid <b>24</b> was synthesized from aldehyde <b>20</b> and chiral ester <b>22</b> via a Masamune <i>anti</i>-aldol reaction,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> as previously described (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The reaction gave a separable mixture of diastereomeric aldol products in a 2:1 ratio, from which the desired product <b>23</b> and bis-<i>epi</i>-<b>23</b> were isolated as pure isomers in 45 and 18% yields, respectively. The configuration of <b>23</b> was previously established by X-ray crystallography of a derived lactam;<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> in this work, we have also obtained an X-ray crystal structure of the minor diastereoisomer, which confirmed its structure as bis-<i>epi</i>-<b>23</b> (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_001.pdf" class="ext-link">Supporting Information</a>). Finally, base-mediated ester hydrolysis with LiOH in MeOH/THF/H<sub>2</sub>O gave the free carboxylic acids <b>24</b> and bis-<i>epi</i>-<b>24</b> in high yields.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0031.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Acids <b>24</b> and bis-<i>epi</i>-<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>c</i>-Hex<sub>2</sub>BOTf, Et<sub>3</sub>N, DCM, −78 °C, 45% (<b>23</b>)/18% (bis-<i>epi</i>-<b>23</b>); (b) LiOH, MeOH/H<sub>2</sub>O/THF (3:2:2), rt, 24 h, 83–96%.</p></p></figure></div><div id="sec2_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Synthesis of Analogs <b>28a</b>–<b>g,i</b></h4><div class="NLM_p">Analogs <b>28a</b>–<b>g,i</b> were all synthesized according to the general strategy outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Thus, Yamaguchi esterification<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> of acid <b>24</b> with alcohols <b>8a</b>–<b>g,i</b> at low temperature (−78 °C to −35 °C)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> provided <b>25a</b>–<b>g,i</b> in low to moderate yields (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Simultaneous removal of all benzyl-protecting groups by catalytic hydrogenation provided the corresponding free amino acids, which were submitted to macrolactamization with HATU<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and DIPEA in DCM/DMF (100:1) at a high dilution to deliver macrocycles <b>26a</b>–<b>g,i</b> in yields between 23 and 62%. The exocyclic amino group was then deprotected with TFA (in the case of <b>26i</b>, this resulted in concomitant cleavage of the TBS ether in the C2 substituent) and the free amines were coupled to 3-HPA (<b>27</b>) with HATU,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> furnishing the targeted pyridomycin analogs <b>28a</b>–<b>g,i</b> in yields between 30 and 65% over two steps. Importantly, an X-ray crystal structure of <b>26c</b> could be obtained, and unequivocally confirmed the absolute configuration of the compound (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of C2-Modified Pyridomycin Analogs <b>28a</b>–<b>g,i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, DMAP, toluene, −78 °C to −35 °C, 43 h, then 0 °C, 2 h, 18–72%; (b) H<sub>2</sub> (1 bar), Pd/C, MeOH, rt, 5 h; (c) HATU, DIPEA, DCM/DMF, rt, 18 h, 23–62% over two steps; (d) TFA, DCM, 0 °C, 10 min, then rt, 2 h; (e) 3-HPA (<b>27</b>), HATU, DIPEA, MeCN, rt, 18 h, 30–65% over two steps.</p></p></figure></div><div id="sec2_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Synthesis of Analog <b>28h</b></h4><div class="NLM_p">Unfortunately, the attempted Yamaguchi esterification<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> of acid <b>24</b> with alcohol <b>8h</b> failed to deliver the desired ester; and the same was true for other esterification methods investigated. As an alternative to acid <b>24</b>, we chose to investigate the esterification of alcohol <b>8h</b> with acid <b>29</b> (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>), which was obtained in 12 steps from <span class="smallcaps smallerCapital">d</span>-glucose following a route that had been described previously by Kinoshita and co-workers<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> as part of their total synthesis of pyridomycin (<b>1</b>) (with some of the steps requiring optimization; see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0012.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of C2-Modified Pyridomycin Analog <b>28h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>8h</b>, DCC, DMAP, DCM, 0 °C to rt, 5 h, 78%; (b) KHCO<sub>3</sub>, MeOH, rt, 1 h, 89%; (c) Pd/C, MeOH, rt, 1.5 h; (d) HATU, DIPEA, DCM, DMF, rt, 16 h, 31% over two steps; (e) TFA, DCM, 3 h; (f) 3-HPA (<b>27</b>), HATU, DIPEA, DMF, 16 h, 43% over two steps.</p></p></figure><div class="NLM_p last">Gratifyingly, acid <b>29</b> could be successfully esterified with alcohol <b>8h</b> under Steglich conditions (DCC, DMAP)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> to deliver ester <b>30</b> in high yield (78%). The formyl protecting group was then removed with KHCO<sub>3</sub> in MeOH, delivering ester <b>31</b> in 89% yield. Subsequent catalytic hydrogenation led to concomitant benzyl removal and azide reduction, furnishing the corresponding amino acid. HATU-mediated macrolactamization followed by BOC removal with TFA and HATU-mediated coupling of the ensuing macrocyclic amine with 3-HPA (<b>27</b>) finally furnished analog <b>28h</b>.</div></div><div id="sec2_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Synthesis of Analog <b>35</b></h4><div class="NLM_p">Instead of protected hydroxy acids <b>5</b> or <b>11</b>, the synthesis of analog <b>35</b> involved the esterification of N<sub>α</sub>-BOC-Thr-OBn (<b>6</b>) with N<sub>α</sub>-Fmoc-<span class="smallcaps smallerCapital">d</span>-Ile (<b>32</b>) (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>). The reaction was again conducted under Yamaguchi conditions<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and furnished the desired ester in excellent yield (98%). Fmoc cleavage with piperidine then gave the free amine <b>33</b>. HATU-mediated coupling of the latter with acid <b>24</b> delivered amide <b>34</b> in 75% yield. Global debenzylation with hydrogen over Pd/C and subsequent macrolactamization with HATU and DIPEA under the previously established conditions furnished the protected macrocycle in a high yield. Cleavage of the BOC group and coupling of the free amine with 3-HPA (<b>27</b>) (HATU/DIPEA) finally gave analog <b>35</b> in 20% yield for the four-step sequence from <b>34</b> (after RP-HPLC purification).</div><figure id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Pyridomycin Analog <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, THF, rt, 5 min, then alcohol <b>6</b>, DMAP, toluene, rt, 1 h, 98%; (b) piperidine, MeCN, rt, 30 min, 64%; (c) <b>24</b>, HATU, DIPEA, MeCN/THF (10:1), 0 °C to rt, 48 h, 75%; (d) H<sub>2</sub> (1 atm), Pd/C (10%), MeOH, rt, 2.75 h, 96% (crude); (e) HATU, DIPEA, DCM, DMF (1%), rt, 18 h, 83%; (f) TFA, DCM, rt, 3 h, quant. (crude); 3-HPA (<b>27</b>), HATU, DIPEA, DMF, rt, 18 h, 25%.</p></p></figure></div><div id="sec2_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Synthesis of Analogs <b>39</b> and <b>40</b></h4><div class="NLM_p">Given the availability of significant amounts of acid bis-<i>epi</i>-<b>24</b> from a number of runs of the aldol reaction between <b>20</b> and <b>22</b>, we also pursued the synthesis of dihydropyridomicin analogs <b>39</b> and <b>40</b> with inverted configurations at the C10 and C11 stereocenters (pyridomycin numbering; <a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>), to gain information on the effect of these stereochemical changes on antimycobacterial activity. The synthesis of these analogs from bis-<i>epi</i>-<b>24</b> and alcohols <b>8c</b> and <b>36</b>, respectively, followed the same strategy as for analogs <b>28a</b>–<b>i</b> (<a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>).</div><figure id="sch10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0054.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0054.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Analogs <b>39</b> and <b>40</b> with Inverted Configurations at C10 and C11<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0054.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, DMAP, toluene, −78 °C to −35 °C, 43 h, then 0 °C, 2 h, 51–52%; (b) H<sub>2</sub> (1 bar), Pd/C, MeOH, rt, 5 h; (c) HATU, DIPEA, DCM/DMF, rt, 18 h, 33–42% over two steps; (d) TFA, DCM, 0 °C, 10 min, then rt, 2 h; (e) 3-HPA (<b>27</b>), HATU, DIPEA, MeCN, rt, 18 h, 37–51% over two steps.</p></p></figure></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Antimycobacterial Activity and InhA Inhibition</h3><div class="NLM_p">Pyridomycin analogs <b>28a</b>–<b>i</b>, <b>35</b>, <b>39</b>, and <b>40</b> were assessed for their antibacterial activity against <i>Mtb</i> strain H37Rv. For those compounds that displayed significant antimycobacterial activity, their IC<sub>50</sub> for inhibition of InhA (S94A) was also determined with either 2-<i>trans</i>-octenoyl-CoA or 2-<i>trans</i>-dodecenoyl-CoA as the substrate.</div><div class="NLM_p">As illustrated by the MIC values summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, all dihydropyridomycins with 2-substituents bulkier than methyl display good antimycobacterial activity, which in several cases (<b>28b</b>–<b>h</b>) surpasses the activity of our initial dihydropyridomycin <b>2</b> and thus begins to approach the activity of pyridomycin (<b>1</b>) itself. In contrast, C2 methyl analog <b>28a</b> is significantly less active than ethyl derivative <b>28b</b>, while the presence of a polar side chain as in <b>28i</b> results in a >150-fold loss in potency. Although we cannot rule out the possibility that the observed loss of activity for <b>28i</b> results from a decreased ability of the compound to penetrate the mycobacterial cell wall, the data are in general agreement with the structural data for the complexes between InhA and <b>1</b> or <b>2</b>, respectively;<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> in these structures, the C2 substituent protrudes into a hydrophobic pocket. At the same time, it is still surprising that a relatively small substituent such as ethyl essentially produces the same activity as the bulkier and more hydrophobic substituents present in <b>28c</b>–<b>h</b>, which would be expected to engage in more extensive hydrophobic interactions with the hydrophobic protein cavity. As for asymmetric C2 side chains as in <b>28d/e</b> and <b>28g/h</b>, the <i>R</i> diastereoisomer (<b>28d</b>) is found to be more potent for the <b>28d/e</b> pair, while no difference is observed between <b>28g</b> and <b>28h</b>. However, even the activity difference between <b>28d</b> and <b>28e</b> is small and may not be biologically significant. Likewise, no meaningful activity difference is observed between the C2 benzyl derivative <b>28f</b> and the branched variants <b>28g/h</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Antimycobacterial and InhA-Inhibitory Activity of Pyridomycin (<b>1</b>) and of Dihydropyridomycins <b>2</b>, <b>3</b>, <b>28a</b>–<b>i</b>, <b>35</b>, <b>39</b>, and <b>40</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">MIC (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">relative MIC (MIC/MIC(<b>1</b>))<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> InhA (S94A) (μM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pyridomycin (<b>1</b>)</td><td class="colsep0 rowsep0" align="left">0.55–3.05</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.43 ± 0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">32.8 ± 9.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">26.0</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">NM<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28a</b></td><td class="colsep0 rowsep0" align="left">49.9</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28b</b></td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">127 ± 2.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28c</b></td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">11.1 ± 0.703</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28d</b></td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">31.5 ± 8.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28e</b></td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">87.2 ± 23.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28f</b></td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">29.12 ± 1.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28g</b></td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28h</b></td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28i</b></td><td class="colsep0 rowsep0" align="left">96.8</td><td class="colsep0 rowsep0" align="left">167</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">184.6</td><td class="colsep0 rowsep0" align="left">250</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">94.6</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">135.8</td><td class="colsep0 rowsep0" align="left">148</td><td class="colsep0 rowsep0" align="left">291 ± 2.42</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Minimal inhibitory concentrations (MICs) were measured against <i>Mtb</i> strain H37Rv using the resazurin method.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Data are average values from at least duplicate experiments. MICs were determined in Middlebrook 7H9 broth (Difco) supplemented with 0.2% glycerol, 0.05% Tween 80, and 10% albumin dextrose catalase (ADC), which is routinely used in the screening for and testing of new antimycobacterial agents. The stability of pyridomycin (<b>1</b>) in this medium after 7 days was found to be >50% (for an initial concentration of 10 μg/mL). Some of the analogs <b>28</b> were also tested in the absence of Tween 80, which led to a 2–4-fold increase in the MIC (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_001.pdf" class="ext-link">Supporting Information</a>). The exact reasons for these changes are unclear, but it appears conceivable that Tween 80 enhances the penetration of pyridomycin and pyridomycin analogs into <i>Mtb</i> by disrupting the outer capsule of the bacterial cell envelope.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The differences in MICs between experiments in the presence or absence of Tween 80 do not affect the general SAR conclusions derived from the data shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">The relative MIC is defined as the ratio of the MIC of the respective analog and the pyridomycin (<b>1</b>) control in the same experiment.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Half-maximal inhibitory concentrations (IC<sub>50</sub>) were measured against InhA (S94A) with 2-<i>trans</i>-octenoyl-CoA or 2-<i>trans</i>-dodecenoyl-CoA as the substrate. For experimental details, cf. ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a>. Data are average values from experiments carried out in triplicates ± standard deviation (SD).</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">NM, no activity detectable up to a concentration of 75 μM.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">ND, no values determined.</p></div></div></div><div class="NLM_p">Unfortunately, the substitution of an ester for an amide moiety in analog <b>35</b> resulted in the complete loss of antimycobacterial activity. This may be attributed to an intolerable conformational change of the macrocycle or to unfavorable interactions of the protein with the more polar amide group. Finally, analogs <b>39</b> and <b>40</b> did not exhibit any antimycobacterial activity, which highlights the importance of the natural configurations of the stereocenters at C10 and C11 (although we cannot exclude that changing only one of these stereocenters, rather than both simultaneously, would have a less pronounced effect).</div><div class="NLM_p">The data in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> also show that there is no clear correlation between the antimycobacterial activity of pyridomycin analogs <b>28</b> and the inhibitory activity against their purported target enzyme InhA in vitro (where determined). There is no straightforward explanation for this discrepancy, but the data might indicate that at least some of our dihydropyridomycins could exhibit additional activity(ies) that are unrelated to InhA, perhaps by targeting other short-chain enoyl reductase(s) in <i>Mtb</i> that is (are) different from but still similar to InhA.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> To address this question, MIC values were determined for a group of compounds against the wild-type H37Rv strain as well as the corresponding InhA-overexpressing H37Rv::pMVinhA strain<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Pyridomycin (<b>1</b>) and isoniazid (INH) were used as positive controls, and both compounds showed significantly decreased activity against the InhA-overexpressing strain (ca. 16- and 31-fold reduction in MIC, respectively). A similar decrease in activity was also observed for analogs <b>28b,f</b>, thus indicating that they, too, target InhA. In contrast, and quite intriguingly, <b>28c,e</b> retained essentially full antimycobacterial activity against H37Rv::pMVinhA. Thus, while <b>28c,e</b> show inhibition of InhA in a biochemical assay, their antibacterial activity appears not to depend critically on the inhibition of bacterial InhA and they act through (an)other mechanism(s) of action that is (are) unaffected by the overexpression of InhA.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antimycobacterial Activity of Selected Analogs and INH against Wild-Type H37Rv and against InhA-Overexpressing H37Rv::pMVinhA<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">MIC H37Rv::pMV261 (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">MIC H37Rv::pMVinhA (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">resistance impact (fold MIC increase)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pyridomycin (<b>1</b>)</td><td class="colsep0 rowsep0" align="char" char=".">0.74</td><td class="colsep0 rowsep0" align="left">11.56</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="left">24.2</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28b</b></td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="left">>19.1<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28e</b></td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28f</b></td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="left">>17.3<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">isoniazid (INH)</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">37.3</td><td class="colsep0 rowsep0" align="left">31</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Minimal inhibitory concentrations (MIC) were measured against <i>Mtb</i> strain H37Rv using the resazurin method<a onclick="showRef(event, 'ref9 ref40'); return false;" href="javascript:void(0);" class="ref ref9 ref40">(9,40)</a> under the conditions detailed in footnote<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> of <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. H37Rv::pMVinhA refers to the <i>Mtb</i> strain H37Rv containing the pMV261::inhA plasmid; H37Rv::pMV261 refers to H37Rv transfected with the empty plasmid vector pMV261.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Highest concentration tested.</p></div></div></div><div class="NLM_p last">Experiments aimed at identifying possible additional targets of these compounds are currently ongoing, but so far have not yielded any conclusive results. Independent of this, the data in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> clearly demonstrate that rather subtle changes in the structure of the C2 substituent in dihydropyridomycins can completely overcome drug resistance due to overexpression of InhA.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have achieved the synthesis of 12 new 2,1′-dihydropyridomycins and we have determined their antimycobacterial activities and, for selected examples, their capacity for inhibition of InhA. By doing so, we have established the importance of the natural configuration of the C10 and C11 stereocenters and the significance of the C12(O)-O1 ester linkage for antibacterial activity. Most importantly, we have identified several new dihydropyridomycins with antimycobacterial activities starting to approach the activity of the lead natural product. At the same time, the (cellular) SAR for lipophilic C2 substituents larger than methyl is surprisingly flat. It remains to be seen if further modifications of the most potent analogs, for example, the attachment of substituents to the phenyl part of analogs <b>28f</b> or <b>28g,h</b> could lead to enhanced activity. In addition, modifications in the hydroxypicolinic acid part of the pyridomycin/dihydropyridomycin structure will be required to enhance metabolic stability, to produce analogs suitable for eventual in vivo applications. These questions will be addressed in a forthcoming publication.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Information</h3><div class="NLM_p">All manipulations were conducted under an argon atmosphere using flame-dried glassware and standard syringe/septa and Schlenk techniques. Absolute solvents were purchased from Fluka (absolute over molecular sieves). Commercial chemicals were used without further purification. Solvents for extractions, flash column chromatography (FC), and thin-layer chromatography (TLC) were purchased as commercial grade and distilled prior to use. TLC was performed on Merck TLC aluminum sheets (silica gel 60 F254). Spots were visualized with UV light (λ = 254 nm) or through staining with Ce<sub>2</sub>(SO<sub>4</sub>)<sub>3</sub>/phosphomolybdic acid/H<sub>2</sub>SO<sub>4</sub> (CPS) or KMnO<sub>4</sub>/K<sub>2</sub>CO<sub>3</sub>. FC was performed using Fluka silica gel 60 for preparative column chromatography (particle size, 40–63 μm). NMR spectra were recorded on a Bruker Avance 400 MHz or 500 MHz NMR spectrometer at 300 K. Chemical shifts (δ) are reported in ppm and are referenced to the solvent signal as an internal standard (CDCl<sub>3</sub> δ 7.26 ppm for <sup>1</sup>H and δ 77.16 ppm for <sup>13</sup>C spectra; CD<sub>3</sub>OD δ 3.31 ppm for <sup>1</sup>H and δ 49.00 ppm for <sup>13</sup>C spectra; (CD<sub>3</sub>)<sub>2</sub>SO δ 2.50 ppm for <sup>1</sup>H and δ 39.43 ppm for <sup>13</sup>C spectra). Data are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sext = sextet, m = multiplet, br. = broad signal, <i>J</i> = coupling constant in Hz. The multiplicity of signals is reported based on appearance (i.e., doublet of doublets that are apparent triplets are described as triplets). All <sup>13</sup>C NMR spectra were measured with complete proton decoupling. <sup>1</sup>H and <sup>13</sup>C signals were assigned using two-dimensional correlation experiments (correlation spectroscopy (COSY), heteronuclear single-quantum coherence (HSQC), heteronuclear multiple-bond correlation (HMBC)). IR spectra were recorded on a Jasco FT/IR-6200 instrument on thin films. Optical rotations were measured on a Jasco P-1020 polarimeter operating at the sodium D line (λ = 589 nm) and are reported as follows: [α]<sub class="stack">D</sub><sup class="stack"><i>T</i></sup>, concentration (<i>c</i> in g/100 mL), and solvent. Melting points were obtained in open capillary tubes using a Büchi melting point apparatus B-540 and are uncorrected. Mass spectra were recorded by the MS service of the Laboratory of Organic Chemistry (LOC) of the ETH Zürich; high-resolution mass spectrometry electrospray ionization (HR<b>-</b>MS, ESI) spectra were measured on a Bruker Daltonics maxis (UHR-TOF) and HR<b>-</b>MS (EI) on a Waters Micromass AutoSpec Ultima instrument. The purity of final products submitted for biological testing was determined by analytical RP-HPLC to be ≥95%. (For HPLC traces, see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_001.pdf" class="ext-link">Supporting Information</a>). As the sole exception, HPLC analysis was not performed on compound <b>28d</b>; the purity of this compound was estimated to be >90% based on the <sup>1</sup>H NMR spectrum included in the Supporting Information.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (2<i>R</i>,3<i>R</i>)-2-Hydroxy-3-methylpentanoic acid (<b>4d</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0006.gif" alt="" id="fx1" /></img><div class="NLM_p last">To a solution of <span class="smallcaps smallerCapital">d</span>-Ile (<b>9d</b>) (500 mg, 3.81 mmol, 1.00 equiv) in 1 M sulfuric acid (10 mL) was added a solution of NaNO<sub>2</sub> (2.10 g, 30.5 mmol, 8.00 equiv) in water (10 mL) dropwise over 4 h a 0 °C. The reaction mixture was stirred at 0 °C for 15 h, allowed to warm to rt, and stirred for further 15 min. The reaction was quenched by adding NaCl until saturation of the solution. The aqueous layer was extracted with EtOAc (3 × 30 mL), and the combined organic layers were washed with water (2 × 10 mL) and with brine (2 × 10 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to deliver <b>4d</b> (489 mg, 97%) as a yellow oil. The crude product was used in the following step without further purification. TLC (SiO<sub>2</sub>, DCM/MeOH 9:1, UV): <i>R</i><sub><i>f</i></sub> = 0.17. [α]<sub class="stack">D</sub><sup class="stack">20</sup>= +12.6° (<i>c</i> 0.70, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 4.18 (d, <i>J</i> = 3.6 Hz, 1H), 1.94–1.85 (m, 1H), 1.49–1.39 (m, 1H), 1.36–1.24 (m, 1H), 1.03 (d, <i>J</i> = 6.9 Hz, 3H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 179.0, 74.8, 39.1, 23.8, 15.5, 11.9. IR (thin film): υ (cm<sup>–1</sup>) = 3449, 2965, 2937, 2879, 1718, 1646, 1461, 1382, 1273, 1242, 1216, 1169.13, 1135, 1071, 1045, 1017. HR-MS (ESI): calcd for C<sub>6</sub>H<sub>13</sub>O<sub>3</sub> [M + H]<sup>+</sup> 133.0859; found 133.0859 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Benzyl (2<i>R</i>,3<i>R</i>)-2-hydroxy-3-methylpentanoate (<b>4dA</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0013.gif" alt="" id="fx2" /></img><div class="NLM_p last">To a solution of <b>4d</b> (453 mg, 3.43 mmol, 1.00 equiv) in DMF (20 mL) were added benzyl bromide (448 μL, 3.77 mmol, 1.10 equiv) and Cs<sub>2</sub>CO<sub>3</sub> (581 mg, 1.78 mmol, 0.52 equiv) at 0 °C. The white suspension was vigorously stirred at rt for 20 h. H<sub>2</sub>O (200 mL) was added, and the mixture was extracted with Et<sub>2</sub>O (3 × 200 mL). The combined organic layers were washed with water (2 × 20 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to deliver <b>4dA</b> (716 mg, 94%) as a yellow oil. The crude product was used in the following step without further purification. TLC (SiO<sub>2</sub>, hexane/EtOAc 7:3, UV): <i>R</i><sub><i>f</i></sub> = 0.48. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +3.3° (<i>c</i> 0.96, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.41–7.28 (m, 5H), 5.22 (dd, <i>J</i> = 19.5, 12.1 Hz, 2H), 4.12 (dd, <i>J</i> = 5.9, 3.7 Hz, 1H), 2.68 (d, <i>J</i> = 6.1 Hz, 1H), 1.88–1.74 (m, 1H), 1.38–1.27 (m, 1H), 1.27–1.16 (m, 1H), 0.97 (d, <i>J</i> = 6.9 Hz, 3H), 0.86 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.0, 135.3, 128.8, 128.7, 128.6, 75.0, 67.4, 39.3, 23.8, 15.6, 11.9. IR (thin film): υ (cm<sup>–1</sup>) = 3501, 2964, 2935, 2877, 1729, 1498, 1455, 1379, 1266, 1214, 1135, 1072, 1045, 963, 749, 697. HR-MS (ESI): calcd for C<sub>13</sub>H<sub>18</sub>NaO<sub>3</sub> [M + Na]<sup>+</sup> 245.1148 <i>m</i>/<i>z</i>; found 245.1154 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Benzyl (2<i>R</i>,3<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methylpentanoate (<b>4dB</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0007.gif" alt="" id="fx3" /></img><div class="NLM_p last">A solution of <b>4dA</b> (700 mg, 3.15 mmol, 1.00 equiv) and 2,6-lutidine (880 μL, 7.56 mmol, 2.40 equiv) in DCM (32 mL) was cooled to −78 °C. TBSOTf (868 μL, 3.78 mmol, 1.20 equiv) was added dropwise over 15 min. The mixture was stirred for 30 min at −78 °C, was slowly allowed to warm to 0 °C, and stirred at rt for 15 h. The solution was quenched by the addition of sat. aq. NaHCO<sub>3</sub>, diluted with Et<sub>2</sub>O (15 mL each), and extracted with Et<sub>2</sub>O (3 × 10 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 9:1 to 6:1 to 4:1) provided <b>4dB</b> (987 mg, 93%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 7:3, UV): <i>R</i><sub><i>f</i></sub> = 0.79. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +33.6° (<i>c</i> 0.71, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.40–7.28 (m, 5H), 5.15 (dd, <i>J</i> = 19.8, 12.2 Hz, 2H), 4.05 (d, <i>J</i> = 5.0 Hz, 1H), 1.82 (m, 1H), 1.50–1.40 (m, 1H), 1.24–1.12 (m, 1H), 0.89 (d, <i>J</i> = 8.3 Hz, 3H overlapping s, 9H), 0.85 (t, <i>J</i> = 7.9 Hz, 3H), 0.01 (s, 3H), 0.00 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 173.5, 135.9, 128.6, 128.4, 76.7, 66.4, 39.6, 25.9, 24.1, 18.4, 15.60, 11.6, −4.8, −5.2. IR (thin film): υ (cm<sup>–1</sup>) = 3026, 2959, 2930, 2880, 2857, 1752, 1731, 1461, 1380, 1252, 1172, 1139, 1069, 1005, 968, 860, 836. HR-MS (ESI): calcd for C<sub>19</sub>H<sub>32</sub>NaO<sub>3</sub>Si [M + Na]<sup>+</sup> 359.2013 <i>m</i>/<i>z</i>; found 359.2020 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (2<i>R</i>,3<i>S</i>)-2-Hydroxy-3-methylpentanoic acid (<b>4e</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0032.gif" alt="" id="fx4" /></img><div class="NLM_p last"><b>4e</b> was prepared from <span class="smallcaps smallerCapital">d</span>-<i>allo</i>-Ile (<b>9e</b>) according to the procedure described for <b>4d</b>. <b>4e</b> (568 mg, quant.) was obtained as a yellow oil. The crude product was used in the following step without further purification. TLC (SiO<sub>2</sub>, DCM/MeOH 9:1, UV): <i>R</i><sub><i>f</i></sub> = 0.08. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +7.4 ° (<i>c</i> 0.35, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 4.29 (d, <i>J</i> = 2.0 Hz, 1H), 1.93–1.86 (m, 1H), 1.62–1.50 (m, 1H), 1.41–1.31 (m, 1H), 0.97 (t, <i>J</i> = 7.4 Hz, 3H), 0.88 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 180.0, 73.0, 38.5, 26.2, 13.3, 11.9. IR (thin film): υ (cm<sup>–1</sup>) = 3521, 2965, 2924, 2863, 1726, 1464, 1373, 1251, 1201, 1145. HR-MS (ESI): calcd for C<sub>6</sub>H<sub>11</sub>Na<sub>2</sub>O<sub>3</sub> [M – H + 2Na]<sup>+</sup> 177.0498; found 177.0496 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Benzyl (2<i>R</i>,3<i>S</i>)-2-Hydroxy-3-methylpentanoate (<b>4eA</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0008.gif" alt="" id="fx5" /></img><div class="NLM_p last"><b>4eA</b> was prepared from <b>4e</b> according to the procedure described for <b>4dA</b>. <b>4eA</b> (829 mg, 90%) was obtained as a yellow oil. The crude product was used in the following step without further purification. TLC (SiO<sub>2</sub>, hexane/EtOAc 7:3, UV): <i>R</i><sub><i>f</i></sub> = 0.50. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +4.3° (<i>c</i> 0.81, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.40–7.34 (m, 5H), 5.22 (dd, <i>J</i> = 17.4, 12.3 Hz, 2H), 4.23 (dd, <i>J</i> = 5.8, 2.9 Hz, 1H), 2.65 (d, <i>J</i> = 5.8 Hz, 1H), 1.83 (ddd, <i>J</i> = 14.2, 7.0, 2.8 Hz, 1H), 1.61–1.46 (m, 1H), 1.58–1.47 (m, 1H), 0.94 (t, <i>J</i> = 7.4 Hz, 3H), 0.78 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.5, 135.4, 128.8, 128.7, 128.6, 73.2, 67.5, 38.6, 26.1, 13.3, 12.0. IR (thin film): υ (cm<sup>–1</sup>) = 3537, 3019, 2964, 2935, 2877, 1730, 1456, 1381, 1251, 1214, 1139, 1112, 1048, 753, 668. HR-MS (ESI): calcd for C<sub>13</sub>H<sub>18</sub>NaO<sub>3</sub> [M + Na]<sup>+</sup> 245.1148; found 245.1143 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Benzyl (2<i>R</i>,3<i>S</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methylpentanoate (<b>4eB</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0033.gif" alt="" id="fx6" /></img><div class="NLM_p last"><b>4eB</b> was prepared from <b>4eA</b> according to the procedure described for <b>4dB</b>. FC (hexane/EtOAc 9:1 to 6:1 to 4:1) provided <b>4eB</b> (956 mg, 77%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 7:3, UV): <i>R</i><sub><i>f</i></sub> = 0.80. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +42.9° (<i>c</i> 0.93, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.38–7.30 (m, 5H), 5.15 (dd, <i>J</i> = 14.3, 12.3 Hz, 2H), 4.15 (d, <i>J</i> = 3.7 Hz, 1H), 1.83–1.75 (m, 1H), 1.48–1.38 (m, 1H), 1.27–1.16 (m, 1H), 0.92–0.88 (t, <i>J</i> = 7.4 Hz, 3H overlapping with s, 9H), 0.84 (d, <i>J</i> = 6.8 Hz, 3H), 0.01 (s, 3H), 0.01 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 173.9, 136.1, 128.7, 128.7, 128.5, 75.3, 66.5, 39.8, 26.3, 26.0, 18.5, 13.9, 12.1, −4.6, −5.2. IR (thin film): υ (cm<sup>–1</sup>) = 2959, 2931, 2881, 2857, 1752, 1461, 1381, 1361, 1252, 1214, 1142, 1072, 836, 752. HR-MS (ESI): calcd for C<sub>19</sub>H<sub>32</sub>NaO<sub>3</sub>Si [M + Na]<sup>+</sup> 359.2013 <i>m</i>/<i>z</i>; found 359.2015 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)propanoic Acid (<b>5a</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0009.gif" alt="" id="fx7" /></img><div class="NLM_p last">To a stirred solution of <i>D</i>-lactic acid (<b>4a</b>) (513 mg, 5.69 mmol, 1.00 equiv) in DMF (6 mL) at 0 °C were added imidazole (762 mg, 11.2 mmol, 1.97 equiv) and TBSCl (3.30 g, 21.9 mmol, 3.85 equiv). The white suspension was stirred at rt for 23 h and diluted with hexane/EtOAc (1:1, 90 mL). The organic layer was washed with aq. 10% citric acid (50 mL) and H<sub>2</sub>O (90 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The crude intermediate (2.29 g) was dissolved in MeOH (40 mL), cooled to 0 °C, and a solution of K<sub>2</sub>CO<sub>3</sub> (1.52 g, 11.1 mmol, 1.95 equiv) in H<sub>2</sub>O (12.5 mL) was added. The reaction mixture was stirred at rt for 4 h, diluted with DCM (150 mL), and acidified to pH = 4 using citric acid (aq. 10%). The aqueous layer was extracted with DCM (3 × 150 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to deliver <b>5a</b> (588 mg, crude) as a slightly brown syrup. <b>5a</b> (crude) was used in the following step without further purification. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:3 +0.5% CH<sub>3</sub>COOH, KMnO<sub>4</sub>): <i>R</i><sub><i>f</i></sub> = 0.18. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) = 7.61 (br. s, 1H), 4.35 (q, <i>J</i> = 6.7 Hz, 1H), 1.43 (d, <i>J</i> = 6.8 Hz, 3H), 0.91 (s, 9H), 0.12 (s, 6H).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)butanoic Acid (<b>5b</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0014.gif" alt="" id="fx8" /></img><div class="NLM_p last"><b>5b</b> was prepared from (<i>R</i>)-hydroxybutyric acid (<b>4b</b>) according to the procedure described for <b>5a</b>. <b>5b</b> (crude) was used in the following step without further purification. TLC (SiO<sub>2</sub>, hexane/EtOAc, 4:1 +1% CH<sub>3</sub>COOH, CPS): <i>R</i><sub><i>f</i></sub> = 0.32. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 4.27 (t, <i>J</i> = 5.0 Hz, 1H), 1.93–1.66 (m, 2H), 0.99–0.94 (m, 3H), 0.93 (s, 9H), 0.13 (s, 6H).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-cyclohexylacetic Acid (<b>5c</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0010.gif" alt="" id="fx9" /></img><div class="NLM_p last"><b>5c</b> was prepared from (<i>R</i>)-hexahydromandelic acid (<b>4c</b>) according to the procedure described for <b>5a</b>. FC (hexane/EtOAc 6:1 to 4:1) provided <b>5c</b> (547 mg, 79% over two steps) as a colorless oil. TLC (SiO<sub>2</sub>, DCM/MeOH 95:5, UV): <i>R</i><sub><i>f</i></sub> = 0.50. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +15.3° (<i>c</i> 1.41, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 4.05 (d, <i>J</i> = 4.0 Hz, 1H), 1.85–1.54 (m, 6H), 1.19 (d, <i>J</i> = 86.5 Hz, 5H), 0.93 (s, 9H), 0.11 (s, 3H), 0.09 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.5, 76.6, 42.5, 29.2, 27.0, 26.1, 26.0, 26.0, 25.7 (3 C), 18.2, −5.0, −5.2. IR (thin film): υ (cm<sup>–1</sup>) = 2929, 2856, 1721, 1451, 1254, 1179, 1142, 900, 837, 777, 406. HR-MS (ESI): calcd for C<sub>14</sub>H<sub>28</sub>NaO<sub>3</sub>Si [M + Na]<sup>+</sup> 295.1700 <i>m</i>/<i>z</i>; found 295.1702 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (2<i>R</i>,3<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methylpentanoic Acid (<b>5d</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0034.gif" alt="" id="fx10" /></img><div class="NLM_p last">A solution of <b>4dB</b> (280 mg, 832 μmol, 1.00 equiv) and Pd/C (10%, 89.0 mg, 83.2 μmol, 0.10 equiv) in EtOAc (16 mL) was stirred under a H<sub>2</sub> atmosphere (5 bar). After 1 h, the suspension was filtered through a plug of celite. The filtrate was evaporated to deliver <b>5d</b> (207 mg, quant.) as a colorless oil. The crude product was used in the following step without further purification. TLC (SiO<sub>2</sub>, DCM/MeOH 9:1, UV): <i>R</i><sub><i>f</i></sub> = 0.50. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +5.4° (<i>c</i> 0.94, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 4.17 (d, <i>J</i> = 3.8 Hz, 1H), 1.83–1.77 (m, 1H), 1.55–1.46 (m, 1H), 1.35–1.24 (m, 1H), 0.98–0.88 (d, <i>J</i> = 8.2 Hz, 3H, overlapping with t, <i>J</i> = 7.5 Hz, 3H), 0.94 (s, 9H), 0.12 (d, <i>J</i> = 5.1 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 171.4, 76.3, 40.0, 25.8, 24.3, 15.2, 11.9, −4.9, −5.1. IR (neat, cm<sup>–1</sup>): 2961, 2932, 2859, 1722, 1461, 1254, 1146, 837, 776. HR-MS (ESI): calcd for C<sub>12</sub>H<sub>25</sub>O<sub>3</sub>Si [M − H]<sup>−</sup> 245.1578 <i>m</i>/<i>z</i>; found 245.1575 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (2<i>R</i>,3<i>S</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methylpentanoic Acid (<b>5e</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0061.gif" alt="" id="fx11" /></img><div class="NLM_p last"><b>5e</b> was prepared from (<b>4eB</b>) according to the procedure described for <b>5d</b>. <b>5e</b> (26.7 mg, 81%) was obtained as a colorless oil. The crude product was used in the following step without further purification. TLC (SiO<sub>2</sub>, DCM/MeOH 9:1, UV): <i>R</i><sub><i>f</i></sub> = 0.61. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +18.3° (<i>c</i> 1.10, EtOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 4.20 (d, <i>J</i> = 3.0 Hz, 1H), 1.88–1.74 (m, 1H), 1.57–1.42 (m, 1H), 1.29–1.15 (m, 1H), 0.96–0.91 (t, <i>J</i> = 7.0 Hz, 3H, overlapping with d, <i>J</i> = 6.8 Hz, 3H),0.95 (s, 9H), 0.12 (d, <i>J</i> = 4.3 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 173.3 (extracted from HMBC), 75.8, 39.9, 25.8, 25.8, 13.7, 12.1, −4.7, −5.1. HR-MS (ESI): calcd for C<sub>12</sub>H<sub>27</sub>O<sub>3</sub>Si [M + H]<sup>+</sup> 247.1724 <i>m</i>/<i>z</i>; found 247.1730 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-phenylpropanoic Acid (<b>5f</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0015.gif" alt="" id="fx12" /></img><div class="NLM_p last"><b>5f</b> was prepared from <span class="smallcaps smallerCapital">d</span>-(+)-3-phenyllactic acid (<b>4f</b>) according to the procedure described for <b>5a</b>. <b>5f</b> (2.24 g, crude) was used in the following step without further purification. TLC (SiO<sub>2</sub>, hexane/EtOAc, 4:1, UV): <i>R</i><sub><i>f</i></sub> = 0.31. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) = 7.33–7.19 (m, 5H), 4.42 (dd, <i>J</i> = 7.8, 3.8 Hz, 1H), 3.12 (dd, <i>J</i> = 13.7, 3.7 Hz, 1H), 2.95 (dd, <i>J</i> = 13.7, 7.8 Hz, 1H), 0.85 (s, 9H), −0.06 (s, 3H), −0.17 (s, 3H).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (2<i>R</i>,3<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-phenylbutanoic Acid (<b>5g</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0062.gif" alt="" id="fx13" /></img><div class="NLM_p last">To a stirred solution of oxalyl chloride (115 mg, 0.91 mmol, 3.00 equiv) in DCM (1.5 mL) was slowly added DMSO (0.13 mL, 1.82 mmol, 6.00 equiv) at −78 °C. The mixture was stirred for 10 min, and a solution of <b>16</b> (85.0 mg, 0.30 mmol, 1.00 equiv) in DCM (1.5 mL) was added at −78 °C. The reaction was stirred at −78 °C for 20 min and Et<sub>3</sub>N (0.34 mL, 2.42 mmol, 8.00 equiv) was added at −78 °C. The mixture was allowed to warm to rt (over 20 min). The reaction was quenched by the addition of brine (2 mL) and was extracted with DCM (3 × 10 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 5:1) provided the aldehyde (yield considered as quantitative) as a slight yellow oil. To a solution of the aldehyde (303 μmol, 1.00 equiv) in <i>t</i>-BuOH/THF 4.5:3 (3 mL) and 2-methyl-2-butene (1.61 mL, 15.2 mmol, 50.0 equiv) were sequentially added at rt a solution of NaH<sub>2</sub>PO<sub>4</sub>·2H<sub>2</sub>O (189 mg, 1.21 mmol, 4.00 equiv) in H<sub>2</sub>O (0.18 mL) and a solution of NaClO<sub>2</sub> (87.7 mg, 0.97 mmol, 3.20 equiv) in H<sub>2</sub>O (0.18 mL). The mixture was stirred for 2 h at rt. The reaction was quenched with sat. aq. NaHCO<sub>3</sub> solution (3 mL) and extracted with EtOAc (3 × 10 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 5:1 to 1:1) provided <b>5g</b> (84.1 mg, 94%) as a white solid. TLC (SiO<sub>2</sub>; hexane/EtOAc 1:1, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.39. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +29.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.32–7.20 (m, 5H), 4.31 (dd, <i>J</i> = 4.9, 2.2 Hz, 1H), 3.26–3.14 (m, 1H), 1.38 (d, <i>J</i> = 7.3, 1.5 Hz, 3H), 0.90 (s, 9H), 0.03 (s, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 177.2, 128.7, 128.4, 127.3, 77.2, 44.00, 25.8, 17.7, −5.3. IR (thin film): υ (cm<sup>–1</sup>) = 2957, 2930, 2886, 2858, 2359, 1721, 1472, 1463, 1455, 1256, 1146, 1115, 1061, 859, 838, 778, 763, 699, 666, 539, 525, 446, 441, 426, 418, 407. HR-MS (ESI): calcd for C<sub>16</sub>H<sub>26</sub>NaO<sub>3</sub>Si [M + Na]<sup>+</sup> 317.1543 <i>m</i>/<i>z</i>; found 317.1543 <i>m/z</i>.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (2<i>R</i>,3<i>S</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-phenylbutanoic Acid (<b>5h</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0055.gif" alt="" id="fx14" /></img><div class="NLM_p last"><b>5h</b> was prepared from <b>18</b> according to the procedure described for <b>5g</b>. FC (hexane/EtOAc 3:1) provided <b>5h</b> (338 mg, 86%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:1, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.45. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +8.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.37–7.18 (m, 5H), 4.33 (d, <i>J</i> = 3.3 Hz, 1H), 3.34 (qd, <i>J</i> = 7.1, 3.3 Hz, 1H), 1.34 (d, <i>J</i> = 7.1 Hz, 3H), 0.86 (s, 9H), −0.15 (s, 3H), −0.36 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 176.1, 142.0, 128.6, 128.5, 128.3, 127.2, 77.3, 43.3, 25.8, 18.2, 13.2, −5.7. IR (thin film): υ (cm<sup>–1</sup>) = 2955, 2929, 2885, 2858, 1721, 1472, 1463, 1454, 1362, 1256, 1147, 1114, 1099, 1055, 1011, 939, 887, 857, 837, 778, 761, 699, 671. HR-MS (ESI): calcd for C<sub>16</sub>H<sub>26</sub>NaO<sub>3</sub>Si [M + Na]<sup>+</sup> 317.1543 <i>m</i>/<i>z</i>; found 317.1543 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((<i>R</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)propanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>7a</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0016.gif" alt="" id="fx15" /></img><div class="NLM_p last">To a stirred solution of crude acid <b>5a</b> (433 mg, 0.873 mmol, 1.00 equiv) in toluene (20 mL) at rt were added Et<sub>3</sub>N (0.92 mL, 6.62 mmol, 3.13 equiv) and 2,4,6-trichlorobenzoyl chloride (0.42 mL, 2.69 mmol, 1.27 equiv). After 5 min, <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-Threonine benzyl ester <b>6</b> (691 mg, 2.23 mmol, 1.06 equiv) and DMAP (559 mg, 4.58 mmol, 2.16 equiv) were added and the suspension was stirred at rt for 18 h. The reaction was quenched with sat. aq. NaHCO<sub>3</sub> (20 mL). The aqueous layer was extracted with EtOAc (4 × 50 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 9:1 to 4:1) provided <b>7a</b> (322 mg, 12% over two steps) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 4:1, UV): <i>R</i><sub><i>f</i></sub> = 0.52. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +38.1° (<i>c</i> 0.67, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.40–7.29 (m, 5H), 5.46 (qd, <i>J</i> = 6.3, 2.5 Hz, 1H), 5.17 (d, <i>J</i> = 10.0 Hz, 1H), 5.13 (d, <i>J</i> = 12.2 Hz, 1H), 5.09 (d, <i>J</i> = 12.1 Hz, 1H), 4.47 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 4.19 (q, <i>J</i> = 6.7 Hz, 1H), 1.46 (s, 9H), 1.30 (d, <i>J</i> = 6.4 Hz, 3H), 1.26 (d, <i>J</i> = 6.7 Hz, 3H), 0.90 (s, 9H), 0.08 (s, 3H), 0.04 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 172.9, 170.1, 156.0, 135.1, 128.8, 128.7, 128.6, 80.4, 71.1, 68.2, 67.8, 57.3, 28.4, 25.8, 21.4, 18.4, 17.1, −4.8, −5.1. IR (thin film): υ (cm<sup>–1</sup>) = 3449, 2980, 2955, 2931, 2890, 2858, 1749, 1720, 1499, 1473, 1456, 1381, 1367, 1346, 1314, 1251, 1200, 1159, 1143, 1085, 1063, 1035, 975, 939, 902, 894, 867, 830, 813, 778, 748, 697, 667, 601, 582, 540, 534. HR-MS (ESI): calcd for C<sub>25</sub>H<sub>41</sub>NNaO<sub>7</sub>Si [M + Na]<sup>+</sup> 518.2544 <i>m</i>/<i>z</i>; found 518.2545 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((<i>R</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)butanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>7b</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0017.gif" alt="" id="fx16" /></img><div class="NLM_p last"><b>7b</b> was prepared from <b>6</b> and <b>5b</b> according to the procedure described for <b>7a</b>. FC (hexane/EtOAc 7:1) provided <b>7b</b> (933 mg, 61% over two steps) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc, 7:1, UV): <i>R</i><sub><i>f</i></sub> = 0.50. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +44.4° (<i>c</i> 1.74, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.39–7.29 (m, 5H), 5.47 (qd, <i>J</i> = 6.3, 2.4 Hz, 1H), 5.18 (d, <i>J</i> = 9.9 Hz, 1H), 5.16–5.03 (m, 2H), 4.47 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 4.05 (dd, <i>J</i> = 7.2, 4.6 Hz, 1H), 1.67–1.52 (m, 2H), 1.46 (s, 9H), 1.30 (d, <i>J</i> = 6.4 Hz, 3H), 0.91 (s, 9H), 0.90–0.86 (m, 3H), 0.06 (s, 3H), 0.03 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 172.6, 170.1, 156.0, 135.1, 128.8, 128.7, 128.6, 80.4, 73.1, 71.0, 67.8, 57.4, 28.4, 28.4, 25.8, 18.4, 17.2, 9.6, −4.8, −5.2. IR (thin film): υ (cm<sup>–1</sup>) = 3448, 2956, 2931, 2887, 2857, 1752, 1721, 1499, 1456, 1366, 1316, 1289, 1250, 1163, 1142, 1084, 1065, 1005, 837, 779, 698. HR-MS (ESI): calcd for C<sub>26</sub>H<sub>44</sub>NO<sub>7</sub>Si [M + H]<sup>+</sup> 510.2882 <i>m</i>/<i>z</i>; found 510.2880 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((<i>R</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-2-cyclohexylacetyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>7c</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0018.gif" alt="" id="fx17" /></img><div class="NLM_p last"><b>7c</b> was prepared from <b>6</b> and <b>5c</b> according to the procedure described for <b>7a</b>. FC (hexane/EtOAc 95:5) provided <b>7c</b> (164 mg, 92%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 95:5, UV): <i>R</i><sub><i>f</i></sub> = 0.28. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +42.1° (<i>c</i> 1.66, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.38–7.29 (m, 5H), 5.48 (qd, <i>J</i> = 6.2, 2.3 Hz, 1H), 5.25–5.11 (m, 2H), 5.02 (d, <i>J</i> = 12.2 Hz, 1H), 4.46 (dd, <i>J</i> = 9.7, 2.3 Hz, 1H), 3.91 (d, <i>J</i> = 4.5 Hz, 1H), 1.78–1.67 (m, 2H), 1.67–1.57 (m, 2H), 1.53–1.37 (m, 11H), 1.30 (d, <i>J</i> = 6.4 Hz, 3H), 1.24–1.03 (m, 5H), 0.91 (s, 9H), 0.03 (s, 3H), 0.01 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 172.2, 170.0, 156.0, 135.0, 128.7, 128.6, 128.4, 80.4, 76.4, 71.1, 67.7, 57.4, 42.4, 29.5, 28.4, 27.0, 26.3, 26.2, 26.1, 25.9, 18.4, 17.2, −4.8, −5.2. IR (thin film): υ (cm<sup>–1</sup>) = 2930, 2856, 1753, 1722, 1499, 1367, 1253, 1163, 1140, 1085, 1065, 837, 7783. HR-MS (ESI): calcd for C<sub>30</sub>H<sub>49</sub>NNaO<sub>7</sub>Si [M + Na]<sup>+</sup> 586.3171; found 586.3167 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl (2<i>R</i>,3<i>R</i>)-2-((<i>tert</i>-Butyl-dimethylsilyl)oxy)-3-methylpentanoate (<b>7d</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0035.gif" alt="" id="fx18" /></img><div class="NLM_p last"><b>7d</b> was prepared from <b>6</b> and <b>5d</b> according to the procedure described for <b>7a</b>. FC (hexane/EtOAc 40:1 to 4:1) provided <b>7d</b> (223 mg, 92%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 7:3, UV): <i>R</i><sub><i>f</i></sub> = 0.55. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +40.8° (<i>c</i> 0.70, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.40–7.30 (m, 5H), 5.49 (qd, <i>J</i> = 6.2, 2.0 Hz, 2H), 5.17 (d, <i>J</i> = 7.7 Hz, 1H), 5.10 (dd, <i>J</i> = 51.5, 12.2 Hz, 1H), 4.46 (dd, <i>J</i> = 9.7, 2.3 Hz, 1H), 3.97 (d, <i>J</i> = 4.4 Hz, 1H), 1.78–1.66 (m, 1H), 1.46 (s, 9H), 1.38–1.32 (m, 1H), 1.30 (d, <i>J</i> = 6.4 Hz, 3H), 1.22–1.11 (m, 1H), 0.91 (s, 9H), 0.90–0.86 (m, 6H), 0.04 (s, 3H), 0.02 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 172.3, 170.1, 156.0, 135.1, 128.8, 128.7, 128.5, 76.5, 71.1, 67.7, 57.4, 39.5, 28.4, 25.9, 23.8, 17.3, 15.6, 11.7, −4.8, −5.2. IR (thin film): υ (cm<sup>–1</sup>) = 2962, 2932, 2858, 1752, 1723, 1253, 1165, 1143, 1066, 838, 779. HR-MS (ESI): calcd for C<sub>28</sub>H<sub>47</sub>NNaO<sub>7</sub>Si [M + Na]<sup>+</sup> 560.3014 <i>m</i>/<i>z</i>; found 560.3020 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl (2<i>R</i>,3<i>S</i>)-2-((<i>tert</i>-butyl-dimethylsilyl)oxy)-3-methylpentanoate (<b>7e</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0019.gif" alt="" id="fx19" /></img><div class="NLM_p last"><b>7e</b> was prepared from <b>6</b> and <b>5e</b> according to the procedure described for <b>7a</b>. FC (hexane/EtOAc 40:1 to 4:1) provided <b>7d</b> (554 mg, 68%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 7:3, UV): <i>R</i><sub><i>f</i></sub> = 0.55. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +35.0° (<i>c</i> 0.75, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.39–7.32 (m, 5H), 5.48 (qd, <i>J</i> = 6.1, 2.5 Hz, 1H), 5.18 (d, <i>J</i> = 9.6 Hz, 1H), 5.10 (dd, <i>J</i> = 52.2, 12.2 Hz, 1H), 4.47 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 4.07 (d, <i>J</i> = 3.2 Hz, 1H), 1.69–1.61 (m, 1H), 1.46 (s, 9H), 1.4–1.37 (m, 1H), 1.30 (d, <i>J</i> = 6.4 Hz, 3H), 1.26–1.16 (m, 1H), 0.92–0.90 (s, 9H overlapping with t, 3H), 0.79 (d, <i>J</i> = 6.8 Hz, 3H), 0.04 (s, 3H), 0.01 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 172.6, 170.1, 156.0, 135.0, 128.8, 128.6, 128.5, 80.4, 74.8, 71.1, 67.8, 57.4, 39.6, 28.4, 26.2, 25.9, 17.2, 13.6, 12.1, −4.7, −5.2. IR (thin film): υ (cm<sup>–1</sup>) = 3460, 2961, 2933, 2859, 1752, 1723, 1499, 1461, 1367, 1252, 1164, 1146, 1065, 837, 776. HR-MS (ESI): calcd for C<sub>28</sub>H<sub>47</sub>NNaO<sub>7</sub>Si [M + Na]<sup>+</sup> 560.3014 <i>m</i>/<i>z</i>; found 560.3014 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((<i>R</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-3-phenylpropanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>7f</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0020.gif" alt="" id="fx20" /></img><div class="NLM_p last"><b>7f</b> was prepared from <b>6</b> and <b>5f</b> according to the procedure described for <b>7a</b>. FC (hexane/EtOAc 4:1) provided <b>7f</b> (466 mg, 39%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc, 4:1, UV): <i>R</i><sub><i>f</i></sub> = 0.66. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +29.2° (<i>c</i> 1.58, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.38–7.30 (m, 5H), 7.30–7.25 (m, 2H), 7.23–7.16 (m, 3H), 5.49 (qd, <i>J</i> = 6.2, 2.3 Hz, 1H), 5.17 (d, <i>J</i> = 9.9 Hz, 1H), 5.14 (d, <i>J</i> = 12.3 Hz, 1H), 5.08 (d, <i>J</i> = 12.1 Hz, 1H), 4.48 (dd, <i>J</i> = 9.7, 2.3 Hz, 1H), 4.22 (dd, <i>J</i> = 9.2, 3.6 Hz, 1H), 2.89 (dd, <i>J</i> = 13.5, 3.6 Hz, 1H), 2.69 (dd, <i>J</i> = 13.5, 9.2 Hz, 1H), 1.47 (s, 9H), 1.28 (d, <i>J</i> = 6.4 Hz, 3H), 0.78 (s, 9H), −0.14 (s, 3H), −0.29 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 172.1, 170.0, 156.0, 137.4, 135.1, 130.0, 128.8, 128.7, 128.6, 128.3, 126.8, 80.5, 73.6, 71.3, 67.8, 57.3, 41.5, 28.4, 25.7, 18.3, 17.1, −5.3, −5.7. IR (thin film): υ (cm<sup>–1</sup>) = 3448, 2953, 2931, 2857, 1751, 1719, 1498, 1457, 1365, 1314, 1252, 1162, 1128, 1082, 1064, 1000, 942, 832, 776, 754, 740, 699, 670. HR-MS (ESI): calcd for C<sub>31</sub>H<sub>45</sub>NNaO<sub>7</sub>Si [M + Na]<sup>+</sup> 594.2858 <i>m</i>/<i>z</i>; found 594.2860 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((2<i>R</i>,3<i>R</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-3-phenylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>7g</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0036.gif" alt="" id="fx21" /></img><div class="NLM_p last"><b>7g</b> was prepared from <b>6</b> and <b>5g</b> according to the procedure described for <b>7a</b>. FC (hexane/EtOAc 5:1) provided <b>7g</b> (100 mg, 75%) as a colorless oil. TLC (SiO<sub>2</sub>; hexane/EtOAc 5:1, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.32. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.40–7.29 (m, 5H), 7.25–7.16 (m, 5H), 5.39 (qd, <i>J</i> = 6.4, 2.4 Hz, 1H), 5.21–4.98 (m, 3H), 4.40 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 4.15 (d, <i>J</i> = 6.2 Hz, 1H), 3.06 (p, <i>J</i> = 7.0 Hz, 1H), 1.47 (s, 9H), 1.22 (d, <i>J</i> = 7.2 Hz, 3H), 1.11 (d, <i>J</i> = 6.4 Hz, 3H), 0.84 (s, 9H), −0.09 (s, 3H), −0.19 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 171.9, 170.1, 156.0, 142.4, 135.1, 128.8, 128.7, 128.5, 128.2, 126.9, 80.4, 77.4, 71.3, 67.8, 57.4, 44.3, 29.8, 28.4, 25.8, 25.7, 18.2, 17.9, 17.1, −5.1, −5.5.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((2<i>R</i>,3<i>S</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-3-phenylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>7h</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0074.gif" alt="" id="fx22" /></img><div class="NLM_p last"><b>7h</b> was prepared from <b>6</b> and <b>5h</b> according to the procedure described for <b>7a</b>. FC (hexane/EtOAc 5:1) provided <b>7h</b> (637 mg, 60%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 5:1, UV, KMnO<sub>4</sub>): <i>R</i><sub><i>f</i></sub> = 0.46. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +23.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.37–7.26 (m, 7H), 7.25–7.18 (m, 3H), 5.45 (m, 1H), 5.20–4.99 (m, 3H), 4.45 (dd, <i>J</i> = 9.6, 2.6 Hz, 1H), 4.21 (d, <i>J</i> = 3.9 Hz, 1H), 3.21–3.09 (m, 1H), 1.47 (s, 9H), 1.27 (d, <i>J</i> = 6.4 Hz, 3H), 1.22 (d, <i>J</i> = 7.1 Hz, 3H), 0.83 (s, 9H), −0.16 (s, 3H), −0.36 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 171.7, 170.0, 142.9, 138.0, 135.1, 129.2, 128.8, 128.7, 128.6, 128.4, 128.3, 126.9, 125.5, 80.5, 76.7, 71.4, 67.8, 57.4, 43.6, 28.5, 25.8, 17.3, 13.8, −5.3, −5.8. IR (thin film): υ (cm<sup>–1</sup>) = 2956, 2931, 2894, 2857, 1753, 1721, 1498, 1472, 1455, 1383, 1367, 1313, 1284, 1254, 1163, 1146, 1114, 1098, 1085, 1064, 1010, 837, 778, 740, 699. HR-MS (ESI): calcd for C<sub>32</sub>H<sub>47</sub>NNaO<sub>7</sub>Si [M + Na]<sup>+</sup> 608.3014 <i>m</i>/<i>z</i>; found 608.3007 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((<i>R</i>)-2-hydroxypropanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>8a</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0021.gif" alt="" id="fx23" /></img><div class="NLM_p last">To a stirred solution of <b>7a</b> (241 mg, 0.486 mmol, 1.00 equiv) in THF (8.0 mL) was added HF·pyridine (70% HF, 30% pyridine, 2.00 mL, 76.0 mmol, 158 equiv) at 0 °C. The reaction was stirred at rt for 21 h and quenched by addition of sat. aq. KHCO<sub>3</sub> until pH 8 and of EtOAc (20 mL). The aqueous layer was extracted with EtOAc (3 × 50 mL), and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 3:1) provided <b>8a</b> (164 mg, 87%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 4:1, UV) <i>R</i><sub><i>f</i></sub> = 0.15. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +21.8° (<i>c</i> 0.57, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.45–7.29 (m, 5H), 5.48 (qd, <i>J</i> = 6.3, 2.6 Hz, 1H), 5.21–5.06 (m, 3H), 4.52 (dd, <i>J</i> = 9.6, 2.5 Hz, 1H), 4.15 (q, <i>J</i> = 6.8 Hz, 1H), 2.60 (s, 1H), 1.46 (s, 9H), 1.32 (d, <i>J</i> = 6.4 Hz, 3H), 1.22 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 174.7, 169.9, 155.9, 135.0, 128.8, 128.7, 80.7, 72.4, 67.9, 66.9, 57.2, 28.4, 20.5, 16.9. IR (thin film): υ (cm<sup>–1</sup>) = 3441, 3357, 3065, 3034, 2980, 2936, 2875, 1744, 1717, 1521, 1500, 1456, 1392, 1382, 1368, 1348, 1315, 1280, 1253, 1214, 1164, 1128, 1085, 1063, 996, 939, 868, 837, 792, 771, 752, 732, 698. HR-MS (ESI): calcd for C<sub>19</sub>H<sub>27</sub>NNaO<sub>7</sub> [M + Na]<sup>+</sup> 404.1680 <i>m</i>/<i>z</i>; found 404.1678 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((<i>R</i>)-2-hydroxybutanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>8b</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0075.gif" alt="" id="fx24" /></img><div class="NLM_p last"><b>8b</b> was prepared from <b>7b</b> according to the procedure described for <b>8a</b>. FC (hexane/EtOAc 3:2) provided <b>8b</b> (189 mg, quant.) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 3:2, UV): <i>R</i><sub><i>f</i></sub> = 0.51. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +20.7° (<i>c</i> 1.02, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.42–7.29 (m, 5H), 5.48 (qd, <i>J</i> = 6.5, 2.6 Hz, 1H), 5.20 (d, <i>J</i> = 9.7 Hz, 1H), 5.17–5.06 (m, 2H), 4.52 (dd, <i>J</i> = 9.6, 2.7 Hz, 1H), 4.03 (ddd, <i>J</i> = 7.3, 5.9, 4.2 Hz, 1H), 2.62 (d, <i>J</i> = 5.9 Hz, 1H), 1.78–1.61 (m, 1H), 1.46 (s, 9H), 1.45–1.38 (m, 1H), 1.32 (d, <i>J</i> = 6.4 Hz, 3H), 0.89 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 174.2, 170.0, 155.9, 135.0, 128.8, 128.7, 80.6, 72.4, 71.8, 67.9, 57.2, 28.4, 27.6, 17.0, 9.1. IR (thin film): υ (cm<sup>–1</sup>) = 3445, 3357, 2979, 2937, 1742, 1717,1500, 1456, 1391, 1367, 1316, 1246, 1212, 1164, 1128, 1084, 1063, 995, 865, 757, 697. HR-MS (ESI): calcd for C<sub>20</sub>H<sub>29</sub>NNaO<sub>7</sub> [M + Na]<sup>+</sup> 418.1836 <i>m</i>/<i>z</i>; found 418.1843 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((<i>R</i>)-2-cyclohexyl-2-hydroxyacetyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>8c</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0037.gif" alt="" id="fx25" /></img><div class="NLM_p last"><b>8c</b> was prepared from <b>7c</b> according to the procedure described for <b>8a</b>. FC (hexane/EtOAc 4:1) provided <b>8c</b> (126 mg, 96%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 4:1, UV): <i>R</i><sub><i>f</i></sub> = 0.20. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +28.5° (<i>c</i> 2.02, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.39–7.29 (m, 5H), 5.49 (qd, <i>J</i> = 6.2, 2.4 Hz, 1H), 5.26 (d, <i>J</i> = 9.6 Hz, 1H), 5.16 (d, <i>J</i> = 12.2 Hz, 1H), 5.05 (d, <i>J</i> = 12.2 Hz, 1H), 4.52 (dd, <i>J</i> = 9.6, 2.3 Hz, 1H), 3.94 (d, <i>J</i> = 3.2 Hz, 1H), 2.64 (br. s, 1H), 1.82–1.53 (m, 5H), 1.46 (s, 9H), 1.32 (d, <i>J</i> = 6.4 Hz, 3H), 1.30–1.04 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 173.7, 169.9, 155.9, 134.9, 128.8, 128.7, 128.4, 80.5, 75.0, 72.5, 67.7, 57.2, 41.8, 29.2, 28.4, 26.3, 26.1, 26.0, 26.0, 17.0. IR (thin film): υ (cm<sup>–1</sup>) = 2929, 2855, 1716, 1499, 1453, 1367, 1346, 1314, 1284, 1250, 1212, 1163, 1116, 1086, 1063, 999, 938, 866, 753, 697. HR-MS (ESI): calcd for C<sub>24</sub>H<sub>35</sub>NNaO<sub>7</sub> [M + Na]<sup>+</sup> 472.2306 <i>m</i>/<i>z</i>; found 472.2308 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl (2<i>R</i>,3<i>R</i>)-2-Hydroxy-3-methylpentanoate (<b>8d</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0022.gif" alt="" id="fx26" /></img><div class="NLM_p last"><b>8d</b> was prepared from <b>7d</b> according to the procedure described for <b>8a</b>. FC (hexane/EtOAc 6:1 to 4:1) provided <b>8d</b> (41.0 mg, quant.) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 7:3, UV): <i>R</i><sub><i>f</i></sub> = 0.39. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +20.2° (<i>c</i> 1.04, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.40–7.32 (m, 5H), 5.50 (qd, <i>J</i> = 6.3, 2.3 Hz, 1H), 5.17 (d, <i>J</i> = 6.5 Hz, 1H), 5.12 (dd, <i>J</i> = 37.7, 12.3 Hz, 2H), 4.51 (dd, <i>J</i> = 9.6, 2.4 Hz, 1H), 3.99 (dd, <i>J</i> = 6.1, 3.6 Hz, 1H), 2.55 (d, <i>J</i> = 6.1 Hz, 1H), 1.77–1.67 (m, 1H), 1.46 (s, 9H), 1.33 (d, <i>J</i> = 6.4 Hz, 3H), 1.19 (m, 2H), 0.95 (d, <i>J</i> = 6.9 Hz, 3H), 0.88 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 173.9, 169.9, 155.94, 135.0, 128.8, 128.8, 128.8, 128.5, 80.6, 75.3, 72.5, 67.8, 57.3, 38.9, 28.4, 23.5, 17.1, 15.4, 11.8. IR (neat, cm<sup>–1</sup>): 3456, 2965, 2939, 2879, 1723, 1498, 1453, 1365, 1251, 1215, 1164, 1139, 1061. HR-MS (ESI): calcd for C<sub>22</sub>H<sub>33</sub>NNaO<sub>7</sub> [M + Na]<sup>+</sup> 446.2149 <i>m</i>/<i>z</i>; found 446.2147 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl (2<i>R</i>,3<i>S</i>)-2-Hydroxy-3-methylpentanoate (<b>8e</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0023.gif" alt="" id="fx27" /></img><div class="NLM_p last"><b>8e</b> was prepared from <b>7e</b> according to the procedure described for <b>8a</b>. FC (hexane/EtOAc 40:1 to 10:1) provided <b>8e</b> (41.0 mg, quant.) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 7:3, UV): <i>R</i><sub><i>f</i></sub> = 0.37. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +37.8° (<i>c</i> 0.45, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.39–7.32 (m, 5H), 5.49 (dd, <i>J</i> = 6.4, 2.6 Hz, 1H), 5.21 (d, <i>J</i> = 9.6 Hz, 1H), 5.12 (dd, <i>J</i> = 39.8, 12.2 Hz, 2H), 4.52 (dd, <i>J</i> = 9.6, 2.4 Hz, 1H), 4.10 (dd, <i>J</i> = 5.8, 2.7 Hz, 1H), 2.60 (d, <i>J</i> = 5.7 Hz, 1H), 1.72–1.62 (m, 1H), 1.53–1.47 (m, 1H), 1.46 (s, 9H), 1.33 (d, <i>J</i> = 6.4 Hz, 3H), 1.31–1.23 (m, 1H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H), 0.72 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 174.4, 169.9, 155.9, 134.9, 128.8, 128.8, 128.5, 80.6, 73.1, 72.6, 67.9, 57.3, 38.4, 28.4, 26.1, 17.0, 13.1, 11.9. IR (thin film): υ (cm<sup>–1</sup>) = 3456, 2968, 2936, 1741, 1720, 1501, 1457, 1383, 1316, 1249, 1214, 1165, 1064. HR-MS (ESI): calcd for C<sub>22</sub>H<sub>33</sub>NNaO<sub>7</sub> [M + Na]<sup>+</sup> 446.2149 <i>m</i>/<i>z</i>; found 446.2141 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((<i>R</i>)-2-hydroxy-3-phenylpropanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>8f</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0024.gif" alt="" id="fx28" /></img><div class="NLM_p last"><b>8f</b> was prepared from <b>7f</b> according to the procedure described for <b>8a</b>. FC (hexane/EtOAc 4:1) provided <b>8f</b> (161 mg, 82%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 4:1, UV): <i>R</i><sub><i>f</i></sub> = 0.23. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +17.4° (<i>c</i> 1.90, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.39–7.33 (m, 5H), 7.32–7.27 (m, 2H), 7.26–7.21 (m, 1H), 7.20–7.16 (m, 2H), 5.48 (qd, <i>J</i> = 6.3, 2.6 Hz, 1H), 5.20–5.09 (m, 3H), 4.52 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 4.34–4.27 (m, 1H), 2.93 (dd, <i>J</i> = 14.1, 4.5 Hz, 1H), 2.67 (dd, <i>J</i> = 14.1, 7.8 Hz, 1H), 2.59 (d, <i>J</i> = 5.0 Hz, 1H), 1.47 (s, 9H), 1.29 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) =173.2, 170.0, 155.9, 136.5, 135.0, 129.5, 128.8, 128.8, 128.7, 128.6, 127.0, 80.6, 72.6, 71.5, 67.9, 57.2, 40.5, 28.4, 16.9. IR (thin film): υ (cm<sup>–1</sup>) = 3403, 2978, 2935, 1741, 1715, 1497, 1455, 1367, 1314, 1248, 1162, 1087, 1062, 1031, 994, 864, 748, 698. HR-MS (ESI): calcd for C<sub>25</sub>H<sub>31</sub>NNaO<sub>7</sub> [M + Na]<sup>+</sup> 480.1993 <i>m</i>/<i>z</i>; found 480.1990 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((2<i>R</i>,3<i>R</i>)-2-hydroxy-3-phenylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>8g</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0038.gif" alt="" id="fx29" /></img><div class="NLM_p last"><b>8g</b> was prepared from <b>7g</b> according to the procedure described for <b>8a</b>. FC (hexane/EtOAc 3:1) provided <b>8g</b> (281 mg, 73%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 3:1, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.34. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +26.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.40–7.27 (m, 7H), 7.25–7.18 (m, 3H), 5.37 (qd, <i>J</i> = 6.2, 1.9 Hz, 1H), 5.22–5.07 (m, 2H), 5.03 (d, <i>J</i> = 9.7 Hz, 1H), 4.46 (dd, <i>J</i> = 9.7, 2.6 Hz, 1H), 4.23 (dd, <i>J</i> = 6.9, 4.0 Hz, 1H), 3.18–3.06 (m, 1H), 2.44 (d, <i>J</i> = 7.0 Hz, 1H), 1.47 (s, 9H), 1.35 (d, <i>J</i> = 7.2 Hz, 3H), 1.18 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 172.7, 170.0, 158.3, 155.9, 140.7, 135.0, 128.8, 128.6, 128.5, 128.4, 128.3, 127.3, 80.6, 75.7, 72.6, 67.9, 57.2, 43.3, 28.4, 17.3, 17.0. IR (thin film): υ (cm<sup>–1</sup>) = 2978, 2933, 1742, 1716, 1497, 1455, 1383, 1367, 1315, 1249, 1215, 1164, 1123, 1086, 1062, 1028, 993, 866, 754, 699, 541. HR-MS (ESI): calcd for C<sub>26</sub>H<sub>33</sub>NNaO<sub>7</sub> [M + Na]<sup>+</sup> 494.2149 <i>m</i>/<i>z</i>; found 494.2158 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((2<i>R</i>,3<i>S</i>)-2-hydroxy-3-phenylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (8h)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0025.gif" alt="" id="fx30" /></img><div class="NLM_p last"><b>8h</b> was prepared from <b>7h</b> according to the procedure described for <b>8a</b>. FC (hexane/EtOAc 3:1) provided <b>8h</b> (396 mg, 77%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 3:1, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.40. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +12.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.37–7.28 (m, 9H), 7.27–7.19 (m, 1H), 5.49 (qd, <i>J</i> = 6.5, 3.1 Hz, 1H), 5.26–4.99 (m, 3H), 4.51 (dd, <i>J</i> = 9.6, 2.7 Hz, 1H), 4.27 (s, 1H), 3.12–3.01 (m, 1H), 2.65 (s, 1H), 1.47 (s, 9H), 1.30 (d, <i>J</i> = 6.5 Hz, 3H), 1.19 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 173.2, 170.0, 155.9, 142.8, 136.0, 128.8, 128.6, 128.3, 128.0, 127.0, 80.7, 74.9, 72.8, 67.9, 57.2, 43.0, 28.4, 17.0, 14.6. IR (thin film): υ (cm<sup>–1</sup>) = 3408, 2978, 2935, 1742, 1716, 1498, 1455, 1384, 1367, 1315, 1249, 1213, 1164, 1126, 1086, 1063, 988, 768, 699. HR-MS (ESI): calcd for C<sub>26</sub>H<sub>33</sub>NNaO<sub>7</sub> [M + Na]<sup>+</sup> 494.2149 <i>m</i>/<i>z</i>; found 494.2150 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((<i>R</i>)-3-((<i>tert</i>-butyldimethylsilyl)oxy)-2-hydroxypropanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>8i</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0026.gif" alt="" id="fx31" /></img><div class="NLM_p last"><b>12A</b> (80.0 mg, 201 μmol, 1.00 equiv), TBSCl (32.0 mg, 211 μmol, 1.05 equiv), and imidazole (18.0 mg, 211 μmol, 1.05 equiv) were dissolved in DCM (1.5 mL) at rt. The mixture was stirred at rt for 18 h and was partitioned between sat. aq. NH<sub>4</sub>Cl (3 mL) and Et<sub>2</sub>O (5 mL). The aqueous layer was extracted with Et<sub>2</sub>O (3 × 5 mL), and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 9:1 to 2:3) provided <b>8i</b> (61.4 mg, 60%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 2:3, UV): <i>R</i><sub><i>f</i></sub> = 0.29. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +5.4° (<i>c</i> 0.63, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.38–7.31 (m, 5H), 5.47 (dt, <i>J</i> = 6.0, 4.6 Hz, 1H), 5.31–5.22 (m, 1H), 5.18–5.07 (m, 2H), 4.49 (dd, <i>J</i> = 9.5, 2.1 Hz, 1H), 4.13–4.06 (m, 1H), 3.78 (dd, <i>J</i> = 3.5, 2.8 Hz, 2H), 1.45 (s, 9H), 1.32 (d, <i>J</i> = 6.4 Hz, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 0.07 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 171.4, 169.8, 155.8, 135.0, 135.0, 128.6, 128.5, 128.5, 80.4, 72.2, 71.9, 67.6, 65.0, 57.1, 28.3, 25.9, 17.0, −5.3, −5.4. IR (thin film): υ (cm<sup>–1</sup>) = 2933, 2856, 1745, 1718, 1504, 1461, 1370, 1313, 1250, 1165, 1122, 1063, 1001, 838, 779, 743, 696. HR-MS (ESI): calcd for C<sub>25</sub>H<sub>41</sub>NNaO<sub>8</sub>Si [M + Na]<sup>+</sup> 534.2494 <i>m</i>/<i>z</i>; found 534.2491 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Potassium (<i>R</i>)-2,2-Dimethyl-1,3-dioxolane-4-carboxylate (<b>11</b>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0027.gif" alt="" id="fx32" /></img><div class="NLM_p last">To a stirred solution of (<i>R</i>)-2,2-dimethyl-1,3-dioxolane-4-carboxylic acid (<b>10</b>) (226 μL, 1.56 mmol, 1.00 equiv) in MeOH (4 mL) was added aq. 2 M KOH (780 μL, 1.56 mmol, 1.00 equiv). The solution was stirred for 1 h at rt. The solvents were removed in vacuo to deliver <b>11</b> (285 mg, 99%) as a white wax. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 4.49–4.37 (m, 1H), 4.26–4.16 (m, 1H), 3.87 (dd, <i>J</i> = 7.9, 7.4 Hz, 1H), 1.44 (s, 3H), 1.36 (s, 3H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 178.2, 111.1, 77.5, 69.0, 26.4, 27.0. HR-MS (ESI): calcd for C<sub>6</sub>H<sub>9</sub>O<sub>4</sub> [M − H]<sup>−</sup> 145.0506 <i>m</i>/<i>z</i>; found 145.0503 <i>m</i>/<i>z</i>. The analytical data are in agreement with those reported in ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl (<i>R</i>)-2,2-dimethyl-1,3-dioxolane-4-carboxylate (<b>12</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0056.gif" alt="" id="fx33" /></img><div class="NLM_p last">To a stirred solution of <b>11</b> (102 mg, 554 μmol, 1.00 equiv) and Et<sub>3</sub>N (162 μL, 1.16 mmol, 2.10 equiv) in THF (1 mL) and DMF (1.5 mL) was added 2,4,6-trichlorobenzoyl chloride (90.9 μL, 581 μmol, 1.05 equiv). After the solution became turbid (5 min), <b>6</b> (180 mg, 581 μmol, 1.05 equiv) and DMAP (67.6 mg, 554 μmol, 1.00 equiv) were added at rt. The mixture was stirred for 18 h at rt. Sat. aq. NaHCO<sub>3</sub> (3 mL) was added and the aqueous layer was extracted with EtOAc (3 × 5 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 4:1) provided <b>12</b> (159 mg, 71%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 4:1, UV): <i>R</i><sub><i>f</i></sub> = 0.28. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +23.3° (<i>c</i> 2.19, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.36–7.27 (m, 5H), 5.47 (dt, <i>J</i> = 8.6, 4.9 Hz, 1H), 5.20 (d, <i>J</i> = 9.6 Hz, 1H), 5.09 (d, <i>J</i> = 2.8 Hz, 2H), 4.48 (dd, <i>J</i> = 9.6, 2.2 Hz, 1H), 4.39 (dd, <i>J</i> = 7.2, 5.0 Hz, 1H), 4.14–4.03 (m, 1H), 3.93–3.81 (m, 1H), 1.43 (s, 9H), 1.43 (s, 3H), 1.35 (s, 3H), 1.28 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 170.0, 169.9, 155.7, 134.9, 128.6, 128.6, 111.3, 80.3, 73.8, 71.6, 67.7, 67.1, 57.0, 28.2, 25.8, 25.5, 16.8. IR (thin film): υ (cm<sup>–1</sup>) = 2981, 1744, 1715, 1500, 1456, 1382, 1369, 1315, 1248, 1198, 1162, 1103, 1063, 995, 865, 842, 753, 699, 606, 580, 517, 491, 467. HR-MS (ESI): calcd for C<sub>22</sub>H<sub>31</sub>NNaO<sub>8</sub> [M + H]<sup>+</sup> 460.1942 <i>m</i>/<i>z</i>; found 460.1942 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Benzyl <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-<i>O</i>-((<i>R</i>)-2,3-dihydroxypropanoyl)-<span class="smallcaps smallerCapital">l</span>-threoninate (<b>12A</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0063.gif" alt="" id="fx34" /></img><div class="NLM_p last">To a stirred solution of <b>12</b> (20.0 mg, 4.57 μmol, 1.00 equiv) in MeOH (1 mL) was added <i>p</i>-TsOH (1.00 mg, 0.46 μmol, 0.10 equiv). The solution was stirred at rt for 2 h but was not complete. <i>p</i>-TsOH (4.5 mg, 1.84 μmol, 0.40 equiv) was added and the solution was stirred at rt for 18 h. Et<sub>3</sub>N (8 μL) was added and the solvents were removed in vacuo. FC (hexane/EtOAc 2:3) provided <b>12A</b> (12.5 mg, 69%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 2:3, UV): <i>R</i><sub><i>f</i></sub> = 0.20. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +39.1° (<i>c</i> 0.63, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.40–7.32 (m, 5H), 5.58–5.48 (m, 1H), 5.31 (d, <i>J</i> = 9.4 Hz, 1H), 5.19–5.09 (m, 2H), 4.52 (d, <i>J</i> = 9.3 Hz, 1H), 4.17 (t, <i>J</i> = 3.4 Hz, 1H), 3.75 (d, <i>J</i> = 2.9 Hz, 2H), 1.46 (s, 9H), 1.34 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 172.0, 170.5, 155.8, 134.8, 128.7, 80.6, 72.6, 71.7, 68.1, 64.1, 57.0, 28.3, 16.9. IR (thin film): υ (cm<sup>–1</sup>) = 3436, 2978, 2937, 1742, 1714, 1503, 1456, 1385, 1367, 1315, 1250, 1213, 1164, 1115, 1062, 998, 865, 753, 699, 581, 493, 462. HR-MS (ESI): calcd for C<sub>19</sub>H<sub>27</sub>NNaO<sub>8</sub> [M + Na]<sup>+</sup> 420.1629 <i>m</i>/<i>z</i>; found 420.1632 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> ((2<i>S</i>,3<i>S</i>)-3-Phenyloxiran-2-yl)methanol (<b>14</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0028.gif" alt="" id="fx35" /></img><div class="NLM_p last">To a stirred solution of <span class="smallcaps smallerCapital">l</span>-(+)-DET (1.46 mL, 8.57 mmol, 0.23 equiv) in DCM (340 mL) with activated molecular sieves (3 Å, 5 g) were added titanium(IV)isopropoxide (1.65 mL, 5.59 mmol, 0.15 equiv) and <i>tert</i>-butyl hydroperoxide (5.5 M in DCM, 13.6 mL, 74.53 mmol, 2.00 equiv) at −20 °C. The mixture was stirred for 1 h at −20 °C. Then, a solution of <i>trans</i>-cinnamyl alcohol (<b>13</b>) (5.00 g, 37.3 mmol, 1.00 equiv) in DCM (7.45 mL) was added dropwise and the reaction mixture was stirred for 16 h at −20 °C. The reaction was quenched by the addition of 10% aq. NaOH solution (ca. 50 mL) and NaCl (ca. 50 g). After stirring the reaction mixture for 10 min, it was filtered through a pad of celite. The aqueous layer was extracted with EtOAc (3 × 150 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (toluene/EtOAc 3:1) provided <b>14</b> (4.14 g, 74%) as a white solid. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:1, UV, KMnO<sub>4</sub>): <i>R</i><sub><i>f</i></sub> = 0.36. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −50.8° (<i>c</i> 1.00, CHCl<sub>3</sub>) {lit.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −49.6° (<i>c</i> 2.4, CHCl<sub>3</sub>)}. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.39–7.27 (m, 5H), 4.06 (dddd, <i>J</i> = 12.8, 5.2, 2.4, 0.5 Hz, 1H), 3.93 (d, <i>J</i> = 2.2 Hz, 1H), 3.81 (ddd, <i>J</i> = 12.7, 7.8, 3.8 Hz, 1H), 3.23 (dt, <i>J</i> = 3.8, 2.3 Hz, 1H), 1.72 (dd, <i>J</i> = 7.9, 5.2 Hz, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 136.8, 128.7, 128.5, 125.9, 62.5, 61.4, 55.7.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (2<i>R</i>,3<i>R</i>)-3-Phenylbutane-1,2-diol (<b>15</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0064.gif" alt="" id="fx36" /></img><div class="NLM_p last">To a stirred suspension of CuCN (1.79 g, 20.0 mmol, 2.00 equiv) in Et<sub>2</sub>O (200 mL) was slowly added MeLi (3.1 M in THF, 11.6 mL, 36.0 mmol, 3.60 equiv) at −78 °C. The mixture was stirred at −78 °C for 1 h, and a solution of <b>14</b> (1.50 g, 10.0 mmol, 1.00 equiv) in Et<sub>2</sub>O (5 mL) was added slowly to the reaction mixture. The reaction was allowed to warm to 0 °C (over 1 h). While stirring for 3 h at 0 °C, the reaction mixture turned into a deep yellow suspension. The reaction was quenched by the addition of sat. aq. NH<sub>4</sub>Cl solution (ca. 60 mL), and the mixture was extracted with EtOAc (3 × 100 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 1:1) provided <b>15</b> (1.23 g, 74%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:1, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.16. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +14.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.38–7.30 (m, 2H), 7.25 (tdd, <i>J</i> = 5.4, 3.3, 2.0 Hz, 3H), 3.84–3.71 (m, 2H), 3.61–3.50 (m, 1H), 2.87 (p, <i>J</i> = 7.2 Hz, 1H), 1.30–1.24 (m, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 143.2, 129.0, 128.9, 128.1, 127.1, 76.4, 64.7, 43.0, 18.0. IR (thin film): υ (cm<sup>–1</sup>) = 3372, 3028, 2965, 2930, 2878, 1495, 1453, 1379, 1335, 1098, 1083, 1047, 1030, 1014, 1002, 943, 910, 864, 777, 763, 678, 607, 573, 558, 515, 504, 486, 476, 456, 445, 415. HR-MS (ESI): calcd for C<sub>10</sub>H<sub>14</sub>NaO<sub>2</sub> [M + Na]<sup>+</sup> 189.0886 <i>m</i>/<i>z</i>; found 189.0888 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>R</i>)-2,2,3,3,8,8,9,9-Octamethyl-5-((<i>R</i>)-1-phenylethyl)-4,7-dioxa-3,8-disiladecane (<b>15A</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0039.gif" alt="" id="fx37" /></img><div class="NLM_p last">To a stirred solution of <b>15</b> (157 mg, 0.95 mmol, 1.00 equiv) and imidazole (386 mg, 5.67 mmol, 6.00 equiv) in DMF (1.9 mL) was added TBSCl (428 mg, 2.84 mmol, 3.00 equiv) at 0 °C. The reaction mixture was allowed to warm to rt (over 1 h) and then stirred for 15 h. The reaction was quenched by the addition of sat. aq. NHCl<sub>4</sub> solution (ca. 5 mL) and extracted with EtOAc (3 × 15 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 10:1) provided <b>15A</b> (348 mg, 93%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 9:1, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.79. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +15.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.33– 7.14 (m, 5H), 3.75 (ddd, <i>J</i> = 6.8, 5.1, 4.1 Hz, 1H), 3.41 (dd, <i>J</i> = 10.0, 5.1 Hz, 1H), 3.20 (dd, <i>J</i> = 10.0, 6.9 Hz, 1H), 3.03 (dd, <i>J</i> = 7.3, 4.1 Hz, 1H), 1.30 (d, <i>J</i> = 7.3 Hz, 3H), 0.89 (s, 9H), 0.86 (s, 9H), 0.02 (s, 3H), −0.01 (s, 3H),. −0.02 (s, 3H), −0.02 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 143.5, 129.3, 127.8, 126.1, 77.2, 65.3, 42.1, 26.1, 26.1, 18.5, 18.4, 18.3, −4.1, −4.9, −5.3. IR (thin film): υ (cm<sup>–1</sup>) = 2955, 2928, 2885, 2857, 1495, 1471, 1463, 1388, 1362, 1254, 1122, 1096, 1058, 1039, 1020, 1005, 988, 952, 939, 878, 831, 813, 773, 698, 672, 551, 516, 467, 456, 439, 422, 411. HR-MS (ESI): calcd for C<sub>22</sub>H<sub>42</sub>NaO<sub>2</sub>Si<sub>2</sub> [M + Na]<sup>+</sup> 417.2616 <i>m</i>/<i>z</i>; found 417.2617 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (2<i>R</i>,3<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-phenylbutan-1-ol (<b>16</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0029.gif" alt="" id="fx38" /></img><div class="NLM_p last">To a stirred solution of <b>15A</b> (233 mg, 0.59 mmol, 1.00 equiv) in a mixture of MeOH/DCM 1:1 (12 mL) was added camphorsulfonic acid (27.4 mg, 0.12 mmol, 0.20 equiv) at 0 °C. The mixture was stirred at 0 °C for 5 h. The reaction was quenched with sat. aq. NaHCO<sub>3</sub> solution (4 mL), and the mixture was extracted with DCM (3× 15 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 3:1 to 1:5) provided <b>16</b> (99.3 mg, 60%) as a colorless oil along with <b>15</b> (24.1 mg, 24%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 9:1, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.22. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +17.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.32–7.17 (m, 5H), 3.78 (dt, <i>J</i> = 6.8, 4.2 Hz, 1H), 3.62 (dd, <i>J</i> = 11.3, 4.4 Hz, 1H), 3.50 (dd, <i>J</i> = 11.3, 3.9 Hz, 1H), 3.00 (p, <i>J</i> = 7.1 Hz, 1H), 1.28 (d, <i>J</i> = 7.2 Hz, 3H), 0.83 (s, 9H), −0.02 (s, 3H), −0.26 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 144.1, 128.5, 128.3, 126.5, 77.5, 64.2, 43.0, 26.0, 17.0, −4.5, −5.1. IR (thin film): υ (cm<sup>–1</sup>) = 2955, 2929, 2884, 2857, 1495, 1471, 1463, 1454, 1389, 1362, 1254, 1104, 1056, 1021, 938, 866, 834, 812, 775, 700, 674, 411. HR-MS (ESI): calcd for C<sub>16</sub>H<sub>28</sub>NaO<sub>2</sub>Si [M + Na]<sup>+</sup> 303.1751 <i>m</i>/<i>z</i>; found 303.1750 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (2<i>R</i>,3<i>S</i>)-3-Phenylbutan-1,2-diol (<b>17</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0065.gif" alt="" id="fx39" /></img><div class="NLM_p last">To a stirred solution of Me<sub>3</sub>Al (2 M in toluene, 10.0 mL, 20.0 mmol, 3.00 equiv) was slowly added a solution of <b>14</b> (1.00 g, 6.66 mmol, 1.00 equiv) in toluene (33 mL) at 0 °C. The mixture was stirred at 0 °C for 2 h. The reaction was quenched at 0 °C with sat. aq. Rochelle’s salt solution (25 mL), and the mixture was diluted with EtOAc (30 mL). The resulting biphasic mixture was stirred at rt for 1 h. The aqueous layer was extracted with Et<sub>2</sub>O (3 × 50 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 1:3) provided <b>17</b> (d.r. = 3.4:1, 853 mg, 77%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:3, UV, KMnO<sub>4</sub>). <i>R</i><sub><i>f</i></sub> = 0.33. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37–7.15 (m, 5H), 3.83–3.74 (m, 1H), 3.50–3.44 (m, 1H), 3.37 (m, 1H), 2.85–2.74 (m, 1H), 1.37 (d, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 143.7, 130.6, 128.9, 128.8, 128.3, 128.1, 127.7, 126.8, 76.8, 65.2, 43.0, 18.0. IR (thin film): (cm<sup>–1</sup>) = 3361, 2965, 2931, 2879, 1494, 1453, 1087, 1061, 1015, 763, 701. HR-MS (ESI): calcd for C<sub>10</sub>H<sub>14</sub>NaO<sub>2</sub> [M + Na]<sup>+</sup> 189.0886 <i>m</i>/<i>z</i>; found 189.0891 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>R</i>)-2,2,3,3,8,8,9,9-Octamethyl-5-((<i>S</i>)-1-phenylethyl)-4,7-dioxa-3,8-disiladecane (<b>17A</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0057.gif" alt="" id="fx40" /></img><div class="NLM_p last"><b>17A</b> was prepared from <b>17</b> according to the procedure described for <b>15A</b>. FC (hexane/EtOAc 95:5) provided <b>17A</b> (d.r. = 7.73:1, 9.02 g, 88%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 95:5, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.71. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.28–7.14 (m, 5H), 3.73 (dt, <i>J</i> = 6.4, 5.0 Hz, 1H), 3.52–3.35 (m, 2H), 3.06 (qd, <i>J</i> = 7.0, 4.4 Hz, 1H), 1.26 (d, <i>J</i> = 7.1 Hz, 3H), 0.89 (d, <i>J</i> = 1.7 Hz, 9H), 0.85 (s, 9H), 0.02 (s, 3H), 0.01 (s, 3H), −0.08 (s, 3H), −0.30 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 145.6, 129.3, 128.3, 128.1, 127.8, 126.1, 77.9, 65.4, 41.2, 26.1, 18.3, 14.1, −4.2, −5.2, −5.3. IR (thin film): υ (cm<sup>–1</sup>) = 2955, 2929, 2885, 2857, 1494, 1472, 1463, 1388, 1362, 1254, 1133, 1088, 1020, 1006, 956, 939, 878, 834, 813, 775, 699, 665. HR-MS (ESI): calcd for C<sub>22</sub>H<sub>42</sub>NaO<sub>2</sub>Si<sub>2</sub> [M + Na]<sup>+</sup> 417.2616 <i>m</i>/<i>z</i>; found 417.2628 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (2<i>R</i>,3<i>S</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-phenylbutan-1-ol (<b>18</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0078.gif" alt="" id="fx41" /></img><div class="NLM_p last"><b>18</b> was prepared from <b>17A</b> according to the procedure described for <b>16</b>. FC (hexane/EtOAc 9:1) provided <b>18</b> (374 mg, 48%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 9:1, UV, KMnO<sub>4</sub>): <i>R</i><sub><i>f</i></sub> = 0.25. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +18.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.32–7.26 (m, 2H), 7.25–7.17 (m, 3H), 3.74 (dt, <i>J</i> = 7.7, 3.7 Hz, 1H), 3.45 (dt, <i>J</i> = 11.3, 4.0 Hz, 1H), 3.30 (ddd, <i>J</i> = 11.4, 8.4, 3.5 Hz, 1H), 3.01 (m 1H), 1.71 (dd, <i>J</i> = 8.4, 4.2 Hz, 1H), 1.31 (d, <i>J</i> = 7.1 Hz, 3H), 0.93 (s, 9H), 0.08 (s, 3H), 0.04 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 144.3, 128.6, 128.3, 128.1, 126.6, 77.8, 64.6, 42.5, 26.1, 26.0, 17.9, −4.2, −4.6. IR (thin film): υ (cm<sup>–1</sup>) = 2955, 2929, 2884, 2857, 1494, 1471, 1463, 1389, 1362, 1254, 1129, 1107, 1050, 1017, 983, 937, 865, 834, 812, 775, 700, 676. HR-MS (ESI): calcd for C<sub>16</sub>H<sub>28</sub>NaO<sub>2</sub>Si [M + Na]<sup>+</sup> 303.1751 <i>m</i>/<i>z</i>; found 303.1752 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (1<i>R</i>,2<i>S</i>)-2-((<i>N</i>-Benzyl-2,4,6-trimethylphenyl)sulfonamido)-1-phenylpropyl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>23</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0040.gif" alt="" id="fx42" /></img><div class="NLM_p last">To a solution of <b>22</b> (1.10 g, 2.29 mmol, 1.50 equiv) in anhydrous DCM (5 mL) was added Et<sub>3</sub>N (0.80 mL, 5.73 mmol, 3.75 equiv) at rt. The reaction mixture was cooled to −78 °C, and dicyclohexylboron trifluoromethanesulfonate (1.64 g, 5.04 mmol, 3.30 equiv) in hexane (5.0 mL) was added dropwise during 15 min. The resulting solution was stirred at −78 °C for 3 h (colorless/light yellow solution). A solution of <b>20</b> (505 mg, 1.53 mmol, 1.00 equiv) in DCM (5.0 mL) was added dropwise during 25 min (syringe pump, 0.05 mL/min), and the solution was stirred at −78 °C for 3 h (orange solution). The mixture was allowed to warm very slowly to 0 °C (around 1 h) and stirred at 0 °C for 1 h. (The acetone of the cooling bath was transferred into another less isolating beaker while the dry ice was left behind. Thereby, the temperature rose only very slowly. At −5 °C, the acetone bath was replaced by a 0 °C water/ice bath.) The reaction was then quenched with phosphate buffer pH 7 (9 mL). The mixture was diluted with MeOH (30 mL), and 30% H<sub>2</sub>O<sub>2</sub> (3 mL) was added carefully. The mixture was stirred at rt for 18 h and then concentrated in vacuo. The residue was taken up in DCM and H<sub>2</sub>O, and the aqueous layer was extracted with DCM (3 × 25 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 3:2) provided <b>23</b> (559 mg, 45%) as a white foam and <i>bis</i>-<i>epi</i>-<b>23</b> (223 mg, 18%) as a white foam. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:1, UV): <i>R</i><sub><i>f</i></sub> = 0.35. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +23.0° (<i>c</i> 1.33, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.46 (br. s, 1H), 8.40 (d, <i>J</i> = 4.1 Hz, 1H), 7.46 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H), 7.36–7.23 (m, 7H), 7.23–7.01 (m, 12H), 6.84–6.80 (m, 4H), 5.77 (d, <i>J</i> = 3.9 Hz, 1H), 4.68 (d, <i>J</i> = 16.5 Hz, 1H), 4.50 (d, <i>J</i> = 16.6 Hz, 1H), 4.18 (d, <i>J</i> = 13.4 Hz, 2H), 4.08 (qd, <i>J</i> = 7.0, 3.9 Hz, 1H), 3.56 (br. s, 1H), 3.42 (d, <i>J</i> = 13.4 Hz, 2H), 3.36–3.27 (m, 1H), 3.12–2.98 (m, 3H), 2.85 (ddd, <i>J</i> = 9.6, 5.6, 4.1 Hz, 1H), 2.44 (s, 6H), 2.23 (s, 3H), 1.10 (d, <i>J</i> = 7.0 Hz, 3H), 0.42 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.0, 150.6, 147.6, 142.6, 140.3, 139.8, 138.4, 138.4, 136.8, 135.7, 133.6, 132.2, 129.2, 128.5, 128.3, 128.0, 127.6, 127.3, 127.1, 125.9, 123.6, 78.4, 73.0, 59.0, 56.9, 55.7, 48.3, 42.7, 26.8, 23.0, 21.0, 13.1, 13.0. IR (thin film): υ (cm<sup>–1</sup>) = 3667, 3018, 2977, 1731, 1604, 1496, 1454, 1379, 1321, 1215, 1152, 1077, 1055, 930, 855, 752, 701, 667. HR-MS (ESI): calcd for C<sub>50</sub>H<sub>56</sub>N<sub>3</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 810.3935 <i>m</i>/<i>z</i>, found 810.3924 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (1<i>R</i>,2<i>S</i>)-2-((<i>N</i>-Benzyl-2,4,6-trimethylphenyl)sulfonamido)-1-phenylpropyl (2<i>S</i>,3<i>R</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (bis-<i>epi</i>-23)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0079.gif" alt="" id="fx43" /></img><div class="NLM_p last">TLC (SiO<sub>2</sub>, hexane/EtOAc 1:1, UV): <i>R</i><sub><i>f</i></sub> = 0.42. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +8.6° (<i>c</i> 1.26, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.46 (br. s, 1H), 8.35 (br. s, 1H), 7.25–7.03 (m, 20H), 6.98–6.93 (m, 2H), 6.84 (s, 2H), 5.91 (d, <i>J</i> = 4.4 Hz, 1H), 4.65 (d, <i>J</i> = 16.3 Hz, 1H), 4.39 (d, <i>J</i> = 16.3 Hz, 1H), 4.26–4.12 (m, 2H), 3.84 (d, <i>J</i> = 14.2 Hz, 2H), 3.53 (d, <i>J</i> = 14.2 Hz, 2H), 3.08–2.88 (m, 3H), 2.76 (dd, <i>J</i> = 13.8, 4.1 Hz, 1H), 2.60–2.51 (m, 1H), 2.50 (s, 6H), 2.26 (s, 3H), 1.25 (d, <i>J</i> = 7.0 Hz, 3H), 0.96 (d, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 174.6, 151.0, 147.2, 142.8, 140.3, 139.8, 138.0, 137.9, 137.1, 136.3, 133.3, 132.2, 128.6, 128.6, 128.5, 128.3, 128.2, 127.7, 127.4, 127.0, 126.4, 123.1, 78.6, 72.2, 60.4, 57.1, 54.5, 48.6, 44.5, 29.1, 23.1, 21.0, 14.6, 14.0. IR (thin film): υ (cm<sup>–1</sup>) = 3026, 2978, 2939, 2927, 2366, 2337, 1737, 1604, 1496, 1454, 1380, 1320, 1216, 1152, 1028, 930, 928, 926, 856, 755, 698, 667. HR-MS (ESI): calcd for C<sub>50</sub>H<sub>56</sub>N<sub>3</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 810.3935 <i>m</i>/<i>z</i>, found 810.3920 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoic Acid (<b>24</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0041.gif" alt="" id="fx44" /></img><div class="NLM_p last">To a solution of <b>23</b> (176 mg, 217 μmol, 1.00 equiv) in MeOH/THF/H<sub>2</sub>O 3:2:2 (5.2 mL) was added LiOH·H<sub>2</sub>O (45.6 mg, 1.09 mmol, 5.00 equiv) at rt. The clear solution was stirred at rt for 24 h and diluted with Et<sub>2</sub>O (7 mL). The aqueous layer was acidified to pH 2 (aq. 1 M HCl), and the cleaved auxiliary was extracted, leaving the product in the aqueous layer. The latter was adjusted to pH 7 (sat. aq. NaHCO<sub>3</sub>), and the product was extracted with CHCl<sub>3</sub> (4 × 15 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to deliver <b>24</b> (84.1 mg, 96%) as a viscous yellow resin. TLC (SiO<sub>2</sub>, hexane/EtOAc 3:7, UV): <i>R</i><sub><i>f</i></sub> = 0.08. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +35.6° (<i>c</i> 0.54, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.48 (s, 1H), 8.40 (d, <i>J</i> = 3.3 Hz, 1H), 7.53 (d, <i>J</i> = 7.9 Hz, 1H), 7.29–7.04 (m, 11H), 4.05 (d, <i>J</i> = 12.8 Hz, 2H), 3.46 (t, <i>J</i> = 5.6 Hz, 1H), 3.39 (d, <i>J</i> = 13.4 Hz, 2H), 3.04–2.89 (m, 3H), 2.80–2.64 (m, 1H), 0.84 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 177.7, 149.5, 146.3, 138.8, 137.8, 136.3, 129.2, 128.5, 127.4, 123.8, 73.0, 61.0, 55.1, 42.2, 28.6, 14.6. IR (thin film): υ (cm<sup>–1</sup>) = 3411, 3062, 3027,2973, 2936, 2804, 1713, 1494, 1454, 1423, 1376, 1302, 1266, 1196, 1129, 1090, 1075, 1049, 1027, 1007, 983, 751, 700. HR-MS (ESI): calcd for C<sub>25</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 405.2173 <i>m</i>/<i>z</i>; found, 405.2173 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (2<i>S</i>,3<i>R</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoic Acid (bis-<i>epi</i>-<b>24</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0080.gif" alt="" id="fx45" /></img><div class="NLM_p last">Bis-<i>epi</i>-<b>24</b> was prepared from bis-<i>epi</i>-<b>23</b> according to the procedure described for <b>24</b>. Bis-<i>epi</i>-<b>24</b> (91.9 mg, 83%) was obtained as a yellow foam. TLC (SiO<sub>2</sub>, DCM/MeOH, 9:1, UV): <i>R</i><sub><i>f</i></sub> = 0.29. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −8.7° (<i>c</i> 1.16, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.40 (d, <i>J</i> = 4.6 Hz, 1H), 8.30 (s, 1H), 7.64 (d, <i>J</i> = 6.7 Hz, 1H), 7.39–7.25 (m, 2H), 7.23–7.14 (m, 7H), 7.14–7.06 (m, 2H), 3.96–3.85 (m, 1H), 3.79 (d, <i>J</i> = 14.0 Hz, 2H), 3.68 (d, <i>J</i> = 14.0 Hz, 2H), 3.16–3.01 (m, 2H), 2.92 (dd, <i>J</i> = 14.1, 5.1 Hz, 1H), 2.84–2.75 (m, 1H), 1.25 (d, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 180.0, 148.1, 144.3, 139.7, 139.5, 138.8, 128.8, 128.4, 127.1, 123.7, 73.7, 62.7, 54.7, 42.7, 30.0, 16.1. IR (thin film): υ (cm<sup>–1</sup>) = 3422, 3060, 3026, 2972, 2933, 2880, 2834, 2803, 1704, 1600, 1581, 1493, 1453, 1424, 1362, 1261, 1213, 1119, 1073, 1045, 1027, 974, 931, 747, 699. HR-MS (ESI): calcd for C<sub>25</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 405.2173 <i>m</i>/<i>z</i>; found 405.2169 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>R</i>)-1-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-1-oxopropan-2-yl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>25a</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0081.gif" alt="" id="fx46" /></img><div class="NLM_p last">To a stirred solution of <b>24</b> (41.5 mg, 0.103 mmol, 1.00 equiv) in THF (0.60 mL) were added Et<sub>3</sub>N (42.0 μL, 0.302 mmol, 2.93 equiv) and 2,4,6-trichlorobenzoyl chloride (28.0 μL, 0.179 mmol, 1.74 equiv). After 5 min, a solution of <b>8a</b> (43.5 mg, 0.114 mmol, 1.11 equiv) in toluene (0.50 mL) and DMAP (18.3 mg, 0.149 mmol, 1.45 equiv) was added. The reaction was stirred at −78 °C for 1 h and then gradually allowed to warm to −35 °C (over 1 h) and stirred at −35 °C for 41.5 h. The mixture was then gradually allowed to warm to 0 °C (over 2.5 h) and stirred at 0 °C for 1 h. The reaction was quenched by addition of sat. aq. NaHCO<sub>3</sub> (2 mL), and the aqueous layer was extracted with EtOAc (3 × 10 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 2:3) provided <b>25a</b> (50.3 mg, 64%) as a pale yellow oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 2:3, UV) <i>R</i><sub><i>f</i></sub> = 0.43. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +47.9° (<i>c</i> 0.43, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.57 (d, <i>J</i> = 1.9 Hz, 1H), 8.47 (dd, <i>J</i> = 4.9, 1.6 Hz, 1H), 7.63 (dt, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.39–7.26 (m, 13H), 7.26–7.17 (m, 3H), 5.64 (d, <i>J</i> = 9.9 Hz, 1H), 5.52 (qd, <i>J</i> = 6.3, 2.5 Hz, 1H), 5.10 (d, <i>J</i> = 12.1 Hz, 1H), 5.08 (d, <i>J</i> = 12.0 Hz, 1H), 4.86 (q, <i>J</i> = 7.1 Hz, 1H), 4.51 (dd, <i>J</i> = 9.9, 2.4 Hz, 1H), 4.36–4.17 (m, 2H), 3.96–3.85 (m, 1H), 3.51–3.36 (m, 3H), 3.28–3.07 (m, 3H), 2.90–2.81 (m, 1H), 1.43 (s, 9H), 1.35 (d, <i>J</i> = 7.1 Hz, 3H), 1.24 (d, <i>J</i> = 6.4 Hz, 3H), 0.35 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.5, 170.3, 170.0, 156.0, 150.7, 147.5, 140.0, 137.1, 135.8, 134.9, 129.4, 128.6, 128.6, 128.3, 127.1, 123.5, 80.3, 73.9, 72.1, 68.7, 67.9, 59.4, 57.1, 55.9, 42.1, 28.3, 27.3, 16.8, 16.6, 13.0. IR (thin film): υ (cm<sup>–1</sup>) = 3084, 3061, 3027, 2978, 2936, 2879, 2803, 1734, 1717, 1655, 1575, 1496, 1455, 1424, 1380, 1367, 1347, 1316, 1250, 1213, 1162, 1130, 1088, 1062, 1028, 1003, 988, 949, 913, 864, 841, 750, 745, 734, 699. HR-MS (ESI): calcd for C<sub>44</sub>H<sub>54</sub>N<sub>3</sub>O<sub>9</sub> [M + H]<sup>+</sup> 768.3855 <i>m</i>/<i>z</i>; found 768.3844 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (<i>R</i>)-1-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-1-oxo-butan-2-yl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>25b</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0042.gif" alt="" id="fx47" /></img><div class="NLM_p last"><b>25b</b> was prepared from <b>24</b> and <b>8b</b> according to the procedure described for <b>25a</b>. FC (hexane/EtOAc 3:1 to 1:1) provided <b>25b</b> (164 mg, 71%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 9:1, UV): <i>R</i><sub><i>f</i></sub> = 0.50. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +56.0° (<i>c</i> 0.98, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.57 (d, <i>J</i> = 1.7 Hz, 1H), 8.47 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 7.63 (dt, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.38–7.27 (m, 13H), 7.27–7.19 (m, 3H), 5.67 (d, <i>J</i> = 9.9 Hz, 1H), 5.54 (qd, <i>J</i> = 6.0, 2.6 Hz, 1H), 5.15–5.03 (m, 2H), 4.76 (dd, <i>J</i> = 7.5, 4.6 Hz, 1H), 4.51 (dd, <i>J</i> = 10.0, 2.4 Hz, 1H), 4.37–4.19 (m, 2H), 3.91 (br. s, 1H), 3.50–3.40 (m, 3H), 3.29–3.11 (m, 3H), 2.88–2.79 (m, 1H), 1.86–1.64 (m, 3H), 1.43 (s, 9H), 1.23 (d, <i>J</i> = 6.4 Hz, 3H), 0.95 (t, <i>J</i> = 7.4 Hz, 3H), 0.32 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.9, 170.5, 169.6, 156.1, 150.9, 147.7, 140.2, 137.2, 135.9, 135.00, 129.6, 128.8, 128.7, 128.7, 128.5, 127.3, 123.7, 80.4, 74.0, 73.44, 72.2, 68.1, 59.5, 57.3, 56.1, 42.3, 28.4, 27.4, 24.6, 16.8, 13.1, 9.6. IR (thin film): υ (cm<sup>–1</sup>) = 3452, 2978, 2931, 2802, 1739, 1715, 1496, 1454, 1367, 1248, 1215, 1161, 1128, 1087, 1062, 982, 752, 699. HR-MS (ESI): calcd for C<sub>45</sub>H<sub>56</sub>N<sub>3</sub>O<sub>9</sub> [M + H]<sup>+</sup> 782.4011 <i>m</i>/<i>z</i>; found 782.3994 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (<i>R</i>)-2-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-1-cyclohexyl-2-oxoethyl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>25c</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0082.gif" alt="" id="fx48" /></img><div class="NLM_p last"><b>25c</b> was prepared from <b>24</b> and <b>8c</b> according to the procedure described for <b>25a</b>. FC (hexane/EtOAc 1:1) provided <b>25c</b> (56.6 mg, 65%) as a pale yellow oil. TLC (SiO<sub>2</sub>; hexane/EtOAc 3:2, UV): <i>R</i><sub><i>f</i></sub> = 0.23. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +53.8° (<i>c</i> 1.04, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.49 (br. s, 1H), 8.44–8.37 (m, 1H), 7.63–7.56 (m, 1H), 7.34–7.21 (m, 12H), 7.21–7.13 (m, 4H), 5.66 (d, <i>J</i> = 10.0 Hz, 1H), 5.50 (qd, <i>J</i> = 6.4, 2.5 Hz, 1H), 5.06 (d, <i>J</i> = 12.2 Hz, 1H), 4.96 (d, <i>J</i> = 12.2 Hz, 1H), 4.61 (d, <i>J</i> = 3.9 Hz, 1H), 4.44 (dd, <i>J</i> = 10.0, 2.5 Hz, 1H), 4.29–4.12 (m, 2H), 3.85 (d, J = 3.9 Hz, 1H), 3.42–3.32 (m, 3H), 3.27–3.03 (m, 3H), 2.75 (dt, <i>J</i> = 10.0, 4.0 Hz, 1H), 1.88–1.75 (m, 1H), 1.66–1.41 (m, 5H), 1.35 (s, 9H), 1.25–0.97 (m, 8H), 0.22 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.9, 170.5, 169.1, 156.2, 150.5, 147.3, 140.2, 137.6, 136.1, 134.9, 129.6, 128.8, 128.7, 128.6, 128.5, 127.3, 123.8, 80.3, 76.7, 74.0, 72.3, 68.1, 59.5, 57.3, 56.1, 42.2, 39.8, 29.3, 28.4, 27.4, 27.4, 26.2, 26.1, 26.0, 16.9, 13.1. IR (thin film): υ (cm<sup>–1</sup>) = 3451, 3086, 3064, 3029, 2978, 2932, 2856, 2802, 1739, 1718, 1496, 1453, 1423, 1367, 1345, 1315, 1251, 1217, 1163, 1134, 1103, 1085, 1062, 1028, 985, 944, 866, 842, 752, 731, 699 cm-1. HR-MS (ESI): calcd for C<sub>49</sub>H<sub>62</sub>N<sub>3</sub>O<sub>9</sub> [M + H]<sup>+</sup> 836.4481 <i>m</i>/<i>z</i>; found, 836.4481 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (2<i>R</i>,3<i>R</i>)-1-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-3-methyl-1-oxopentan-2-yl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>25d</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0043.gif" alt="" id="fx49" /></img><div class="NLM_p last"><b>25d</b> was prepared from <b>24</b> and <b>8d</b> according to the procedure described for <b>25a</b>. FC (hexane/EtOAc 4:1 to 1:1) provided <b>25d</b> (13.4 mg, 21%) as a yellow oil. TLC (SiO<sub>2</sub>, MeOH/DCM 95:5, UV): <i>R</i><sub><i>f</i></sub> = 0.43. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +40.1° (<i>c</i> 0.43, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.57 (d, <i>J</i> = 1.8 Hz, 1H), 8.47 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 7.63 (dt, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.35–7.29 (m, 10H), 7.24–7.15 (m, 5H), 7.11–7.09 (m, 1H), 5.73 (d, <i>J</i> = 10.0 Hz, 1H), 5.58 (qd, <i>J</i> = 6.3, 2.3 Hz, 1H), 5.15 (d, <i>J</i> = 12.0 Hz, 1H), 5.09 (dd, <i>J</i> = 31.3, 12.1 Hz, 2H), 4.75 (d, <i>J</i> = 4.0 Hz, 1H), 4.51 (dd, <i>J</i> = 9.9, 2.4 Hz, 1H), 4.28 (dd, <i>J</i> = 17.3, 7.6 Hz, 2H), 3.93 (m, 1H), 3.45 (d, <i>J</i> = 13.2 Hz, 1H), 3.43–3.35 (m, 2H), 3.32–3.12 (m, 3H), 2.82 (dd, <i>J</i> = 5.6, 4.0 Hz, 1H), 2.01–1.91 (m, 1H), 1.42 (s, 9H), 1.35–1.28 (m, 2H), 1.23 (d, <i>J</i> = 6.4 Hz, 3H), 0.95 (d, <i>J</i> = 7.0 Hz, 3H), 0.92 (t, <i>J</i> = 7.5 Hz, 3H), 0.29 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 151.1, 150.9, 147.7, 137.2, 129.6, 128.8, 128.7, 128.5, 127.3, 123.7, 76.5, 74.1, 72.2, 68.1, 59.4, 57.4, 56.1, 42.3, 36.8, 28.4, 24.5, 16.9, 15.6, 13.2, 11.7. Three of the carbonyl carbons were not detectable. IR (thin film): υ (cm<sup>–1</sup>) = 3464, 3019, 2969, 2933, 1742, 1495, 1455, 1381, 1367, 1253, 1217, 1164, 1131, 1062, 774, 752. HR-MS (ESI): calcd for C<sub>47</sub>H<sub>60</sub>N<sub>3</sub>O<sub>9</sub> [M + Na]<sup>+</sup> 810.4324 <i>m</i>/<i>z</i>; found 810.4329 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (2<i>R</i>,3<i>S</i>)-1-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-3-methyl-1-oxopentan-2-yl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>25e</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0076.gif" alt="" id="fx50" /></img><div class="NLM_p last"><b>25e</b> was prepared from <b>24</b> and <b>8e</b> according to the procedure described for <b>25a</b>. FC (hexane/EtOAc 4:1 to 1:1) provided <b>25e</b> (14.3 mg, 18%) as a yellow oil. TLC (SiO<sub>2</sub>, DCM/MeOH 95:5, UV): <i>R</i><sub><i>f</i></sub> = 0.29. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +51.1° (<i>c</i> 0.73, CHCl<sub>3</sub>). <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) = 8.54 (d, <i>J</i> = 1.7 Hz, 1H), 8.40 (dd, <i>J</i> = 4.8, 1.4 Hz, 1H), 7.69 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H), 7.37–7.30 (m, 14H), 7.25–7.21 (m, 2H), 5.26–5.20 (m, 1H), 5.12–5.02 (m, 3H), 4.76 (d, <i>J</i> = 3.2 Hz, 1H), 4.39 (dd, <i>J</i> = 9.2, 3.7 Hz, 1H), 4.14 (s, 1H), 3.47 (d, <i>J</i> = 13.3 Hz, 2H), 3.31 (d, <i>J</i> = 9.7 Hz, 1H), 3.14 (dd, <i>J</i> = 13.0, 2.9 Hz, 1H), 2.99 (d, <i>J</i> = 26.9 Hz, 2H), 2.56 (dt, <i>J</i> = 10.5, 3.1 Hz, 1H), 1.83 (qd, <i>J</i> = 7.0, 3.2 Hz, 1H), 1.39 (s, 9H), 1.27–1.23 (m, 2H), 1.14 (d, <i>J</i> = 6.3 Hz, 3H), 0.79 (t, <i>J</i> = 7.4 Hz, 3H), 0.68 (d, <i>J</i> = 6.9 Hz, 3H), 0.08 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (126 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) = 174.7, 170.1, 168.9, 156.3, 151.0, 147.6, 140.7, 137.1, 136.5, 135.9, 129.6, 128.8, 128.6, 128.2, 127.3, 123.8, 79.2, 74.0, 73.0, 71.1, 66.9, 59.3, 57.4, 55.6, 43.4, 36.0, 28.6, 26.9, 25.9, 16.8, 14.3, 13.3, 11.9. IR (thin film): υ (cm<sup>–1</sup>) = 3521, 3037, 2842, 2763, 1796, 1423, 1382, 1397, 1225, 1216, 1159, 1132, 1073, 776. HR-MS (ESI): calcd for C<sub>47</sub>H<sub>60</sub>N<sub>3</sub>O<sub>9</sub> [M + H]<sup>+</sup> 810.4324 <i>m</i>/<i>z</i>; found 810.4321 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (<i>R</i>)-1-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-1-oxo-3-phenylpropan-2-yl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>25f</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0066.gif" alt="" id="fx51" /></img><div class="NLM_p last"><b>25f</b> was prepared from <b>24</b> and <b>8f</b> according to the procedure described for <b>25a</b>. FC (hexane/EtOAc 4:1 to 0:1) provided <b>25f</b> (55.0 mg, 66%) as a pale yellow oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 4:1, UV): <i>R</i><sub><i>f</i></sub> = 0.40. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +48.8° (<i>c</i> 1.14, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.55 (d, <i>J</i> = 1.7 Hz, 1H), 8.47 (dd, <i>J</i> = 4.7, 1.2 Hz 1H), 7.59 (d, <i>J</i> = 7.8 Hz, 1H), 7.37–7.28 (m, 13H), 7.27–7.24 (m, 3H), 7.23–7.16 (m, 4H), 5.60 (d, <i>J</i> = 9.9 Hz, 1H), 5.52 (qd, <i>J</i> = 6.0, 2.6 Hz, 1H), 5.10 (s, 2H), 5.03 (dd, <i>J</i> = 9.0, 3.8 Hz, 1H), 4.49 (dd, <i>J</i> = 9.9, 2.3 Hz, 1H), 4.34–4.19 (m, 2H), 3.64 (s, 1H), 3.45 (d, <i>J</i> = 13.3 Hz, 2H), 3.41–3.34 (m, 1H), 3.25–3.11 (m, 3H), 3.07 (dd, <i>J</i> = 14.4, 3.7 Hz, 1H), 2.91 (dd, <i>J</i> = 14.3, 9.1 Hz, 1H), 2.82–2.75 (m, 1H), 1.41 (s, 9H), 1.12 (d, <i>J</i> = 6.4 Hz, 3H), 0.17 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.2, 170.5, 168.8, 156.1, 150.8, 147.7, 140.2, 137.1, 135.9, 135.9, 135.0, 129.5, 129.5, 128.7, 128.7, 128.7, 128.6, 128.5, 127.3, 127.2, 123.6, 80.3, 73.8, 72.8, 72.4, 68.1, 59.2, 57.3, 56.1, 42.5, 37.2, 28.4, 27.2, 16.6, 13.0. IR (thin film): υ (cm<sup>–1</sup>) = 3422, 3030, 2979, 2931, 2806, 1740, 1715, 1496, 1454, 1366, 1312, 1274, 1247, 1160, 1082, 1028, 865, 751, 698. HR-MS (ESI): calcd for C<sub>50</sub>H<sub>58</sub>N<sub>3</sub>O<sub>9</sub> [M + H]<sup>+</sup> 844.4168 <i>m</i>/<i>z</i>; found 844.4153 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (2<i>R</i>,3<i>R</i>)-1-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-1-oxo-3-phenylbutan-2-yl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>25g</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0077.gif" alt="" id="fx52" /></img><div class="NLM_p last"><b>25g</b> was prepared from <b>24</b> and <b>8g</b> according to the procedure described for <b>25a</b>. FC (hexane/EtOAc 1:1) provided <b>25g</b> (38.2 mg, 41%) as a beige foam. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:1, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.31. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +50.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.59–8.41 (m, 2H), 7.68–7.56 (m, 1H), 7.44–7.28 (m, 15H), 7.25–7.18 (m, 6H), 5.61–5.52 (m, 1H), 5.41 (m, 1H), 5.13–4.98 (m, 2H), 4.98–4.88 (m, 1H), 4.40 (d, <i>J</i> = 9.9 Hz, 1H), 4.26 (m, 2H), 3.48–3.14 (m, 7H), 2.81 (s, 1H), 1.37 (s, 9H), 1.33 (d, <i>J</i> = 5.1 Hz, 3H), 0.83 (d, <i>J</i> = 4.4 Hz, 3H), 0.26 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.7, 170.6, 168.4, 156.1, 150.8, 147.7, 140.7, 140.1, 137.2, 135.9, 135.0, 129.5, 128.7, 128.7, 128.5, 128.4, 127.3, 127.3, 127.2, 123.7, 80.2, 76.4, 73.7, 72.0, 68.1, 59.3, 57.2, 56.1, 42.6, 41.4, 28.5, 28.4, 27.3, 18.2, 16.3, 13.3. IR (thin film): υ (cm<sup>–1</sup>) = 3029, 2977, 2934, 1739, 1716, 1496, 1454, 1380, 1366, 1347, 1314, 1266, 1218, 1163, 1112, 1088, 1061, 1027, 984, 945, 752, 699. HR-MS (ESI): calcd for C<sub>51</sub>H<sub>60</sub>N<sub>3</sub>O<sub>9</sub> [M + H]<sup>+</sup> 858.4324 <i>m</i>/<i>z</i>; found 858.4313 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (6<i>R</i>,9<i>R</i>,10<i>S</i>)-10-((Benzyloxy)carbonyl)-2,2,3,3,9,14,14-heptamethyl-7,12-dioxo-4,8,13-trioxa-11-aza-3-silapentadecan-6-yl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>25i</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0044.gif" alt="" id="fx53" /></img><div class="NLM_p last"><b>25i</b> was prepared from <b>24</b> and <b>8i</b> according to the procedure described for <b>25a</b>. FC (hexane/EtOAc 3:2) provided <b>25i</b> (38.1 mg, 72%) as a yellow oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 3:2, UV): <i>R</i><sub><i>f</i></sub> = 0.26. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +47.3° (<i>c</i> 1.48, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.53 (d, <i>J</i> = 1.8 Hz, 1H), 8.44 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 7.62 (d, <i>J</i> = 7.8 Hz, 1H), 7.39–7.24 (m, 10H), 7.24–7.12 (m, 6H), 5.70 (d, <i>J</i> = 10.0 Hz, 1H), 5.52 (qd, <i>J</i> = 6.4, 2.6 Hz, 1H), 5.06 (s, 2H), 4.90 (dd, <i>J</i> = 5.4, 2.9 Hz, 1H), 4.48 (dd, <i>J</i> = 10.0, 2.4 Hz, 1H), 4.36–4.18 (m, 2H), 3.89 (qd, <i>J</i> = 11.3, 4.2 Hz, 3H), 3.43 (d, <i>J</i> = 13.3 Hz, 3H), 3.30–3.11 (m, 3H), 2.79 (dd, <i>J</i> = 9.9, 7.3 Hz, 1H), 1.37 (s, 9H), 1.19 (d, <i>J</i> = 6.4 Hz, 3H), 0.84 (s, 9H), 0.26 (d, <i>J</i> = 6.8 Hz, 3H), 0.04 (d, <i>J</i> = 7.0 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.7, 170.5, 167.3, 156.1, 150.4, 147.2, 140.0, 137.4, 136.0, 134.9, 129.4, 128.6, 128.5, 128.5, 128.3, 127.1, 123.6, 80.1, 73.7, 73.7, 72.4, 68.0, 62.8, 59.1, 57.2, 56.0, 42.6, 28.3, 26.9, 25.7, 16.7, 13.0, −5.3, −5.4. IR (thin film): υ (cm<sup>–1</sup>) = 2954, 2931, 2857, 1742, 1718, 1497, 1455, 1366, 1303, 1253, 1216, 1162, 1133, 1088, 1062, 1027, 1006, 948, 837, 780, 752, 700. HR-MS (ESI): calcd for C<sub>50</sub>H<sub>68</sub>N<sub>3</sub>O<sub>10</sub>Si [M + H]<sup>+</sup> 898.4668 <i>m</i>/<i>z</i>; found 898.4672 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-10-Hydroxy-2,5,11-trimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>26a</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0083.gif" alt="" id="fx54" /></img><div class="NLM_p last">To a solution of <b>25a</b> (60.4 mg, 0.079 mmol, 1.00 equiv) in degassed MeOH (1.8 mL) was added Pd/C (10%, 32.6 mg, 0.031 mmol, 0.39 equiv), and the argon atmosphere was exchanged with a H<sub>2</sub> atmosphere (1 bar). The reaction was stirred at rt for 3 h 15 min, filtered over celite, and concentrated in vacuo. The ensuing amino acid (45.5 mg, crude) was used in the following step without further purification. To a stirred solution of HATU (103 mg, 0.271 mmol, 1.76 equiv) and DIPEA (70.0 μL, 0.405 mmol, 2.62 equiv) in DCM/DMF (100:1, 70 mL) was added the above amino acid (76.7 mg, 0.154 mmol, 1.00 equiv) in DCM/DMF (100:1, 47 mL) dropwise over 4 h (syringe pump). The reaction mixture was stirred at rt for 13 h, and the reaction was then quenched by addition of sat. aq. NaHCO<sub>3</sub> (80 mL). The aqueous layer was extracted with DCM (4 × 100 mL), and the combined organic layers were washed with H<sub>2</sub>O (4 × 100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 4:1 to 0:1) provided <b>26a</b> (21.9 mg, 34% over two steps, containing tetramethyl urea impurities) as a white foam. TLC (SiO<sub>2</sub>, EtOAc, UV) <i>R</i><sub><i>f</i></sub> = 0.19. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −22.6° (<i>c</i> 0.43, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) = 8.53 (s, 1H), 8.47 (d, <i>J</i> = 4.5 Hz, 1H), 7.63 (d, <i>J</i> = 7.8 Hz, 1H), 7.22 (dd, <i>J</i> = 7.6, 4.8 Hz, 1H), 6.33 (br. s, 1H), 5.32–5.22 (m, 2H), 5.15 (q, <i>J</i> = 7.0 Hz, 1H), 4.44 (br. s, 1H), 4.32–4.22 (m, 1H), 4.04–3.94 (m, 1H), 3.54 (s, 1H), 3.06–2.90 (m, 2H), 2.45 (qd, <i>J</i> = 7.5, 1.0 Hz, 1H), 1.50 (d, <i>J</i> = 7.1 Hz, 3H), 1.44 (s, 9H), 1.37 (d, <i>J</i> = 7.4 Hz, 3H), 1.29 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ (ppm) = 178.5, 168.4, 154.8, 150.9, 148.2, 137.3, 133.6, 123.6, 80.6, 72.9, 69.6, 57.1, 55.3, 40.9, 38.7, 35.7, 28.4, 17.7, 16.5, 14.0. IR (thin film): υ (cm<sup>–1</sup>) = 3483, 3430, 2246, 3202, 2979, 2939, 2875, 1745, 1716, 1671, 1597, 1578, 1498, 1453, 1427, 1381, 1368, 1320, 1250, 1166, 1065, 1048, 1027, 967, 913, 860, 753, 715. HR-MS (ESI): calcd for C<sub>23</sub>H<sub>34</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 480.2340 <i>m</i>/<i>z</i>; found 480.2343 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-Ethyl-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>26b</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0045.gif" alt="" id="fx55" /></img><div class="NLM_p last"><b>26b</b> was prepared from <b>25b</b> according to the procedure described for <b>26a</b>. FC (hexane/EtOAc 4:1 to 1:0) provided <b>26b</b> (6.60 mg, 23% over two steps, containing some tetramethyl urea impurities) as a pale yellow film. TLC (SiO<sub>2</sub>, hexane/EtOAc 3:2, UV): <i>R</i><sub><i>f</i></sub> = 0.33. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −27.4° (<i>c</i> 0.37, MeOH). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.48–8.43 (m, 1H), 8.37 (d, <i>J</i> = 3.9 Hz, 1H), 7.73 (d, <i>J</i> = 7.8 Hz, 1H), 7.33 (dd, <i>J</i> = 7.6, 5.0 Hz, 1H), 5.21–5.12 (m, 1H), 4.86–4.78 (m, 1H), 4.28–4.20 (m, 1H), 4.14–4.03 (m, 1H), 3.63 (br. s, 1H), 3.07–2.91 (m, 2H), 2.56 (qd, <i>J</i> = 7.4, 1.0 Hz, 1H), 1.93–1.78 (m, 2H), 1.45 (s, 9H), 1.37 (d, <i>J</i> = 7.3 Hz, 3H), 1.29 (d, <i>J</i> = 6.5 Hz, 3H), 0.98 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 178.3, 170.9, 169.8, 157.1, 151.0, 148.0, 139.2, 136.3, 125.0, 81.0, 75.7, 75.6, 71.0, 57.7, 56.8, 42.4, 36.4, 28.7, 25.1, 17.9, 14.9, 9.6. IR (thin film): υ (cm<sup>–1</sup>) = 3356, 2974, 2935, 2878, 1744, 1716, 1669, 1496, 1457, 1383, 1367, 1245, 1167, 1091, 1046, 1028, 960, 865, 711. HR-MS (ESI): calcd for C<sub>24</sub>H<sub>36</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 494.2497 <i>m</i>/<i>z</i>; found 494.2497 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-Cyclohexyl-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>26c</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0084.gif" alt="" id="fx56" /></img><div class="NLM_p last"><b>26c</b> was prepared from <b>25c</b> according to the procedure described for <b>26a</b>. FC (hexane/EtOAc 1:9 to 0:1) provided <b>26c</b> (27.4 mg, 42% over two steps) as a yellow oil. TLC (SiO<sub>2</sub>; EtOAc, UV): <i>R</i><sub><i>f</i></sub> = 0.35. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −14.28° (<i>c</i> 0.98, CHCl<sub>3</sub>). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.46 (s, 1H), 8.41–8.33 (m, 1H), 7.73 (d, <i>J</i> = 7.7 Hz, 1H), 7.33 (dd, <i>J</i> = 7.9, 4.9 Hz, 1H), 5.25–5.13 (m, 1H), 4.68 (d, <i>J</i> = 4.9 Hz, 1H), 4.27 (d, <i>J</i> = 5.8 Hz, 1H), 4.10 (t, <i>J</i> = 6.8 Hz, 1H), 3.66–3.61 (m, 1H), 2.99 (ddd, <i>J</i> = 30.6, 13.5, 7.5 Hz, 2H), 2.62–2.52 (m, 1H), 1.94–1.85 (m, 1H), 1.80–1.72 (m, 2H), 1.70–1.61 (m, 3H), 1.45 (s, 9H), 1.37 (d, <i>J</i> = 7.3 Hz, 3H), 1.30 (d, <i>J</i> = 6.5 Hz, 3H), 1.27–1.09 (m, 5H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD): δ (ppm) = 178.4, 170.8, 169.2, 157.0, 151.0, 148.0, 139.2, 136.2, 125.0, 81.0, 78.7, 75.6, 71.0, 57.6, 56.8, 42.3, 40.3, 36.4, 29.8, 29.0, 28.7, 27.0, 26.9, 26.8, 18.0, 15.1. IR (thin film): υ (cm<sup>–1</sup>) = 2975, 2930, 2855, 1744, 1715, 1698, 1671, 1451, 1405, 1393, 1367, 1261, 1168, 1050, 1026, 994, 857, 769 cm<sup>–1</sup>. HR-MS (ESI): calcd for C<sub>28</sub>H<sub>42</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 548.2966 <i>m</i>/<i>z</i>; found, 548.2957 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-((<i>R</i>)-<i>sec</i>-Butyl)-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>26d</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0085.gif" alt="" id="fx57" /></img><div class="NLM_p last"><b>26d</b> was prepared from <b>25d</b> according to the procedure described for <b>26a</b>. FC (hexane/EtOAc 5:95 to 0:1) provided <b>26d</b> (6.8 mg, 62% over two steps) as a colorless film. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:9, UV): <i>R</i><sub><i>f</i></sub> = 0.39. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +19.7° (<i>c</i> 0.10, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.55 (d, <i>J</i> = 1.7 Hz, 1H), 8.48 (dd, <i>J</i> = 4.8, 1.4 Hz, 1H), 7.63 (d, <i>J</i> = 7.7 Hz, 1H), 7.23 (dd, <i>J</i> = 7.6, 5.1 Hz, 1H), 6.10 (d, <i>J</i> = 8.9 Hz, 1H), 5.36–5.32 (m, 1H), 5.21 (d, <i>J</i> = 8.9 Hz, 1H), 4.94 (d, <i>J</i> = 4.2 Hz, 1H), 4.27–4.17 (m, 1H), 4.05–3.91 (m, 1H), 3.56–3.41 (m, 1H), 3.08–2.90 (m, 2H), 2.55–2.43 (m, 1H), 2.16–2.03 (m, 1H), 1.45 (s, 9H), 1.38 (d, <i>J</i> = 7.4 Hz, 3H), 1.39–1.30 (m, 2H), 1.29 (d, <i>J</i> = 6.6 Hz, 3H), 0.96 (d, <i>J</i> = 6.9 Hz, 3H), 0.89 (t, <i>J</i> = 7.2 Hz, 3H). IR (thin film): υ (cm<sup>–1</sup>) = 2925, 2856, 2320, 2118, 2103, 1735, 1719, 1673, 1502, 1453, 1369, 1263, 803, 776, 692, 545. HR-MS (ESI): <i>m</i>/<i>z</i> calcd. for C<sub>26</sub>H<sub>40</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 522.2810 <i>m</i>/<i>z</i>; found 522.2807 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-((<i>S</i>)-<i>sec</i>-Butyl)-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>26e</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0046.gif" alt="" id="fx58" /></img><div class="NLM_p last"><b>26e</b> was prepared from <b>25e</b> according to the procedure described for <b>26a</b>. FC (hexane/EtOAc 1:9 to 0:1) provided <b>26e</b> (16.4 mg, 49% over two steps) as a colorless film. TLC (SiO<sub>2</sub>, EtOAc, UV): <i>R</i><sub><i>f</i></sub> = 0.46. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +27.2° (<i>c</i> 0.47, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.55 (d, <i>J</i> = 1.8 Hz, 1H), 8.48 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 7.63 (d, <i>J</i> = 7.8 Hz, 1H), 7.23 (dd, <i>J</i> = 7.7, 4.8 Hz, 1H), 6.12 (d, <i>J</i> = 8.5 Hz, 1H), 5.40–5.30 (m, 1H), 5.22 (d, <i>J</i> = 8.2 Hz, 1H), 5.07 (d, <i>J</i> = 3.2 Hz, 1H), 4.26–4.18 (m, 1H), 4.05–3.94 (m, 1H), 3.61–3.40 (m, 1H), 3.05–2.91 (m, 2H), 2.50 (q, <i>J</i> = 8.1, 7.4 Hz, 1H), 2.20–2.05 (m, 1H), 1.45 (s, 9H), 1.38 (d, <i>J</i> = 7.5 Hz, 3H), 1.37–1.25 (m, 2H), 1.29 (d, <i>J</i> = 6.5 Hz, 3H), 0.94–0.83 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 150.9, 148.2, 137.3, 123.6, 75.5, 72.8, 69.2, 57.1, 55.4, 40.9, 36.5, 28.4, 27.3, 26.0, 17.8, 14.2, 14.2, 11.6. HR-MS (ESI): calcd for C<sub>26</sub>H<sub>40</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 522.2810 <i>m</i>/<i>z</i>; found 522.2806 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-Benzyl-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>26f</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0086.gif" alt="" id="fx59" /></img><div class="NLM_p last"><b>26f</b> was prepared from <b>25f</b> according to the procedure described for <b>26a</b>. FC (hexane/EtOAc 8:2 to 1:0) provided <b>26f</b> (8.30 mg, 26% over two steps, containing tetramethyl urea impurities) as a yellow film. TLC (SiO<sub>2</sub>, EtOAc, UV): <i>R</i><sub><i>f</i></sub> = 0.30. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −23.2° (<i>c</i> 0.35, MeOH). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.46–8.42 (m, 1H), 8.36 (d, <i>J</i> = 3.8 Hz, 1H), 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.34–7.19 (m, 6H), 5.19–5.07 (m, 2H), 4.22 (d, <i>J</i> = 5.6 Hz, 1H), 4.08–4.01 (m, 1H), 3.59 (br. s, 1H), 3.20 (dd, <i>J</i> = 14.3, 4.4 Hz, 1H), 3.09 (dd, <i>J</i> = 14.3, 8.5 Hz, 1H), 3.03–2.89 (m, 2H), 2.51 (qd, <i>J</i> = 7.4, 1.3 Hz, 1H), 1.45 (s, 9H), 1.21 (d, <i>J</i> = 7.3 Hz, 3H), 1.15 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 178.0, 170.9, 169.1, 157.1, 151.0, 148.0, 139.2, 137.1, 136.3, 130.6, 129.4, 128.1, 125.0, 81.0, 75.5, 75.0, 71.1, 57.6, 56.8, 42.4, 37.5, 36.4, 28.7, 17.7, 14.6. IR (thin film): υ (cm<sup>–1</sup>) = 3334, 2974, 2934, 1747, 1717, 1669, 1507, 1456, 1386, 1367, 1247, 1163, 1063, 1023, 700. HR-MS (ESI): calcd for C<sub>29</sub>H<sub>38</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 556.2653 <i>m</i>/<i>z</i>; found 556.2652 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-10-Hydroxy-5,11-dimethyl-3,7,12-trioxo-2-((<i>R</i>)-1-phenylethyl)-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>26g</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0047.gif" alt="" id="fx60" /></img><div class="NLM_p last"><b>26g</b> was prepared from <b>25g</b> according to the procedure described for <b>26a</b>. FC (EtOAc) provided <b>26g</b> (24.2 mg, 52% over 2 steps) as a slightly yellow oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:9, UV, KMnO<sub>4</sub>): <i>R</i><sub><i>f</i></sub> = 0.23. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −4.0° (<i>c</i> 0.50, MeOH). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.48–8.40 (m, 1H), 8.35 (dd, <i>J</i> = 5.0, 1.6 Hz, 1H), 7.70 (d, <i>J</i> = 7.9 Hz, 1H), 7.36–7.15 (m, 6H), 5.03 (d, <i>J</i> = 6.3 Hz, 2H), 4.15 (d, <i>J</i> = 5.7 Hz, 1H), 4.02 (t, <i>J</i> = 7.5 Hz, 1H), 3.61 (s, 1H), 3.35 (qd, <i>J</i> = 7.3, 6.3 Hz, 1H), 2.98 (m, 2H), 2.53 (qd, <i>J</i> = 7.4, 1.2 Hz, 1H), 1.44 (s, 9H), 1.36 (d, <i>J</i> = 7.2 Hz, 3H), 1.27 (d, <i>J</i> = 7.5 Hz, 3H), 0.90 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 178.2, 170.9, 168.8, 151.0, 147.9, 142.4, 139.3, 136.3, 129.3, 128.2, 125.0, 78.5, 75.7, 70.9, 57.7, 56.8, 42.4, 42.3, 42.0, 36.1, 28.6, 18.3, 17.8, 14.4. IR (thin film): υ (cm<sup>–1</sup>) = 3397, 2977, 2930, 1744, 1415, 1673, 1496, 1455, 1388, 1369, 1268, 1165, 1064, 845, 702, 559. HR-MS (ESI): calcd for C<sub>30</sub>H<sub>40</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 570.2810 <i>m</i>/<i>z</i>; found 570.2809 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-10-Hydroxy-5,11-dimethyl-3,7,12-trioxo-2-((<i>S</i>)-1-phenylethyl)-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>26h</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0087.gif" alt="" id="fx61" /></img><div class="NLM_p last">To a stirred solution of <b>31</b> (33.4 mg, 47.5 μmol, 1.00 equiv) in MeOH (3.0 mL) was added Pd/C (10%, 10.1 mg, 9.5 μmol) at rt. The reaction mixture was put under a hydrogen atmosphere (balloon) and stirred for 1 h. To the mixture was added more Pd/C (10%, 10.1 mg, 9.5 μmol), and stirring under hydrogen (balloon) was continued for 1 h. The reaction was filtered through a pad of celite and concentrated in vacuo. The ensuing amino acid (27.9 mg, quant., crude) was obtained as a slight yellow oil and was used in the following step without further purification. To a stirred solution of HATU (30.7 mg, 80.8 μmol, 1.70 equiv) and DIPEA (21.5 μL, 0.12 mmol, 2.60 equiv) in DMF (0.18 mL) and DCM (18 mL) was added at rt a solution of the above amino acid (27.9 mg, 47.5 μmol, 1.00 equiv) in DMF (0.18 mL) and DCM (18 mL) over 4 h. The mixture was stirred at rt for 48 h. The reaction was then quenched with sat. aq. NaHCO<sub>3</sub> solution (5 mL), and the mixture was extracted with DCM (3 × 20 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (EtOAc) provided <b>26h</b> (8.3 mg, 31% over two steps, containing tetramethyl urea impurities) as a slightly yellow oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 9:1, UV, KMnO<sub>4</sub>): <i>R</i><sub><i>f</i></sub> = 0.14. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −20.0° (<i>c</i> 0.50, MeOH). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.47–8.42 (m, 1H), 8.36 (dd, <i>J</i> = 5.0, 1.6 Hz, 1H), 7.72 (dt, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.34–7.17 (m, 6H), 5.12 (t, <i>J</i> = 6.4 Hz, 1H), 4.99 (d, <i>J</i> = 5.0 Hz, 1H), 4.24 (d, <i>J</i> = 6.0 Hz, 1H), 4.13–4.05 (m, 1H), 3.62–3.58 (m, 1H), 3.41 (qd, <i>J</i> = 7.1, 4.9 Hz, 1H), 3.04–2.89 (m, 2H), 2.58 (qd, <i>J</i> = 7.3, 1.4 Hz, 1H), 1.45 (s, 9H), 1.35 (d, <i>J</i> = 7.1 Hz, 3H), 1.23 (dd, <i>J</i> = 6.9, 4.2 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD): δ (ppm) = 178.0, 170.8, 168.6, 157.0, 151.0, 148.0, 142.4, 139.2, 136.2, 129.5, 129.3, 128.9, 128.3, 128.2, 125.0, 81.0, 78.6, 75.5, 71.1, 57.6, 56.7, 42.3, 41.9, 36.4, 33.0, 28.7, 17.7, 15.8, 14.8. IR (thin film): υ (cm<sup>–1</sup>) = 3334, 2978, 2928, 2854, 1743, 1717, 1669, 1496, 1455, 1425, 1387, 1367, 1249, 1166, 1046, 1025, 716, 700, 445, 432. HR-MS (ESI): calcd for C<sub>30</sub>H<sub>40</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 570.2810 <i>m</i>/<i>z</i>; found 570.2820 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>26i</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0058.gif" alt="" id="fx62" /></img><div class="NLM_p last"><b>26i</b> was prepared from <b>25i</b> according to the procedure described for <b>26a</b>. FC (hexane/EtOAc 1:9) provided <b>26i</b> (11.4 mg, 57% over two steps) as an orange oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:9, UV): <i>R</i><sub><i>f</i></sub> = 0.22. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −9.3° (<i>c</i> 0.76, MeOH). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.46 (d, <i>J</i> = 1.6 Hz, 1H), 8.37 (dd, <i>J</i> = 4.9, 1.5 Hz, 1H), 7.74 (dt, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.33 (dd, <i>J</i> = 7.6, 4.9 Hz, 1H), 5.25–5.11 (m, 1H), 5.03 (t, <i>J</i> = 3.5 Hz, 1H), 4.26 (d, <i>J</i> = 6.2 Hz, 1H), 4.17–4.04 (m, 2H), 3.96 (dd, <i>J</i> = 11.5, 3.0 Hz, 1H), 3.64 (s, 1H), 2.98 (qd, <i>J</i> = 13.6, 7.4 Hz, 2H), 2.57 (qd, <i>J</i> = 7.2, 1.1 Hz, 1H), 1.46 (s, 10H), 1.38 (d, <i>J</i> = 7.4 Hz, 3H), 1.27 (d, <i>J</i> = 6.5 Hz, 3H), 0.88 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 178.0, 168.1, 151.1, 148.0, 139.3, 136.3, 125.0, 75.7, 75.4, 71.0, 63.6, 57.5, 56.5, 42.6, 36.5, 28.7, 26.3, 19.2, 17.8, 15.0, −5.2, −5.3. IR (thin film): υ (cm<sup>–1</sup>) = 3377, 2932, 2856, 1746, 1718, 1675, 1496, 1387, 1367, 1253, 1166, 1046, 1026, 838, 779, 559, 526. HR-MS (ESI): calcd for C<sub>29</sub>H<sub>48</sub>N<sub>3</sub>O<sub>9</sub>Si [M + H]<sup>+</sup> 610.3160 <i>m</i>/<i>z</i>; found 610.3158 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 3-Hydroxy-<i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-10-hydroxy-2,5,11-trimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)picolinamide (<b>28a</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0067.gif" alt="" id="fx63" /></img><div class="NLM_p last">To a stirred solution of <b>26a</b> (13.1 mg, 0.027 mmol, 1.00 equiv) in DCM (1.6 mL) at 0 °C was added TFA (0.21 mL, 2.73 mmol, 100 equiv). The solution was allowed to warm to rt and stirred for 3.5 h. The solvent was then evaporated in vacuo to deliver the free amine (as the TFA salt) (18.4 mg, crude), which was used in the following step without further purification. To a stirred solution of HATU (15.2 mg, 0.040 mmol, 2.50 equiv) and DIPEA (16.0 μL, 0.090 mmol, 5.50 equiv) in MeCN (0.25 mL) were added 3-hydroxypicolinic acid (<b>27</b>) (4.60 mg, 0.033 mmol, 2.00 equiv) and a solution of the above TFA salt (8.10 mg, 0.016 mmol, 1.00 equiv) in MeCN (1.2 mL) at rt. The solution was stirred at rt for 20 h and then diluted with DCM (2 mL) and NaHCO<sub>3</sub> (1 mL). The aqueous layer was extracted with DCM (4 × 10 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (EtOAc/MeOH 9:1) provided <b>28a</b> as a green oil. Further purification by RP-HPLC (10 to 30% MeCN/0.1% TFA in 0.1% aq. TFA) gave <b>28a</b> (3.28 mg, 55% over two steps) as a colorless film. TLC (SiO<sub>2</sub>, EtOAc/MeOH 9:1, UV) <i>R</i><sub><i>f</i></sub> = 0.32. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −43.5° (<i>c</i> 0.23, MeOH). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.76 (s, 1H), 8.53 (d, <i>J</i> = 4.7 Hz, 1H), 8.41 (d, <i>J</i> = 7.1 Hz, 1H), 8.22–8.14 (m, 2H), 7.72 (t, <i>J</i> = 5.9 Hz, 1H), 7.52 (dd, <i>J</i> = 8.5, 4.4 Hz, 1H), 7.42 (d, <i>J</i> = 8.5 Hz, 1H), 5.31 (p, <i>J</i> = 6.4 Hz, 1H), 5.04 (q, <i>J</i> = 6.9 Hz, 1H), 4.69 (d, <i>J</i> = 6.1 Hz, 1H), 4.33–4.22 (m, 1H), 3.81 (s, 1H), 3.22 (d, <i>J</i> = 6.5 Hz, 2H), 2.70–2.62 (m, 1H), 1.49 (d, <i>J</i> = 7.1 Hz, 3H), 1.44 (d, <i>J</i> = 7.3 Hz, 3H), 1.29 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD): δ (ppm) = 178.1, 170.4, 170.2, 169.4, 159.2, 148.1, 144.2, 141.2, 140.5, 131.6, 130.8, 127.7, 127.52, 76.3, 71.1, 70.1, 57.0, 54.8, 42.4, 36.7, 17.8, 16.6, 14.8. IR (thin film): υ (cm<sup>–1</sup>) = 3399, 2920, 2852, 1738, 1653, 1522, 1451, 1385, 1268, 1182, 1141, 1063, 1035, 841, 558. HR-MS (ESI): calcd for C<sub>24</sub>H<sub>29</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 501.1980 <i>m</i>/<i>z</i>; found 501.1975 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> <i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-Ethyl-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)-3-hydroxypicolinamide (<b>28b</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0048.gif" alt="" id="fx64" /></img><div class="NLM_p last"><b>28b</b> was prepared from <b>26b</b> according to the procedure described for <b>28a</b>. FC (DCM/MeOH, 98:2 to 95:5) provided a pale yellow oil. Further purification by RP-HPLC (20 to 40% MeCN/0.1% TFA in 0.1% aq. TFA) gave <b>28b</b> (4.07 mg, 45% over two steps) as a colorless film. TLC (SiO<sub>2</sub>, DCM/MeOH 9:1, UV): <i>R</i><sub><i>f</i></sub> = 0.43. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −10.0° (<i>c</i> 0.20, CHCl<sub>3</sub>). <sup><b>1</b></sup><b>H NMR</b> (500 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.83 (s, 1H), 8.52 (d, <i>J</i> = 5.2 Hz, 1H), 8.40–8.32 (m, 1H), 8.27–8.20 (m, 1H), 8.10 (d, <i>J</i> = 3.9 Hz, 1H), 7.59 (t, <i>J</i> = 6.8 Hz, 1H), 7.39 (dd, <i>J</i> = 8.5, 4.3 Hz, 1H), 7.32 (d, <i>J</i> = 8.3 Hz, 1H), 6.93 (br. s, 1H), 5.40 (p, <i>J</i> = 6.5 Hz, 1H), 5.01 (t, <i>J</i> = 6.1 Hz, 1H), 4.70 (t, <i>J</i> = 7.0 Hz, 1H), 4.24 (q, <i>J</i> = 7.7 Hz, 1H), 3.75 (s, 1H), 3.30–3.13 (m, 2H), 2.68–2.60 (m, 1H), 2.02–1.83 (m, 2H), 1.47 (d, <i>J</i> = 7.4 Hz, 3H), 1.32 (d, <i>J</i> = 6.5 Hz, 3H), 0.99 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ (ppm) = 178.3, 168.2, 168.0, 168.0, 158.0, 145.2, 143.9, 140.6, 140.0, 138.1, 130.5, 129.5, 126.8, 125.9, 74.5, 74.4, 68.8, 56.1, 53.6, 41.1, 36.0, 24.2, 17.7, 14.4, 9.5. IR (thin film): υ (cm<sup>–1</sup>) = 3361, 2927, 1745, 1730, 1669, 1650, 1517, 1449, 1380, 1289, 1259, 1171, 1137, 1095, 1061, 795, 749, 719. HR-MS (ESI): calcd for C<sub>25</sub>H<sub>31</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 515.2136 <i>m</i>/<i>z</i>; found 515.2135 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> <i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-Cyclohexyl-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)-3-hydroxypicolinamide (<b>28c</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0068.gif" alt="" id="fx65" /></img><div class="NLM_p last"><b>28c</b> was prepared from <b>26c</b> according to the procedure described for <b>28a</b>. FC (DCM/MeOH 95:5) provided <b>28c</b> (35.9 mg, 90%) as a pale yellow oil. Further purification by RP-HPLC (20 to 60% MeCN/0.1% TFA in 0.1% aq. TFA) gave <b>28c</b> (16.2 mg, 41% over two steps) as a white lyophilisate. TLC (SiO<sub>2</sub>, EtOAc, UV): <i>R</i><sub><i>f</i></sub> = 0.21. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −24.9° (<i>c</i> 0.07, MeOH). <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) = 11.81 (s, 1H), 8.42 (br. s, 1H), 8.37 (d, <i>J</i> = 1.8 Hz, 1H), 8.20 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.16 (d, <i>J</i> = 4.0 Hz, 1H), 8.08 (d, <i>J</i> = 9.4 Hz, 1H), 7.61–7.51 (m, 2H), 7.45 (d, <i>J</i> = 8.3 Hz, 1H), 7.07 (dd, <i>J</i> = 7.7, 4.8 Hz, 1H), 5.28 (p, <i>J</i> = 6.4 Hz, 1H), 4.73 (d, <i>J</i> = 8.8 Hz, 1H), 4.71–4.65 (m, 2H), 4.11–4.03 (m, 1H), 3.61 (d, <i>J</i> = 8.9 Hz, 1H), 2.86 (dd, <i>J</i> = 13.4, 6.1 Hz, 1H), 2.76 (dd, <i>J</i> = 13.4, 8.7 Hz, 1H), 2.59 (q, <i>J</i> = 7.1 Hz, 1H), 1.86–1.76 (m, 1H), 1.68 (dd, <i>J</i> = 12.6, 1.7 Hz, 2H), 1.60 (d, <i>J</i> = 11.6 Hz, 3H), 1.27 (d, <i>J</i> = 7.3 Hz, 3H), 1.23–1.01 (m, 8H). <sup>13</sup>C NMR (126 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) = 176.2, 168.1, 168.1, 167.5, 157.9, 150.8, 147.6, 140.4, 137.0, 134.6, 130.9, 130.1, 126.9, 123.4, 77.1, 73.8, 68.8, 56.1, 53.3, 41.4, 38.9, 35.2, 28.5, 27.9, 26.0, 25.8, 25.6, 17.4, 15.1. IR (thin film): υ (cm<sup>–1</sup>) = 2934, 1747, 1652, 1523, 1451, 1296, 1259, 1168, 1057, 1033, 1008, 685, 470. HR-MS (ESI): calcd for C<sub>29</sub>H<sub>37</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 569.2606 <i>m</i>/<i>z</i>; found 569.2608 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> <i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-((<i>R</i>)-<i>sec</i>-Butyl)-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)-3-hydroxypicolinamide (<b>28d</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0069.gif" alt="" id="fx66" /></img><div class="NLM_p last"><b>28d</b> was prepared from <b>26d</b> according to the procedure described for <b>28a</b>. FC (DCM/MeOH 97.5:2.5 to 9:1) provided <b>28d</b> (5.40 mg, 49%) as a yellow oil. Part of this material was purified by RP-HPLC (30 to 100% MeCN/0.1% TFA in 0.1% aq. TFA) to provide a pure sample for biological testing (recovery yield not determined). TLC (DCM/MeOH 9:1): <i>R</i><sub><i>f</i></sub> = 0.26. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +13.0° (<i>c</i> 0.023, MeOH). <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) = 11.89 (s, 1H), 8.37 (d, <i>J</i> = 2.2 Hz, 1H), 8.20 (dd, <i>J</i> = 4.8, 1.7 Hz, 1H), 8.18 (d, <i>J</i> = 4.4 Hz, 1H), 8.10 (d, <i>J</i> = 9.4 Hz, 1H), 7.61–7.53 (m, 2H), 7.46 (d, <i>J</i> = 8.5 Hz, 1H), 7.07 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 5.27 (t, <i>J</i> = 6.4 Hz, 1H), 4.78–4.66 (m, 3H), 4.08 (q, <i>J</i> = 8.2 Hz, 1H), 3.62 (d, <i>J</i> = 9.5 Hz, 1H), 2.86 (dd, <i>J</i> = 13.4, 6.0 Hz, 1H), 2.77 (dd, <i>J</i> = 13.4, 8.7 Hz, 1H), 2.65–2.56 (m, 1H), 1.95–1.85 (m, 1H), 1.51–1.40 (m, 1H), 1.27 (d, <i>J</i> = 7.3 Hz, 3H), 1.21 (d, <i>J</i> = 6.5 Hz, 3H), 0.89 (d, <i>J</i> = 6.9 Hz, 3H), 0.86 (t, <i>J</i> = 7.5 Hz, 3H). <sup>13</sup>C NMR (126 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) = 168.4, 167.8, 167.4, 161.2, 151.0, 147.9, 145.2, 140.7, 137.3, 134.8, 131.7, 131.4, 130.4, 123.7, 77.1, 74.1, 69.2, 56.4, 53.6, 41.7, 36.1, 35.5, 24.9, 17.6, 15.3, 15.3, 11.7. IR (thin film): υ (cm<sup>–1</sup>) = 2924, 2855, 1742, 1712, 1653, 1518, 1457, 1377, 1289, 1263, 842, 772, 731, 686, 558. HR-MS (ESI): calcd for C<sub>27</sub>H<sub>34</sub>N<sub>4</sub>O<sub>8</sub> [M + Na]<sup>+</sup> 543.2449 <i>m</i>/<i>z</i>; found 543.2448 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-((<i>S</i>)-<i>sec</i>-Butyl)-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)-3-hydroxypicolinamide (<b>28e</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0049.gif" alt="" id="fx67" /></img><div class="NLM_p last"><b>28e</b> was prepared from <b>26e</b> according to the procedure described for <b>28a</b>. FC (DCM/MeOH 97.5:2.5 to 9:1) provided <b>28e</b> (6.7 mg, 66%) as a colorless film. Part of this material was purified by RP-HPLC (30 to 100% MeCN/0.1% TFA in 0.1% aq. TFA) to provide a pure sample for biological testing (recovery yield not determined). TLC (SiO<sub>2</sub>, DCM/MeOH 9:1, UV): <i>R</i><sub><i>f</i></sub> = 0.26. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +8.7° (<i>c</i> 0.012, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 11.78 (br. s, 1H), 8.37 (d, <i>J</i> = 2.1 Hz, 1H), 8.20 (dd, <i>J</i> = 4.8, 1.7 Hz, 1H), 8.16 (d, <i>J</i> = 4.4 Hz, 1H), 8.09 (d, <i>J</i> = 9.5 Hz, 1H), 7.60–7.53 (m, 2H), 7.45 (d, <i>J</i> = 8.5 Hz, 1H), 7.07 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 5.29 (p, <i>J</i> = 6.4 Hz, 1H), 4.86 (d, <i>J</i> = 4.4 Hz, 1H), 4.77–4.67 (m, 2H), 4.08 (q, <i>J</i> = 8.9 Hz, 1H), 3.61 (d, <i>J</i> = 9.1 Hz, 1H), 2.87 (dd, <i>J</i> = 13.5, 6.2 Hz, 1H), 2.76 (dd, <i>J</i> = 13.4, 8.6 Hz, 1H), 2.60 (q, <i>J</i> = 7.7 Hz, 1H), 1.94 (p, <i>J</i> = 6.6 Hz, 1H), 1.40 (dt, <i>J</i> = 13.8, 6.9 Hz, 1H), 1.27 (d, <i>J</i> = 7.3 Hz, 3H), 1.20 (d, <i>J</i> = 6.5 Hz, 3H), 0.90–0.83 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 175.7, 168.0, 167.6, 167.0, 150.3, 147.2, 139.9, 136.6, 134.1, 130.4, 129.7, 126.4, 123.0, 119.6, 75.0, 73.3, 68.2, 55.6, 52.7, 41.0, 35.8, 34.8, 25.0, 17.0, 14.4, 14.2, 11.2. IR (thin film): υ (cm<sup>–1</sup>) = 3368, 2966, 2931, 1742, 1652, 1524, 1451, 1385, 1294, 1255, 1169, 1063, 815, 784, 712, 662. HR-MS (ESI): calcd for C<sub>27</sub>H<sub>34</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 543.2449 <i>m</i>/<i>z</i>; found 543.2441 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> <i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-2-Benzyl-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)-3-hydroxypicolinamide (<b>28f</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0070.gif" alt="" id="fx68" /></img><div class="NLM_p last"><b>28f</b> was prepared from <b>26f</b> according to the procedure described for <b>28a</b>. FC (DCM/MeOH, 98:2 to 95:5) provided <b>28f</b> as a pale yellow oil. Further purification by RP-HPLC (20 to 60% MeCN/0.1% TFA in 0.1% aq. TFA) gave <b>28f</b> (5.36 mg, 65% over two steps) as a white lyophilisate. TLC (SiO<sub>2</sub>, DCM/MeOH 9:1, UV): <i>R</i><sub><i>f</i></sub> = 0.53. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −7.4° (<i>c</i> 0.27, CHCl<sub>3</sub>). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.81 (s, 1H), 8.50 (d, <i>J</i> = 5.1 Hz, 1H), 8.31 (d, <i>J</i> = 6.7 Hz, 1H), 8.25–8.20 (m, 1H), 8.10 (d, <i>J</i> = 4.2 Hz, 1H), 7.63–7.55 (m, 1H), 7.40–7.36 (m, 1H), 7.34–7.30 (m, 1H), 7.29–7.25 (m, 2H), 7.25–7.22 (m, 1H), 7.21–7.18 (m, 2H), 7.06–6.91 (m, 1H), 5.37–5.32 (m, 1H), 5.30 (dd, <i>J</i> = 8.8, 4.3 Hz, 1H), 4.75–4.65 (m, 1H), 4.28–4.19 (m, 1H), 3.72 (br. s, 1H), 3.29–3.07 (m, 4H), 2.59 (q, <i>J</i> = 7.2 Hz, 1H), 1.28 (d, <i>J</i> = 7.4 Hz, 3H), 1.18 (d, <i>J</i> = 5.6 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ (ppm) = 177.7, 168.1, 167.4, 157.9, 145.4, 143.7, 140.4, 139.9, 138.2, 135.4, 130.5, 129.5, 129.4, 128.7, 127.4, 126.8, 125.9, 74.3, 73.6, 69.0, 56.0, 53.5, 41.1, 36.7, 36.0, 17.4, 14.1. IR (thin film): υ (cm<sup>–1</sup>) = 3361, 3064, 2935, 1745, 1669, 1650, 1517, 1456, 1380, 1255, 1186, 1133, 1061, 799, 741. HR-MS (ESI): calcd for C<sub>30</sub>H<sub>33</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 577.2293 <i>m</i>/<i>z</i>; found 577.2290 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 3-Hydroxy-<i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-10-Hydroxy-5,11-dimethyl-3,7,12-trioxo-2-((<i>R</i>)-1-phenylethyl)-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)picolinamide (<b>28g</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0059.gif" alt="" id="fx69" /></img><div class="NLM_p last"><b>28g</b> was prepared from <b>26g</b> according to the procedure described for <b>28a</b>, except that the coupling with <b>27</b> was performed in DMF. FC (DCM/MeOH 95:5) followed by RP-HPLC (20 to 85% MeCN/0.1% TFA in 0.1% aq. TFA) provided <b>28g</b> (17.0 mg, 36% over 2 steps) as a white lyophilisate. TLC (SiO<sub>2</sub>, DCM/MeOH 95:5, UV, KMnO<sub>4</sub>): <i>R</i><sub><i>f</i></sub> = 0.26. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −8.0° (<i>c</i> 0.50, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.83 (s, 1H), 8.56–8.45 (m, 1H), 8.22 (dd, <i>J</i> = 8.2, 1.8 Hz, 2H), 8.09 (dd, <i>J</i> = 4.3, 1.5 Hz, 1H), 7.59 (dd, <i>J</i> = 7.9, 5.5 Hz, 1H), 7.42–7.30 (m, 2H), 7.25–7.18 (m, 4H), 6.77 (d, <i>J</i> = 9.1 Hz, 1H), 5.26 (q, <i>J</i> = 6.5 Hz, 1H), 5.20 (d, <i>J</i> = 5.7 Hz, 1H), 4.61 (dd, <i>J</i> = 8.3, 6.1 Hz, 1H), 4.28–4.16 (m, 1H), 3.74 (s, 1H), 3.50–3.39 (m, 1H), 3.28–3.11 (m, 2H), 2.68–2.54 (m, 1H), 1.41 (dd, <i>J</i> = 7.3, 4.9 Hz, 6H), 0.85 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 178.1, 168.0, 166.9, 162.5, 162.1, 158.0, 145.5, 143.6, 140.3, 139.7, 138.3, 130.3, 129.5, 128.5, 128.3, 127.5, 125.9, 77.2, 74.5, 68.3, 56.0, 53.5, 41.1, 40.9, 36.0, 18.0, 17.6, 13.7. IR (thin film): υ (cm<sup>–1</sup>) = 1743, 1671, 1648, 1602, 1522, 1450, 1387, 1296, 1266, 1172, 1137, 1062, 796, 753, 720, 699, 660, 621, 572, 544, 521. HR-MS (ESI): calcd for C<sub>31</sub>H<sub>35</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 591.2449 <i>m</i>/<i>z</i>; found 591.2446 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 3-Hydroxy-<i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-2-((<i>S</i>)-1-phenylethyl)-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)picolinamide (<b>28h</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0088.gif" alt="" id="fx70" /></img><div class="NLM_p last"><b>28h</b> was prepared from <b>26h</b> according to the procedure described for <b>28a</b>, except that the coupling with <b>27</b> was performed in DMF. FC (DCM/MeOH 95:5) followed by RP-HPLC (20 to 85% MeCN/0.1% TFA in 0.1% aq. TFA) provided <b>28h</b> (3.75 mg, 43% over two steps) as a white lyophilisate. TLC (SiO<sub>2</sub>, DCM/MeOH 9:1, UV, CPS): <i>R</i><sub><i>f</i></sub> = 0.47. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −23.3° (<i>c</i> 0.30, MeOH). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.75 (d, <i>J</i> = 4.6 Hz, 1H), 8.52 (d, <i>J</i> = 5.9 Hz, 1H), 8.39 (d, <i>J</i> = 7.7 Hz, 1H), 8.18 (dd, <i>J</i> = 4.3, 1.3 Hz, 1H), 8.16–8.12 (m, 1H), 7.70 (dd, <i>J</i> = 8.0, 5.6 Hz, 1H), 7.52 (dd, <i>J</i> = 8.6, 4.4 Hz, 1H), 7.41 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 7.30 (d, <i>J</i> = 4.3 Hz, 4H), 7.27–7.21 (m, 1H), 5.29 (p, <i>J</i> = 6.5 Hz, 1H), 5.08 (d, <i>J</i> = 4.8 Hz, 1H), 4.66 (dd, <i>J</i> = 6.3, 2.3 Hz, 1H), 4.34–4.22 (m, 1H), 3.82–3.74 (m, 1H), 3.45 (qd, <i>J</i> = 7.1, 4.8 Hz, 1H), 3.24–3.09 (m, 2H), 2.72–2.64 (m, 1H), 1.38 (d, <i>J</i> = 7.1 Hz, 3H), 1.30 (d, <i>J</i> = 7.3 Hz, 3H), 1.23 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD): δ (ppm) = 176.6, 168.8, 167.9, 167.1, 157.8, 141.0, 139.8, 130.3, 129.4, 129.3, 128.1, 128.0, 127.5, 127.4, 127.0, 126.8, 126.3, 126.0, 77.1, 74.8, 68.7, 55.5, 53.2, 40.9, 40.6, 35.4, 16.3, 14.3, 13.4. IR (thin film): υ (cm<sup>–1</sup>) = 1742, 1672, 1526, 1451, 1388, 1298, 1262, 1175, 1138, 1061, 702, 484, 472, 418. HR-MS (ESI): calcd for C<sub>31</sub>H<sub>35</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 591.2449 <i>m</i>/<i>z</i>; found 591.2450 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 3-Hydroxy-<i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>R</i>)-10-hydroxy-2-(hydroxymethyl)-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)picolinamide (<b>28i</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0050.gif" alt="" id="fx71" /></img><div class="NLM_p last"><b>28i</b> was prepared from <b>26i</b> according to the procedure described for <b>28a</b>. FC (DCM/MeOH, 98:2 to 95:5) provided <b>28i</b> (10.7 mg, quant.) as a colorless film. Further purification by RP-HPLC (5 to 50% MeCN in H<sub>2</sub>O) gave <b>28i</b> (2.90 mg, 30% yield over 2 steps) as a white lyophilisate. TLC (SiO<sub>2</sub>, DCM/MeOH 9:1, UV): <i>R</i><sub><i>f</i></sub> = 0.27. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −15.9° (<i>c</i> 0.47, MeOH). <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) = 11.80 (br. s, 1H), 8.45 (br. s, 1H), 8.38 (d, <i>J</i> = 2.1 Hz, 1H), 8.21 (dd, <i>J</i> = 4.7, 0.9 Hz, 1H), 8.16 (d, <i>J</i> = 4.0 Hz, 1H), 8.06 (d, <i>J</i> = 9.3 Hz, 1H), 7.60–7.53 (m, 2H), 7.44 (d, <i>J</i> = 8.5 Hz, 1H), 7.09 (dd, <i>J</i> = 7.7, 4.8 Hz, 1H), 5.32–5.23 (m, 2H), 4.95 (dd, <i>J</i> = 4.8, 3.8 Hz, 1H), 4.79 (d, <i>J</i> = 8.6 Hz, 1H), 4.76–4.70 (m, 1H), 4.10–4.03 (m, 1H), 3.84–3.76 (m, 1H), 3.76–3.68 (m, 1H), 3.62 (d, <i>J</i> = 9.0 Hz, 1H), 2.87 (dd, <i>J</i> = 13.4, 6.3 Hz, 1H), 2.77 (dd, <i>J</i> = 13.4, 8.3 Hz, 1H), 2.59 (qd, <i>J</i> = 7.0, 0.9 Hz, 1H), 1.28 (d, <i>J</i> = 7.3 Hz, 3H), 1.18 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) = 176.0, 168.1, 167.6, 167.4, 150.8, 147.7, 140.3, 137.1, 134.6, 131.0, 130.1, 126.9, 123.5, 74.8, 73.5, 68.6, 60.9, 56.2, 53.1, 41.6, 35.3, 17.2, 14.8. IR (thin film): υ (cm<sup>–1</sup>) = 3354, 1676, 1542, 1455, 1203, 1136, 844, 800, 779, 722, 558, 458, 433. HR-MS (ESI): calcd for C<sub>24</sub>H<sub>29</sub>N<sub>4</sub>O<sub>9</sub> [M + H]<sup>+</sup> 517.1922 <i>m</i>/<i>z</i>; found 517.1922 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> (2<i>R</i>,3<i>S</i>)-1-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-1-oxo-3-phenylbutan-2-yl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-azido-3-(formyloxy)-2-methyl-5-(pyridin-3-yl)pentanoate (<b>30</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0089.gif" alt="" id="fx72" /></img><div class="NLM_p last">To a stirred solution of <b>29</b> (63.9 mg, 230 μmol, 1.00 equiv), DMAP (2.8 mg, 23.0 μmol, 0.10 equiv), and <b>8h</b> (130 mg, 0.28 mmol, 1.20 equiv) in DCM (2.3 mL) was added DCC (56.9 mg, 276 μmol, 1.20 equiv) at 0 °C. The mixture was allowed to warm to rt and stirred for 5 h. The reaction mixture was diluted with hexane (3 mL), filtered through a pad of celite, and concentrated in vacuo. FC (hexane/EtOAc 1:1) provides <b>30</b> (132 mg, 78%) as a colorless semisolid. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:5, UV, KMnO<sub>4</sub>): <i>R</i><sub><i>f</i></sub> = 0.45. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −9.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.56–8.49 (m, 2H), 8.11 (s, 1H), 7.60 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H), 7.39–7.27 (m, 9H), 7.23 (dd, <i>J</i> = 7.1, 2.9 Hz, 2H), 5.50–5.42 (m, 1H), 5.37 (ddd, <i>J</i> = 6.7, 4.4, 0.9 Hz, 1H), 5.22–5.07 (m, 4H), 4.49 (dd, <i>J</i> = 9.9, 2.8 Hz, 1H), 3.73 (dt, <i>J</i> = 10.2, 4.0 Hz, 1H), 3.33–3.25 (m, 1H), 3.14–3.05 (m, 1H), 3.00 (dd, <i>J</i> = 14.3, 3.9 Hz, 1H), 2.79 (dd, <i>J</i> = 14.3, 10.3 Hz, 1H), 1.46 (s, 9H), 1.30 (d, <i>J</i> = 6.9 Hz, 6H), 1.17 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 172.1, 170.0, 167.7, 160.0, 155.9, 150.4, 148.5, 141.1, 137.4, 137.1, 135.0, 132.5, 128.8, 128.7, 128.6, 128.5, 127.8, 127.4, 123.8, 80.6, 76.9, 74.8, 72.6, 67.9, 62.7, 57.2, 41.4, 40.6, 34.7, 28.4, 16.9, 15.1, 13.2. IR (thin film): υ (cm<sup>–1</sup>) = 2979, 2934, 2115, 1742, 1498, 1455, 1384, 1367, 1346, 1314, 1260, 1212, 1164, 1086, 1062, 756, 701. HR-MS (ESI): calcd for C<sub>38</sub>H<sub>46</sub>N<sub>5</sub>O<sub>10</sub> [M + H]<sup>+</sup> 732.3239 <i>m</i>/<i>z</i>; found 732.3229 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> (2<i>R</i>,3<i>S</i>)-1-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-1-oxo-3-phenylbutan-2-yl (2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-azido-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>31</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0051.gif" alt="" id="fx73" /></img><div class="NLM_p last">To a stirred solution of <b>30</b> (47.3 mg, 64.6 μmol, 1.00 equiv) in MeOH (1.5 mL) was added KHCO<sub>3</sub> (7.1 mg, 71.1 μmol, 1.10 equiv). The mixture was stirred at rt for 65 min, the reaction was quenched with sat. aq. NaCl solution (5 mL), and the mixture was extracted with EtOAc (3 × 10 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 1:1) provided <b>31</b> (40.4 mg, 89%) as a slight yellow oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:3, UV, KMnO<sub>4</sub>): <i>R</i><sub><i>f</i></sub> = 0.37. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +13.0° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.74–8.41 (m, 2H), 7.75 (d, <i>J</i> = 7.9 Hz, 1H), 7.44–7.27 (m, 10H), 7.26–7.21 (m, 1H), 5.61–5.49 (m, 2H), 5.20–5.01 (m, 3H), 4.54 (dd, <i>J</i> = 9.9, 2.7 Hz, 1H), 3.86 (d, <i>J</i> = 5.4 Hz, 1H), 3.75–3.66 (m, 1H), 3.45–3.32 (m, 2H), 3.25–3.09 (m, 2H), 2.92 (dq, <i>J</i> = 8.7, 7.0 Hz, 1H), 1.47 (s, 9H), 1.34 (d, <i>J</i> = 7.2 Hz, 3H), 1.29 (d, <i>J</i> = 6.4 Hz, 3H), 0.96 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 174.7, 170.5, 168.4, 156.2, 150.4, 148.3, 141.3, 137.2, 133.3, 128.7, 128.6, 128.6, 128.2, 127.8, 127.8, 127.4, 123.8, 80.5, 76.7, 74.2, 72.6, 68.2, 62.9, 57.3, 43.6, 40.9, 34.1, 34.1, 28.4, 28.4, 28.4, 28.3, 28.2, 25.7, 25.1, 16.9, 16.9, 14.8, 13.4. IR (thin film): υ (cm<sup>–1</sup>) = 2978, 2932, 2112, 1743, 1715, 1508, 1499, 1455, 1382, 1367, 1339, 1314, 1260, 1217, 1165, 1086, 1060, 992, 754, 700. HR-MS (ESI): calcd for C<sub>37</sub>H<sub>46</sub>N<sub>5</sub>O<sub>9</sub> [M + H]<sup>+</sup> 704.3290 <i>m</i>/<i>z</i>; found 704.3290 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> (2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl (((9H-fluoren-9-yl)methoxy)carbonyl)-<span class="smallcaps smallerCapital">d</span>-isoleucinate (<b>32A</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0090.gif" alt="" id="fx74" /></img><div class="NLM_p last">To a stirred solution of Fmoc-<span class="smallcaps smallerCapital">d</span>-Ile-OH (<b>32</b>) (1.40 g, 3.96 mmol, 1.00 equiv) and Et<sub>3</sub>N (1.10 mL, 7.92 mmol, 2.00 equiv) in THF (20 mL) was added 2,4,6-trichlorobenzoyl chloride (712 μL, 4.56 mmol, 1.15 equiv). As the mixture became turbid (5 min), a solution of <b>6</b> (1.23 g, 3.96 mmol, 1.00 equiv) in toluene (20 mL) and DMAP (72.6 mg, 594 μmol, 0.15 equiv) were added at rt. The white slurry was stirred at rt for 1 h. Sat. aq. NH<sub>4</sub>Cl (10 mL) was added, and the aqueous layer was extracted with EtOAc (3 × 15 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 4:1) provided <b>32A</b> (2.51 g, 98%) as a white foam. TLC (SiO<sub>2</sub>, hexane/EtOAc 4:1, UV): <i>R</i><sub><i>f</i></sub> = 0.24. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +24.9° (<i>c</i> 1.30, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.78 (d, <i>J</i> = 0.5 Hz, 1H), 7.76 (d, <i>J</i> = 0.6 Hz, 1H), 7.64–7.58 (m, 2H), 7.44–7.29 (m, 9H), 5.53–5.42 (m, 1H), 5.24–5.19 (m, 1H, NH), 5.12 (dd, <i>J</i> = 30.9, 12.2 Hz, 2H), 4.50 (dd, <i>J</i> = 9.5, 1.8 Hz, 1H), 4.47–4.36 (m, 2H), 4.31–4.20 (m, 2H), 1.89–1.75 (m, 1H), 1.64 (s, 1H), 1.46 (s, 9H), 1.36–1.29 (m, 4H), 1.17–1.02 (m, 1H), 0.97–0.86 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 170.9, 169.9, 156.1, 155.8, 143.9, 143.8, 141.3 (2 C), 134.9, 128.7 (2 C), 128.6 (2 C), 128.3, 127.7 (2 C), 127.1 (2 C), 125.1 (2 C), 120.0, 120.0, 80.5, 72.2, 67.7, 67.1, 58.7, 57.1, 47.2, 37.6, 28.3 (3 C), 24.6, 17.0, 15.4, 11.5. IR (thin film): υ (cm<sup>–1</sup>) = 2969, 1712, 1504, 1452, 1384, 1367, 1316, 1248, 1211, 1162, 1085, 1063, 996, 756, 739, 698. HR-MS (ESI): calcd for C<sub>37</sub>H<sub>44</sub>N<sub>2</sub>NaO<sub>8</sub> [M + Na]<sup>+</sup> 667.2990 <i>m</i>/<i>z</i>; found 667.2988 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> (2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl-<span class="smallcaps smallerCapital">d</span>-isoleucinate (<b>33</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0091.gif" alt="" id="fx75" /></img><div class="NLM_p last"><b>32A</b> (800 mg, 1.24 mmol, 1.00 equiv) was dissolved in MeCN (14 mL) and piperidine (3.5 mL). The solution was stirred at rt for 30 min and then concentrated in vacuo very quickly to remove most of the solvent. FC (hexane/EtOAc 1:0 to 1:4) provided <b>33</b> (337 mg, 64%) as a yellow oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 1:4, UV): <i>R</i><sub><i>f</i></sub> = 0.35. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +26.6° (<i>c</i> 1.00, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 7.39–7.30 (m, 5H), 5.44 (qd, <i>J</i> = 6.3, 2.5 Hz, 1H), 5.24–5.04 (m, 3H), 4.48 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 3.20 (d, <i>J</i> = 5.1 Hz, 1H), 1.71–1.59 (m, 1H), 1.45 (s, 9H), 1.36–1.32 (m, 1H), 1.30 (d, <i>J</i> = 6.4 Hz, 3H), 1.18–1.05 (m, 1H), 0.91–0.84 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 174.3, 170.0, 155.8, 135.0, 128.7 (3 C), 128.6, 128.4, 80.4, 71.2, 67.6, 59.5, 57.2, 38.6, 28.3 (3 C), 24.2, 17.0, 15.7, 11.6. IR (thin film): υ (cm<sup>–1</sup>) = 2968, 2935, 1717, 1502, 1457, 1368, 1345, 1314, 1247, 1215, 1163, 1085, 1063, 993, 699. HR-MS (ESI): calcd for C<sub>22</sub>H<sub>35</sub>N<sub>2</sub>O<sub>6</sub> [M + H]<sup>+</sup> 423.2490 <i>m</i>/<i>z</i>; found 423.2493 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> (2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl ((2<i>R</i>,3<i>S</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoyl)-<span class="smallcaps smallerCapital">d</span>-isoleucinate (<b>34</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0052.gif" alt="" id="fx76" /></img><div class="NLM_p last">To a solution of <b>24</b> (30.0 mg, 74.2 μmol, 1.00 equiv) and <b>33</b> (34.5 mg, 81.6 μmol, 1.10 equiv) in MeCN (1 mL) and THF (0.1 mL) were added HATU (62.0 mg, 163 μmol, 2.2 equiv) and DIPEA (41.1 μL, 237 μmol, 3.20 equiv) at 0 °C. The mixture was stirred for 48 h and slowly allowed to warm to rt. The mixture was diluted with EtOAc (1.5 mL) and sat. aq. NaHCO<sub>3</sub> (2 mL). The aqueous layer was extracted with EtOAc (3 × 5 mL), and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. FC (hexane/EtOAc 2:3) provided <b>34</b> (44.8 mg, 75%) as a colorless film. TLC (SiO<sub>2</sub>, hexane/EtOAc 2:3, UV): <i>R</i><sub><i>f</i></sub> = 0.22. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +25.5° (<i>c</i> 1.00, MeOH). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.41 (d, <i>J</i> = 1.7 Hz, 1H), 8.35 (dd, <i>J</i> = 4.9, 1.6 Hz, 1H), 7.65–7.59 (m, 1H), 7.37–7.24 (m, 14H), 7.23–7.16 (m, 2H), 5.42 (qd, <i>J</i> = 6.3, 3.0 Hz, 1H), 4.42 (d, <i>J</i> = 2.9 Hz, 1H), 4.24 (d, <i>J</i> = 5.9 Hz, 1H), 4.14 (d, <i>J</i> = 13.3 Hz, 2H), 3.58 (d, <i>J</i> = 13.4 Hz, 3H), 3.11–2.99 (m, 2H), 2.95–2.85 (m, 2H), 1.83–1.71 (m, 1H), 1.45 (s, 9H), 1.37–1.31 (m, 1H), 1.23 (d, <i>J</i> = 6.4 Hz, 3H), 1.15–1.03 (m, 1H), 0.85 (t, <i>J</i> = 7.4 Hz, 3H), 0.80 (d, <i>J</i> = 6.8 Hz, 3H), 0.65 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 178.9, 172.0, 171.5, 158.3, 151.1, 147.5, 141.5, 139.3 (2 C), 138.5, 136.8, 130.5 (6 C), 129.6, 129.4, 129.3 (6 C), 128.1, 125.2, 81.1, 79.5, 75.4, 72.6, 68.5, 61.8, 58.8, 58.3, 56.5, 44.3, 37.8, 29.5, 28.8, 26.1, 17.2, 16.0, 15.7, 11.8. IR (thin film): υ (cm<sup>–1</sup>) = 2970, 2935, 2362, 2355, 1742, 1719, 1667, 1501, 1455, 1368, 1250, 1165, 1134, 1063, 838, 751, 701, 424, 415; HR-MS (ESI): calcd for C<sub>47</sub>H<sub>61</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 809.4484 <i>m</i>/<i>z</i>; found 809.4465 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> <i>tert</i>-Butyl ((3<i>R</i>,6<i>R</i>,7<i>S</i>,8<i>S</i>,11<i>S</i>,12<i>R</i>)-3-((<i>R</i>)-<i>sec</i>-Butyl)-7-hydroxy-6,12-dimethyl-2,5,10-trioxo-8-(pyridin-3-ylmethyl)-1-oxa-4,9-diazacyclododecan-11-yl)carbamate (<b>34A</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0071.gif" alt="" id="fx77" /></img><div class="NLM_p last"><b>34</b> (17.1 mg, 21.1 μmol, 1.00 equiv) was dissolved in MeOH (1 mL), and Pd/C (10%, 9.00 mg, 8.45 μmol, 0.40 equiv) was added under argon. The atmosphere was exchanged with H<sub>2</sub> (1 bar), and the mixture was stirred at rt for 2.75 h. The suspension was filtered over celite, the filter cake was washed with MeOH, and the filtrate was concentrated in vacuo to deliver the ensuing amino acid (11.0 mg, 96%, crude) as a white solid. To a suspension of DIPEA (36.3 μL, 210 μmol, 2.60 equiv) and HATU (52.2 mg, 137 μmol, 1.70 equiv) in DCM (30 mL), the above amino acid (43.5 mg, 80.8 μmol, 1.00 equiv) was added in 1% DMF/DCM (15 ml) at rt over 1.5 h (pale yellow color develops). The solution was stirred at rt for 18 h. Sat. aq. NaHCO<sub>3</sub> (10 mL) was added, and the aqueous layer was extracted with DCM (3 × 15 mL). The combined organic layers were dried over MgSO<sub>4,</sub> filtered, and concentrated in vacuo. FC (DCM/MeOH 95:5) provided <b>34A</b> (34.9 mg, 83%) as a yellow solid. TLC (SiO<sub>2</sub>, DCM/MeOH 95:5, UV): <i>R</i><sub><i>f</i></sub> = 0.24. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −25.1° (<i>c</i> 1.40, MeOH). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.46 (d, <i>J</i> = 1.6 Hz, 1H), 8.36 (dd, <i>J</i> = 4.9, 1.4 Hz, 1H), 7.72 (d, <i>J</i> = 7.8 Hz, 1H), 7.33 (dd, <i>J</i> = 7.7, 5.0 Hz, 1H), 5.18–5.07 (m, 1H), 4.29 (d, <i>J</i> = 5.8 Hz, 1H), 4.08 (t, <i>J</i> = 7.0 Hz, 1H), 4.01 (d, <i>J</i> = 7.6 Hz, 1H), 3.59 (s, 1H), 2.98 (dd, <i>J</i> = 13.5, 7.2 Hz, 1H), 2.91 (dd, <i>J</i> = 13.5, 7.7 Hz, 1H), 2.45 (qd, <i>J</i> = 7.0, 0.7 Hz, 1H), 1.89–1.77 (m, 1H), 1.59–1.50 (m, 1H), 1.46 (s, 9H), 1.33 (d, <i>J</i> = 5.7 Hz, 3H), 1.31 (d, <i>J</i> = 5.0 Hz, 3H), 1.29–1.18 (m, 1H), 0.95–0.88 (m, 6H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 180.5, 171.3, 170.9, 157.2, 151.1, 148.0, 139.3, 136.4, 125.0, 81.0, 76.5, 70.8, 59.7, 57.8, 56.5, 41.8, 37.0, 36.4, 28.7, 26.8, 19.1, 15.9, 15.0, 11.3. IR (thin film): υ (cm<sup>–1</sup>) = 3339, 2970, 2934, 1737, 1718, 1664, 1535, 1496, 1457, 1388, 1368, 1317, 1244, 1167, 1064, 1049, 1027, 844, 716, 557. HR-MS (ESI): calcd for C<sub>26</sub>H<sub>41</sub>N<sub>4</sub>O<sub>7</sub> [M + H]<sup>+</sup> 521.2970 <i>m</i>/<i>z</i>; found 521.2969 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> <i>N</i>-((3<i>R</i>,6<i>R</i>,7<i>S</i>,8<i>S</i>,11<i>S</i>,12<i>R</i>)-3-((<i>R</i>)-<i>sec</i>-Butyl)-7-hydroxy-6,12-dimethyl-2,5,10-trioxo-8-(pyridin-3-ylmethyl)-1-oxa-4,9-diazacyclododecan-11-yl)-3-hydroxypicolinamide (<b>35</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0072.gif" alt="" id="fx78" /></img><div class="NLM_p last"><b>35</b> was prepared from <b>34A</b> according to the procedure described for <b>28a</b>. FC (DCM/MeOH 95:5) followed by RP-HPLC (10 to 50% MeCN/0.1% TFA in 0.1% aq. TFA) provided <b>35</b> (5.1 mg, 25% over 2 steps) as a white lyophilisate. TLC (SiO<sub>2</sub>, DCM/MeOH 95:5, UV): <i>R</i><sub><i>f</i></sub> = 0.21. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −12.4° (<i>c</i> 0.15, MeOH). <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) = 8.69 (s, 1H), 8.65 (d, <i>J</i> = 7.0 Hz, 1H), 8.56 (d, <i>J</i> = 4.7 Hz, 1H), 8.24 (d, <i>J</i> = 7.5 Hz, 1H), 8.20 (dd, <i>J</i> = 4.4, 1.2 Hz, 1H), 8.14 (d, <i>J</i> = 8.6 Hz, 1H), 8.02 (d, <i>J</i> = 8.2 Hz, 1H), 7.66 (t, <i>J</i> = 6.6 Hz, 1H), 7.60 (dd, <i>J</i> = 8.5, 4.4 Hz, 1H), 7.47 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 5.22 (p, <i>J</i> = 6.4 Hz, 1H), 4.65 (dd, <i>J</i> = 8.2, 5.9 Hz, 1H), 4.14 (tdd, <i>J</i> = 9.9, 4.5, 1.3 Hz, 1H), 3.90 (t, <i>J</i> = 7.3 Hz, 1H), 3.66 (s, 1H), 3.04 (dd, <i>J</i> = 13.2, 4.5 Hz, 1H), 2.96 (dd, <i>J</i> = 13.2, 10.2 Hz, 1H), 2.57–2.52 (m, 1H), 1.79–1.69 (m, 1H), 1.51–1.41 (m, 1H), 1.27 (d, <i>J</i> = 7.2 Hz, 3H), 1.25–1.17 (m, 1H), 1.16 (d, <i>J</i> = 6.5 Hz, 3H), 0.87–0.79 (m, 6H). <sup>13</sup>C NMR (126 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) = 178.7, 170.1, 167.9, 167.8, 158.9 (q, <i>J</i> = 34.4 Hz, TFA), 157.6, 145.7, 143.9, 141.1, 140.7, 138.8, 130.6, 130.3, 126.9, 126.2, 116.8 (d, <i>J</i> = 293.0 Hz, TFA), 76.2, 68.5, 58.5, 56.0, 53.5, 39.8, 35.8, 35.0, 25.6, 19.0, 15.7, 15.1, 11.3. IR (thin film): υ (cm<sup>–1</sup>) = 3361, 3289, 2365, 1970, 1742, 1673, 1651, 1526, 1452, 1199, 1138, 801, 723, 682, 651, 567, 458. HR-MS (ESI): calcd for C<sub>27</sub>H<sub>36</sub>N<sub>5</sub>O<sub>7</sub> [M + H]<sup>+</sup> 542.2609 <i>m</i>/<i>z</i>; found 542.2609 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> (<i>R</i>)-1-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-3-methyl-1-oxobutan-2-yl (2<i>S</i>,3<i>R</i>,4<i>S</i>)-4-(Dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>37</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0095.gif" alt="" id="fx79" /></img><div class="NLM_p last"><b>37</b> was prepared from bis-<i>epi</i>-<b>24</b> and <b>36</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> according to the procedure described for <b>25a</b>. FC (hexane/EtOAc 3:2) provided <b>37</b> (82.6 mg, 52%) as a pale yellow oil. TLC (SiO<sub>2</sub>, hexane/EtOAc, 1:1, UV): <i>R</i><sub><i>f</i></sub> = 0.29. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +11.9° (<i>c</i> 0.51, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.49 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.42 (d, <i>J</i> = 1.8 Hz, 1H), 7.40–7.30 (m, 7H), 7.23–7.13 (m, 7H), 7.12–7.07 (m, 4H), 5.57–5.50 (m, 1H), 5.45 (d, <i>J</i> = 9.7 Hz, 1H), 5.18 (d, <i>J</i> = 12.1 Hz, 1H), 5.10 (d, <i>J</i> = 12.1 Hz, 1H), 4.85 (d, <i>J</i> = 3.7 Hz, 1H), 4.53 (dd, <i>J</i> = 9.7, 2.3 Hz, 1H), 4.27–4.20 (m, 1H), 3.97 (d, <i>J</i> = 14.3 Hz, 2H), 3.58 (d, <i>J</i> = 14.3 Hz, 2H), 3.50 (d, <i>J</i> = 4.6 Hz, 1H), 3.08 (dd, <i>J</i> = 14.2, 9.3 Hz, 1H), 2.99–2.92 (m, 1H), 2.86 (dd, <i>J</i> = 14.2, 3.8 Hz, 1H), 2.69–2.59 (m, 1H), 2.27–2.15 (m, 2H), 1.45 (s, 9H), 1.33 (d, <i>J</i> = 6.4 Hz, 3H), 1.02 (dd, <i>J</i> = 9.7, 7.1 Hz, 6H), 0.95 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 174.1, 169.9, 169.3, 156.0, 151.0, 147.3, 139.8, 137.1, 136.4, 134.9, 128.8, 128.7, 128.6, 128.5, 128.4, 128.3, 127.0, 123.1, 80.5, 76.3, 72.9, 72.0, 67.9, 60.2, 57.1, 54.5, 45.2, 30.1, 29.0, 28.4, 19.0, 16.9, 14.8. IR (thin film): υ (cm<sup>–1</sup>) = 3026, 2976, 2935, 2802, 1739, 1723, 1495, 1455, 1367, 1314, 1252, 1212, 1166, 1128, 1084, 1023, 985, 749, 699. HR-MS (ESI): calcd for C<sub>46</sub>H<sub>58</sub>N<sub>3</sub>O<sub>9</sub> [M + H]<sup>+</sup> 796.4168 <i>m</i>/<i>z</i>; found 796.4159 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>R</i>,11<i>S</i>)-10-Hydroxy-2-isopropyl-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>37A</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0073.gif" alt="" id="fx80" /></img><div class="NLM_p last"><b>37A</b> was prepared from <b>37</b> according to the procedure described for <b>26a</b>. FC (hexane/EtOAc 5:95) provided <b>37A</b> (13.0 mg, 33% over two steps) as a pale yellow film. TLC (SiO<sub>2</sub>, hexane/EtOAc, 0.5:10): <i>R</i><sub><i>f</i></sub> = 0.28. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −10.4 (<i>c</i> 0.37, MeOH). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.43 (s, 1H), 8.34 (d, <i>J</i> = 3.6 Hz, 1H), 7.69 (d, <i>J</i> = 7.8 Hz, 1H), 7.27 (dd, <i>J</i> = 7.5, 5.0 Hz, 1H), 7.21 (d, <i>J</i> = 9.4 Hz, 1H exchanged), 6.22 (d, <i>J</i> = 8.5 Hz, 1H exchanged), 5.23–5.13 (m, 1H), 4.88–4.78 (m, 1H), 4.41 (d, <i>J</i> = 8.4 Hz, 1H), 4.13 (d, <i>J</i> = 5.4 Hz, 1H), 4.06 (br. s, 1H), 3.33–3.28 (m, 1H), 2.90 (qd, <i>J</i> = 7.1, 2.2 Hz, 1H), 2.74 (br. s, 1H), 2.30–2.18 (m, 1H), 1.45 (s, 9H), 1.27 (d, <i>J</i> = 7.3 Hz, 3H), 1.20 (d, <i>J</i> = 6.5 Hz, 3H), 0.99 (dd, <i>J</i> = 9.6, 6.9 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD): δ (ppm) = 175.3, 169.7, 169.2, 156.8, 151.0, 147.7, 139.5, 136.1, 124.7, 80.9, 78.5, 73.0, 70.5, 56.7, 53.3, 45.3, 36.4, 31.2, 28.7, 18.9, 17.6, 14.9, 8.7. IR (thin film): υ (cm<sup>–1</sup>) = 3357, 2969, 2924, 2851, 1744, 1716, 1670, 1521, 1496, 1456, 1390, 1367, 1290, 1246, 1163, 1067, 1044, 1024, 989, 863, 713. HR-MS (ESI): calcd for C<sub>25</sub>H<sub>38</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 508.2653 <i>m</i>/<i>z</i>; found 508.2655 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> (<i>R</i>)-2-(((2<i>R</i>,3<i>S</i>)-4-(Benzyloxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutan-2-yl)oxy)-1-cyclohexyl-2-oxoethyl (2<i>S</i>,3<i>R</i>,4<i>S</i>)-4-(dibenzylamino)-3-hydroxy-2-methyl-5-(pyridin-3-yl)pentanoate (<b>38</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0060.gif" alt="" id="fx81" /></img><div class="NLM_p last"><b>38</b> was prepared from bis-<i>epi</i>-<b>24</b> and <b>8c</b> according to the procedure described for <b>25a</b>. FC (hexane/EtOAc 3:1) provided <b>38</b> (39.9 mg, 51%) as a colorless oil. TLC (SiO<sub>2</sub>, hexane/EtOAc 3:1, UV): <i>R</i><sub><i>f</i></sub> = 0.15. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +12.5° (<i>c</i> 0.64, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 8.49 (dd, <i>J</i> = 4.9, 1.6 Hz, 1H), 8.42 (d, <i>J</i> = 2.2 Hz, 1H), 7.43–7.30 (m, 6H), 7.24–7.14 (m, 7H), 7.14–7.06 (m, 4H), 5.54 (qd, <i>J</i> = 6.4, 2.4 Hz, 1H), 5.47 (d, <i>J</i> = 9.7 Hz, 1H), 5.18 (d, <i>J</i> = 12.3 Hz, 1H), 5.09 (d, <i>J</i> = 12.2 Hz, 1H), 4.84 (d, <i>J</i> = 4.0 Hz, 1H), 4.53 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 4.27–4.19 (m, 1H), 3.97 (d, <i>J</i> = 14.2 Hz, 2H), 3.59 (d, <i>J</i> = 14.2 Hz, 2H), 3.52 (br. s, 1H), 3.10 (dd, <i>J</i> = 14.2, 9.2 Hz, 1H), 3.00–2.93 (m, 1H), 2.87 (dd, <i>J</i> = 14.3, 4.0 Hz, 1H), 2.65 (p, <i>J</i> = 7.2 Hz, 1H), 1.94–1.59 (m, 5H), 1.52 (dd, <i>J</i> = 12.2, 3.3 Hz, 1H), 1.45 (s, 9H), 1.33 (d, <i>J</i> = 6.4 Hz, 3H), 1.31–1.10 (m, 5H), 1.05 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 174.2, 169.8, 169.3, 156.0, 151.1, 147.3, 139.8, 137.1, 136.5, 135.0, 128.8, 128.7, 128.6, 128.4, 128.3, 127.0, 123.1, 80.5, 76.2, 72.9, 72.1, 67.8, 60.3, 57.2, 54.5, 45.2, 39.5, 29.3, 29.0, 28.4, 27.5, 26.1, 26.0, 25.9, 17.0, 14.8. IR (thin film): υ (cm<sup>–1</sup>) = 2977, 2929, 2854, 1742, 1495, 1454, 1424, 1381, 1367, 1314, 1258, 1209, 1164, 1085, 1065, 992, 740, 698 cm<sup>–1</sup>. HR-MS (ESI): calcd for C<sub>49</sub>H<sub>62</sub>N<sub>3</sub>O<sub>9</sub> [M + H]<sup>+</sup> 836.4481 <i>m</i>/<i>z</i>; found 836.4481 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>R</i>,11<i>S</i>)-2-Cyclohexyl-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)carbamate (<b>38A</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0092.gif" alt="" id="fx82" /></img><div class="NLM_p last"><b>38A</b> was prepared from <b>38</b> according to the procedure described for <b>26a</b>. FC (EtOAc) provided <b>38A</b> (9.0 mg, 42% over two steps) as a colorless film. TLC (SiO<sub>2</sub>, EtOAc, UV, KMnO<sub>4</sub>): <i>R</i><sub><i>f</i></sub> = 0.20. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +29.6° (<i>c</i> 0.98, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.46–8.39 (m, 1H), 8.35 (dd, <i>J</i> = 5.0, 1.6 Hz, 1H), 7.70 (dt, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.30 (dd, <i>J</i> = 7.8, 4.9 Hz, 1H), 5.19–5.08 (m, 1H), 4.82 (br. s, 1H), 4.46–4.33 (m, 1H), 4.08 (d, <i>J</i> = 5.5 Hz, 1H), 4.01 (br. s, 1H), 3.29 (br. s, 1H), 2.92–2.84 (m, 1H), 2.75 (br. s, 1H), 1.98–1.88 (m, 1H), 1.81–1.74 (m, 2H), 1.72–1.63 (m, 3H), 1.45 (s, 9H), 1.38–1.10 (m, 11H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 175.3, 170.0, 169.3, 156.9, 150.8, 147.5, 139.9, 136.5, 124.9, 81.0, 78.3, 73.1, 70.7, 57.0, 53.5, 45.4, 40.6, 36.2, 30.1, 28.9, 28.7, 27.1, 27.1, 26.9, 15.0, 8.7. IR (thin film): υ (cm<sup>–1</sup>) = 3429, 3359, 2979, 2928, 2856, 1745, 1719, 1675, 1497, 1451, 1433, 1391, 1367, 1318, 1291, 1251, 1166, 1106, 1086, 1047, 1025. HR-MS (ESI): calcd for C<sub>28</sub>H<sub>42</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 548.2966 <i>m</i>/<i>z</i>; found 548.2965 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 3-Hydroxy-<i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>R</i>,11<i>S</i>)-10-hydroxy-2-isopropyl-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)picolinamide (<b>39</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0096.gif" alt="" id="fx83" /></img><div class="NLM_p last"><b>39</b> was prepared from <b>37A</b> according to the procedure described for <b>28a</b>. FC (DCM/MeOH 9:1) provided <b>39</b> (10 mg) as a yellow oil. Further purification by RP-HPLC (20 to 65% MeCN/0.1% TFA in 0.1% aq. TFA) gave <b>39</b> (3.30 mg, 37% over 2 steps) as a white lyophilisate. TLC (SiO<sub>2</sub>, DCM/MeOH, 9:1, UV) <i>R</i><sub><i>f</i></sub> = 0.40. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −28.2° (<i>c</i> 0.07, MeOH). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ (ppm) = 11.62 (s, 1H), 8.50 (d, <i>J</i> = 3.6 Hz, 1H), 8.48 (s, 1H), 8.32 (br. s, 1H), 8.09–8.06 (m, 1H), 7.54 (d, <i>J</i> = 7.8 Hz, 1H), 7.39–7.32 (m, 1H), 7.32–7.28 (m, 1H), 7.18–7.12 (m, 1H), 6.09 (br. s, 1H), 5.52–5.44 (m, 1H), 4.97 (d, <i>J</i> = 3.9 Hz, 1H), 4.55 (dd, <i>J</i> = 8.0, 5.6 Hz, 1H), 4.50 (br. s, 1H), 4.12 (br. s, 1H), 3.07 (dd, <i>J</i> = 14.8, 3.7 Hz, 1H), 3.03–2.91 (m, 2H), 2.40–2.32 (m, 1H), 1.36 (d, <i>J</i> = 7.2 Hz, 3H), 1.31 (d, <i>J</i> = 6.6 Hz, 3H), 1.03 (d, <i>J</i> = 6.9 Hz, 3H), 1.00 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ (ppm) = 176.3, 168.4, 167.2, 166.9, 157.9, 150.5, 147.8, 140.1, 137.3, 133.1, 130.9, 129.2, 126.2, 123.7, 77.8, 68.4, 54.0, 43.7 (HMBC), 34.8, 30.3, 18.9, 17.1, 14.5 IR (thin film): υ (cm<sup>–1</sup>) = 3363, 2965, 2930, 2855, 1746, 1726, 1651, 1598, 1521, 1449, 1389, 1294, 1252, 1045, 997, 810, 716, 658. HR-MS (ESI): calcd for C<sub>26</sub>H<sub>33</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 529.2293 <i>m</i>/<i>z</i>; found 529.2290 <i>m</i>/<i>z</i>.</div></div><div id="sec4_1_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> <i>N</i>-((2<i>R</i>,5<i>R</i>,6<i>S</i>,9<i>S</i>,10<i>R</i>,11<i>S</i>)-2-Cyclohexyl-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl)-3-hydroxypicolinamide (<b>40</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0093.gif" alt="" id="fx84" /></img><div class="NLM_p last"><b>40</b> was prepared from <b>38A</b> according to the procedure described for <b>28a</b>. FC (DCM/MeOH 95:5) provided <b>40</b> (6.2 mg) as a colorless oil. Further purification by RP-HPLC (20 to 60% MeCN/0.1% TFA in 0.1% aq. TFA) provided <b>40</b> (3.7 mg, 51% over 2 steps) as a white lyophilisate. TLC (SiO<sub>2</sub>, DCM/MeOH 95:5, UV): <i>R</i><sub><i>f</i></sub> = 0.16. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −8.1° (<i>c</i> 0.37, MeOH). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.70 (d, <i>J</i> = 2.1 Hz, 1H), 8.47–8.41 (m, 1H), 8.40–8.35 (m, 1H), 8.15 (dd, <i>J</i> = 4.4, 1.4 Hz, 1H), 7.72–7.59 (m, 2H), 7.52 (dd, <i>J</i> = 8.5, 4.4 Hz, 1H), 7.41 (dd, <i>J</i> = 8.5, 1.3 Hz, 1H), 5.35 (p, <i>J</i> = 6.4 Hz, 1H), 4.96–4.90 (br. s, 1 H), 4.51 (d, <i>J</i> = 6.0 Hz, 2H), 4.15 (br. s, 1H), 3.62–3.53 (m, 1H), 2.98–2.82 (m, 2H), 2.00–1.92 (m, 1H), 1.83–1.76 (m, 2H), 1.74–1.65 (m, 3H), 1.39–1.13 (m, 11H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD): δ (ppm) = 175.1, 169.4, 169.1, 159.1, 148.1, 144.4, 141.2, 141.2, 140.7, 131.7, 130.8, 127.6, 127.4, 78.3, 73.2, 69.7, 55.0, 53.1, 45.4, 40.8, 36.9, 30.1, 28.9, 27.1, 27.0, 15.1, 8.6. IR (thin film): υ (cm<sup>–1</sup>) = 3366, 2932, 1733, 1675, 1559, 1523, 1452, 1262, 1200, 1140, 1050, 885. HR-MS (ESI): calcd for C<sub>29</sub>H<sub>37</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 569.2606 <i>m</i>/<i>z</i>; found 569.2605 <i>m</i>/<i>z</i>.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> MIC Determinations</h3><div class="NLM_p last">MICs were determined in a resazurin reduction microplate assay (REMA),<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> as described previously.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Briefly, frozen stocks of H37Rv, H37Rv:pMV261, and H37Rv:pMVInhA (all frozen at OD<sub>600</sub> of 1) were diluted 1 in 2500 (v/v) into Middlebrook 7H9 media supplemented 10% ADC, 0.2% glycerol, and 0.05% Tween 80 (25 μg/mL kanamycin was also used for maintenance of the pMV261 and pMVInhA contain strains). Diluted bacterial suspensions were added to a 96-well plate (100 μL) in the presence of serial dilutions of the compounds of interest (maximum DMSO concentration of 1%). The plates were sealed with a PCR film and incubated (7 days, 37 °C). Bacterial viability was determined using the redox indicator, resazurin (0.025% w/v, 16 h), and measured by fluorescence (Ex: 560 nm, Em: 590 nm) using a Tecan Infinite M200 microplate reader. The minimal inhibitory concentration (MIC) was determined as the lowest concentration of compound where the resazurin fluorescence was at the background level (equal to no bacteria control). Experiments were carried out at least in duplicate and average values are reported.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i112"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01457" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01457?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01457</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental protocols for the synthesis of acid <b>29</b> (including copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra of acid <b>29</b> and all intermediates); <sup>1</sup>H and <sup>13</sup>C NMR spectra of final products and intermediates; HPLC traces for all final products, except <b>28e</b>; MIC values of compounds <b>1</b>, <b>2</b>, <b>28c</b>, <b>28e</b>, and <b>35</b> in the absence of Tween 80; and X-ray crystal structures of bis-<i>epi</i>-<b>23</b> and <b>26c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of all new compounds and associated biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_001.pdf">jm9b01457_si_001.pdf (17.09 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_002.csv">jm9b01457_si_002.csv (9.87 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01457" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71570" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71570" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karl-Heinz Altmann</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Applied Biosciences, Institute of Pharmaceutical
Sciences, ETH Zürich, 8093 Zurich, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0747-9734" title="Orcid link">http://orcid.org/0000-0002-0747-9734</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#87ece6f5ebaaefe2eee9fda9e6ebf3eae6e9e9c7f7efe6f5eae6a9e2f3effda9e4ef"><span class="__cf_email__" data-cfemail="eb808a9987c6838e828591c58a879f868a8585ab9b838a99868ac58e9f8391c58883">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maryline Kienle</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Applied Biosciences, Institute of Pharmaceutical
Sciences, ETH Zürich, 8093 Zurich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Eisenring</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Applied Biosciences, Institute of Pharmaceutical
Sciences, ETH Zürich, 8093 Zurich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Stoessel</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Applied Biosciences, Institute of Pharmaceutical
Sciences, ETH Zürich, 8093 Zurich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver P. Horlacher</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Applied Biosciences, Institute of Pharmaceutical
Sciences, ETH Zürich, 8093 Zurich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samuel Hasler</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Applied Biosciences, Institute of Pharmaceutical
Sciences, ETH Zürich, 8093 Zurich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gwénaëlle van Colen</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Applied Biosciences, Institute of Pharmaceutical
Sciences, ETH Zürich, 8093 Zurich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruben C. Hartkoorn</span> - <span class="hlFld-Affiliation affiliation">Global
Health Institute, École Polytechnique
Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland</span>; 
    <span>Present Address:
                        Centre for Infection and Immunity of Lille, U1019-UMR8204, Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Lille, France (R.C.H.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony Vocat</span> - <span class="hlFld-Affiliation affiliation">Global
Health Institute, École Polytechnique
Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stewart T. Cole</span> - <span class="hlFld-Affiliation affiliation">Global
Health Institute, École Polytechnique
Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland</span>; 
    <span>Present Address:
                        FRS, President, Institut Pasteur, 25–28, rue du Docteur Roux, 75724 Paris Cedex 15, France (S.T.C.)</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>K.-H.A., B.S., M.K., O.P.H., and P.E. designed the research; M.K., B.S., O.P.H., P.E., and R.C.H. designed the experiments; B.S., M.K., O.P.H., P.E., S.H., G.v.C., R.C.H., and A.V. carried out the experiments; S.T.C. and K.-H.A. provided supervision. M.K. and K.-H.A. wrote the article. M.K., P.E., B.S., and O.P.H. contributed equally to this work.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported by the European Community Framework Programme 7, grant agreement no. 260872 (O.P.H, R.C.H, S.T.C, K.-H.A), and by the Swiss National Science Foundation (M.K., project 200021_149253; P.E., project 200020_175744). Financial support was also provided by ETH Zurich through base funding to K.-H.A. (B.S., S.H.).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e12930-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i116">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors gratefully acknowledge financial support by the European Community Framework Programme 7 (grant agreement no. 260872) and the Swiss National Science Foundation (projects 200021_149253 and 200020_175744). They are indebted to Dr. Bernhard Pfeiffer (ETHZ) for NMR support and to Dr. Xiangyang Zhang, Louis Bertschi, Rolf Häfliger, and Oswald Greter (ETHZ) for HR-MS spectra. Kurt Hauenstein is acknowledged for crucial technical support. The authors are grateful to Nils Trapp for providing the X-ray crystal structures of cpds. <i>ent</i>-<b>23</b> and <b>26c</b>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">CSA</td><td class="NLM_def"><p class="first last">camphorsulfonic acid</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term"><i>c</i>-Hex<sub>2</sub>BOTf</td><td class="NLM_def"><p class="first last">dicyclohexylboron trifluoromethanesulfonate</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">3-HPA</td><td class="NLM_def"><p class="first last">3-hydroxypicolinic acid</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximum inhibitory concentration</p></td></tr><tr><td class="NLM_term"><span class="smallcaps smallerCapital">l</span>-(+)-DET</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-(+)-diethyl tartrate</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term"><i>Mtb</i></td><td class="NLM_def"><p class="first last"><i>Mycobacterium tuberculosis</i></p></td></tr><tr><td class="NLM_term">Pd/C</td><td class="NLM_def"><p class="first last">palladium on charcoal</p></td></tr><tr><td class="NLM_term"><i>p</i>-TsOH</td><td class="NLM_def"><p class="first last"><i>para</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">REMA</td><td class="NLM_def"><p class="first last">resazurin reduction microplate assay</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reversed phase</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">TBSCl</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl chloride</p></td></tr><tr><td class="NLM_term">TBSOTf</td><td class="NLM_def"><p class="first last">trifluoromethanesulfonic acid <i>tert</i>-butyldimethylsilyl ester</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TTIP</td><td class="NLM_def"><p class="first last">titanium isopropoxide</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i118">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span> <i>Global Tuberculosis Report
2018</i>; <span class="NLM_publisher-name">World Health
Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2018</span>, Licence: CC BY-NC-SA 3.0 IGO.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global+Tuberculosis+Report%0A2018%3B+World+Health%0AOrganization%3A+Geneva%2C+2018%2C+Licence%3A+CC+BY-NC-SA+3.0+IGO."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Tuberculosis%2520Report%250A2018%26pub%3DWorld%2520Health%250AOrganization%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zumla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nahid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Advances in the Development of New Tuberculosis Drugs and Treatment Regimens</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1038/nrd4001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1038%2Fnrd4001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=23629506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Kmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=388-404&author=A.+Zumlaauthor=P.+Nahidauthor=S.+T.+Cole&title=Advances+in+the+Development+of+New+Tuberculosis+Drugs+and+Treatment+Regimens&doi=10.1038%2Fnrd4001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the development of new tuberculosis drugs and treatment regimens</span></div><div class="casAuthors">Zumla, Alimuddin; Nahid, Payam; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">388-404</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid, rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to cause considerable morbidity and mortality worldwide.  For the first time since the 1960s, new and novel drugs and regimens for all forms of TB are emerging.  Such regimens are likely to utilize both repurposed drugs and new chem. entities, and several of these regimens are now progressing through clin. trials.  This article covers current concepts and recent advances in TB drug discovery and development, including an update of ongoing TB treatment trials, newer clin. trial designs, TB biomarkers and adjunct host-directed therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs_a1A-oQwcrVg90H21EOLACvtfcHk0lgvx3rOra_6Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Kmsrk%253D&md5=fbf12f867a19ffff4d7fb74a98699682</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd4001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4001%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DNahid%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DAdvances%2520in%2520the%2520Development%2520of%2520New%2520Tuberculosis%2520Drugs%2520and%2520Treatment%2520Regimens%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D388%26epage%3D404%26doi%3D10.1038%2Fnrd4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sensi, P.</span></span> <span> </span><span class="NLM_article-title">History of the development of rifampin</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S402</span>– <span class="NLM_lpage">S406</span>, <span class="refDoi"> DOI: 10.1093/clinids/5.Supplement_3.S402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1093%2Fclinids%2F5.Supplement_3.S402" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1983&pages=S402-S406&author=P.+Sensi&title=History+of+the+development+of+rifampin&doi=10.1093%2Fclinids%2F5.Supplement_3.S402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fclinids%2F5.Supplement_3.S402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fclinids%252F5.Supplement_3.S402%26sid%3Dliteratum%253Aachs%26aulast%3DSensi%26aufirst%3DP.%26atitle%3DHistory%2520of%2520the%2520development%2520of%2520rifampin%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D1983%26volume%3D5%26spage%3DS402%26epage%3DS406%26doi%3D10.1093%2Fclinids%2F5.Supplement_3.S402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, R.</span></span> <span> </span><span class="NLM_article-title">Bedaquiline: First FDA-Approved Tuberculosis Drug in 40 Years</span>. <i>Int. J. Appl. Basic Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">2</span>, <span class="refDoi"> DOI: 10.4103/2229-516X.112228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.4103%2F2229-516X.112228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=23776831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A280%3ADC%252BC3sjjsVymsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1-2&author=R.+Mahajan&title=Bedaquiline%3A+First+FDA-Approved+Tuberculosis+Drug+in+40+Years&doi=10.4103%2F2229-516X.112228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Bedaquiline: First FDA-approved tuberculosis drug in 40 years</span></div><div class="casAuthors">Mahajan Rajiv</div><div class="citationInfo"><span class="NLM_cas:title">International journal of applied & basic medical research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-2</span>
        ISSN:<span class="NLM_cas:issn">2229-516X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMuPJrm3KbPlw2ofyr07jXfW6udTcc2eaiCGMDVkYF5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjjsVymsQ%253D%253D&md5=b588035f9b17ee7beb4f5c57a58a0eff</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4103%2F2229-516X.112228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2229-516X.112228%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DR.%26atitle%3DBedaquiline%253A%2520First%2520FDA-Approved%2520Tuberculosis%2520Drug%2520in%252040%2520Years%26jtitle%3DInt.%2520J.%2520Appl.%2520Basic%2520Med.%2520Res.%26date%3D2013%26volume%3D3%26spage%3D1%26epage%3D2%26doi%3D10.4103%2F2229-516X.112228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andries, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhasselt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemont, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göhlmann, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neefs, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gestel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Chaffoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huitric, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truffot-Pernot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lounis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarlier, V.</span></span> <span> </span><span class="NLM_article-title">A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium Tuberculosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1126/science.1106753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1126%2Fscience.1106753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=15591164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVKkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=223-227&author=K.+Andriesauthor=P.+Verhasseltauthor=J.+Guillemontauthor=H.+W.+G%C3%B6hlmannauthor=J.-M.+Neefsauthor=H.+Winklerauthor=J.+Van+Gestelauthor=P.+Timmermanauthor=M.+Zhuauthor=E.+Leeauthor=P.+Williamsauthor=D.+de+Chaffoyauthor=E.+Huitricauthor=S.+Hoffnerauthor=E.+Cambauauthor=C.+Truffot-Pernotauthor=N.+Lounisauthor=V.+Jarlier&title=A+Diarylquinoline+Drug+Active+on+the+ATP+Synthase+of+Mycobacterium+Tuberculosis&doi=10.1126%2Fscience.1106753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis</span></div><div class="casAuthors">Andries, Koen; Verhasselt, Peter; Guillemont, Jerome; Goehlmann, Hinrich W. H.; Neefs, Jean-Marc; Winkler, Hans; Van Gestel, Jef; Timmerman, Philip; Zhu, Min; Lee, Ennis; Williams, Peter; de Chaffoy, Didier; Huitric, Emma; Hoffner, Sven; Cambau, Emmanuelle; Truffot-Pernot, Chantal; Lounis, Nacer; Jarlier, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5707</span>),
    <span class="NLM_cas:pages">223-227</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The incidence of tuberculosis has been increasing substantially on a worldwide basis over the past decade, but no tuberculosis-specific drugs have been discovered in 40 years.  We identified a diarylquinoline, R207910, that potently inhibits both drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro (min. inhibitory concn. 0.06 μg/mL).  In mice, R207910 exceeded the bactericidal activities of isoniazid and rifampin by at least 1 log unit.  Substitution of drugs included in the World Health Organization's first-line tuberculosis treatment regimen (rifampin, isoniazid, and pyrazinamide) with R207910 accelerated bactericidal activity, leading to complete culture conversion after 2 mo of treatment in some combinations.  A single dose of R207910 inhibited mycobacterial growth for 1 wk.  Plasma levels assocd. with efficacy in mice were well tolerated in healthy human volunteers.  Mutants selected in vitro suggest that the drug targets the proton pump of ATP (ATP) synthase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9LY7RSAIXUrVg90H21EOLACvtfcHk0lhsMKGpd1uYyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVKkug%253D%253D&md5=099b643f173bb77e70cf1aa6e9871ffe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106753%26sid%3Dliteratum%253Aachs%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DVerhasselt%26aufirst%3DP.%26aulast%3DGuillemont%26aufirst%3DJ.%26aulast%3DG%25C3%25B6hlmann%26aufirst%3DH.%2BW.%26aulast%3DNeefs%26aufirst%3DJ.-M.%26aulast%3DWinkler%26aufirst%3DH.%26aulast%3DVan%2BGestel%26aufirst%3DJ.%26aulast%3DTimmerman%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DP.%26aulast%3Dde%2BChaffoy%26aufirst%3DD.%26aulast%3DHuitric%26aufirst%3DE.%26aulast%3DHoffner%26aufirst%3DS.%26aulast%3DCambau%26aufirst%3DE.%26aulast%3DTruffot-Pernot%26aufirst%3DC.%26aulast%3DLounis%26aufirst%3DN.%26aulast%3DJarlier%26aufirst%3DV.%26atitle%3DA%2520Diarylquinoline%2520Drug%2520Active%2520on%2520the%2520ATP%2520Synthase%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D223%26epage%3D227%26doi%3D10.1126%2Fscience.1106753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haraguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itotani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishige, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubouchi, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antituberculosis Activity of a Novel Series of Optically Active 6-Nitro-2,3-dihydroimidazo[2,1-b]oxazoles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7854</span>– <span class="NLM_lpage">7860</span>, <span class="refDoi"> DOI: 10.1021/jm060957y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060957y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12lsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7854-7860&author=H.+Sasakiauthor=Y.+Haraguchiauthor=M.+Itotaniauthor=H.+Kurodaauthor=H.+Hashizumeauthor=T.+Tomishigeauthor=M.+Kawasakiauthor=M.+Matsumotoauthor=M.+Komatsuauthor=H.+Tsubouchi&title=Synthesis+and+Antituberculosis+Activity+of+a+Novel+Series+of+Optically+Active+6-Nitro-2%2C3-dihydroimidazo%5B2%2C1-b%5Doxazoles&doi=10.1021%2Fjm060957y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antituberculosis Activity of a Novel Series of Optically Active 6-Nitro-2,3-dihydroimidazo[2,1-b]oxazoles</span></div><div class="casAuthors">Sasaki, Hirofumi; Haraguchi, Yoshikazu; Itotani, Motohiro; Kuroda, Hideaki; Hashizume, Hiroyuki; Tomishige, Tatsuo; Kawasaki, Masanori; Matsumoto, Makoto; Komatsu, Makoto; Tsubouchi, Hidetsugu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7854-7860</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to develop potent new antituberculosis agents that would be effective against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis, a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles substituted at the 2-position with various phenoxymethyl groups and a Me group were prepd. and the in vitro and in vivo activity of these compds. was investigated.  Several of these derivs. showed potent in vitro and in vivo activity, and I (OPC-67683) in particular displayed excellent in vitro activity against both drug-susceptible and drug-resistant strains of M. tuberculosis H37Rv (MIC = 0.006 μg/mL) and dose-dependent and significant in vivo efficacy at lower oral doses than rifampicin in mouse models infected with M. tuberculosis Kurono.  The synthesis and structure-activity relationships of these new compds. are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4pncGTcyjYbVg90H21EOLACvtfcHk0lguhTI6Xcy0NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12lsL%252FP&md5=5d21a9ba54be1fdbf0bd0b3fa5a2e620</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm060957y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060957y%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DHaraguchi%26aufirst%3DY.%26aulast%3DItotani%26aufirst%3DM.%26aulast%3DKuroda%26aufirst%3DH.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DTomishige%26aufirst%3DT.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DTsubouchi%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520Antituberculosis%2520Activity%2520of%2520a%2520Novel%2520Series%2520of%2520Optically%2520Active%25206-Nitro-2%252C3-dihydroimidazo%255B2%252C1-b%255Doxazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7854%26epage%3D7860%26doi%3D10.1021%2Fjm060957y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishige, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubouchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice</span>. <i>PLoS Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e466</span> <span class="refDoi"> DOI: 10.1371/journal.pmed.0030466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1371%2Fjournal.pmed.0030466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=17132069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A280%3ADC%252BD28npsFKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&author=M.+Matsumotoauthor=H.+Hashizumeauthor=T.+Tomishigeauthor=M.+Kawasakiauthor=H.+Tsubouchiauthor=H.+Sasakiauthor=Y.+Shimokawaauthor=M.+Komatsu&title=OPC-67683%2C+a+Nitro-Dihydro-Imidazooxazole+Derivative+with+Promising+Action+against+Tuberculosis+In+Vitro+and+In+Mice&doi=10.1371%2Fjournal.pmed.0030466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice</span></div><div class="casAuthors">Matsumoto Makoto; Hashizume Hiroyuki; Tomishige Tatsuo; Kawasaki Masanori; Tsubouchi Hidetsugu; Sasaki Hirofumi; Shimokawa Yoshihiko; Komatsu Makoto</div><div class="citationInfo"><span class="NLM_cas:title">PLoS medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e466</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Tuberculosis (TB) is still a leading cause of death worldwide.  Almost a third of the world's population is infected with TB bacilli, and each year approximately 8 million people develop active TB and 2 million die as a result.  Today's TB treatment, which dates back to the 1970s, is long and burdensome, requiring at least 6 mo of multidrug chemotherapy.  The situation is further compounded by the emergence of multidrug-resistant TB (MDR-TB) and by the infection's lethal synergy with HIV/AIDS.  Global health and philanthropic organizations are now pleading for new drug interventions that can address these unmet needs in TB treatment.  METHODS AND FINDINGS:  Here we report OPC-67683, a nitro-dihydro-imidazooxazole derivative that was screened to help combat the unmet needs in TB treatment.  The compound is a mycolic acid biosynthesis inhibitor found to be free of mutagenicity and to possess highly potent activity against TB, including MDR-TB, as shown by its exceptionally low minimum inhibitory concentration (MIC) range of 0.006-0.024 microg/ml in vitro and highly effective therapeutic activity at low doses in vivo.  Additionally, the results of the post-antibiotic effect of OPC-67683 on intracellular Mycobacterium tuberculosis showed the agent to be highly and dose-dependently active also against intracellular M. tuberculosis H37Rv after a 4-h pulsed exposure, and this activity at a concentration of 0.1 microg/ml was similar to that of the first-line drug rifampicin (RFP) at a concentration of 3 microg/ml.  The combination of OPC-67683 with RFP and pyrazinamide (PZA) exhibited a remarkably quicker eradication (by at least 2 mo) of viable TB bacilli in the lung in comparison with the standard regimen consisting of RFP, isoniazid (INH), ethambutol (EB), and PZA.  Furthermore, OPC-67683 was not affected by nor did it affect the activity of liver microsome enzymes, suggesting the possibility for OPC-67683 to be used in combination with drugs, including anti-retrovirals, that induce or are metabolized by cytochrome P450 enzymes.  CONCLUSIONS:  We concluded that based on these properties OPC-67683 has the potential to be used as a TB drug to help combat the unmet needs in TB treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSF0z_BNLNYeRS7coPn-RtfW6udTcc2eZzD_qC3s0ezLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28npsFKgug%253D%253D&md5=8a80560cc653b1c76ff4d47430317d18</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0030466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0030466%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DTomishige%26aufirst%3DT.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DTsubouchi%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DShimokawa%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DOPC-67683%252C%2520a%2520Nitro-Dihydro-Imidazooxazole%2520Derivative%2520with%2520Promising%2520Action%2520against%2520Tuberculosis%2520In%2520Vitro%2520and%2520In%2520Mice%26jtitle%3DPLoS%2520Med.%26date%3D2006%26volume%3D3%26doi%3D10.1371%2Fjournal.pmed.0030466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umezawa, H.</span></span> <span> </span><span class="NLM_article-title">A New Antibiotic, Pyridomycin</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=13096450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaG1MXjtV2lsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1953&pages=140&author=K.+Maedaauthor=H.+Kosakaauthor=Y.+Okamiauthor=H.+Umezawa&title=A+New+Antibiotic%2C+Pyridomycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A new antibiotic, pyridomycin</span></div><div class="casAuthors">Maeda, Kenji; Kosaka, Hiroko; Okami, Yoshiro; Umezawa, Hamao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics, Series A</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">Ser. A</span>),
    <span class="NLM_cas:pages">140</span>CODEN:
                <span class="NLM_cas:coden">JAJAAA</span>;
        ISSN:<span class="NLM_cas:issn">0368-1173</span>.
    </div><div class="casAbstract">Pyridomycin (I), active against mycobacteria, Escherichia coli, and Salmonella typhosa, was isolated from the broth filtrate of Streptomyces albidofuscus by extn. with BuOAc, concn., addn. of Et2O, and recrystn. from EtOH.  I is colorless crystals, m. 222°, contg. C 60.73%, H 5.96%, and N 10.34%, absorption max. 303 mμ (E1%1cm. 209, EtOH) 303 mμ (E1%1cm. 250, 0.1N HCl), and 331 mμ (E1%1cm. 166, 0.1N NaOH), sol. in MeOH, EtOH, BuOH, EtOAc, BuOAc, C6H6, CHCl3, Me2CO, dioxane, Cellosolve, and tetrahydrofuran, and sparingly sol. in Et2O and petr. ether.  Mice tolerated injection of 10 mg. intraperitoneally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou-yIs-0dL7LVg90H21EOLACvtfcHk0lguhTI6Xcy0NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXjtV2lsQ%253D%253D&md5=004c7a37f0bbefd879a27a161e042b3e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DKosaka%26aufirst%3DH.%26aulast%3DOkami%26aufirst%3DY.%26aulast%3DUmezawa%26aufirst%3DH.%26atitle%3DA%2520New%2520Antibiotic%252C%2520Pyridomycin%26jtitle%3DJ.%2520Antibiot.%26date%3D1953%26volume%3D6%26spage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uplekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boy-Röttger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Towards a New Tuberculosis Drug: Pyridomycin - Nature’s Isoniazid</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1042</span>, <span class="refDoi"> DOI: 10.1002/emmm.201201689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1002%2Femmm.201201689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=22987724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVeiur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1032-1042&author=R.+C.+Hartkoornauthor=C.+Salaauthor=J.+Neresauthor=F.+Pojerauthor=S.+Magnetauthor=R.+Mukherjeeauthor=S.+Uplekarauthor=S.+Boy-R%C3%B6ttgerauthor=K.-H.+Altmannauthor=S.+T.+Cole&title=Towards+a+New+Tuberculosis+Drug%3A+Pyridomycin+-+Nature%E2%80%99s+Isoniazid&doi=10.1002%2Femmm.201201689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a new tuberculosis drug: pyridomycin - nature's isoniazid</span></div><div class="casAuthors">Hartkoorn, Ruben C.; Sala, Claudia; Neres, Joao; Pojer, Florence; Magnet, Sophie; Mukherjee, Raju; Uplekar, Swapna; Boy-Roettger, Stefanie; Altmann, Karl-Heinz; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1032-1042</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tuberculosis, a global threat to public health, is becoming untreatable due to widespread drug resistance to frontline drugs such as the InhA-inhibitor isoniazid.  Historically, by inhibiting highly vulnerable targets, natural products were an important source of antibiotics including potent anti-tuberculosis agents.  Here, the authors describe pyridomycin, a compd. produced by Dactylosporangium fulvum with specific cidal activity against mycobacteria.  By selecting pyridomycin-resistant mutants of Mycobacterium tuberculosis, whole-genome sequencing and genetic validation, we identified the NADH-dependent enoyl- (Acyl-Carrier-Protein) reductase InhA as the principal target and demonstrate that pyridomycin inhibits mycolic acid synthesis in M. tuberculosis.  Furthermore, biochem. and structural studies show that pyridomycin inhibits InhA directly as a competitive inhibitor of the NADH-binding site, thereby identifying a new, druggable pocket in InhA.  Importantly, the most frequently encountered isoniazid-resistant clin. isolates remain fully susceptible to pyridomycin, thus opening new avenues for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3ty3Lo--847Vg90H21EOLACvtfcHk0lguhTI6Xcy0NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVeiur%252FL&md5=65e35a6ea7de92263cc77db92253d24e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201689%26sid%3Dliteratum%253Aachs%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DMagnet%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DR.%26aulast%3DUplekar%26aufirst%3DS.%26aulast%3DBoy-R%25C3%25B6ttger%26aufirst%3DS.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DTowards%2520a%2520New%2520Tuberculosis%2520Drug%253A%2520Pyridomycin%2520-%2520Nature%25E2%2580%2599s%2520Isoniazid%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D1032%26epage%3D1042%26doi%3D10.1002%2Femmm.201201689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Timmins, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deretic, V.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Action of Isoniazid</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1220</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2006.05467.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1111%2Fj.1365-2958.2006.05467.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=17074073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlenu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=1220-1227&author=G.+S.+Timminsauthor=V.+Deretic&title=Mechanisms+of+Action+of+Isoniazid&doi=10.1111%2Fj.1365-2958.2006.05467.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of action of isoniazid</span></div><div class="casAuthors">Timmins, Graham S.; Deretic, Vojo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1220-1227</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  For decades after its introduction, the mechanisms of action of the front-line antituberculosis therapeutic agent isoniazid (INH) remained unclear.  Recent developments have shown that peroxidative activation of isoniazid by the mycobacterial enzyme KatG generates reactive species that form adducts with NAD+ and NADP+ that are potent inhibitors of lipid and nucleic acid biosynthetic enzymes.  A direct role for some isoniazid-derived reactive species, such as nitric oxide, in inhibiting mycobacterial metabolic enzymes has also been shown.  The concerted effects of these activities - inhibition of cell wall lipid synthesis, depletion of nucleic acid pools and metabolic depression - drive the exquisite potency and selectivity of this agent.  To understand INH action and resistance fully, a synthesis of knowledge is required from multiple sep. lines of research - including mol. genetic approaches, in vitro biochem. studies and free radical chem. - which is the intent of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq9OybVddk-rVg90H21EOLACvtfcHk0lj4hIrYWY47sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlenu7jE&md5=fbc095f0f79cd443b55d54c19b36f932</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2006.05467.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2006.05467.x%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DG.%2BS.%26aulast%3DDeretic%26aufirst%3DV.%26atitle%3DMechanisms%2520of%2520Action%2520of%2520Isoniazid%26jtitle%3DMol.%2520Microbiol.%26date%3D2006%26volume%3D62%26spage%3D1220%26epage%3D1227%26doi%3D10.1111%2Fj.1365-2958.2006.05467.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilchèze, C.</span>; <span class="NLM_string-name">Jacobs, W. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Resistance to Isoniazid and Ethionamide in Mycobacterium Tuberculosis: Genes, Mutations, and Causalities</span>.  <i>Molecular Genetics of Mycobacteria</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">American Society of Microbiology</span>: <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">453</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=431-453&author=C.+Vilch%C3%A8ze&author=W.+R.+Jacobs&title=Molecular+Genetics+of+Mycobacteria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVilch%25C3%25A8ze%26aufirst%3DC.%26atitle%3DResistance%2520to%2520Isoniazid%2520and%2520Ethionamide%2520in%2520Mycobacterium%2520Tuberculosis%253A%2520Genes%252C%2520Mutations%252C%2520and%2520Causalities%26btitle%3DMolecular%2520Genetics%2520of%2520Mycobacteria%26pub%3DAmerican%2520Society%2520of%2520Microbiology%26date%3D2014%26spage%3D431%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truglio, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyne, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novichenok, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slayden, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, P. J.</span></span> <span> </span><span class="NLM_article-title">High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains of Mycobacterium Tuberculosis</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1021/cb0500042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb0500042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlOkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=43-53&author=T.+J.+Sullivanauthor=J.+J.+Truglioauthor=M.+E.+Boyneauthor=P.+Novichenokauthor=X.+Zhangauthor=C.+F.+Strattonauthor=H.-J.+Liauthor=T.+Kaurauthor=A.+Aminauthor=F.+Johnsonauthor=R.+A.+Slaydenauthor=C.+Kiskerauthor=P.+J.+Tonge&title=High+Affinity+InhA+Inhibitors+with+Activity+against+Drug-Resistant+Strains+of+Mycobacterium+Tuberculosis&doi=10.1021%2Fcb0500042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis</span></div><div class="casAuthors">Sullivan, Todd J.; Truglio, James J.; Boyne, Melissa E.; Novichenok, Polina; Zhang, Xujie; Stratton, Christopher F.; Li, Huei-Jiun; Kaur, Tejinder; Amin, Amol; Johnson, Francis; Slayden, Richard A.; Kisker, Caroline; Tonge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel chemotherapeutics for treating multidrug-resistant (MDR) strains of Mycobacterium tuberculosis (MTB) are required to combat the spread of tuberculosis, a disease that kills more than 2 million people annually.  Using structure-based drug design, the authors have developed a series of alkyl di-Ph ethers that are uncompetitive inhibitors of InhA, the enoyl reductase enzyme in the MTB fatty acid biosynthesis pathway.  The most potent compd. has a K'i value of 1 nM for InhA and MIC99 values of 2-3 μg mL-1 (6-10 μM) for both drug-sensitive and drug-resistant strains of MTB.  Overexpression of InhA in MTB results in a 9-12-fold increase in MIC99, consistent with the belief that these compds. target InhA within the cell.  In addn., transcriptional response studies reveal that the alkyl di-Ph ethers fail to upregulate a putative efflux pump and arom. dioxygenase, detoxification mechanisms that are triggered by the lead compd. triclosan.  These di-Ph ether-based InhA inhibitors do not require activation by the mycobacterial KatG enzyme, thereby circumventing the normal mechanism of resistance to the front line drug isoniazid (INH) and thus accounting for their activity against INH-resistant strains of MTB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqncsjJzA3TprVg90H21EOLACvtfcHk0lj4hIrYWY47sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlOkurc%253D&md5=69acf9afc4ea02a2a7c63a45cc2f0a82</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcb0500042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb0500042%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DT.%2BJ.%26aulast%3DTruglio%26aufirst%3DJ.%2BJ.%26aulast%3DBoyne%26aufirst%3DM.%2BE.%26aulast%3DNovichenok%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DStratton%26aufirst%3DC.%2BF.%26aulast%3DLi%26aufirst%3DH.-J.%26aulast%3DKaur%26aufirst%3DT.%26aulast%3DAmin%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DF.%26aulast%3DSlayden%26aufirst%3DR.%2BA.%26aulast%3DKisker%26aufirst%3DC.%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26atitle%3DHigh%2520Affinity%2520InhA%2520Inhibitors%2520with%2520Activity%2520against%2520Drug-Resistant%2520Strains%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2006%26volume%3D1%26spage%3D43%26epage%3D53%26doi%3D10.1021%2Fcb0500042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz de Montellano, P. R.</span></span> <span> </span><span class="NLM_article-title">Pyrrolidine Carboxamides as a Novel Class of Inhibitors of Enoyl Acyl Carrier Protein Reductase from Mycobacterium Tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6308</span>– <span class="NLM_lpage">6323</span>, <span class="refDoi"> DOI: 10.1021/jm060715y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060715y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVShs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6308-6323&author=X.+Heauthor=A.+Alianauthor=R.+Stroudauthor=P.+R.+Ortiz+de+Montellano&title=Pyrrolidine+Carboxamides+as+a+Novel+Class+of+Inhibitors+of+Enoyl+Acyl+Carrier+Protein+Reductase+from+Mycobacterium+Tuberculosis&doi=10.1021%2Fjm060715y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrolidine Carboxamides as a Novel Class of Inhibitors of Enoyl Acyl Carrier Protein Reductase from Mycobacterium tuberculosis</span></div><div class="casAuthors">He, Xin; Alian, Akram; Stroud, Robert; Ortiz de Montellano, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6308-6323</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In view of the worldwide spread of multidrug resistance of Mycobacterium tuberculosis, there is an urgent need to discover antituberculosis agent with novel structures.  InhA, the enoyl acyl carrier protein reductase (ENR) from M. tuberculosis, is one of the key enzymes involved in the mycobacterial fatty acid elongation cycle and has been validated as an effective antimicrobial target.  We report here the discovery, through high-throughput screening, of a series of pyrrolidine carboxamides as a novel class of potent InhA inhibitors.  Crystal structures of InhA complexed with three inhibitors have been used to elucidate the inhibitor binding mode.  The potency of the lead compd. was improved over 160-fold by subsequent optimization through iterative microtiter library synthesis followed by in situ activity screening without purifn.  Resoln. of racemic mixts. of several inhibitors indicate that only one enantiomer is active as an inhibitor of InhA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrldntzbtEtUbVg90H21EOLACvtfcHk0li1sl7PKs8frg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVShs7rJ&md5=582fb6b1da8f9fcbe78c5cb679ce498b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm060715y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060715y%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DAlian%26aufirst%3DA.%26aulast%3DStroud%26aufirst%3DR.%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DP.%2BR.%26atitle%3DPyrrolidine%2520Carboxamides%2520as%2520a%2520Novel%2520Class%2520of%2520Inhibitors%2520of%2520Enoyl%2520Acyl%2520Carrier%2520Protein%2520Reductase%2520from%2520Mycobacterium%2520Tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6308%26epage%3D6323%26doi%3D10.1021%2Fjm060715y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz de
Montellano, P. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase InhA by Arylamides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6649</span>– <span class="NLM_lpage">6658</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2Fj.bmc.2007.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=17723305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCisbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=6649-6658&author=X.+Heauthor=A.+Alianauthor=P.+R.+Ortiz+de%0AMontellano&title=Inhibition+of+the+Mycobacterium+Tuberculosis+Enoyl+Acyl+Carrier+Protein+Reductase+InhA+by+Arylamides&doi=10.1016%2Fj.bmc.2007.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides</span></div><div class="casAuthors">He, Xin; Alian, Akram; Ortiz de Montellano, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6649-6658</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">InhA, the enoyl acyl carrier protein reductase (ENR) from Mycobacterium tuberculosis, is one of the key enzymes involved in the type II fatty acid biosynthesis pathway of M. tuberculosis.  We report here the discovery, through high-throughput screening, of a series of arylamides as a novel class of potent InhA inhibitors.  These direct InhA inhibitors require no mycobacterial enzymic activation and thus circumvent the resistance mechanism to antitubercular prodrugs such as INH and ETA that is most commonly obsd. in drug-resistant clin. isolates.  The crystal structure of InhA complexed with one representative inhibitor reveals the binding mode of the inhibitor within the InhA active site.  Further optimization through a microtiter synthesis strategy followed by in situ activity screening led to the discovery of a potent InhA inhibitor with in vitro IC50 = 90 nM, representing a 34-fold potency improvement over the lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWuJ8KSbr69LVg90H21EOLACvtfcHk0li1sl7PKs8frg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCisbfO&md5=1fe4629f86c1b41640c6eeb2ab3324f4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DAlian%26aufirst%3DA.%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DP.%2BR.%26atitle%3DInhibition%2520of%2520the%2520Mycobacterium%2520Tuberculosis%2520Enoyl%2520Acyl%2520Carrier%2520Protein%2520Reductase%2520InhA%2520by%2520Arylamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D6649%26epage%3D6658%26doi%3D10.1016%2Fj.bmc.2007.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hameed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwas, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span> <span> </span><span class="NLM_article-title">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium Tuberculosis and Are Efficacious in Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9701</span>– <span class="NLM_lpage">9708</span>, <span class="refDoi"> DOI: 10.1021/jm401382v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401382v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9701-9708&author=P.+S.+Shirudeauthor=R.+Shandilauthor=C.+Sadlerauthor=M.+Naikauthor=V.+Hosagraharaauthor=S.+Hameedauthor=V.+Shindeauthor=C.+Bathulaauthor=V.+Humnabadkarauthor=N.+Kumarauthor=J.+Reddyauthor=V.+Pandugaauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=H.+Gardnerauthor=P.+Madhavapeddiauthor=V.+Ramachandranauthor=P.+Kaurauthor=A.+Narayanauthor=S.+Gupthaauthor=D.+Awasthyauthor=C.+Narayanauthor=J.+Mahadevaswamyauthor=K.+G.+Vishwasauthor=V.+Ahujaauthor=A.+Srivastavaauthor=K.+R.+Prabhakarauthor=S.+Bharathauthor=R.+Kaleauthor=M.+Ramaiahauthor=N.+R.+Choudhuryauthor=V.+K.+Sambandamurthyauthor=S.+Solapureauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Azaindoles%3A+Noncovalent+DprE1+Inhibitors+from+Scaffold+Morphing+Efforts%2C+Kill+Mycobacterium+Tuberculosis+and+Are+Efficacious+in+Vivo&doi=10.1021%2Fjm401382v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha; Sadler, Claire; Naik, Maruti; Hosagrahara, Vinayak; Hameed, Shahul; Shinde, Vikas; Bathula, Chandramohan; Humnabadkar, Vaishali; Kumar, Naveen; Reddy, Jitendar; Panduga, Vijender; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Whiteaker, James; McLaughlin, Robert E.; Gardner, Humphrey; Madhavapeddi, Prashanti; Ramachandran, Vasanthi; Kaur, Parvinder; Narayan, Ashwini; Guptha, Supreeth; Awasthy, Disha; Narayan, Chandan; Mahadevaswamy, Jyothi; Vishwas, K. G.; Ahuja, Vijaykamal; Srivastava, Abhishek; Prabhakar, K. R.; Bharath, Sowmya; Kale, Ramesh; Ramaiah, Manjunatha; Choudhury, Nilanjana Roy; Sambandamurthy, Vasan K.; Solapure, Suresh; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9701-9708</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report 1,4-azaindoles as a new inhibitor class that kills Mycobacterium tuberculosis in vitro and demonstrates efficacy in mouse tuberculosis models.  The series emerged from scaffold morphing efforts and was demonstrated to noncovalently inhibit decaprenylphosphoryl-β-d-ribose2'-epimerase (DprE1).  With "drug-like" properties and no expectation of pre-existing resistance in the clinic, this chem. class has the potential to be developed as a therapy for drug-sensitive and drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskQvJK4M2yrVg90H21EOLACvtfcHk0li1sl7PKs8frg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM&md5=eba42d1952b164f66fd0ca620aaa4f19</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401382v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401382v%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DHameed%26aufirst%3DS.%26aulast%3DShinde%26aufirst%3DV.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVishwas%26aufirst%3DK.%2BG.%26aulast%3DAhuja%26aufirst%3DV.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DKale%26aufirst%3DR.%26aulast%3DRamaiah%26aufirst%3DM.%26aulast%3DChoudhury%26aufirst%3DN.%2BR.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DAzaindoles%253A%2520Noncovalent%2520DprE1%2520Inhibitors%2520from%2520Scaffold%2520Morphing%2520Efforts%252C%2520Kill%2520Mycobacterium%2520Tuberculosis%2520and%2520Are%2520Efficacious%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9701%26epage%3D9708%26doi%3D10.1021%2Fjm401382v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Šink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosič, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Živec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Menendez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Gomez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Roman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales-Cortez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas-Triconado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell-Pages, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encinas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1021/jm501029r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501029r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOgsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=613-624&author=R.+%C5%A0inkauthor=I.+Sosi%C4%8Dauthor=M.+%C5%BDivecauthor=R.+Fernandez-Menendezauthor=S.+Turkauthor=S.+Pajkauthor=D.+Alvarez-Gomezauthor=E.+M.+Lopez-Romanauthor=C.+Gonzales-Cortezauthor=J.+Rullas-Triconadoauthor=I.+Angulo-Barturenauthor=D.+Barrosauthor=L.+Ballell-Pagesauthor=R.+J.+Youngauthor=L.+Encinasauthor=S.+Gobec&title=Design%2C+Synthesis%2C+and+Evaluation+of+New+Thiadiazole-Based+Direct+Inhibitors+of+Enoyl+Acyl+Carrier+Protein+Reductase+%28InhA%29+for+the+Treatment+of+Tuberculosis&doi=10.1021%2Fjm501029r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis</span></div><div class="casAuthors">Sink, Roman; Sosic, Izidor; Zivec, Matej; Fernandez-Menendez, Raquel; Turk, Samo; Pajk, Stane; Alvarez-Gomez, Daniel; Lopez-Roman, Eva Maria; Gonzales-Cortez, Carolina; Rullas-Triconado, Joaquin; Angulo-Barturen, Inigo; Barros, David; Ballell-Pages, Lluis; Young, Robert J.; Encinas, Lourdes; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">613-624</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mycobacterial enoyl acyl carrier protein reductase (InhA) is a clin. validated target for the treatment of tuberculosis infections, a disease that still causes the death of at least a million people annually.  A known class of potent, direct, and competitive InhA inhibitors based on a tetracyclic thiadiazole structure has been shown to have in vivo activity in murine models of tuberculosis infection.  On the basis of this template, we have here explored the medicinal chem. of truncated analogs that have only three arom. rings.  In particular, compds. I [Aryl = 6-methyl-2-pyridyl, 6-bromo-2-pyridyl (8d), 6-(trifluoromethyl)-2-pyridyl, 5-bromo-2-pyridyl and 5-bromo-6-(trifluoromethyl)-2-pyridyl] show interesting features, including low nanomolar InhA IC50, submicromolar antimycobacterial potency, and improved physicochem. profiles in comparison with the tetracyclic analogs.  From this series, 8d is identified as having the best balance of potency and properties, whereby the resolved 8d S-enantiomer shows encouraging in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMhr0INTijhLVg90H21EOLACvtfcHk0lgbtcnXugKRUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOgsL3O&md5=01311420c022fc076432829c1b1896c8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm501029r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501029r%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0ink%26aufirst%3DR.%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3D%25C5%25BDivec%26aufirst%3DM.%26aulast%3DFernandez-Menendez%26aufirst%3DR.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DPajk%26aufirst%3DS.%26aulast%3DAlvarez-Gomez%26aufirst%3DD.%26aulast%3DLopez-Roman%26aufirst%3DE.%2BM.%26aulast%3DGonzales-Cortez%26aufirst%3DC.%26aulast%3DRullas-Triconado%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBallell-Pages%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DEncinas%26aufirst%3DL.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520New%2520Thiadiazole-Based%2520Direct%2520Inhibitors%2520of%2520Enoyl%2520Acyl%2520Carrier%2520Protein%2520Reductase%2520%2528InhA%2529%2520for%2520the%2520Treatment%2520of%2520Tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D613%26epage%3D624%26doi%3D10.1021%2Fjm501029r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guardia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulten, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullás, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mata, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuiñán, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell Pages, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Pichel, J.</span></span> <span> </span><span class="NLM_article-title">N-Benzyl-4-((Heteroaryl)Methyl)Benzamides: A New Class of Direct NADH-Dependent 2-Trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1002%2Fcmdc.201600020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=26934341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFelsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=687-701&author=A.+Guardiaauthor=G.+Gultenauthor=R.+Fernandezauthor=J.+G%C3%B3mezauthor=F.+Wangauthor=M.+Converyauthor=D.+Blancoauthor=M.+Mart%C3%ADnezauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=M.+Alonsoauthor=F.+Ortegaauthor=J.+Rull%C3%A1sauthor=D.+Calvoauthor=L.+Mataauthor=R.+Youngauthor=J.+C.+Sacchettiniauthor=A.+Mendoza-Losanaauthor=M.+Remui%C3%B1%C3%A1nauthor=L.+Ballell+Pagesauthor=J.+Castro-Pichel&title=N-Benzyl-4-%28%28Heteroaryl%29Methyl%29Benzamides%3A+A+New+Class+of+Direct+NADH-Dependent+2-Trans+Enoyl-Acyl+Carrier+Protein+Reductase+%28InhA%29+Inhibitors+with+Antitubercular+Activity&doi=10.1002%2Fcmdc.201600020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity</span></div><div class="casAuthors">Guardia, Ana; Gulten, Gulcin; Fernandez, Raquel; Gomez, Jesus; Wang, Feng; Convery, Maire; Blanco, Delia; Martinez, Maria; Perez-Herran, Esther; Alonso, Marta; Ortega, Fatima; Rullas, Joaquin; Calvo, David; Mata, Lydia; Young, Robert; Sacchettini, James C.; Mendoza-Losana, Alfonso; Remuinan, Modesto; Ballell Pages, Lluis; Castro-Pichel, Julia</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">687-701</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Isoniazid (INH) remains one of the cornerstones of antitubercular chemotherapy for drug-sensitive strains of M. tuberculosis bacteria.  However, the increasing prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains contg. mutations in the KatG enzyme, which is responsible for the activation of INH into its antitubercular form, have rendered this drug of little or no use in many cases of drug-resistant tuberculosis.  Presented herein is a novel family of antitubercular direct NADH-dependent 2-trans enoyl-acyl carrier protein reductase (InhA) inhibitors based on an N-benzyl-4-((heteroaryl)methyl)benzamide template; unlike INH, these do not require prior activation by KatG.  Given their direct InhA target engagement, these compds. should be able to circumvent KatG-related resistance in the clinic.  The lead mols. were shown to be potent inhibitors of InhA and showed activity against M. tuberculosis bacteria.  This new family of inhibitors was found to be chem. tractable, as exemplified by the facile synthesis of analogs and the establishment of structure-activity relationships.  Furthermore, a co-crystal structure of the initial hit with the enzyme is disclosed, providing valuable information toward the design of new InhA inhibitors for the treatment of MDR/XDR tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ9O80rhvxk7Vg90H21EOLACvtfcHk0lgbtcnXugKRUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFelsrg%253D&md5=205a15ef88b422a0371940b5180e440d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600020%26sid%3Dliteratum%253Aachs%26aulast%3DGuardia%26aufirst%3DA.%26aulast%3DGulten%26aufirst%3DG.%26aulast%3DFernandez%26aufirst%3DR.%26aulast%3DG%25C3%25B3mez%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DConvery%26aufirst%3DM.%26aulast%3DBlanco%26aufirst%3DD.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DRull%25C3%25A1s%26aufirst%3DJ.%26aulast%3DCalvo%26aufirst%3DD.%26aulast%3DMata%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DRemui%25C3%25B1%25C3%25A1n%26aufirst%3DM.%26aulast%3DBallell%2BPages%26aufirst%3DL.%26aulast%3DCastro-Pichel%26aufirst%3DJ.%26atitle%3DN-Benzyl-4-%2528%2528Heteroaryl%2529Methyl%2529Benzamides%253A%2520A%2520New%2520Class%2520of%2520Direct%2520NADH-Dependent%25202-Trans%2520Enoyl-Acyl%2520Carrier%2520Protein%2520Reductase%2520%2528InhA%2529%2520Inhibitors%2520with%2520Antitubercular%2520Activity%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D687%26epage%3D701%26doi%3D10.1002%2Fcmdc.201600020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pajk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Živec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosič, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Hoyos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Gómez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Ruíz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Pichel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell-Pages, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encinas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">New Direct Inhibitors of InhA with Antimycobacterial Activity Based on a Tetrahydropyran Scaffold</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2Fj.ejmech.2016.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=26900657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslCqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2016&pages=252-257&author=S.+Pajkauthor=M.+%C5%BDivecauthor=R.+%C5%A0inkauthor=I.+Sosi%C4%8Dauthor=M.+Neuauthor=C.+Chungauthor=M.+Mart%C3%ADnez-Hoyosauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=D.+%C3%81lvarez-G%C3%B3mezauthor=E.+%C3%81lvarez-Ru%C3%ADzauthor=A.+Mendoza-Losanaauthor=J.+Castro-Pichelauthor=D.+Barrosauthor=L.+Ballell-Pagesauthor=R.+J.+Youngauthor=M.+A.+Converyauthor=L.+Encinasauthor=S.+Gobec&title=New+Direct+Inhibitors+of+InhA+with+Antimycobacterial+Activity+Based+on+a+Tetrahydropyran+Scaffold&doi=10.1016%2Fj.ejmech.2016.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold</span></div><div class="casAuthors">Pajk, Stane; Zivec, Matej; Sink, Roman; Sosic, Izidor; Neu, Margarete; Chung, Chun-wa; Martinez-Hoyos, Maria; Perez-Herran, Esther; Alvarez-Gomez, Daniel; Alvarez-Ruiz, Emilio; Mendoza-Losana, Alfonso; Castro-Pichel, Julia; Barros, David; Ballell-Pages, Lluis; Young, Robert J.; Convery, Maire A.; Encinas, Lourdes; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-257</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Tetrahydropyran derivs. I [R1 = piperidinyl, morpholinyl, 3,5-di-Me pyrazolyl, etc; R2 = 4-methoxyphenyl, pyridinyl, 4-phenylthiazolyl,etc] were synthesized. the compd. I [R1 = 3,5-di-Me pyrazolyl; R2 = 4-phenylthiazolyl] was discovered in a high-throughput screening campaign to find new inhibitors of mycobacterial InhA.  Following initial in-vitro profiling, a structure-activity relationship study was initiated and a focused library of analogs was synthesized and evaluated.  This yielded compd. I [R1 = 3,5-di-Me pyrazolyl; R2 = 4-(2-methoxyphenyl)thiazolyl] with improved antimycobacterial activity and low cytotoxicity.  Addnl., the crystal structure of InhA in complex with inhibitor I [R1 = 3,5-di-Me pyrazolyl; R2 = 4-phenylthiazolyl] was resolved, to reveal the binding mode and provide hints for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHDO5sXoLHa7Vg90H21EOLACvtfcHk0lgOXf-X_7VxQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslCqsr4%253D&md5=1a18421ecbef975f0757e6bcc235e7ab</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DPajk%26aufirst%3DS.%26aulast%3D%25C5%25BDivec%26aufirst%3DM.%26aulast%3D%25C5%25A0ink%26aufirst%3DR.%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3DNeu%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DMart%25C3%25ADnez-Hoyos%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3D%25C3%2581lvarez-G%25C3%25B3mez%26aufirst%3DD.%26aulast%3D%25C3%2581lvarez-Ru%25C3%25ADz%26aufirst%3DE.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DCastro-Pichel%26aufirst%3DJ.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBallell-Pages%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DEncinas%26aufirst%3DL.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DNew%2520Direct%2520Inhibitors%2520of%2520InhA%2520with%2520Antimycobacterial%2520Activity%2520Based%2520on%2520a%2520Tetrahydropyran%2520Scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D112%26spage%3D252%26epage%3D257%26doi%3D10.1016%2Fj.ejmech.2016.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Hoyos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Herran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulten, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encinas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Gómez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Bazaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Pérez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas-Trincado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruano, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castañeda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menéndez, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González del Valle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorino-Gelo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Bustos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavandera, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Casabona, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Pichel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span> <span> </span><span class="NLM_article-title">Antitubercular Drugs for an Old Target: GSK693 as a Promising InhA Direct Inhibitor</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2016.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2Fj.ebiom.2016.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=27428438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A280%3ADC%252BC2s3hvVWksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=291-301&author=M.+Mart%C3%ADnez-Hoyosauthor=E.+Perez-Herranauthor=G.+Gultenauthor=L.+Encinasauthor=D.+%C3%81lvarez-G%C3%B3mezauthor=E.+Alvarezauthor=S.+Ferrer-Bazagaauthor=A.+Garc%C3%ADa-P%C3%A9rezauthor=F.+Ortegaauthor=I.+Angulo-Barturenauthor=J.+Rullas-Trincadoauthor=D.+B.+Ruanoauthor=P.+Torresauthor=P.+Casta%C3%B1edaauthor=S.+Hussauthor=R.+F.+Men%C3%A9ndezauthor=S.+Gonz%C3%A1lez+del+Valleauthor=L.+Ballellauthor=D.+Barrosauthor=S.+Modhaauthor=N.+Dharauthor=F.+Signorino-Geloauthor=J.+D.+McKinneyauthor=J.+F.+Garc%C3%ADa-Bustosauthor=J.+L.+Lavanderaauthor=J.+C.+Sacchettiniauthor=M.+S.+Jimenezauthor=N.+Mart%C3%ADn-Casabonaauthor=J.+Castro-Pichelauthor=A.+Mendoza-Losana&title=Antitubercular+Drugs+for+an+Old+Target%3A+GSK693+as+a+Promising+InhA+Direct+Inhibitor&doi=10.1016%2Fj.ebiom.2016.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor</span></div><div class="casAuthors">Martinez-Hoyos Maria; Perez-Herran Esther; Encinas Lourdes; Alvarez-Gomez Daniel; Alvarez Emilio; Ferrer-Bazaga Santiago; Garcia-Perez Adolfo; Ortega Fatima; Angulo-Barturen Inigo; Rullas-Trincado Joaquin; Blanco Ruano Delia; Torres Pedro; Castaneda Pablo; Huss Sophie; Fernandez Menendez Raquel; Gonzalez Del Valle Silvia; Ballell Lluis; Barros David; Garcia-Bustos Jose Francisco; Lavandera Jose Luis; Castro-Pichel Julia; Gulten Gulcin; Sacchettini James C; Modha Sundip; Signorino-Gelo Francois; McKinney John D; Dhar Neeraj; Jimenez M Soledad; Martin-Casabona Nuria; Mendoza-Losana Alfonso</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-301</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite being one of the first antitubercular agents identified, isoniazid (INH) is still the most prescribed drug for prophylaxis and tuberculosis (TB) treatment and, together with rifampicin, the pillars of current chemotherapy.  A high percentage of isoniazid resistance is linked to mutations in the pro-drug activating enzyme KatG, so the discovery of direct inhibitors (DI) of the enoyl-ACP reductase (InhA) has been pursued by many groups leading to the identification of different enzyme inhibitors, active against Mycobacterium tuberculosis (Mtb), but with poor physicochemical properties to be considered as preclinical candidates.  Here, we present a series of InhA DI active against multidrug (MDR) and extensively (XDR) drug-resistant clinical isolates as well as in TB murine models when orally dosed that can be a promising foundation for a future treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBKqsJCl5WvbZpSb_XWfMrfW6udTcc2ebPGCv5qVBbNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3hvVWksg%253D%253D&md5=21f1dbf20ad29185ba9c322829755ebb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2016.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2016.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Hoyos%26aufirst%3DM.%26aulast%3DPerez-Herran%26aufirst%3DE.%26aulast%3DGulten%26aufirst%3DG.%26aulast%3DEncinas%26aufirst%3DL.%26aulast%3D%25C3%2581lvarez-G%25C3%25B3mez%26aufirst%3DD.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DFerrer-Bazaga%26aufirst%3DS.%26aulast%3DGarc%25C3%25ADa-P%25C3%25A9rez%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DRullas-Trincado%26aufirst%3DJ.%26aulast%3DRuano%26aufirst%3DD.%2BB.%26aulast%3DTorres%26aufirst%3DP.%26aulast%3DCasta%25C3%25B1eda%26aufirst%3DP.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DR.%2BF.%26aulast%3DGonz%25C3%25A1lez%2Bdel%2BValle%26aufirst%3DS.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DModha%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DSignorino-Gelo%26aufirst%3DF.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DJimenez%26aufirst%3DM.%2BS.%26aulast%3DMart%25C3%25ADn-Casabona%26aufirst%3DN.%26aulast%3DCastro-Pichel%26aufirst%3DJ.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26atitle%3DAntitubercular%2520Drugs%2520for%2520an%2520Old%2520Target%253A%2520GSK693%2520as%2520a%2520Promising%2520InhA%2520Direct%2520Inhibitor%26jtitle%3DEBioMedicine%26date%3D2016%26volume%3D8%26spage%3D291%26epage%3D301%26doi%3D10.1016%2Fj.ebiom.2016.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkegian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolhiser, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruppo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaerts, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, MRK.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Cofactor-Independent Inhibitor of Mycobacterium Tuberculosis InhA</span>. <i>Life Sci. Alliance</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">e201800025</span> <span class="refDoi"> DOI: 10.26508/lsa.201800025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.26508%2Flsa.201800025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=30456352" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&author=Y.+Xiaauthor=Y.+Zhouauthor=D.+S.+Carterauthor=M.+B.+McNeilauthor=W.+Choiauthor=J.+Halladayauthor=P.+W.+Berryauthor=W.+Maoauthor=V.+Hernandezauthor=T.+O%E2%80%99Malleyauthor=A.+Korkegianauthor=B.+Sundeauthor=L.+Flintauthor=L.+K.+Woolhiserauthor=M.+S.+Shermanauthor=V.+Gruppoauthor=C.+Hastingsauthor=G.+T.+Robertsonauthor=T.+R.+Ioergerauthor=J.+Sacchettiniauthor=P.+J.+Tongeauthor=A.+Lenaertsauthor=T.+Parishauthor=MRK.+Alley&title=Discovery+of+a+Cofactor-Independent+Inhibitor+of+Mycobacterium+Tuberculosis+InhA&doi=10.26508%2Flsa.201800025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.26508%2Flsa.201800025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26508%252Flsa.201800025%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DCarter%26aufirst%3DD.%2BS.%26aulast%3DMcNeil%26aufirst%3DM.%2BB.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DP.%2BW.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DT.%26aulast%3DKorkegian%26aufirst%3DA.%26aulast%3DSunde%26aufirst%3DB.%26aulast%3DFlint%26aufirst%3DL.%26aulast%3DWoolhiser%26aufirst%3DL.%2BK.%26aulast%3DSherman%26aufirst%3DM.%2BS.%26aulast%3DGruppo%26aufirst%3DV.%26aulast%3DHastings%26aufirst%3DC.%26aulast%3DRobertson%26aufirst%3DG.%2BT.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26aulast%3DLenaerts%26aufirst%3DA.%26aulast%3DParish%26aufirst%3DT.%26aulast%3DAlley%26aufirst%3DMRK.%26atitle%3DDiscovery%2520of%2520a%2520Cofactor-Independent%2520Inhibitor%2520of%2520Mycobacterium%2520Tuberculosis%2520InhA%26jtitle%3DLife%2520Sci.%2520Alliance%26date%3D2018%26volume%3D1%26doi%3D10.26508%2Flsa.201800025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horlacher, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Pyridomycin Bridges the NADH- and Substrate-Binding Pockets of the Enoyl Reductase InhA</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1038%2Fnchembio.1405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=24292073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGru7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=96-98&author=R.+C.+Hartkoornauthor=F.+Pojerauthor=J.+A.+Readauthor=H.+Gingellauthor=J.+Neresauthor=O.+P.+Horlacherauthor=K.-H.+Altmannauthor=S.+T.+Cole&title=Pyridomycin+Bridges+the+NADH-+and+Substrate-Binding+Pockets+of+the+Enoyl+Reductase+InhA&doi=10.1038%2Fnchembio.1405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA</span></div><div class="casAuthors">Hartkoorn, Ruben C.; Pojer, Florence; Read, Jon A.; Gingell, Helen; Neres, Joao; Horlacher, Oliver P.; Altmann, Karl-Heinz; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">96-98</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pyridomycin, a natural product with potent antituberculosis activity, inhibits a major drug target, enoyl-ACP reductase InhA.  Here, the authors unveil the co-crystal structure and unique ability of pyridomycin to block both the NADH cofactor- and lipid substrate-binding pockets of InhA.  This is to the authors' knowledge a 1st-of-a-kind binding mode that discloses a new means of InhA inhibition.  Proof-of-principle studies showed how structure-assisted drug design could improve the activity of new pyridomycin derivs., OH 139 and OH 141.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDXuoCfd497Vg90H21EOLACvtfcHk0ljWz97wNqeZHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGru7jF&md5=14631b559d1d19a6fc3b06e7211a2cc8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1405%26sid%3Dliteratum%253Aachs%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DRead%26aufirst%3DJ.%2BA.%26aulast%3DGingell%26aufirst%3DH.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DHorlacher%26aufirst%3DO.%2BP.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DPyridomycin%2520Bridges%2520the%2520NADH-%2520and%2520Substrate-Binding%2520Pockets%2520of%2520the%2520Enoyl%2520Reductase%2520InhA%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D96%26epage%3D98%26doi%3D10.1038%2Fnchembio.1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, Y.</span></span> <span> </span><span class="NLM_article-title">Synthetic Studies of Pyridomycin. IV. Syntheses of Some Twelve-membered Ring Compounds Designed for Construction of Intact Ring System with Exocyclic (Z)-s-Butylidene Side Chain in Pyridomycin</span>. <i>Bull. Chem. Soc. Jpn.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3298</span>– <span class="NLM_lpage">3308</span>, <span class="refDoi"> DOI: 10.1246/bcsj.58.3298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1246%2Fbcsj.58.3298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaL28Xltlemu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1985&pages=3298-3308&author=M.+Kinoshitaauthor=Y.+Mori&title=Synthetic+Studies+of+Pyridomycin.+IV.+Syntheses+of+Some+Twelve-membered+Ring+Compounds+Designed+for+Construction+of+Intact+Ring+System+with+Exocyclic+%28Z%29-s-Butylidene+Side+Chain+in+Pyridomycin&doi=10.1246%2Fbcsj.58.3298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic studies of pyridomycin.  IV.  Syntheses of some twelve-membered ring compounds designed for construction of intact ring system with exocyclic (Z)-s-butylidene side chain in pyridomycin</span></div><div class="casAuthors">Kinoshita, Mitsuhiro; Mori, Yasuharu</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Chemical Society of Japan</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3298-308</span>CODEN:
                <span class="NLM_cas:coden">BCSJA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2673</span>.
    </div><div class="casAbstract">The (2R,1'S)-azadioxacyclododecanetriones (2R,1'S)-I (R = H, Me) and (2S,1'R)-I (R = Me) were enantiospecifically synthesized from carbohydrate and L-threonine derivs.  Attempts to convert I into a pyridomycin precursor with the 2-(Z)-sec-butylidene side chain were unsuccessful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDWige9hxTM7Vg90H21EOLACvtfcHk0ljWz97wNqeZHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xltlemu7w%253D&md5=76a18369d6edb13ee10085e10417a0fc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.58.3298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.58.3298%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DY.%26atitle%3DSynthetic%2520Studies%2520of%2520Pyridomycin.%2520IV.%2520Syntheses%2520of%2520Some%2520Twelve-membered%2520Ring%2520Compounds%2520Designed%2520for%2520Construction%2520of%2520Intact%2520Ring%2520System%2520with%2520Exocyclic%2520%2528Z%2529-s-Butylidene%2520Side%2520Chain%2520in%2520Pyridomycin%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1985%26volume%3D58%26spage%3D3298%26epage%3D3308%26doi%3D10.1246%2Fbcsj.58.3298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takarada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsuta, K.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis of Pyridomycin</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">7419</span>– <span class="NLM_lpage">7422</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)70713-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2FS0040-4039%2800%2970713-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFOhtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1989&pages=7419-7422&author=M.+Kinoshitaauthor=M.+Nakataauthor=K.+Takaradaauthor=K.+Tatsuta&title=Total+Synthesis+of+Pyridomycin&doi=10.1016%2FS0040-4039%2800%2970713-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic studies of pyridomycin.  V.  Total synthesis of pyridomycin</span></div><div class="casAuthors">Kinoshita, Mitsuhiro; Nakata, Masaya; Takarada, Kenji; Tatsuta, Kuniaki</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">7419-22</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The first total synthesis of pyridomycin (I) is described including the stereocontrolled construction of the exocyclic (Z)-s-butylidene moiety in the 12-membered ring system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCC1nkRMVkLVg90H21EOLACvtfcHk0ljWz97wNqeZHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFOhtLg%253D&md5=182dd97e25649179fa001cd5754613c4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2970713-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252970713-1%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DM.%26aulast%3DNakata%26aufirst%3DM.%26aulast%3DTakarada%26aufirst%3DK.%26aulast%3DTatsuta%26aufirst%3DK.%26atitle%3DTotal%2520Synthesis%2520of%2520Pyridomycin%26jtitle%3DTetrahedron%2520Lett.%26date%3D1989%26volume%3D30%26spage%3D7419%26epage%3D7422%26doi%3D10.1016%2FS0040-4039%2800%2970713-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horlacher, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K.-H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antimycobacterial Activity of 2,1′-Dihydropyridomycins</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1021/ml300385q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300385q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCqsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=264-268&author=O.+P.+Horlacherauthor=R.+C.+Hartkoornauthor=S.+T.+Coleauthor=K.-H.+Altmann&title=Synthesis+and+Antimycobacterial+Activity+of+2%2C1%E2%80%B2-Dihydropyridomycins&doi=10.1021%2Fml300385q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antimycobacterial Activity of 2,1'-Dihydropyridomycins</span></div><div class="casAuthors">Horlacher, Oliver P.; Hartkoorn, Ruben C.; Cole, Stewart T.; Altmann, Karl-Heinz</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-268</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dihydropyridomycins 2 and 3 (II, 2R and 2S, resp.), which lack the characteristic enol ester moiety of the potent antimycobacterial natural product pyridomycin 1 (I), have been prepd. from L-Thr, R- and S-hydroxy isovaleric acid, and 3-pyridinecarboxaldehyde.  The 2R isomer 2 shows only 4-fold lower anti-Mtb activity than 1, indicating that the enol ester moiety in the natural product is not crit. for its biol. activity.  This finding establishes 2 as a potent and more practical lead for anti-TB drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Dm4UKBOKirVg90H21EOLACvtfcHk0lhDizogzP71Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCqsLvF&md5=2b81e23c2b644a1c23cc9c17feb68f30</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml300385q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300385q%26sid%3Dliteratum%253Aachs%26aulast%3DHorlacher%26aufirst%3DO.%2BP.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DAltmann%26aufirst%3DK.-H.%26atitle%3DSynthesis%2520and%2520Antimycobacterial%2520Activity%2520of%25202%252C1%25E2%2580%25B2-Dihydropyridomycins%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D264%26epage%3D268%26doi%3D10.1021%2Fml300385q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inanaga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, M.</span></span> <span> </span><span class="NLM_article-title">A Rapid Esterification by Means of Mixed Anhydride and Its Application to Large-Ring Lactonization</span>. <i>Bull. Chem. Soc. Jpn.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1989</span>– <span class="NLM_lpage">1993</span>, <span class="refDoi"> DOI: 10.1246/bcsj.52.1989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1246%2Fbcsj.52.1989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaE1MXltl2rt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1979&pages=1989-1993&author=J.+Inanagaauthor=K.+Hirataauthor=H.+Saekiauthor=T.+Katsukiauthor=M.+Yamaguchi&title=A+Rapid+Esterification+by+Means+of+Mixed+Anhydride+and+Its+Application+to+Large-Ring+Lactonization&doi=10.1246%2Fbcsj.52.1989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid esterification by mixed anhydride and its application to large-ring lactonization</span></div><div class="casAuthors">Inanaga, Junji; Hirata, Kuniko; Saeki, Hiroko; Katsuki, Tsutomu; Yamaguchi, Masaru</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Chemical Society of Japan</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1989-93</span>CODEN:
                <span class="NLM_cas:coden">BCSJA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2673</span>.
    </div><div class="casAbstract">A rapid and mild esterification method using carboxylic 2,4,6-trichlorobenzoic anhydrides in the presence of 4-(dimethylamino)pyridine was developed.  The method was also successfully applied to the synthesis of large-ring lactones, including DL-2,4,6-tridemethyl-3-deoxymethynolide (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwvGlZSKrReLVg90H21EOLACvtfcHk0lhDizogzP71Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXltl2rt78%253D&md5=73880dc7e3aebc06844628a0e9ff6a68</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.52.1989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.52.1989%26sid%3Dliteratum%253Aachs%26aulast%3DInanaga%26aufirst%3DJ.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DSaeki%26aufirst%3DH.%26aulast%3DKatsuki%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DM.%26atitle%3DA%2520Rapid%2520Esterification%2520by%2520Means%2520of%2520Mixed%2520Anhydride%2520and%2520Its%2520Application%2520to%2520Large-Ring%2520Lactonization%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1979%26volume%3D52%26spage%3D1989%26epage%3D1993%26doi%3D10.1246%2Fbcsj.52.1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-L.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Characterization and Activity of New Phosphonate Dipeptides as Potential Inhibitors of VanX</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.10.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2Fj.bmcl.2011.10.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=22113110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=482-484&author=C.+Jiaauthor=K.-W.+Yangauthor=C.-C.+Liuauthor=L.+Fengauthor=J.-M.+Xiaoauthor=L.-S.+Zhouauthor=Y.-L.+Zhang&title=Synthesis%2C+Characterization+and+Activity+of+New+Phosphonate+Dipeptides+as+Potential+Inhibitors+of+VanX&doi=10.1016%2Fj.bmcl.2011.10.094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization and activity of new phosphonate dipeptides as potential inhibitors of VanX</span></div><div class="casAuthors">Jia, Chao; Yang, Ke-Wu; Liu, Cheng-Cheng; Feng, Lei; Xiao, Jian-Min; Zhou, Li-Sheng; Zhang, Yi-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">482-484</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">VanX, a Zn(II)-dependent D-Ala-D-Ala dipeptidase, is essential for vancomycin resistance in Enterococcus faecium.  The enzymic activity of VanX was previously found to be inhibited competitively by 2-{[(1-aminoethyl)(hydroxy) phosphoryl]oxy}propanoic acid.  Here we report the synthesis and characterization of seven phosphonate dipeptide analogs of D-Ala-D-Ala with various substituents, the activity evaluation indicated that six of these phosphonate analogs inhibit VanX with IC50 of 0.48-8.21 mM.  These data revealed a structure-activity relationship which is that the large substituent group on β-carbon resulted in low binding affinity of the phosphonate analog to VanX.  This information will be helpful to guide the design and synthesis of the tightly-binding inhibitors for VanX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9a3BvD2RYQLVg90H21EOLACvtfcHk0lhDizogzP71Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVymug%253D%253D&md5=3625bbfc09d5a815315edbf03675a78c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.094%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DK.-W.%26aulast%3DLiu%26aufirst%3DC.-C.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DJ.-M.%26aulast%3DZhou%26aufirst%3DL.-S.%26aulast%3DZhang%26aufirst%3DY.-L.%26atitle%3DSynthesis%252C%2520Characterization%2520and%2520Activity%2520of%2520New%2520Phosphonate%2520Dipeptides%2520as%2520Potential%2520Inhibitors%2520of%2520VanX%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D482%26epage%3D484%26doi%3D10.1016%2Fj.bmcl.2011.10.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapuis, J.-C.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic Agents. 571. Total Synthesis of Bacillistatin 2</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1021/np800607x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np800607x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVChtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=372-379&author=G.+R.+Pettitauthor=S.+Huauthor=J.+C.+Knightauthor=J.-C.+Chapuis&title=Antineoplastic+Agents.+571.+Total+Synthesis+of+Bacillistatin+2&doi=10.1021%2Fnp800607x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic Agents. 571. Total Synthesis of Bacillistatin 2</span></div><div class="casAuthors">Pettit, George R.; Hu, Shougang; Knight, John C.; Chapuis, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">372-379</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The cyclic peptide macrolactone/macrolactam bacillistatin 2 I is prepd. for the first time using a convergent route in 24 steps and 22.9% overall yield; the synthesis uses the Mitsunobu reactions of oligopeptides terminated with hydroxy acids with oligopeptides and a 2-methyl-6-nitrobenzoic acid anhydride-mediated macrolactonization reaction as the key steps.  I and intermediates and side products in its synthesis are tested for their anticancer activities in human cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJOCvETQNNRLVg90H21EOLACvtfcHk0lhDizogzP71Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVChtbg%253D&md5=e51e11fefa7a04ca25aca208b669e687</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fnp800607x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp800607x%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DKnight%26aufirst%3DJ.%2BC.%26aulast%3DChapuis%26aufirst%3DJ.-C.%26atitle%3DAntineoplastic%2520Agents.%2520571.%2520Total%2520Synthesis%2520of%2520Bacillistatin%25202%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2009%26volume%3D72%26spage%3D372%26epage%3D379%26doi%3D10.1021%2Fnp800607x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glomb, M. A.</span></span> <span> </span><span class="NLM_article-title">Degradation of 1-Deoxy-d-erythro-hexo-2,3-diulose in the Presence of Lysine Leads to Formation of Carboxylic Acid Amides</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6458</span>– <span class="NLM_lpage">6464</span>, <span class="refDoi"> DOI: 10.1021/jf100334r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf100334r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=6458-6464&author=M.+Smudaauthor=M.+Voigtauthor=M.+A.+Glomb&title=Degradation+of+1-Deoxy-d-erythro-hexo-2%2C3-diulose+in+the+Presence+of+Lysine+Leads+to+Formation+of+Carboxylic+Acid+Amides&doi=10.1021%2Fjf100334r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Degradation of 1-Deoxy-D-erythro-hexo-2,3-diulose in the Presence of Lysine Leads to Formation of Carboxylic Acid Amides</span></div><div class="casAuthors">Smuda, Mareen; Voigt, Michael; Glomb, Marcus A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6458-6464</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel species of amides formed from degrdn. of one of the most important key intermediates in Maillard hexose chem.-1-deoxyhexo-2,3-diulose-was investigated.  In 1-deoxyhexo-2,3-diulose/Nα-t-BOC-lysine reaction mixts. four amides, Nε-acetyl lysine, Nε-formyl lysine, Nε-lactoyl lysine and Nε-glycerinyl lysine, were identified and their structures verified by authentic ref. stds.  Amides and corresponding carboxylic acids (acetic acid, formic acid, lactic acid and glyceric acid) accumulated over time.  Both Nε-lysine amides and carboxylic acids were thus detd. as stable Maillard end products.  Results of model incubations suggested the synthesis of amides to be mechanistically closely related to the formation of their corresponding carboxylic acids by β-dicarbonyl cleavage.  Due to the different chem. properties of all the compds. monitored, various anal. strategies had to be carried out (LC-MS2, GC-MS, GC-FID, enzymic detn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRT5jjS82mPrVg90H21EOLACvtfcHk0lioDRhqtKeiTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSksLs%253D&md5=2e705fef5fb43ad59898f897ff3ee6f0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjf100334r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf100334r%26sid%3Dliteratum%253Aachs%26aulast%3DSmuda%26aufirst%3DM.%26aulast%3DVoigt%26aufirst%3DM.%26aulast%3DGlomb%26aufirst%3DM.%2BA.%26atitle%3DDegradation%2520of%25201-Deoxy-d-erythro-hexo-2%252C3-diulose%2520in%2520the%2520Presence%2520of%2520Lysine%2520Leads%2520to%2520Formation%2520of%2520Carboxylic%2520Acid%2520Amides%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2010%26volume%3D58%26spage%3D6458%26epage%3D6464%26doi%3D10.1021%2Fjf100334r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Au, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jwad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhadbhade, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, L.</span></span> <span> </span><span class="NLM_article-title">Scalable, Stereoselective Syntheses of α,β-Difluoro-γ-Amino Acids</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">3305</span>– <span class="NLM_lpage">3317</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2016.04.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2Fj.tet.2016.04.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslWkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=3305-3317&author=A.+R.+Patelauthor=X.-G.+Huauthor=A.+Lawerauthor=M.+I.+Ahmedauthor=C.+Auauthor=R.+Jwadauthor=J.+Trinhauthor=C.+Gonzalezauthor=E.+Hannahauthor=M.+M.+Bhadbhadeauthor=L.+Hunter&title=Scalable%2C+Stereoselective+Syntheses+of+%CE%B1%2C%CE%B2-Difluoro-%CE%B3-Amino+Acids&doi=10.1016%2Fj.tet.2016.04.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Scalable, stereoselective syntheses of α,β-difluoro-γ-amino acids</span></div><div class="casAuthors">Patel, Alpesh Ramanlal; Hu, Xiang-Guo; Lawer, Aggie; Ahmed, Md. Iqbal; Au, Catherine; Jwad, Rasha; Trinh, Johny; Gonzalez, Christina; Hannah, Elizabeth; Bhadbhade, Mohan M.; Hunter, Luke</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3305-3317</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Backbone-fluorinated gamma-amino acids are novel shape-controlled building blocks that have potential utility in a variety of biol. contexts.  However, their synthesis poses challenges in terms of chemo-, regio- and stereoselectivity, and this has proven to be the major bottleneck in the ongoing development of their various biol. applications.  To address this problem, several new synthetic strategies were investigated in this work.  This has led to the identification of new methods that are superior in terms of yield and stereocontrol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoROZ0ZiZzOMbVg90H21EOLACvtfcHk0lioDRhqtKeiTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslWkt70%253D&md5=8d3dc6a87951d80c1168b2b6cb3fd0a5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2016.04.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2016.04.070%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%2BR.%26aulast%3DHu%26aufirst%3DX.-G.%26aulast%3DLawer%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DM.%2BI.%26aulast%3DAu%26aufirst%3DC.%26aulast%3DJwad%26aufirst%3DR.%26aulast%3DTrinh%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DC.%26aulast%3DHannah%26aufirst%3DE.%26aulast%3DBhadbhade%26aufirst%3DM.%2BM.%26aulast%3DHunter%26aufirst%3DL.%26atitle%3DScalable%252C%2520Stereoselective%2520Syntheses%2520of%2520%25CE%25B1%252C%25CE%25B2-Difluoro-%25CE%25B3-Amino%2520Acids%26jtitle%3DTetrahedron%26date%3D2016%26volume%3D72%26spage%3D3305%26epage%3D3317%26doi%3D10.1016%2Fj.tet.2016.04.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borhan, B.</span></span> <span> </span><span class="NLM_article-title">Prompt Determination of Absolute Configuration for Epoxy Alcohols via Exciton Chirality Protocol</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">16126</span>– <span class="NLM_lpage">16127</span>, <span class="refDoi"> DOI: 10.1021/ja805058t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja805058t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=16126-16127&author=X.+Liauthor=B.+Borhan&title=Prompt+Determination+of+Absolute+Configuration+for+Epoxy+Alcohols+via+Exciton+Chirality+Protocol&doi=10.1021%2Fja805058t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Prompt Determination of Absolute Configuration for Epoxy Alcohols via Exciton Chirality Protocol</span></div><div class="casAuthors">Li, Xiaoyong; Borhan, Babak</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">16126-16127</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A microscale protocol for detn. of abs. configurations of 2,3-epoxy alcs. is described.  2,3-Disubstituted (cis and trans), 2,2-disubstituted, 2,2,3-trisubstituted, and 2,3,3-trisubstituted epoxy alcs. rendered prominent ECCD signals upon complexing with a Lewis acidic porphyrin tweezer and consequently provide straightforward assignment of chirality for epoxy alcs.  This method proved to be rapid, simple, sensitive, and reliable for the class of mols. listed above.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb0BmDUX9r8rVg90H21EOLACvtfcHk0lioDRhqtKeiTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGku7fM&md5=221ce1aa464930238ee7b3bdf9aaf04a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fja805058t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja805058t%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBorhan%26aufirst%3DB.%26atitle%3DPrompt%2520Determination%2520of%2520Absolute%2520Configuration%2520for%2520Epoxy%2520Alcohols%2520via%2520Exciton%2520Chirality%2520Protocol%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D16126%26epage%3D16127%26doi%3D10.1021%2Fja805058t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pastó, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pericàs, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riera, A.</span></span> <span> </span><span class="NLM_article-title">A Catalytic Asymmetric Synthesis of N-Boc-β-Methylphenylalanines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8425</span>– <span class="NLM_lpage">8431</span>, <span class="refDoi"> DOI: 10.1021/jo971178f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971178f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1CjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=8425-8431&author=M.+Past%C3%B3author=A.+Moyanoauthor=M.+A.+Peric%C3%A0sauthor=A.+Riera&title=A+Catalytic+Asymmetric+Synthesis+of+N-Boc-%CE%B2-Methylphenylalanines&doi=10.1021%2Fjo971178f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A Catalytic Asymmetric Synthesis of N-Boc-β-Methylphenylalanines</span></div><div class="casAuthors">Pasto, Mireia; Moyano, Albert; Pericas, Miquel A.; Riera, Antoni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8425-8431</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient, stereodivergent, and enantioselective synthesis of the syn and anti diastereomers of N-Boc-β-methylphenylalanine has been developed.  Starting from enantiomerically pure (2S,3S)-2,3-epoxy-3-phenyl-1-propanol, a three-step sequence, consisting of the oxidn. of the primary alc. up to the carboxyl stage, ring opening of the epoxy acid with Me2CuCNLi2, and esterification of the resulting hydroxy acid with Me iodide, leads to the hydroxy ester anti-I, which has been converted in a stereodivergent manner into both the (2S,3R) and the (2R,3R) diastereomers of N-Boc-β-methylphenylalanine, syn-II and anti-III, resp.  Activation of the secondary hydroxy group in anti-I as a mesylate, followed by nucleophilic displacement with sodium azide, hydrogenolysis with simultaneous protection of the amino group, and sapon. with LiOH, affords syn-II.  The same reaction sequence applied to syn-IV, obtained in turn by Mitsunobu reaction of anti-I with p-nitrobenzoic acid followed by the hydrolysis of the resulting p-nitrobenzoate, leads to anti-III.  Both products have been obtained with 99% enantiomeric excess.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq36Eoz9gFFg7Vg90H21EOLACvtfcHk0ljj-TKTKVb5kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1CjtL4%253D&md5=f0c4865a7054e9b813872fb47dbf8da0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo971178f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971178f%26sid%3Dliteratum%253Aachs%26aulast%3DPast%25C3%25B3%26aufirst%3DM.%26aulast%3DMoyano%26aufirst%3DA.%26aulast%3DPeric%25C3%25A0s%26aufirst%3DM.%2BA.%26aulast%3DRiera%26aufirst%3DA.%26atitle%3DA%2520Catalytic%2520Asymmetric%2520Synthesis%2520of%2520N-Boc-%25CE%25B2-Methylphenylalanines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D8425%26epage%3D8431%26doi%3D10.1021%2Fjo971178f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomioka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozaki, H.</span></span> <span> </span><span class="NLM_article-title">Regio- and Stereoselective Ring Opening of Epoxy Alcohols with Organoaluminium Compounds Leading to 1,2-Diols</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3597</span>– <span class="NLM_lpage">3600</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)87680-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2FS0040-4039%2800%2987680-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaL3sXltlWhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1982&pages=3597-3600&author=T.+Suzukiauthor=H.+Saimotoauthor=H.+Tomiokaauthor=K.+Oshimaauthor=H.+Nozaki&title=Regio-+and+Stereoselective+Ring+Opening+of+Epoxy+Alcohols+with+Organoaluminium+Compounds+Leading+to+1%2C2-Diols&doi=10.1016%2FS0040-4039%2800%2987680-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Regio- and stereoselective ring opening of epoxy alcohols with organoaluminum compounds leading to 1,2-diols</span></div><div class="casAuthors">Suzuki, Toshifumi; Saimoto, Hiroyuki; Tomioka, Hiroki; Oshima, Koichiro; Nozaki, Hitosi</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">3597-600</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">Ring cleavage of epoxy alcs. with organoaluminum compds. introduced alkyl, alkynyl, or hydride regioselectively at the 3 position with inversion of configuration.  E.g., reaction of epoxide I with Me3Al in hexane at 0° for 30 min gave 94% diol II.  The reaction mechanism involves initial conversion of the OH group into Al alkoxide followed by coordination of the epoxy O to the Al and C-3-O bond cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorxaCjHwNy7rVg90H21EOLACvtfcHk0ljj-TKTKVb5kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXltlWhsA%253D%253D&md5=7cbec96e1a09c8f5a6cc7e8e012935e3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2987680-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252987680-7%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DSaimoto%26aufirst%3DH.%26aulast%3DTomioka%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DNozaki%26aufirst%3DH.%26atitle%3DRegio-%2520and%2520Stereoselective%2520Ring%2520Opening%2520of%2520Epoxy%2520Alcohols%2520with%2520Organoaluminium%2520Compounds%2520Leading%2520to%25201%252C2-Diols%26jtitle%3DTetrahedron%2520Lett.%26date%3D1982%26volume%3D23%26spage%3D3597%26epage%3D3600%26doi%3D10.1016%2FS0040-4039%2800%2987680-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swern, D.</span></span> <span> </span><span class="NLM_article-title">Oxidation of Alcohols by “Activated” Dimethyl Sulfoxide. a Preparative, Steric and Mechanistic Study</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1651</span>– <span class="NLM_lpage">1660</span>, <span class="refDoi"> DOI: 10.1016/0040-4020(78)80197-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2F0040-4020%2878%2980197-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaE1MXos1Cjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1978&pages=1651-1660&author=K.+Omuraauthor=D.+Swern&title=Oxidation+of+Alcohols+by+%E2%80%9CActivated%E2%80%9D+Dimethyl+Sulfoxide.+a+Preparative%2C+Steric+and+Mechanistic+Study&doi=10.1016%2F0040-4020%2878%2980197-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of alcohols by "activated" dimethyl sulfoxide.  A preparative steric and mechanistic study</span></div><div class="casAuthors">Omura, Kanji; Swern, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1651-60</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">The oxidn. of allylic and arom. alcs., cycloalkanols and alkanols with Me2SO activated by electrophiles to give carbonyl compds., was studied.  Paths for carbonyl and by-product formation are presented.  In general, yields of carbonyl compds. increased with increased steric hindrance in the alcs.  Steric effects of tertiary amines on the oxidns. were also studied.  With (COCl)2 as activator, yields of carbonyl compds. were generally >95%.  E.g., oxidn. of PhCH:CHCH2OH with Me2SO/(COCl)2 gave 100% PhCH:CHCHO.  High yields were also obtained using SOCl2 as activator.  ROCH2SMe [R = Me(CH2)9, Me(CH2)5CHMe, cyclohexyl, Ph(CH2)2, trans-PrCH:CHCH2] were prepd. (60-70%) by treatment of ROH with Me2SO/NEt3 contg. BF3.Et2O.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojfAH5e5aTWbVg90H21EOLACvtfcHk0ljj-TKTKVb5kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXos1Cjtg%253D%253D&md5=b242305766e00a62b9220db412ca84ce</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0040-4020%2878%2980197-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4020%252878%252980197-5%26sid%3Dliteratum%253Aachs%26aulast%3DOmura%26aufirst%3DK.%26aulast%3DSwern%26aufirst%3DD.%26atitle%3DOxidation%2520of%2520Alcohols%2520by%2520%25E2%2580%259CActivated%25E2%2580%259D%2520Dimethyl%2520Sulfoxide.%2520a%2520Preparative%252C%2520Steric%2520and%2520Mechanistic%2520Study%26jtitle%3DTetrahedron%26date%3D1978%26volume%3D34%26spage%3D1651%26epage%3D1660%26doi%3D10.1016%2F0040-4020%2878%2980197-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span> <span> </span><span class="NLM_article-title">Synthetic Studies toward Verrucarol. 1. Synthesis of the AB Ring System</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4820</span>– <span class="NLM_lpage">4825</span>, <span class="refDoi"> DOI: 10.1021/jo01312a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01312a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaL3MXkslGhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=4820-4825&author=G.+A.+Krausauthor=B.+Roth&title=Synthetic+Studies+toward+Verrucarol.+1.+Synthesis+of+the+AB+Ring+System&doi=10.1021%2Fjo01312a003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic studies toward verrucarol.  1.  Synthesis of the AB ring system</span></div><div class="casAuthors">Kraus, George A.; Frazier, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4820-5</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The hydroxy ketone I, a synthon for verrucarol, was prepd. in 7.9% yield in 9 steps via the Diels-Alder adduct II (R = R1 = H) of isoprene and Me 2-oxo-2H-pyran-5-carboxylate (III).  Transformation of II (R = R1 = H) into the hydroxy lactone II (R = OH, R1 = Me) involved Me2CuLi addn., hydroxylation, and oxidn. with N-chlorosuccinimide.  Enol ether formation, redn. of the lactone and ester functions, and hydrolysis of the enol ether gave I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX8vamd2KLq7Vg90H21EOLACvtfcHk0ljj_mXUkgh6WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkslGhsA%253D%253D&md5=039aa698f645d2c1c8a247c8e666b07f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo01312a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01312a003%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DG.%2BA.%26aulast%3DRoth%26aufirst%3DB.%26atitle%3DSynthetic%2520Studies%2520toward%2520Verrucarol.%25201.%2520Synthesis%2520of%2520the%2520AB%2520Ring%2520System%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D4820%26epage%3D4825%26doi%3D10.1021%2Fjo01312a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taschner, M. J.</span></span> <span> </span><span class="NLM_article-title">Model Studies for the Synthesis of Quassinoids. 1. Construction of the BCE Ring System</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1176</span>, <span class="refDoi"> DOI: 10.1021/jo01294a058</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01294a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaL3cXhs1Cis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=1175-1176&author=G.+A.+Krausauthor=M.+J.+Taschner&title=Model+Studies+for+the+Synthesis+of+Quassinoids.+1.+Construction+of+the+BCE+Ring+System&doi=10.1021%2Fjo01294a058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Model studies for the synthesis of quassinoids.  1.  Construction of the BCE ring system</span></div><div class="casAuthors">Kraus, George A.; Taschner, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1175-6</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The synthesis of a key intermediate I for the prepn. of quassimarin (II) is described.  The BC ring system is constructed using a Diels-Alder reaction involving the in situ generated carbomethoxybenzoquinone.  The E ring is introduced by a selenoetherification reaction.  The trans diaxial diol unit can be constructed by intramol. epoxide opening.  Attempts to open the epoxide with external nucleophiles failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXJGvgihSziLVg90H21EOLACvtfcHk0ljj_mXUkgh6WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhs1Cis70%253D&md5=9202fa3b893c40e56d1700545f3a3a3d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo01294a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01294a058%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DG.%2BA.%26aulast%3DTaschner%26aufirst%3DM.%2BJ.%26atitle%3DModel%2520Studies%2520for%2520the%2520Synthesis%2520of%2520Quassinoids.%25201.%2520Construction%2520of%2520the%2520BCE%2520Ring%2520System%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D1175%26epage%3D1176%26doi%3D10.1021%2Fjo01294a058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abiko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masamune, S.</span></span> <span> </span><span class="NLM_article-title">The Anti-Selective Boron-Mediated Asymmetric Aldol Reaction of Carboxylic Esters</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">2586</span>– <span class="NLM_lpage">2587</span>, <span class="refDoi"> DOI: 10.1021/ja963754f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja963754f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaK2sXitFSrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=2586-2587&author=A.+Abikoauthor=J.+Liuauthor=S.+Masamune&title=The+Anti-Selective+Boron-Mediated+Asymmetric+Aldol+Reaction+of+Carboxylic+Esters&doi=10.1021%2Fja963754f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The Anti-Selective Boron-Mediated Asymmetric Aldol Reaction of Carboxylic Esters</span></div><div class="casAuthors">Abiko, Atsushi; Liu, Ji-Feng; Masamune, Satoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2586-2587</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A highly efficient, reliable method for the diastereo- and enantioselective construction of the anti-3-hydroxy-2-methylcarbonyl system has been devised using 2-[benzyl(mesitylenesulfonyl)amino]-1-phenylpropyl propionate (I), which is readily derived from norephedrine.  The boron-mediated aldol reaction (dicyclohexylboron triflate and triethylamine) of I proceeded with excellent anti-selectivity (anti:syn >98:2) and diastereofacial selectivity for anti-isomers (>95:5).  The ease of the operation and the mildness of the boron aldol reaction render this aldol method truly practical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGNWl1_jyoQ7Vg90H21EOLACvtfcHk0ljj_mXUkgh6WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitFSrtLg%253D&md5=772b991a8905de20b6e80a70143b2a51</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja963754f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja963754f%26sid%3Dliteratum%253Aachs%26aulast%3DAbiko%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMasamune%26aufirst%3DS.%26atitle%3DThe%2520Anti-Selective%2520Boron-Mediated%2520Asymmetric%2520Aldol%2520Reaction%2520of%2520Carboxylic%2520Esters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D2586%26epage%3D2587%26doi%3D10.1021%2Fja963754f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, L. A.</span></span> <span> </span><span class="NLM_article-title">1-Hydroxy-7-Azabenzotriazole. An Efficient Peptide Coupling Additive</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4398</span>, <span class="refDoi"> DOI: 10.1021/ja00063a082</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00063a082" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaK3sXkslejurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1993&pages=4397-4398&author=L.+A.+Carpino&title=1-Hydroxy-7-Azabenzotriazole.+An+Efficient+Peptide+Coupling+Additive&doi=10.1021%2Fja00063a082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive</span></div><div class="casAuthors">Carpino, Louis A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4397-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The title compd. (HOAt) (I), the 7-aza analog of the well-known, currently most-often preferred peptide coupling additive 1-hydroxybenzotriazole (HOBt), speeds up the coupling process and reduces racemization relative to HOBt.  In addn., HOAt signals completion of the reaction by a color change.  Uronium salts incorporating HOAt in place of HOBt show similar advantages.  These reagents are more effective than HOBt analogs for hindered systems.  Racemization is reduced 25-50% over that obsd. with HOBt for a series of model peptide couplings.  The isomeric 4-aza-1-hydroxybenzotriazole also speeds up the coupling process, but it does not show the racemization inhibition shown by HOAt, thus suggesting the importance of neighboring group effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbpCTFVq8bzbVg90H21EOLACvtfcHk0ljj_mXUkgh6WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkslejurc%253D&md5=39c0adaddc5e2dd1c15032ad524f3b88</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja00063a082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00063a082%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DL.%2BA.%26atitle%3D1-Hydroxy-7-Azabenzotriazole.%2520An%2520Efficient%2520Peptide%2520Coupling%2520Additive%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1993%26volume%3D115%26spage%3D4397%26epage%3D4398%26doi%3D10.1021%2Fja00063a082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariyama, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of (2R, 3S, 4S)-4-Amino-3-Hydroxy-2-Methyl-5-(3-Pyridyl)Pentanoic Acid Present in Antibiotic Pyridomycin</span>. <i>Bull. Chem. Soc. Jpn.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2081</span>– <span class="NLM_lpage">2083</span>, <span class="refDoi"> DOI: 10.1246/bcsj.48.2081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1246%2Fbcsj.48.2081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaE2MXlsVOltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1975&pages=2081-2083&author=M.+Kinoshitaauthor=S.+Mariyama&title=Synthesis+of+%282R%2C+3S%2C+4S%29-4-Amino-3-Hydroxy-2-Methyl-5-%283-Pyridyl%29Pentanoic+Acid+Present+in+Antibiotic+Pyridomycin&doi=10.1246%2Fbcsj.48.2081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (2R,3S,4S)-4-amino-3-hydroxy-2-methyl-5-(3-pyridyl)pentanoic acid present in antibiotic pyridomycin</span></div><div class="casAuthors">Kinoshita, Mitsuhiro; Mariyama, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Chemical Society of Japan</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2081-3</span>CODEN:
                <span class="NLM_cas:coden">BCSJA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2673</span>.
    </div><div class="casAbstract">(2R,3S,4S)-4-amino-3-hydroxy-2-methyl-5-(3-pyridyl)pentanoic acid (I) was prepd. from II by hydrolysis and oxidn. with periodate-bromine in aq. HOAc.  5,6-Anhydro-1,2-O-isopropylidene-3-C-methyl-α-D-allofuranose (III) was prepd. from 3-deoxy-1,2;5,6-di-O-isopropylidene-3-C-methyl-α-D-allofuranose.  Regiospecific introduction of 3-pyridyl group to the C-6 of III was effected by 3-pyridyllithium and the product was converted to II by SN2 substitution reaction of the 5-mesylate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3r8kR052Q5rVg90H21EOLACvtfcHk0lifqaxrCsnyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXlsVOltbg%253D&md5=c4bb19cc2a9af823f47f37c6d18dd4ce</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.48.2081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.48.2081%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DM.%26aulast%3DMariyama%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520%25282R%252C%25203S%252C%25204S%2529-4-Amino-3-Hydroxy-2-Methyl-5-%25283-Pyridyl%2529Pentanoic%2520Acid%2520Present%2520in%2520Antibiotic%2520Pyridomycin%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1975%26volume%3D48%26spage%3D2081%26epage%3D2083%26doi%3D10.1246%2Fbcsj.48.2081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neises, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steglich, W.</span></span> <span> </span><span class="NLM_article-title">Simple Method for the Esterification of Carboxylic Acids</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1002/anie.197805221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1002%2Fanie.197805221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1978&pages=522-524&author=B.+Neisesauthor=W.+Steglich&title=Simple+Method+for+the+Esterification+of+Carboxylic+Acids&doi=10.1002%2Fanie.197805221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fanie.197805221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.197805221%26sid%3Dliteratum%253Aachs%26aulast%3DNeises%26aufirst%3DB.%26aulast%3DSteglich%26aufirst%3DW.%26atitle%3DSimple%2520Method%2520for%2520the%2520Esterification%2520of%2520Carboxylic%2520Acids%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1978%26volume%3D17%26spage%3D522%26epage%3D524%26doi%3D10.1002%2Fanie.197805221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portaels, F.</span></span> <span> </span><span class="NLM_article-title">Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium Tuberculosis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2720</span>– <span class="NLM_lpage">2722</span>, <span class="refDoi"> DOI: 10.1128/AAC.46.8.2720-2722.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1128%2FAAC.46.8.2720-2722.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=12121966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFGiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=2720-2722&author=J.-C.+Palominoauthor=A.+Martinauthor=M.+Camachoauthor=H.+Guerraauthor=J.+Swingsauthor=F.+Portaels&title=Resazurin+Microtiter+Assay+Plate%3A+Simple+and+Inexpensive+Method+for+Detection+of+Drug+Resistance+in+Mycobacterium+Tuberculosis&doi=10.1128%2FAAC.46.8.2720-2722.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis</span></div><div class="casAuthors">Palomino, Juan-Carlos; Martin, Anandi; Camacho, Mirtha; Guerra, Humberto; Swings, Jean; Portaels, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2720-2722</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A method for detecting multidrug-resistant Mycobacterium tuberculosis by using a redn. of resazurin is described.  Eighty clin. isolates were evaluated against isoniazid and rifampin; results at 7 days were compared with those of the proportion method.  Specificity and sensitivity were excellent.  The method is simple, inexpensive, and rapid and might be used with other antituberculosis drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCEstIM6doRbVg90H21EOLACvtfcHk0lifqaxrCsnyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFGiu7w%253D&md5=555848714bd1528e6a8eb913b5971c9a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.8.2720-2722.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.8.2720-2722.2002%26sid%3Dliteratum%253Aachs%26aulast%3DPalomino%26aufirst%3DJ.-C.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DCamacho%26aufirst%3DM.%26aulast%3DGuerra%26aufirst%3DH.%26aulast%3DSwings%26aufirst%3DJ.%26aulast%3DPortaels%26aufirst%3DF.%26atitle%3DResazurin%2520Microtiter%2520Assay%2520Plate%253A%2520Simple%2520and%2520Inexpensive%2520Method%2520for%2520Detection%2520of%2520Drug%2520Resistance%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D2720%26epage%3D2722%26doi%3D10.1128%2FAAC.46.8.2720-2722.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houben, E. N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geurtsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Punder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wever, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piersma, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daffé, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appelmelk, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitter, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Wel1, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, P. J.</span></span> <span> </span><span class="NLM_article-title">Direct Visualization by Cryo-EM of the Mycobacterial Capsular Layer: A Labile Structure Containing ESX-1-Secreted Proteins</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1000794</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1000794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1371%2Fjournal.ppat.1000794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=20221442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A280%3ADC%252BC3c7nsFSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&author=M.+Saniauthor=E.+N.+G.+Houbenauthor=J.+Geurtsenauthor=J.+Piersonauthor=K.+de+Punderauthor=M.+van+Zonauthor=B.+Weverauthor=S.+R.+Piersmaauthor=C.+R.+Jim%C3%A9nezauthor=M.+Daff%C3%A9author=B.+J.+Appelmelkauthor=W.+Bitterauthor=N.+van+der%0AWel1author=P.+J.+Peters&title=Direct+Visualization+by+Cryo-EM+of+the+Mycobacterial+Capsular+Layer%3A+A+Labile+Structure+Containing+ESX-1-Secreted+Proteins&doi=10.1371%2Fjournal.ppat.1000794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins</span></div><div class="casAuthors">Sani Musa; Houben Edith N G; Geurtsen Jeroen; Pierson Jason; de Punder Karin; van Zon Maaike; Wever Brigitte; Piersma Sander R; Jimenez Connie R; Daffe Mamadou; Appelmelk Ben J; Bitter Wilbert; van der Wel Nicole; Peters Peter J</div><div class="citationInfo"><span class="NLM_cas:title">PLoS pathogens</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1000794</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The cell envelope of mycobacteria, a group of Gram positive bacteria, is composed of a plasma membrane and a Gram-negative-like outer membrane containing mycolic acids.  In addition, the surface of the mycobacteria is coated with an ill-characterized layer of extractable, non-covalently linked glycans, lipids and proteins, collectively known as the capsule, whose occurrence is a matter of debate.  By using plunge freezing cryo-electron microscopy technique, we were able to show that pathogenic mycobacteria produce a thick capsule, only present when the cells were grown under unperturbed conditions and easily removed by mild detergents.  This detergent-labile capsule layer contains arabinomannan, alpha-glucan and oligomannosyl-capped glycolipids.  Further immunogenic and proteomic analyses revealed that Mycobacterium marinum capsule contains high amounts of proteins that are secreted via the ESX-1 pathway.  Finally, cell infection experiments demonstrated the importance of the capsule for binding to cells and dampening of pro-inflammatory cytokine response.  Together, these results show a direct visualization of the mycobacterial capsular layer as a labile structure that contains ESX-1-secreted proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4xIZFY6FAWr9KldV63DuefW6udTcc2eZ6fytugsGHqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7nsFSkug%253D%253D&md5=0610ea5e56b6df489d1ff191169a60f5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1000794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1000794%26sid%3Dliteratum%253Aachs%26aulast%3DSani%26aufirst%3DM.%26aulast%3DHouben%26aufirst%3DE.%2BN.%2BG.%26aulast%3DGeurtsen%26aufirst%3DJ.%26aulast%3DPierson%26aufirst%3DJ.%26aulast%3Dde%2BPunder%26aufirst%3DK.%26aulast%3Dvan%2BZon%26aufirst%3DM.%26aulast%3DWever%26aufirst%3DB.%26aulast%3DPiersma%26aufirst%3DS.%2BR.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DC.%2BR.%26aulast%3DDaff%25C3%25A9%26aufirst%3DM.%26aulast%3DAppelmelk%26aufirst%3DB.%2BJ.%26aulast%3DBitter%26aufirst%3DW.%26aulast%3Dvan%2Bder%2BWel1%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DP.%2BJ.%26atitle%3DDirect%2520Visualization%2520by%2520Cryo-EM%2520of%2520the%2520Mycobacterial%2520Capsular%2520Layer%253A%2520A%2520Labile%2520Structure%2520Containing%2520ESX-1-Secreted%2520Proteins%26jtitle%3DPLoS%2520Pathog.%26date%3D2010%26volume%3D6%26doi%3D10.1371%2Fjournal.ppat.1000794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Massengo-Tiassé, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronan, J. E.</span></span> <span> </span><span class="NLM_article-title">Diversity in Enoyl-Acyl Carrier Protein Reductases</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1507</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1007/s00018-009-8704-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1007%2Fs00018-009-8704-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=19151923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnslyltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1507-1517&author=R.+P.+Massengo-Tiass%C3%A9author=J.+E.+Cronan&title=Diversity+in+Enoyl-Acyl+Carrier+Protein+Reductases&doi=10.1007%2Fs00018-009-8704-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Diversity in enoyl-acyl carrier protein reductases</span></div><div class="casAuthors">Massengo-Tiasse, R. P.; Cronan, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1507-1517</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  The enoyl-acyl carrier protein reductase (ENR) is the last enzyme in the fatty acid elongation cycle.  Unlike most enzymes in this essential pathway, ENR displays an unusual diversity among organisms.  The growing interest in ENRs is mainly due to the fact that a variety of both synthetic and natural antibacterial compds. are shown to specifically target their activity.  The primary anti-tuberculosis drug, isoniazid, and the broadly used antibacterial compd., triclosan, both target this enzyme.  In this review, the diversity of ENRs, and their inhibitors are discussed in the light of current research progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokuNowzqaKvLVg90H21EOLACvtfcHk0liyfpOmpHJMjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnslyltb0%253D&md5=d81da4c7b92cc18a09901870f1189df8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-8704-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-8704-7%26sid%3Dliteratum%253Aachs%26aulast%3DMassengo-Tiass%25C3%25A9%26aufirst%3DR.%2BP.%26aulast%3DCronan%26aufirst%3DJ.%2BE.%26atitle%3DDiversity%2520in%2520Enoyl-Acyl%2520Carrier%2520Protein%2520Reductases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26spage%3D1507%26epage%3D1517%26doi%3D10.1007%2Fs00018-009-8704-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubnau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quemard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Um, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lisle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, W. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">InhA, a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium Tuberculosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>263</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.1126/science.8284673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1126%2Fscience.8284673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=8284673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFylt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=227-230&author=A.+Banerjeeauthor=E.+Dubnauauthor=A.+Quemardauthor=V.+Balasubramanianauthor=K.+S.+Umauthor=T.+Wilsonauthor=D.+Collinsauthor=G.+de+Lisleauthor=W.+R.+Jacobs&title=InhA%2C+a+Gene+Encoding+a+Target+for+Isoniazid+and+Ethionamide+in+Mycobacterium+Tuberculosis&doi=10.1126%2Fscience.8284673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis</span></div><div class="casAuthors">Banerjee, Asesh; Dubnau, Eugenie; Quemard, Annaik; Balasubramanian, V.; Um, Kyung Sun; Wilson, Theresa; Collins, Des; de Lisle, Geoffrey; Jacobs, William, R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue">5144</span>),
    <span class="NLM_cas:pages">227-30</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Isoniazid (isonicotinic acid hydrazide, INH) is one of the most widely used antituberculosis drugs, yet its precise target of action on Mycobacterium tuberculosis is unknown.  A missense mutation within the mycobacterial inhA gene was shown to confer resistance to both INH and ethionamide (ETH) in M. smegmatis and in M. bovis.  The wild-type inhA gene also conferred INH and ETH resistance when transferred on a multicopy plasmid vector to M. smegmatis and M. bovis BCG.  The InhA protein shows a significant sequence conservation with the Escherichia coli enzyme EnvM, and cell-free assays indicate that it may be involved in mycolic acid biosynthesis.  These results suggest that InhA is likely a primary target of action for INH and ETH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUYkDS4hfHFrVg90H21EOLACvtfcHk0liyfpOmpHJMjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFylt7c%253D&md5=12f3eabbca02009180332c1e65db8c15</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1126%2Fscience.8284673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8284673%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DDubnau%26aufirst%3DE.%26aulast%3DQuemard%26aufirst%3DA.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DUm%26aufirst%3DK.%2BS.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DD.%26aulast%3Dde%2BLisle%26aufirst%3DG.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26atitle%3DInhA%252C%2520a%2520Gene%2520Encoding%2520a%2520Target%2520for%2520Isoniazid%2520and%2520Ethionamide%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D227%26epage%3D230%26doi%3D10.1126%2Fscience.8284673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilchèze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salfinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heifets, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazbon, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alland, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, W. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Overexpression of InhA, but Not KasA, Confers Resistance to Isoniazid and Ethionamide in Mycobacterium Smegmatis, M. bovis BCG and M. Tuberculosis</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2002.03162.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1046%2Fj.1365-2958.2002.03162.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=12406221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD38XosVartrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=453-466&author=M.+H.+Larsenauthor=C.+Vilch%C3%A8zeauthor=L.+Kremerauthor=G.+S.+Besraauthor=L.+Parsonsauthor=M.+Salfingerauthor=L.+Heifetsauthor=M.+H.+Hazbonauthor=D.+Allandauthor=J.+C.+Sacchettiniauthor=W.+R.+Jacobs&title=Overexpression+of+InhA%2C+but+Not+KasA%2C+Confers+Resistance+to+Isoniazid+and+Ethionamide+in+Mycobacterium+Smegmatis%2C+M.+bovis+BCG+and+M.+Tuberculosis&doi=10.1046%2Fj.1365-2958.2002.03162.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis</span></div><div class="casAuthors">Larsen, Michelle H.; Vilcheze, Catherine; Kremer, Laurent; Besra, Gurdyal S.; Parsons, Linda; Salfinger, Max; Heifets, Leonid; Hazbon, Manzour H.; Alland, David; Sacchettini, James C.; Jacobs, William R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">x453-466</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The inhA and kasA genes of Mycobacterium tuberculosis have each been proposed to encode the primary target of the antibiotic isoniazid (INH).  Previous studies investigating whether overexpressed inhA or kasA could confer resistance to INH yielded disparate results.  In this work, multicopy plasmids expressing either inhA or kasA genes were transformed into M. smegmatis, M. bovis BCG and three different M. tuberculosis strains.  The resulting transformants, as well as previously published M. tuberculosis strains with multicopy inhA or kasAB plasmids, were tested for their resistance to INH, ethionamide (ETH) or thiolactomycin (TLM).  Mycobacteria contg. inhA plasmids uniformly exhibited 20-fold or greater increased resistance to INH and 10-fold or greater increased resistance to ETH.  In contrast, the kasA plasmid conferred no increased resistance to INH or ETH in any of the five strains, but it did confer resistance to thiolactomycin, a known KasA inhibitor.  INH is known to increase the expression of kasA in INH-susceptible M. tuberculosis strains.  Using mol. beacons, quantified inhA and kasA mRNA levels showed that increased inhA mRNA levels correlated with INH resistance, whereas kasA mRNA levels did not.  In summary, anal. of strains harboring inhA or kasA plasmids yielded the same conclusion: overexpressed inhA, but not kasA, confers INH and ETH resistance to M. smegmatis, M. bovis BCG and M. tuberculosis.  Therefore, InhA is the primary target of action of INH and ETH in all three species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1zb4K7kRTF7Vg90H21EOLACvtfcHk0liyfpOmpHJMjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosVartrw%253D&md5=422c40b60fbf6d5b8fb564f7009d82ec</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2002.03162.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2002.03162.x%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DM.%2BH.%26aulast%3DVilch%25C3%25A8ze%26aufirst%3DC.%26aulast%3DKremer%26aufirst%3DL.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DParsons%26aufirst%3DL.%26aulast%3DSalfinger%26aufirst%3DM.%26aulast%3DHeifets%26aufirst%3DL.%26aulast%3DHazbon%26aufirst%3DM.%2BH.%26aulast%3DAlland%26aufirst%3DD.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26atitle%3DOverexpression%2520of%2520InhA%252C%2520but%2520Not%2520KasA%252C%2520Confers%2520Resistance%2520to%2520Isoniazid%2520and%2520Ethionamide%2520in%2520Mycobacterium%2520Smegmatis%252C%2520M.%2520bovis%2520BCG%2520and%2520M.%2520Tuberculosis%26jtitle%3DMol.%2520Microbiol.%26date%3D2002%26volume%3D46%26spage%3D453%26epage%3D466%26doi%3D10.1046%2Fj.1365-2958.2002.03162.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunder, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masamune, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">Catalytic Asymmetric Epoxidation and Kinetic Resolution: Modified Procedures Including in Situ Derivatization</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">5765</span>– <span class="NLM_lpage">5780</span>, <span class="refDoi"> DOI: 10.1021/ja00253a032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00253a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaL2sXltlemu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1987&pages=5765-5780&author=Y.+Gaoauthor=R.+M.+Hansonauthor=J.+M.+Klunderauthor=S.+Y.+Koauthor=H.+Masamuneauthor=K.+B.+Sharpless&title=Catalytic+Asymmetric+Epoxidation+and+Kinetic+Resolution%3A+Modified+Procedures+Including+in+Situ+Derivatization&doi=10.1021%2Fja00253a032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic asymmetric epoxidation and kinetic resolution: modified procedures including in situ derivatization</span></div><div class="casAuthors">Gao, Yun; Klunder, Janice M.; Hanson, Robert M.; Masamune, Hiroko; Ko, Soo Y.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5765-80</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The use of 3A or 4A mol. sieves (zeolites) substantially increases the scope of the Ti(IV)-catalyzed asym. epoxidn. of primary allylic alcs.  High conversions (>95%) and enantioselectivities (90-95%) are obtained.  The epoxidns. of 20 primary alcs. are described, and the kinetic resoln. of 4 secondary alcs. is also carried out.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb1HGdyJEcirVg90H21EOLACvtfcHk0lhdg6fQ6-Oywg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXltlemu7w%253D&md5=0f720a2212642b9f747e05dca6b9ba58</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fja00253a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00253a032%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DHanson%26aufirst%3DR.%2BM.%26aulast%3DKlunder%26aufirst%3DJ.%2BM.%26aulast%3DKo%26aufirst%3DS.%2BY.%26aulast%3DMasamune%26aufirst%3DH.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DCatalytic%2520Asymmetric%2520Epoxidation%2520and%2520Kinetic%2520Resolution%253A%2520Modified%2520Procedures%2520Including%2520in%2520Situ%2520Derivatization%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1987%26volume%3D109%26spage%3D5765%26epage%3D5780%26doi%3D10.1021%2Fja00253a032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wei Wang, Shan Zhang, Jianhua Wang, Furan Wu, Tao Wang, <span class="NLM_string-name hlFld-ContribAuthor">Gong Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactivity-Guided Synthesis Accelerates the Discovery of 3-(Iso)quinolinyl-4-chromenones as Potent Fungicide Candidates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2021,</strong> <em>69 </em>
                                    (1)
                                     , 491-500. <a href="https://doi.org/10.1021/acs.jafc.0c06700" title="DOI URL">https://doi.org/10.1021/acs.jafc.0c06700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.0c06700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.0c06700%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DBioactivity-Guided%252BSynthesis%252BAccelerates%252Bthe%252BDiscovery%252Bof%252B3-%252528Iso%252529quinolinyl-4-chromenones%252Bas%252BPotent%252BFungicide%252BCandidates%26aulast%3DWang%26aufirst%3DWei%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22102020%26date%3D18122020%26date%3D16122020%26date%3D31122020%26volume%3D69%26issue%3D1%26spage%3D491%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Cazzaniga</span>, <span class="hlFld-ContribAuthor ">Matteo  Mori</span>, <span class="hlFld-ContribAuthor ">Laurent Roberto  Chiarelli</span>, <span class="hlFld-ContribAuthor ">Arianna  Gelain</span>, <span class="hlFld-ContribAuthor ">Fiorella  Meneghetti</span>, <span class="hlFld-ContribAuthor ">Stefania  Villa</span>. </span><span class="cited-content_cbyCitation_article-title">Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>63 </em>, 113732. <a href="https://doi.org/10.1016/j.ejmech.2021.113732" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113732</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113732%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNatural%252Bproducts%252Bagainst%252Bkey%252BMycobacterium%252Btuberculosis%252Benzymatic%252Btargets%25253A%252BEmerging%252Bopportunities%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DCazzaniga%26aufirst%3DGiulia%26date%3D2021%26volume%3D63%26spage%3D113732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rudy  Antoine</span>, <span class="hlFld-ContribAuthor ">Cyril  Gaudin</span>, <span class="hlFld-ContribAuthor ">Ruben C.  Hartkoorn</span>, . </span><span class="cited-content_cbyCitation_article-title">Intragenic Distribution of IS
              6110
              in Clinical Mycobacterium tuberculosis Strains: Bioinformatic Evidence for Gene Disruption Leading to Underdiagnosed Antibiotic Resistance. </span><span class="cited-content_cbyCitation_journal-name">Microbiology Spectrum</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1128/Spectrum.00019-21" title="DOI URL">https://doi.org/10.1128/Spectrum.00019-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/Spectrum.00019-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FSpectrum.00019-21%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobiology%2520Spectrum%26atitle%3DIntragenic%252BDistribution%252Bof%252BIS%252B6110%252Bin%252BClinical%252BMycobacterium%252Btuberculosis%252BStrains%25253A%252BBioinformatic%252BEvidence%252Bfor%252BGene%252BDisruption%252BLeading%252Bto%252BUnderdiagnosed%252BAntibiotic%252BResistance%26aulast%3DAntoine%26aufirst%3DRudy%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0094.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0094.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0053.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0053.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of pyridomycin (<b>1</b>) and of 2,1′-dihydropyridomycins <b>2</b> and <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Retrosynthesis of Pyridomycin Analogs <b>28</b> and <b>35</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Alcohols <b>8a</b>–<b>c,f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) TBSCl, imidazole, DMF, room temperature (rt), 24 h, (ii) K<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (5:2), 0 °C to rt, 4 h, 79% to quant.; (b) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, toluene, rt, 5 min, then alcohol <b>6</b>, DMAP, rt, 18 h, 12–92%; (c) HF·pyridine, THF, 0 °C to rt, 17 h, 82% to quant.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0030.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Alcohols <b>8d,e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub> (aq. 1 M), NaNO<sub>2</sub>, H<sub>2</sub>O, 0 °C, 19 h, then rt, 15 min, 97% and quant.; (b) benzyl bromide, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 0 °C to rt, 20 h, 94 and 90%; (c) TBSOTf, lutidine, DCM, −78 °C, 30 min, then rt, 15 h, 93 and 77%; (d) H<sub>2</sub> (5 bar), Pd/C (10%), EtOAc, rt, 1 h, quant. and 81%; (e) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, toluene, rt, 5 min, then alcohol <b>6</b>, DMAP, rt, 18 h, 92 and 68%; (f) HF·pyridine, THF, 0 °C to rt, 17 h, quant. The first yield given is for the respective intermediate leading to <b>8d</b>, the second for the one leading to <b>8e</b>.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Alcohol <b>8i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KOH (aq. 2 M), MeOH, rt, 1 h, 99%; (b) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, THF/DMF (2:3), rt, 5 min, then alcohol <b>6</b>, DMAP, rt, 18 h, 71%; (c) <i>p</i>-TsOH, MeOH, rt, 20 h, 69%; (d) TBSCl, imidazole, DCM, rt, 18 h, 60%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Alcohols <b>8g,h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <span class="smallcaps smallerCapital">l</span>-(+)-DET, TTIP, <i>t</i>-BuOOH, DCM, −20 °C, 16 h, 74%; (b) for <b>15</b>, CuCN, MeLi, Et<sub>2</sub>O, −78 °C to 0 °C, 3 h, 74%; for <b>17</b>, Me<sub>3</sub>Al, toluene, 0 °C, 2 h, 77% (3.4:1 mixture of diastereoisomers); (c) TBSCl, imidazole, DMF, 0 °C to rt, 12–15 h, 93 and 88% (7.73:1 mixture of diastereoisomers); (d) CSA, DCM/MeOH 1:1, 0 °C, 3–5 h, 60 and 48%; (e) (i) (COCl)<sub>2</sub>, DMSO, Et<sub>3</sub>N, DCM, −78 °C to rt; (ii) NaClO<sub>2</sub>, NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O, <i>t</i>-BuOH/THF/H<sub>2</sub>O (4.5:3:1), rt, 2 h, 94 and 86%; (f) <b>6</b>, 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, DMAP, toluene, 0 °C to rt, 2 h, 75 and 60%; (g) HF·pyridine, THF, pyridine, 0 °C to rt, 16 h, 73 and 77%. The first yield is for the respective intermediate leading to <b>8g</b>; the second is for the one leading to <b>8h</b>.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0031.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Acids <b>24</b> and bis-<i>epi</i>-<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>c</i>-Hex<sub>2</sub>BOTf, Et<sub>3</sub>N, DCM, −78 °C, 45% (<b>23</b>)/18% (bis-<i>epi</i>-<b>23</b>); (b) LiOH, MeOH/H<sub>2</sub>O/THF (3:2:2), rt, 24 h, 83–96%.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of C2-Modified Pyridomycin Analogs <b>28a</b>–<b>g,i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, DMAP, toluene, −78 °C to −35 °C, 43 h, then 0 °C, 2 h, 18–72%; (b) H<sub>2</sub> (1 bar), Pd/C, MeOH, rt, 5 h; (c) HATU, DIPEA, DCM/DMF, rt, 18 h, 23–62% over two steps; (d) TFA, DCM, 0 °C, 10 min, then rt, 2 h; (e) 3-HPA (<b>27</b>), HATU, DIPEA, MeCN, rt, 18 h, 30–65% over two steps.</p></p></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0012.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of C2-Modified Pyridomycin Analog <b>28h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>8h</b>, DCC, DMAP, DCM, 0 °C to rt, 5 h, 78%; (b) KHCO<sub>3</sub>, MeOH, rt, 1 h, 89%; (c) Pd/C, MeOH, rt, 1.5 h; (d) HATU, DIPEA, DCM, DMF, rt, 16 h, 31% over two steps; (e) TFA, DCM, 3 h; (f) 3-HPA (<b>27</b>), HATU, DIPEA, DMF, 16 h, 43% over two steps.</p></p></figure><figure data-id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Pyridomycin Analog <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, THF, rt, 5 min, then alcohol <b>6</b>, DMAP, toluene, rt, 1 h, 98%; (b) piperidine, MeCN, rt, 30 min, 64%; (c) <b>24</b>, HATU, DIPEA, MeCN/THF (10:1), 0 °C to rt, 48 h, 75%; (d) H<sub>2</sub> (1 atm), Pd/C (10%), MeOH, rt, 2.75 h, 96% (crude); (e) HATU, DIPEA, DCM, DMF (1%), rt, 18 h, 83%; (f) TFA, DCM, rt, 3 h, quant. (crude); 3-HPA (<b>27</b>), HATU, DIPEA, DMF, rt, 18 h, 25%.</p></p></figure><figure data-id="sch10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/medium/jm9b01457_0054.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0054.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Analogs <b>39</b> and <b>40</b> with Inverted Configurations at C10 and C11<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01457/20200207/images/large/jm9b01457_0054.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01457&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4,6-trichlorobenzoyl chloride, Et<sub>3</sub>N, DMAP, toluene, −78 °C to −35 °C, 43 h, then 0 °C, 2 h, 51–52%; (b) H<sub>2</sub> (1 bar), Pd/C, MeOH, rt, 5 h; (c) HATU, DIPEA, DCM/DMF, rt, 18 h, 33–42% over two steps; (d) TFA, DCM, 0 °C, 10 min, then rt, 2 h; (e) 3-HPA (<b>27</b>), HATU, DIPEA, MeCN, rt, 18 h, 37–51% over two steps.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i118">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span> <i>Global Tuberculosis Report
2018</i>; <span class="NLM_publisher-name">World Health
Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2018</span>, Licence: CC BY-NC-SA 3.0 IGO.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global+Tuberculosis+Report%0A2018%3B+World+Health%0AOrganization%3A+Geneva%2C+2018%2C+Licence%3A+CC+BY-NC-SA+3.0+IGO."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Tuberculosis%2520Report%250A2018%26pub%3DWorld%2520Health%250AOrganization%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zumla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nahid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Advances in the Development of New Tuberculosis Drugs and Treatment Regimens</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1038/nrd4001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1038%2Fnrd4001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=23629506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Kmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=388-404&author=A.+Zumlaauthor=P.+Nahidauthor=S.+T.+Cole&title=Advances+in+the+Development+of+New+Tuberculosis+Drugs+and+Treatment+Regimens&doi=10.1038%2Fnrd4001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the development of new tuberculosis drugs and treatment regimens</span></div><div class="casAuthors">Zumla, Alimuddin; Nahid, Payam; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">388-404</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid, rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to cause considerable morbidity and mortality worldwide.  For the first time since the 1960s, new and novel drugs and regimens for all forms of TB are emerging.  Such regimens are likely to utilize both repurposed drugs and new chem. entities, and several of these regimens are now progressing through clin. trials.  This article covers current concepts and recent advances in TB drug discovery and development, including an update of ongoing TB treatment trials, newer clin. trial designs, TB biomarkers and adjunct host-directed therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs_a1A-oQwcrVg90H21EOLACvtfcHk0lg5BVYF7Sa_Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Kmsrk%253D&md5=fbf12f867a19ffff4d7fb74a98699682</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd4001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4001%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DNahid%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DAdvances%2520in%2520the%2520Development%2520of%2520New%2520Tuberculosis%2520Drugs%2520and%2520Treatment%2520Regimens%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D388%26epage%3D404%26doi%3D10.1038%2Fnrd4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sensi, P.</span></span> <span> </span><span class="NLM_article-title">History of the development of rifampin</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S402</span>– <span class="NLM_lpage">S406</span>, <span class="refDoi"> DOI: 10.1093/clinids/5.Supplement_3.S402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1093%2Fclinids%2F5.Supplement_3.S402" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1983&pages=S402-S406&author=P.+Sensi&title=History+of+the+development+of+rifampin&doi=10.1093%2Fclinids%2F5.Supplement_3.S402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fclinids%2F5.Supplement_3.S402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fclinids%252F5.Supplement_3.S402%26sid%3Dliteratum%253Aachs%26aulast%3DSensi%26aufirst%3DP.%26atitle%3DHistory%2520of%2520the%2520development%2520of%2520rifampin%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D1983%26volume%3D5%26spage%3DS402%26epage%3DS406%26doi%3D10.1093%2Fclinids%2F5.Supplement_3.S402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, R.</span></span> <span> </span><span class="NLM_article-title">Bedaquiline: First FDA-Approved Tuberculosis Drug in 40 Years</span>. <i>Int. J. Appl. Basic Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">2</span>, <span class="refDoi"> DOI: 10.4103/2229-516X.112228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.4103%2F2229-516X.112228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=23776831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A280%3ADC%252BC3sjjsVymsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1-2&author=R.+Mahajan&title=Bedaquiline%3A+First+FDA-Approved+Tuberculosis+Drug+in+40+Years&doi=10.4103%2F2229-516X.112228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Bedaquiline: First FDA-approved tuberculosis drug in 40 years</span></div><div class="casAuthors">Mahajan Rajiv</div><div class="citationInfo"><span class="NLM_cas:title">International journal of applied & basic medical research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-2</span>
        ISSN:<span class="NLM_cas:issn">2229-516X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMuPJrm3KbPlw2ofyr07jXfW6udTcc2eY0WBsob3XMrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjjsVymsQ%253D%253D&md5=b588035f9b17ee7beb4f5c57a58a0eff</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4103%2F2229-516X.112228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2229-516X.112228%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DR.%26atitle%3DBedaquiline%253A%2520First%2520FDA-Approved%2520Tuberculosis%2520Drug%2520in%252040%2520Years%26jtitle%3DInt.%2520J.%2520Appl.%2520Basic%2520Med.%2520Res.%26date%3D2013%26volume%3D3%26spage%3D1%26epage%3D2%26doi%3D10.4103%2F2229-516X.112228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andries, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhasselt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemont, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göhlmann, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neefs, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gestel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Chaffoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huitric, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truffot-Pernot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lounis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarlier, V.</span></span> <span> </span><span class="NLM_article-title">A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium Tuberculosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1126/science.1106753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1126%2Fscience.1106753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=15591164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVKkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=223-227&author=K.+Andriesauthor=P.+Verhasseltauthor=J.+Guillemontauthor=H.+W.+G%C3%B6hlmannauthor=J.-M.+Neefsauthor=H.+Winklerauthor=J.+Van+Gestelauthor=P.+Timmermanauthor=M.+Zhuauthor=E.+Leeauthor=P.+Williamsauthor=D.+de+Chaffoyauthor=E.+Huitricauthor=S.+Hoffnerauthor=E.+Cambauauthor=C.+Truffot-Pernotauthor=N.+Lounisauthor=V.+Jarlier&title=A+Diarylquinoline+Drug+Active+on+the+ATP+Synthase+of+Mycobacterium+Tuberculosis&doi=10.1126%2Fscience.1106753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis</span></div><div class="casAuthors">Andries, Koen; Verhasselt, Peter; Guillemont, Jerome; Goehlmann, Hinrich W. H.; Neefs, Jean-Marc; Winkler, Hans; Van Gestel, Jef; Timmerman, Philip; Zhu, Min; Lee, Ennis; Williams, Peter; de Chaffoy, Didier; Huitric, Emma; Hoffner, Sven; Cambau, Emmanuelle; Truffot-Pernot, Chantal; Lounis, Nacer; Jarlier, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5707</span>),
    <span class="NLM_cas:pages">223-227</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The incidence of tuberculosis has been increasing substantially on a worldwide basis over the past decade, but no tuberculosis-specific drugs have been discovered in 40 years.  We identified a diarylquinoline, R207910, that potently inhibits both drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro (min. inhibitory concn. 0.06 μg/mL).  In mice, R207910 exceeded the bactericidal activities of isoniazid and rifampin by at least 1 log unit.  Substitution of drugs included in the World Health Organization's first-line tuberculosis treatment regimen (rifampin, isoniazid, and pyrazinamide) with R207910 accelerated bactericidal activity, leading to complete culture conversion after 2 mo of treatment in some combinations.  A single dose of R207910 inhibited mycobacterial growth for 1 wk.  Plasma levels assocd. with efficacy in mice were well tolerated in healthy human volunteers.  Mutants selected in vitro suggest that the drug targets the proton pump of ATP (ATP) synthase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9LY7RSAIXUrVg90H21EOLACvtfcHk0liFBMynD0gXqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVKkug%253D%253D&md5=099b643f173bb77e70cf1aa6e9871ffe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106753%26sid%3Dliteratum%253Aachs%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DVerhasselt%26aufirst%3DP.%26aulast%3DGuillemont%26aufirst%3DJ.%26aulast%3DG%25C3%25B6hlmann%26aufirst%3DH.%2BW.%26aulast%3DNeefs%26aufirst%3DJ.-M.%26aulast%3DWinkler%26aufirst%3DH.%26aulast%3DVan%2BGestel%26aufirst%3DJ.%26aulast%3DTimmerman%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DP.%26aulast%3Dde%2BChaffoy%26aufirst%3DD.%26aulast%3DHuitric%26aufirst%3DE.%26aulast%3DHoffner%26aufirst%3DS.%26aulast%3DCambau%26aufirst%3DE.%26aulast%3DTruffot-Pernot%26aufirst%3DC.%26aulast%3DLounis%26aufirst%3DN.%26aulast%3DJarlier%26aufirst%3DV.%26atitle%3DA%2520Diarylquinoline%2520Drug%2520Active%2520on%2520the%2520ATP%2520Synthase%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D223%26epage%3D227%26doi%3D10.1126%2Fscience.1106753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haraguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itotani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishige, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubouchi, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antituberculosis Activity of a Novel Series of Optically Active 6-Nitro-2,3-dihydroimidazo[2,1-b]oxazoles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7854</span>– <span class="NLM_lpage">7860</span>, <span class="refDoi"> DOI: 10.1021/jm060957y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060957y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12lsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7854-7860&author=H.+Sasakiauthor=Y.+Haraguchiauthor=M.+Itotaniauthor=H.+Kurodaauthor=H.+Hashizumeauthor=T.+Tomishigeauthor=M.+Kawasakiauthor=M.+Matsumotoauthor=M.+Komatsuauthor=H.+Tsubouchi&title=Synthesis+and+Antituberculosis+Activity+of+a+Novel+Series+of+Optically+Active+6-Nitro-2%2C3-dihydroimidazo%5B2%2C1-b%5Doxazoles&doi=10.1021%2Fjm060957y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antituberculosis Activity of a Novel Series of Optically Active 6-Nitro-2,3-dihydroimidazo[2,1-b]oxazoles</span></div><div class="casAuthors">Sasaki, Hirofumi; Haraguchi, Yoshikazu; Itotani, Motohiro; Kuroda, Hideaki; Hashizume, Hiroyuki; Tomishige, Tatsuo; Kawasaki, Masanori; Matsumoto, Makoto; Komatsu, Makoto; Tsubouchi, Hidetsugu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7854-7860</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to develop potent new antituberculosis agents that would be effective against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis, a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles substituted at the 2-position with various phenoxymethyl groups and a Me group were prepd. and the in vitro and in vivo activity of these compds. was investigated.  Several of these derivs. showed potent in vitro and in vivo activity, and I (OPC-67683) in particular displayed excellent in vitro activity against both drug-susceptible and drug-resistant strains of M. tuberculosis H37Rv (MIC = 0.006 μg/mL) and dose-dependent and significant in vivo efficacy at lower oral doses than rifampicin in mouse models infected with M. tuberculosis Kurono.  The synthesis and structure-activity relationships of these new compds. are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4pncGTcyjYbVg90H21EOLACvtfcHk0liFBMynD0gXqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12lsL%252FP&md5=5d21a9ba54be1fdbf0bd0b3fa5a2e620</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm060957y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060957y%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DHaraguchi%26aufirst%3DY.%26aulast%3DItotani%26aufirst%3DM.%26aulast%3DKuroda%26aufirst%3DH.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DTomishige%26aufirst%3DT.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DTsubouchi%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520Antituberculosis%2520Activity%2520of%2520a%2520Novel%2520Series%2520of%2520Optically%2520Active%25206-Nitro-2%252C3-dihydroimidazo%255B2%252C1-b%255Doxazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7854%26epage%3D7860%26doi%3D10.1021%2Fjm060957y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishige, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubouchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice</span>. <i>PLoS Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e466</span> <span class="refDoi"> DOI: 10.1371/journal.pmed.0030466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1371%2Fjournal.pmed.0030466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=17132069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A280%3ADC%252BD28npsFKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&author=M.+Matsumotoauthor=H.+Hashizumeauthor=T.+Tomishigeauthor=M.+Kawasakiauthor=H.+Tsubouchiauthor=H.+Sasakiauthor=Y.+Shimokawaauthor=M.+Komatsu&title=OPC-67683%2C+a+Nitro-Dihydro-Imidazooxazole+Derivative+with+Promising+Action+against+Tuberculosis+In+Vitro+and+In+Mice&doi=10.1371%2Fjournal.pmed.0030466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice</span></div><div class="casAuthors">Matsumoto Makoto; Hashizume Hiroyuki; Tomishige Tatsuo; Kawasaki Masanori; Tsubouchi Hidetsugu; Sasaki Hirofumi; Shimokawa Yoshihiko; Komatsu Makoto</div><div class="citationInfo"><span class="NLM_cas:title">PLoS medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e466</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Tuberculosis (TB) is still a leading cause of death worldwide.  Almost a third of the world's population is infected with TB bacilli, and each year approximately 8 million people develop active TB and 2 million die as a result.  Today's TB treatment, which dates back to the 1970s, is long and burdensome, requiring at least 6 mo of multidrug chemotherapy.  The situation is further compounded by the emergence of multidrug-resistant TB (MDR-TB) and by the infection's lethal synergy with HIV/AIDS.  Global health and philanthropic organizations are now pleading for new drug interventions that can address these unmet needs in TB treatment.  METHODS AND FINDINGS:  Here we report OPC-67683, a nitro-dihydro-imidazooxazole derivative that was screened to help combat the unmet needs in TB treatment.  The compound is a mycolic acid biosynthesis inhibitor found to be free of mutagenicity and to possess highly potent activity against TB, including MDR-TB, as shown by its exceptionally low minimum inhibitory concentration (MIC) range of 0.006-0.024 microg/ml in vitro and highly effective therapeutic activity at low doses in vivo.  Additionally, the results of the post-antibiotic effect of OPC-67683 on intracellular Mycobacterium tuberculosis showed the agent to be highly and dose-dependently active also against intracellular M. tuberculosis H37Rv after a 4-h pulsed exposure, and this activity at a concentration of 0.1 microg/ml was similar to that of the first-line drug rifampicin (RFP) at a concentration of 3 microg/ml.  The combination of OPC-67683 with RFP and pyrazinamide (PZA) exhibited a remarkably quicker eradication (by at least 2 mo) of viable TB bacilli in the lung in comparison with the standard regimen consisting of RFP, isoniazid (INH), ethambutol (EB), and PZA.  Furthermore, OPC-67683 was not affected by nor did it affect the activity of liver microsome enzymes, suggesting the possibility for OPC-67683 to be used in combination with drugs, including anti-retrovirals, that induce or are metabolized by cytochrome P450 enzymes.  CONCLUSIONS:  We concluded that based on these properties OPC-67683 has the potential to be used as a TB drug to help combat the unmet needs in TB treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSF0z_BNLNYeRS7coPn-RtfW6udTcc2eaJD6kkwSyVIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28npsFKgug%253D%253D&md5=8a80560cc653b1c76ff4d47430317d18</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0030466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0030466%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DTomishige%26aufirst%3DT.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DTsubouchi%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DShimokawa%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DOPC-67683%252C%2520a%2520Nitro-Dihydro-Imidazooxazole%2520Derivative%2520with%2520Promising%2520Action%2520against%2520Tuberculosis%2520In%2520Vitro%2520and%2520In%2520Mice%26jtitle%3DPLoS%2520Med.%26date%3D2006%26volume%3D3%26doi%3D10.1371%2Fjournal.pmed.0030466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umezawa, H.</span></span> <span> </span><span class="NLM_article-title">A New Antibiotic, Pyridomycin</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=13096450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaG1MXjtV2lsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1953&pages=140&author=K.+Maedaauthor=H.+Kosakaauthor=Y.+Okamiauthor=H.+Umezawa&title=A+New+Antibiotic%2C+Pyridomycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A new antibiotic, pyridomycin</span></div><div class="casAuthors">Maeda, Kenji; Kosaka, Hiroko; Okami, Yoshiro; Umezawa, Hamao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics, Series A</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">Ser. A</span>),
    <span class="NLM_cas:pages">140</span>CODEN:
                <span class="NLM_cas:coden">JAJAAA</span>;
        ISSN:<span class="NLM_cas:issn">0368-1173</span>.
    </div><div class="casAbstract">Pyridomycin (I), active against mycobacteria, Escherichia coli, and Salmonella typhosa, was isolated from the broth filtrate of Streptomyces albidofuscus by extn. with BuOAc, concn., addn. of Et2O, and recrystn. from EtOH.  I is colorless crystals, m. 222°, contg. C 60.73%, H 5.96%, and N 10.34%, absorption max. 303 mμ (E1%1cm. 209, EtOH) 303 mμ (E1%1cm. 250, 0.1N HCl), and 331 mμ (E1%1cm. 166, 0.1N NaOH), sol. in MeOH, EtOH, BuOH, EtOAc, BuOAc, C6H6, CHCl3, Me2CO, dioxane, Cellosolve, and tetrahydrofuran, and sparingly sol. in Et2O and petr. ether.  Mice tolerated injection of 10 mg. intraperitoneally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou-yIs-0dL7LVg90H21EOLACvtfcHk0lhm63CKEX7a5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXjtV2lsQ%253D%253D&md5=004c7a37f0bbefd879a27a161e042b3e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DKosaka%26aufirst%3DH.%26aulast%3DOkami%26aufirst%3DY.%26aulast%3DUmezawa%26aufirst%3DH.%26atitle%3DA%2520New%2520Antibiotic%252C%2520Pyridomycin%26jtitle%3DJ.%2520Antibiot.%26date%3D1953%26volume%3D6%26spage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uplekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boy-Röttger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Towards a New Tuberculosis Drug: Pyridomycin - Nature’s Isoniazid</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1042</span>, <span class="refDoi"> DOI: 10.1002/emmm.201201689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1002%2Femmm.201201689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=22987724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVeiur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1032-1042&author=R.+C.+Hartkoornauthor=C.+Salaauthor=J.+Neresauthor=F.+Pojerauthor=S.+Magnetauthor=R.+Mukherjeeauthor=S.+Uplekarauthor=S.+Boy-R%C3%B6ttgerauthor=K.-H.+Altmannauthor=S.+T.+Cole&title=Towards+a+New+Tuberculosis+Drug%3A+Pyridomycin+-+Nature%E2%80%99s+Isoniazid&doi=10.1002%2Femmm.201201689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a new tuberculosis drug: pyridomycin - nature's isoniazid</span></div><div class="casAuthors">Hartkoorn, Ruben C.; Sala, Claudia; Neres, Joao; Pojer, Florence; Magnet, Sophie; Mukherjee, Raju; Uplekar, Swapna; Boy-Roettger, Stefanie; Altmann, Karl-Heinz; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1032-1042</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tuberculosis, a global threat to public health, is becoming untreatable due to widespread drug resistance to frontline drugs such as the InhA-inhibitor isoniazid.  Historically, by inhibiting highly vulnerable targets, natural products were an important source of antibiotics including potent anti-tuberculosis agents.  Here, the authors describe pyridomycin, a compd. produced by Dactylosporangium fulvum with specific cidal activity against mycobacteria.  By selecting pyridomycin-resistant mutants of Mycobacterium tuberculosis, whole-genome sequencing and genetic validation, we identified the NADH-dependent enoyl- (Acyl-Carrier-Protein) reductase InhA as the principal target and demonstrate that pyridomycin inhibits mycolic acid synthesis in M. tuberculosis.  Furthermore, biochem. and structural studies show that pyridomycin inhibits InhA directly as a competitive inhibitor of the NADH-binding site, thereby identifying a new, druggable pocket in InhA.  Importantly, the most frequently encountered isoniazid-resistant clin. isolates remain fully susceptible to pyridomycin, thus opening new avenues for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3ty3Lo--847Vg90H21EOLACvtfcHk0lhm63CKEX7a5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVeiur%252FL&md5=65e35a6ea7de92263cc77db92253d24e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201689%26sid%3Dliteratum%253Aachs%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DMagnet%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DR.%26aulast%3DUplekar%26aufirst%3DS.%26aulast%3DBoy-R%25C3%25B6ttger%26aufirst%3DS.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DTowards%2520a%2520New%2520Tuberculosis%2520Drug%253A%2520Pyridomycin%2520-%2520Nature%25E2%2580%2599s%2520Isoniazid%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D1032%26epage%3D1042%26doi%3D10.1002%2Femmm.201201689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Timmins, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deretic, V.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Action of Isoniazid</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1220</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2006.05467.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1111%2Fj.1365-2958.2006.05467.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=17074073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlenu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=1220-1227&author=G.+S.+Timminsauthor=V.+Deretic&title=Mechanisms+of+Action+of+Isoniazid&doi=10.1111%2Fj.1365-2958.2006.05467.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of action of isoniazid</span></div><div class="casAuthors">Timmins, Graham S.; Deretic, Vojo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1220-1227</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  For decades after its introduction, the mechanisms of action of the front-line antituberculosis therapeutic agent isoniazid (INH) remained unclear.  Recent developments have shown that peroxidative activation of isoniazid by the mycobacterial enzyme KatG generates reactive species that form adducts with NAD+ and NADP+ that are potent inhibitors of lipid and nucleic acid biosynthetic enzymes.  A direct role for some isoniazid-derived reactive species, such as nitric oxide, in inhibiting mycobacterial metabolic enzymes has also been shown.  The concerted effects of these activities - inhibition of cell wall lipid synthesis, depletion of nucleic acid pools and metabolic depression - drive the exquisite potency and selectivity of this agent.  To understand INH action and resistance fully, a synthesis of knowledge is required from multiple sep. lines of research - including mol. genetic approaches, in vitro biochem. studies and free radical chem. - which is the intent of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq9OybVddk-rVg90H21EOLACvtfcHk0lgcyW-vJN6NOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlenu7jE&md5=fbc095f0f79cd443b55d54c19b36f932</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2006.05467.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2006.05467.x%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DG.%2BS.%26aulast%3DDeretic%26aufirst%3DV.%26atitle%3DMechanisms%2520of%2520Action%2520of%2520Isoniazid%26jtitle%3DMol.%2520Microbiol.%26date%3D2006%26volume%3D62%26spage%3D1220%26epage%3D1227%26doi%3D10.1111%2Fj.1365-2958.2006.05467.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilchèze, C.</span>; <span class="NLM_string-name">Jacobs, W. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Resistance to Isoniazid and Ethionamide in Mycobacterium Tuberculosis: Genes, Mutations, and Causalities</span>.  <i>Molecular Genetics of Mycobacteria</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">American Society of Microbiology</span>: <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">453</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=431-453&author=C.+Vilch%C3%A8ze&author=W.+R.+Jacobs&title=Molecular+Genetics+of+Mycobacteria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVilch%25C3%25A8ze%26aufirst%3DC.%26atitle%3DResistance%2520to%2520Isoniazid%2520and%2520Ethionamide%2520in%2520Mycobacterium%2520Tuberculosis%253A%2520Genes%252C%2520Mutations%252C%2520and%2520Causalities%26btitle%3DMolecular%2520Genetics%2520of%2520Mycobacteria%26pub%3DAmerican%2520Society%2520of%2520Microbiology%26date%3D2014%26spage%3D431%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truglio, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyne, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novichenok, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slayden, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, P. J.</span></span> <span> </span><span class="NLM_article-title">High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains of Mycobacterium Tuberculosis</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1021/cb0500042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb0500042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlOkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=43-53&author=T.+J.+Sullivanauthor=J.+J.+Truglioauthor=M.+E.+Boyneauthor=P.+Novichenokauthor=X.+Zhangauthor=C.+F.+Strattonauthor=H.-J.+Liauthor=T.+Kaurauthor=A.+Aminauthor=F.+Johnsonauthor=R.+A.+Slaydenauthor=C.+Kiskerauthor=P.+J.+Tonge&title=High+Affinity+InhA+Inhibitors+with+Activity+against+Drug-Resistant+Strains+of+Mycobacterium+Tuberculosis&doi=10.1021%2Fcb0500042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis</span></div><div class="casAuthors">Sullivan, Todd J.; Truglio, James J.; Boyne, Melissa E.; Novichenok, Polina; Zhang, Xujie; Stratton, Christopher F.; Li, Huei-Jiun; Kaur, Tejinder; Amin, Amol; Johnson, Francis; Slayden, Richard A.; Kisker, Caroline; Tonge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel chemotherapeutics for treating multidrug-resistant (MDR) strains of Mycobacterium tuberculosis (MTB) are required to combat the spread of tuberculosis, a disease that kills more than 2 million people annually.  Using structure-based drug design, the authors have developed a series of alkyl di-Ph ethers that are uncompetitive inhibitors of InhA, the enoyl reductase enzyme in the MTB fatty acid biosynthesis pathway.  The most potent compd. has a K'i value of 1 nM for InhA and MIC99 values of 2-3 μg mL-1 (6-10 μM) for both drug-sensitive and drug-resistant strains of MTB.  Overexpression of InhA in MTB results in a 9-12-fold increase in MIC99, consistent with the belief that these compds. target InhA within the cell.  In addn., transcriptional response studies reveal that the alkyl di-Ph ethers fail to upregulate a putative efflux pump and arom. dioxygenase, detoxification mechanisms that are triggered by the lead compd. triclosan.  These di-Ph ether-based InhA inhibitors do not require activation by the mycobacterial KatG enzyme, thereby circumventing the normal mechanism of resistance to the front line drug isoniazid (INH) and thus accounting for their activity against INH-resistant strains of MTB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqncsjJzA3TprVg90H21EOLACvtfcHk0lgcyW-vJN6NOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlOkurc%253D&md5=69acf9afc4ea02a2a7c63a45cc2f0a82</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcb0500042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb0500042%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DT.%2BJ.%26aulast%3DTruglio%26aufirst%3DJ.%2BJ.%26aulast%3DBoyne%26aufirst%3DM.%2BE.%26aulast%3DNovichenok%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DStratton%26aufirst%3DC.%2BF.%26aulast%3DLi%26aufirst%3DH.-J.%26aulast%3DKaur%26aufirst%3DT.%26aulast%3DAmin%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DF.%26aulast%3DSlayden%26aufirst%3DR.%2BA.%26aulast%3DKisker%26aufirst%3DC.%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26atitle%3DHigh%2520Affinity%2520InhA%2520Inhibitors%2520with%2520Activity%2520against%2520Drug-Resistant%2520Strains%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2006%26volume%3D1%26spage%3D43%26epage%3D53%26doi%3D10.1021%2Fcb0500042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz de Montellano, P. R.</span></span> <span> </span><span class="NLM_article-title">Pyrrolidine Carboxamides as a Novel Class of Inhibitors of Enoyl Acyl Carrier Protein Reductase from Mycobacterium Tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6308</span>– <span class="NLM_lpage">6323</span>, <span class="refDoi"> DOI: 10.1021/jm060715y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060715y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVShs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6308-6323&author=X.+Heauthor=A.+Alianauthor=R.+Stroudauthor=P.+R.+Ortiz+de+Montellano&title=Pyrrolidine+Carboxamides+as+a+Novel+Class+of+Inhibitors+of+Enoyl+Acyl+Carrier+Protein+Reductase+from+Mycobacterium+Tuberculosis&doi=10.1021%2Fjm060715y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrolidine Carboxamides as a Novel Class of Inhibitors of Enoyl Acyl Carrier Protein Reductase from Mycobacterium tuberculosis</span></div><div class="casAuthors">He, Xin; Alian, Akram; Stroud, Robert; Ortiz de Montellano, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6308-6323</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In view of the worldwide spread of multidrug resistance of Mycobacterium tuberculosis, there is an urgent need to discover antituberculosis agent with novel structures.  InhA, the enoyl acyl carrier protein reductase (ENR) from M. tuberculosis, is one of the key enzymes involved in the mycobacterial fatty acid elongation cycle and has been validated as an effective antimicrobial target.  We report here the discovery, through high-throughput screening, of a series of pyrrolidine carboxamides as a novel class of potent InhA inhibitors.  Crystal structures of InhA complexed with three inhibitors have been used to elucidate the inhibitor binding mode.  The potency of the lead compd. was improved over 160-fold by subsequent optimization through iterative microtiter library synthesis followed by in situ activity screening without purifn.  Resoln. of racemic mixts. of several inhibitors indicate that only one enantiomer is active as an inhibitor of InhA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrldntzbtEtUbVg90H21EOLACvtfcHk0lgcyW-vJN6NOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVShs7rJ&md5=582fb6b1da8f9fcbe78c5cb679ce498b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm060715y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060715y%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DAlian%26aufirst%3DA.%26aulast%3DStroud%26aufirst%3DR.%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DP.%2BR.%26atitle%3DPyrrolidine%2520Carboxamides%2520as%2520a%2520Novel%2520Class%2520of%2520Inhibitors%2520of%2520Enoyl%2520Acyl%2520Carrier%2520Protein%2520Reductase%2520from%2520Mycobacterium%2520Tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6308%26epage%3D6323%26doi%3D10.1021%2Fjm060715y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz de
Montellano, P. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase InhA by Arylamides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6649</span>– <span class="NLM_lpage">6658</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2Fj.bmc.2007.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=17723305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCisbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=6649-6658&author=X.+Heauthor=A.+Alianauthor=P.+R.+Ortiz+de%0AMontellano&title=Inhibition+of+the+Mycobacterium+Tuberculosis+Enoyl+Acyl+Carrier+Protein+Reductase+InhA+by+Arylamides&doi=10.1016%2Fj.bmc.2007.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides</span></div><div class="casAuthors">He, Xin; Alian, Akram; Ortiz de Montellano, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6649-6658</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">InhA, the enoyl acyl carrier protein reductase (ENR) from Mycobacterium tuberculosis, is one of the key enzymes involved in the type II fatty acid biosynthesis pathway of M. tuberculosis.  We report here the discovery, through high-throughput screening, of a series of arylamides as a novel class of potent InhA inhibitors.  These direct InhA inhibitors require no mycobacterial enzymic activation and thus circumvent the resistance mechanism to antitubercular prodrugs such as INH and ETA that is most commonly obsd. in drug-resistant clin. isolates.  The crystal structure of InhA complexed with one representative inhibitor reveals the binding mode of the inhibitor within the InhA active site.  Further optimization through a microtiter synthesis strategy followed by in situ activity screening led to the discovery of a potent InhA inhibitor with in vitro IC50 = 90 nM, representing a 34-fold potency improvement over the lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWuJ8KSbr69LVg90H21EOLACvtfcHk0lhqNXM9pAhPjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCisbfO&md5=1fe4629f86c1b41640c6eeb2ab3324f4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DAlian%26aufirst%3DA.%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DP.%2BR.%26atitle%3DInhibition%2520of%2520the%2520Mycobacterium%2520Tuberculosis%2520Enoyl%2520Acyl%2520Carrier%2520Protein%2520Reductase%2520InhA%2520by%2520Arylamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D6649%26epage%3D6658%26doi%3D10.1016%2Fj.bmc.2007.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hameed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwas, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span> <span> </span><span class="NLM_article-title">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium Tuberculosis and Are Efficacious in Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9701</span>– <span class="NLM_lpage">9708</span>, <span class="refDoi"> DOI: 10.1021/jm401382v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401382v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9701-9708&author=P.+S.+Shirudeauthor=R.+Shandilauthor=C.+Sadlerauthor=M.+Naikauthor=V.+Hosagraharaauthor=S.+Hameedauthor=V.+Shindeauthor=C.+Bathulaauthor=V.+Humnabadkarauthor=N.+Kumarauthor=J.+Reddyauthor=V.+Pandugaauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=H.+Gardnerauthor=P.+Madhavapeddiauthor=V.+Ramachandranauthor=P.+Kaurauthor=A.+Narayanauthor=S.+Gupthaauthor=D.+Awasthyauthor=C.+Narayanauthor=J.+Mahadevaswamyauthor=K.+G.+Vishwasauthor=V.+Ahujaauthor=A.+Srivastavaauthor=K.+R.+Prabhakarauthor=S.+Bharathauthor=R.+Kaleauthor=M.+Ramaiahauthor=N.+R.+Choudhuryauthor=V.+K.+Sambandamurthyauthor=S.+Solapureauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Azaindoles%3A+Noncovalent+DprE1+Inhibitors+from+Scaffold+Morphing+Efforts%2C+Kill+Mycobacterium+Tuberculosis+and+Are+Efficacious+in+Vivo&doi=10.1021%2Fjm401382v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha; Sadler, Claire; Naik, Maruti; Hosagrahara, Vinayak; Hameed, Shahul; Shinde, Vikas; Bathula, Chandramohan; Humnabadkar, Vaishali; Kumar, Naveen; Reddy, Jitendar; Panduga, Vijender; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Whiteaker, James; McLaughlin, Robert E.; Gardner, Humphrey; Madhavapeddi, Prashanti; Ramachandran, Vasanthi; Kaur, Parvinder; Narayan, Ashwini; Guptha, Supreeth; Awasthy, Disha; Narayan, Chandan; Mahadevaswamy, Jyothi; Vishwas, K. G.; Ahuja, Vijaykamal; Srivastava, Abhishek; Prabhakar, K. R.; Bharath, Sowmya; Kale, Ramesh; Ramaiah, Manjunatha; Choudhury, Nilanjana Roy; Sambandamurthy, Vasan K.; Solapure, Suresh; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9701-9708</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report 1,4-azaindoles as a new inhibitor class that kills Mycobacterium tuberculosis in vitro and demonstrates efficacy in mouse tuberculosis models.  The series emerged from scaffold morphing efforts and was demonstrated to noncovalently inhibit decaprenylphosphoryl-β-d-ribose2'-epimerase (DprE1).  With "drug-like" properties and no expectation of pre-existing resistance in the clinic, this chem. class has the potential to be developed as a therapy for drug-sensitive and drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskQvJK4M2yrVg90H21EOLACvtfcHk0lhqNXM9pAhPjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM&md5=eba42d1952b164f66fd0ca620aaa4f19</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401382v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401382v%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DHameed%26aufirst%3DS.%26aulast%3DShinde%26aufirst%3DV.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVishwas%26aufirst%3DK.%2BG.%26aulast%3DAhuja%26aufirst%3DV.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DKale%26aufirst%3DR.%26aulast%3DRamaiah%26aufirst%3DM.%26aulast%3DChoudhury%26aufirst%3DN.%2BR.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DAzaindoles%253A%2520Noncovalent%2520DprE1%2520Inhibitors%2520from%2520Scaffold%2520Morphing%2520Efforts%252C%2520Kill%2520Mycobacterium%2520Tuberculosis%2520and%2520Are%2520Efficacious%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9701%26epage%3D9708%26doi%3D10.1021%2Fjm401382v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Šink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosič, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Živec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Menendez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Gomez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Roman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales-Cortez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas-Triconado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell-Pages, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encinas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1021/jm501029r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501029r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOgsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=613-624&author=R.+%C5%A0inkauthor=I.+Sosi%C4%8Dauthor=M.+%C5%BDivecauthor=R.+Fernandez-Menendezauthor=S.+Turkauthor=S.+Pajkauthor=D.+Alvarez-Gomezauthor=E.+M.+Lopez-Romanauthor=C.+Gonzales-Cortezauthor=J.+Rullas-Triconadoauthor=I.+Angulo-Barturenauthor=D.+Barrosauthor=L.+Ballell-Pagesauthor=R.+J.+Youngauthor=L.+Encinasauthor=S.+Gobec&title=Design%2C+Synthesis%2C+and+Evaluation+of+New+Thiadiazole-Based+Direct+Inhibitors+of+Enoyl+Acyl+Carrier+Protein+Reductase+%28InhA%29+for+the+Treatment+of+Tuberculosis&doi=10.1021%2Fjm501029r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis</span></div><div class="casAuthors">Sink, Roman; Sosic, Izidor; Zivec, Matej; Fernandez-Menendez, Raquel; Turk, Samo; Pajk, Stane; Alvarez-Gomez, Daniel; Lopez-Roman, Eva Maria; Gonzales-Cortez, Carolina; Rullas-Triconado, Joaquin; Angulo-Barturen, Inigo; Barros, David; Ballell-Pages, Lluis; Young, Robert J.; Encinas, Lourdes; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">613-624</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mycobacterial enoyl acyl carrier protein reductase (InhA) is a clin. validated target for the treatment of tuberculosis infections, a disease that still causes the death of at least a million people annually.  A known class of potent, direct, and competitive InhA inhibitors based on a tetracyclic thiadiazole structure has been shown to have in vivo activity in murine models of tuberculosis infection.  On the basis of this template, we have here explored the medicinal chem. of truncated analogs that have only three arom. rings.  In particular, compds. I [Aryl = 6-methyl-2-pyridyl, 6-bromo-2-pyridyl (8d), 6-(trifluoromethyl)-2-pyridyl, 5-bromo-2-pyridyl and 5-bromo-6-(trifluoromethyl)-2-pyridyl] show interesting features, including low nanomolar InhA IC50, submicromolar antimycobacterial potency, and improved physicochem. profiles in comparison with the tetracyclic analogs.  From this series, 8d is identified as having the best balance of potency and properties, whereby the resolved 8d S-enantiomer shows encouraging in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMhr0INTijhLVg90H21EOLACvtfcHk0liQor0XCcPdMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOgsL3O&md5=01311420c022fc076432829c1b1896c8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm501029r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501029r%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0ink%26aufirst%3DR.%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3D%25C5%25BDivec%26aufirst%3DM.%26aulast%3DFernandez-Menendez%26aufirst%3DR.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DPajk%26aufirst%3DS.%26aulast%3DAlvarez-Gomez%26aufirst%3DD.%26aulast%3DLopez-Roman%26aufirst%3DE.%2BM.%26aulast%3DGonzales-Cortez%26aufirst%3DC.%26aulast%3DRullas-Triconado%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBallell-Pages%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DEncinas%26aufirst%3DL.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520New%2520Thiadiazole-Based%2520Direct%2520Inhibitors%2520of%2520Enoyl%2520Acyl%2520Carrier%2520Protein%2520Reductase%2520%2528InhA%2529%2520for%2520the%2520Treatment%2520of%2520Tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D613%26epage%3D624%26doi%3D10.1021%2Fjm501029r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guardia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulten, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullás, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mata, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuiñán, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell Pages, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Pichel, J.</span></span> <span> </span><span class="NLM_article-title">N-Benzyl-4-((Heteroaryl)Methyl)Benzamides: A New Class of Direct NADH-Dependent 2-Trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1002%2Fcmdc.201600020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=26934341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFelsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=687-701&author=A.+Guardiaauthor=G.+Gultenauthor=R.+Fernandezauthor=J.+G%C3%B3mezauthor=F.+Wangauthor=M.+Converyauthor=D.+Blancoauthor=M.+Mart%C3%ADnezauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=M.+Alonsoauthor=F.+Ortegaauthor=J.+Rull%C3%A1sauthor=D.+Calvoauthor=L.+Mataauthor=R.+Youngauthor=J.+C.+Sacchettiniauthor=A.+Mendoza-Losanaauthor=M.+Remui%C3%B1%C3%A1nauthor=L.+Ballell+Pagesauthor=J.+Castro-Pichel&title=N-Benzyl-4-%28%28Heteroaryl%29Methyl%29Benzamides%3A+A+New+Class+of+Direct+NADH-Dependent+2-Trans+Enoyl-Acyl+Carrier+Protein+Reductase+%28InhA%29+Inhibitors+with+Antitubercular+Activity&doi=10.1002%2Fcmdc.201600020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity</span></div><div class="casAuthors">Guardia, Ana; Gulten, Gulcin; Fernandez, Raquel; Gomez, Jesus; Wang, Feng; Convery, Maire; Blanco, Delia; Martinez, Maria; Perez-Herran, Esther; Alonso, Marta; Ortega, Fatima; Rullas, Joaquin; Calvo, David; Mata, Lydia; Young, Robert; Sacchettini, James C.; Mendoza-Losana, Alfonso; Remuinan, Modesto; Ballell Pages, Lluis; Castro-Pichel, Julia</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">687-701</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Isoniazid (INH) remains one of the cornerstones of antitubercular chemotherapy for drug-sensitive strains of M. tuberculosis bacteria.  However, the increasing prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains contg. mutations in the KatG enzyme, which is responsible for the activation of INH into its antitubercular form, have rendered this drug of little or no use in many cases of drug-resistant tuberculosis.  Presented herein is a novel family of antitubercular direct NADH-dependent 2-trans enoyl-acyl carrier protein reductase (InhA) inhibitors based on an N-benzyl-4-((heteroaryl)methyl)benzamide template; unlike INH, these do not require prior activation by KatG.  Given their direct InhA target engagement, these compds. should be able to circumvent KatG-related resistance in the clinic.  The lead mols. were shown to be potent inhibitors of InhA and showed activity against M. tuberculosis bacteria.  This new family of inhibitors was found to be chem. tractable, as exemplified by the facile synthesis of analogs and the establishment of structure-activity relationships.  Furthermore, a co-crystal structure of the initial hit with the enzyme is disclosed, providing valuable information toward the design of new InhA inhibitors for the treatment of MDR/XDR tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ9O80rhvxk7Vg90H21EOLACvtfcHk0liQor0XCcPdMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFelsrg%253D&md5=205a15ef88b422a0371940b5180e440d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600020%26sid%3Dliteratum%253Aachs%26aulast%3DGuardia%26aufirst%3DA.%26aulast%3DGulten%26aufirst%3DG.%26aulast%3DFernandez%26aufirst%3DR.%26aulast%3DG%25C3%25B3mez%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DConvery%26aufirst%3DM.%26aulast%3DBlanco%26aufirst%3DD.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DRull%25C3%25A1s%26aufirst%3DJ.%26aulast%3DCalvo%26aufirst%3DD.%26aulast%3DMata%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DRemui%25C3%25B1%25C3%25A1n%26aufirst%3DM.%26aulast%3DBallell%2BPages%26aufirst%3DL.%26aulast%3DCastro-Pichel%26aufirst%3DJ.%26atitle%3DN-Benzyl-4-%2528%2528Heteroaryl%2529Methyl%2529Benzamides%253A%2520A%2520New%2520Class%2520of%2520Direct%2520NADH-Dependent%25202-Trans%2520Enoyl-Acyl%2520Carrier%2520Protein%2520Reductase%2520%2528InhA%2529%2520Inhibitors%2520with%2520Antitubercular%2520Activity%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D687%26epage%3D701%26doi%3D10.1002%2Fcmdc.201600020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pajk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Živec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosič, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Hoyos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Gómez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Ruíz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Pichel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell-Pages, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encinas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">New Direct Inhibitors of InhA with Antimycobacterial Activity Based on a Tetrahydropyran Scaffold</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2Fj.ejmech.2016.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=26900657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslCqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2016&pages=252-257&author=S.+Pajkauthor=M.+%C5%BDivecauthor=R.+%C5%A0inkauthor=I.+Sosi%C4%8Dauthor=M.+Neuauthor=C.+Chungauthor=M.+Mart%C3%ADnez-Hoyosauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=D.+%C3%81lvarez-G%C3%B3mezauthor=E.+%C3%81lvarez-Ru%C3%ADzauthor=A.+Mendoza-Losanaauthor=J.+Castro-Pichelauthor=D.+Barrosauthor=L.+Ballell-Pagesauthor=R.+J.+Youngauthor=M.+A.+Converyauthor=L.+Encinasauthor=S.+Gobec&title=New+Direct+Inhibitors+of+InhA+with+Antimycobacterial+Activity+Based+on+a+Tetrahydropyran+Scaffold&doi=10.1016%2Fj.ejmech.2016.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold</span></div><div class="casAuthors">Pajk, Stane; Zivec, Matej; Sink, Roman; Sosic, Izidor; Neu, Margarete; Chung, Chun-wa; Martinez-Hoyos, Maria; Perez-Herran, Esther; Alvarez-Gomez, Daniel; Alvarez-Ruiz, Emilio; Mendoza-Losana, Alfonso; Castro-Pichel, Julia; Barros, David; Ballell-Pages, Lluis; Young, Robert J.; Convery, Maire A.; Encinas, Lourdes; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-257</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Tetrahydropyran derivs. I [R1 = piperidinyl, morpholinyl, 3,5-di-Me pyrazolyl, etc; R2 = 4-methoxyphenyl, pyridinyl, 4-phenylthiazolyl,etc] were synthesized. the compd. I [R1 = 3,5-di-Me pyrazolyl; R2 = 4-phenylthiazolyl] was discovered in a high-throughput screening campaign to find new inhibitors of mycobacterial InhA.  Following initial in-vitro profiling, a structure-activity relationship study was initiated and a focused library of analogs was synthesized and evaluated.  This yielded compd. I [R1 = 3,5-di-Me pyrazolyl; R2 = 4-(2-methoxyphenyl)thiazolyl] with improved antimycobacterial activity and low cytotoxicity.  Addnl., the crystal structure of InhA in complex with inhibitor I [R1 = 3,5-di-Me pyrazolyl; R2 = 4-phenylthiazolyl] was resolved, to reveal the binding mode and provide hints for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHDO5sXoLHa7Vg90H21EOLACvtfcHk0lhPFELwx6Ua3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslCqsr4%253D&md5=1a18421ecbef975f0757e6bcc235e7ab</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DPajk%26aufirst%3DS.%26aulast%3D%25C5%25BDivec%26aufirst%3DM.%26aulast%3D%25C5%25A0ink%26aufirst%3DR.%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3DNeu%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DMart%25C3%25ADnez-Hoyos%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3D%25C3%2581lvarez-G%25C3%25B3mez%26aufirst%3DD.%26aulast%3D%25C3%2581lvarez-Ru%25C3%25ADz%26aufirst%3DE.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DCastro-Pichel%26aufirst%3DJ.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBallell-Pages%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DEncinas%26aufirst%3DL.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DNew%2520Direct%2520Inhibitors%2520of%2520InhA%2520with%2520Antimycobacterial%2520Activity%2520Based%2520on%2520a%2520Tetrahydropyran%2520Scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D112%26spage%3D252%26epage%3D257%26doi%3D10.1016%2Fj.ejmech.2016.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Hoyos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Herran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulten, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encinas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Gómez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Bazaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Pérez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas-Trincado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruano, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castañeda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menéndez, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González del Valle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorino-Gelo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Bustos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavandera, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Casabona, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Pichel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span> <span> </span><span class="NLM_article-title">Antitubercular Drugs for an Old Target: GSK693 as a Promising InhA Direct Inhibitor</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2016.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2Fj.ebiom.2016.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=27428438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A280%3ADC%252BC2s3hvVWksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=291-301&author=M.+Mart%C3%ADnez-Hoyosauthor=E.+Perez-Herranauthor=G.+Gultenauthor=L.+Encinasauthor=D.+%C3%81lvarez-G%C3%B3mezauthor=E.+Alvarezauthor=S.+Ferrer-Bazagaauthor=A.+Garc%C3%ADa-P%C3%A9rezauthor=F.+Ortegaauthor=I.+Angulo-Barturenauthor=J.+Rullas-Trincadoauthor=D.+B.+Ruanoauthor=P.+Torresauthor=P.+Casta%C3%B1edaauthor=S.+Hussauthor=R.+F.+Men%C3%A9ndezauthor=S.+Gonz%C3%A1lez+del+Valleauthor=L.+Ballellauthor=D.+Barrosauthor=S.+Modhaauthor=N.+Dharauthor=F.+Signorino-Geloauthor=J.+D.+McKinneyauthor=J.+F.+Garc%C3%ADa-Bustosauthor=J.+L.+Lavanderaauthor=J.+C.+Sacchettiniauthor=M.+S.+Jimenezauthor=N.+Mart%C3%ADn-Casabonaauthor=J.+Castro-Pichelauthor=A.+Mendoza-Losana&title=Antitubercular+Drugs+for+an+Old+Target%3A+GSK693+as+a+Promising+InhA+Direct+Inhibitor&doi=10.1016%2Fj.ebiom.2016.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor</span></div><div class="casAuthors">Martinez-Hoyos Maria; Perez-Herran Esther; Encinas Lourdes; Alvarez-Gomez Daniel; Alvarez Emilio; Ferrer-Bazaga Santiago; Garcia-Perez Adolfo; Ortega Fatima; Angulo-Barturen Inigo; Rullas-Trincado Joaquin; Blanco Ruano Delia; Torres Pedro; Castaneda Pablo; Huss Sophie; Fernandez Menendez Raquel; Gonzalez Del Valle Silvia; Ballell Lluis; Barros David; Garcia-Bustos Jose Francisco; Lavandera Jose Luis; Castro-Pichel Julia; Gulten Gulcin; Sacchettini James C; Modha Sundip; Signorino-Gelo Francois; McKinney John D; Dhar Neeraj; Jimenez M Soledad; Martin-Casabona Nuria; Mendoza-Losana Alfonso</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-301</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite being one of the first antitubercular agents identified, isoniazid (INH) is still the most prescribed drug for prophylaxis and tuberculosis (TB) treatment and, together with rifampicin, the pillars of current chemotherapy.  A high percentage of isoniazid resistance is linked to mutations in the pro-drug activating enzyme KatG, so the discovery of direct inhibitors (DI) of the enoyl-ACP reductase (InhA) has been pursued by many groups leading to the identification of different enzyme inhibitors, active against Mycobacterium tuberculosis (Mtb), but with poor physicochemical properties to be considered as preclinical candidates.  Here, we present a series of InhA DI active against multidrug (MDR) and extensively (XDR) drug-resistant clinical isolates as well as in TB murine models when orally dosed that can be a promising foundation for a future treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBKqsJCl5WvbZpSb_XWfMrfW6udTcc2eZ2yExGkOro2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3hvVWksg%253D%253D&md5=21f1dbf20ad29185ba9c322829755ebb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2016.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2016.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Hoyos%26aufirst%3DM.%26aulast%3DPerez-Herran%26aufirst%3DE.%26aulast%3DGulten%26aufirst%3DG.%26aulast%3DEncinas%26aufirst%3DL.%26aulast%3D%25C3%2581lvarez-G%25C3%25B3mez%26aufirst%3DD.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DFerrer-Bazaga%26aufirst%3DS.%26aulast%3DGarc%25C3%25ADa-P%25C3%25A9rez%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DRullas-Trincado%26aufirst%3DJ.%26aulast%3DRuano%26aufirst%3DD.%2BB.%26aulast%3DTorres%26aufirst%3DP.%26aulast%3DCasta%25C3%25B1eda%26aufirst%3DP.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DR.%2BF.%26aulast%3DGonz%25C3%25A1lez%2Bdel%2BValle%26aufirst%3DS.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DModha%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DSignorino-Gelo%26aufirst%3DF.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DJimenez%26aufirst%3DM.%2BS.%26aulast%3DMart%25C3%25ADn-Casabona%26aufirst%3DN.%26aulast%3DCastro-Pichel%26aufirst%3DJ.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26atitle%3DAntitubercular%2520Drugs%2520for%2520an%2520Old%2520Target%253A%2520GSK693%2520as%2520a%2520Promising%2520InhA%2520Direct%2520Inhibitor%26jtitle%3DEBioMedicine%26date%3D2016%26volume%3D8%26spage%3D291%26epage%3D301%26doi%3D10.1016%2Fj.ebiom.2016.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkegian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolhiser, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruppo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaerts, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, MRK.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Cofactor-Independent Inhibitor of Mycobacterium Tuberculosis InhA</span>. <i>Life Sci. Alliance</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">e201800025</span> <span class="refDoi"> DOI: 10.26508/lsa.201800025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.26508%2Flsa.201800025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=30456352" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&author=Y.+Xiaauthor=Y.+Zhouauthor=D.+S.+Carterauthor=M.+B.+McNeilauthor=W.+Choiauthor=J.+Halladayauthor=P.+W.+Berryauthor=W.+Maoauthor=V.+Hernandezauthor=T.+O%E2%80%99Malleyauthor=A.+Korkegianauthor=B.+Sundeauthor=L.+Flintauthor=L.+K.+Woolhiserauthor=M.+S.+Shermanauthor=V.+Gruppoauthor=C.+Hastingsauthor=G.+T.+Robertsonauthor=T.+R.+Ioergerauthor=J.+Sacchettiniauthor=P.+J.+Tongeauthor=A.+Lenaertsauthor=T.+Parishauthor=MRK.+Alley&title=Discovery+of+a+Cofactor-Independent+Inhibitor+of+Mycobacterium+Tuberculosis+InhA&doi=10.26508%2Flsa.201800025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.26508%2Flsa.201800025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26508%252Flsa.201800025%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DCarter%26aufirst%3DD.%2BS.%26aulast%3DMcNeil%26aufirst%3DM.%2BB.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DP.%2BW.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DT.%26aulast%3DKorkegian%26aufirst%3DA.%26aulast%3DSunde%26aufirst%3DB.%26aulast%3DFlint%26aufirst%3DL.%26aulast%3DWoolhiser%26aufirst%3DL.%2BK.%26aulast%3DSherman%26aufirst%3DM.%2BS.%26aulast%3DGruppo%26aufirst%3DV.%26aulast%3DHastings%26aufirst%3DC.%26aulast%3DRobertson%26aufirst%3DG.%2BT.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26aulast%3DLenaerts%26aufirst%3DA.%26aulast%3DParish%26aufirst%3DT.%26aulast%3DAlley%26aufirst%3DMRK.%26atitle%3DDiscovery%2520of%2520a%2520Cofactor-Independent%2520Inhibitor%2520of%2520Mycobacterium%2520Tuberculosis%2520InhA%26jtitle%3DLife%2520Sci.%2520Alliance%26date%3D2018%26volume%3D1%26doi%3D10.26508%2Flsa.201800025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horlacher, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Pyridomycin Bridges the NADH- and Substrate-Binding Pockets of the Enoyl Reductase InhA</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1038%2Fnchembio.1405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=24292073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGru7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=96-98&author=R.+C.+Hartkoornauthor=F.+Pojerauthor=J.+A.+Readauthor=H.+Gingellauthor=J.+Neresauthor=O.+P.+Horlacherauthor=K.-H.+Altmannauthor=S.+T.+Cole&title=Pyridomycin+Bridges+the+NADH-+and+Substrate-Binding+Pockets+of+the+Enoyl+Reductase+InhA&doi=10.1038%2Fnchembio.1405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA</span></div><div class="casAuthors">Hartkoorn, Ruben C.; Pojer, Florence; Read, Jon A.; Gingell, Helen; Neres, Joao; Horlacher, Oliver P.; Altmann, Karl-Heinz; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">96-98</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pyridomycin, a natural product with potent antituberculosis activity, inhibits a major drug target, enoyl-ACP reductase InhA.  Here, the authors unveil the co-crystal structure and unique ability of pyridomycin to block both the NADH cofactor- and lipid substrate-binding pockets of InhA.  This is to the authors' knowledge a 1st-of-a-kind binding mode that discloses a new means of InhA inhibition.  Proof-of-principle studies showed how structure-assisted drug design could improve the activity of new pyridomycin derivs., OH 139 and OH 141.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDXuoCfd497Vg90H21EOLACvtfcHk0lhrcHb2kwnlBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGru7jF&md5=14631b559d1d19a6fc3b06e7211a2cc8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1405%26sid%3Dliteratum%253Aachs%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DRead%26aufirst%3DJ.%2BA.%26aulast%3DGingell%26aufirst%3DH.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DHorlacher%26aufirst%3DO.%2BP.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DPyridomycin%2520Bridges%2520the%2520NADH-%2520and%2520Substrate-Binding%2520Pockets%2520of%2520the%2520Enoyl%2520Reductase%2520InhA%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D96%26epage%3D98%26doi%3D10.1038%2Fnchembio.1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, Y.</span></span> <span> </span><span class="NLM_article-title">Synthetic Studies of Pyridomycin. IV. Syntheses of Some Twelve-membered Ring Compounds Designed for Construction of Intact Ring System with Exocyclic (Z)-s-Butylidene Side Chain in Pyridomycin</span>. <i>Bull. Chem. Soc. Jpn.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3298</span>– <span class="NLM_lpage">3308</span>, <span class="refDoi"> DOI: 10.1246/bcsj.58.3298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1246%2Fbcsj.58.3298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaL28Xltlemu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1985&pages=3298-3308&author=M.+Kinoshitaauthor=Y.+Mori&title=Synthetic+Studies+of+Pyridomycin.+IV.+Syntheses+of+Some+Twelve-membered+Ring+Compounds+Designed+for+Construction+of+Intact+Ring+System+with+Exocyclic+%28Z%29-s-Butylidene+Side+Chain+in+Pyridomycin&doi=10.1246%2Fbcsj.58.3298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic studies of pyridomycin.  IV.  Syntheses of some twelve-membered ring compounds designed for construction of intact ring system with exocyclic (Z)-s-butylidene side chain in pyridomycin</span></div><div class="casAuthors">Kinoshita, Mitsuhiro; Mori, Yasuharu</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Chemical Society of Japan</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3298-308</span>CODEN:
                <span class="NLM_cas:coden">BCSJA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2673</span>.
    </div><div class="casAbstract">The (2R,1'S)-azadioxacyclododecanetriones (2R,1'S)-I (R = H, Me) and (2S,1'R)-I (R = Me) were enantiospecifically synthesized from carbohydrate and L-threonine derivs.  Attempts to convert I into a pyridomycin precursor with the 2-(Z)-sec-butylidene side chain were unsuccessful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDWige9hxTM7Vg90H21EOLACvtfcHk0lhrcHb2kwnlBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xltlemu7w%253D&md5=76a18369d6edb13ee10085e10417a0fc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.58.3298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.58.3298%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DY.%26atitle%3DSynthetic%2520Studies%2520of%2520Pyridomycin.%2520IV.%2520Syntheses%2520of%2520Some%2520Twelve-membered%2520Ring%2520Compounds%2520Designed%2520for%2520Construction%2520of%2520Intact%2520Ring%2520System%2520with%2520Exocyclic%2520%2528Z%2529-s-Butylidene%2520Side%2520Chain%2520in%2520Pyridomycin%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1985%26volume%3D58%26spage%3D3298%26epage%3D3308%26doi%3D10.1246%2Fbcsj.58.3298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takarada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsuta, K.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis of Pyridomycin</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">7419</span>– <span class="NLM_lpage">7422</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)70713-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2FS0040-4039%2800%2970713-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFOhtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1989&pages=7419-7422&author=M.+Kinoshitaauthor=M.+Nakataauthor=K.+Takaradaauthor=K.+Tatsuta&title=Total+Synthesis+of+Pyridomycin&doi=10.1016%2FS0040-4039%2800%2970713-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic studies of pyridomycin.  V.  Total synthesis of pyridomycin</span></div><div class="casAuthors">Kinoshita, Mitsuhiro; Nakata, Masaya; Takarada, Kenji; Tatsuta, Kuniaki</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">7419-22</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The first total synthesis of pyridomycin (I) is described including the stereocontrolled construction of the exocyclic (Z)-s-butylidene moiety in the 12-membered ring system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCC1nkRMVkLVg90H21EOLACvtfcHk0lhrcHb2kwnlBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFOhtLg%253D&md5=182dd97e25649179fa001cd5754613c4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2970713-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252970713-1%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DM.%26aulast%3DNakata%26aufirst%3DM.%26aulast%3DTakarada%26aufirst%3DK.%26aulast%3DTatsuta%26aufirst%3DK.%26atitle%3DTotal%2520Synthesis%2520of%2520Pyridomycin%26jtitle%3DTetrahedron%2520Lett.%26date%3D1989%26volume%3D30%26spage%3D7419%26epage%3D7422%26doi%3D10.1016%2FS0040-4039%2800%2970713-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horlacher, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K.-H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antimycobacterial Activity of 2,1′-Dihydropyridomycins</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1021/ml300385q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300385q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCqsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=264-268&author=O.+P.+Horlacherauthor=R.+C.+Hartkoornauthor=S.+T.+Coleauthor=K.-H.+Altmann&title=Synthesis+and+Antimycobacterial+Activity+of+2%2C1%E2%80%B2-Dihydropyridomycins&doi=10.1021%2Fml300385q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antimycobacterial Activity of 2,1'-Dihydropyridomycins</span></div><div class="casAuthors">Horlacher, Oliver P.; Hartkoorn, Ruben C.; Cole, Stewart T.; Altmann, Karl-Heinz</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-268</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dihydropyridomycins 2 and 3 (II, 2R and 2S, resp.), which lack the characteristic enol ester moiety of the potent antimycobacterial natural product pyridomycin 1 (I), have been prepd. from L-Thr, R- and S-hydroxy isovaleric acid, and 3-pyridinecarboxaldehyde.  The 2R isomer 2 shows only 4-fold lower anti-Mtb activity than 1, indicating that the enol ester moiety in the natural product is not crit. for its biol. activity.  This finding establishes 2 as a potent and more practical lead for anti-TB drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Dm4UKBOKirVg90H21EOLACvtfcHk0lhmc3zQgbLZ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCqsLvF&md5=2b81e23c2b644a1c23cc9c17feb68f30</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml300385q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300385q%26sid%3Dliteratum%253Aachs%26aulast%3DHorlacher%26aufirst%3DO.%2BP.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DAltmann%26aufirst%3DK.-H.%26atitle%3DSynthesis%2520and%2520Antimycobacterial%2520Activity%2520of%25202%252C1%25E2%2580%25B2-Dihydropyridomycins%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D264%26epage%3D268%26doi%3D10.1021%2Fml300385q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inanaga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, M.</span></span> <span> </span><span class="NLM_article-title">A Rapid Esterification by Means of Mixed Anhydride and Its Application to Large-Ring Lactonization</span>. <i>Bull. Chem. Soc. Jpn.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1989</span>– <span class="NLM_lpage">1993</span>, <span class="refDoi"> DOI: 10.1246/bcsj.52.1989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1246%2Fbcsj.52.1989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaE1MXltl2rt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1979&pages=1989-1993&author=J.+Inanagaauthor=K.+Hirataauthor=H.+Saekiauthor=T.+Katsukiauthor=M.+Yamaguchi&title=A+Rapid+Esterification+by+Means+of+Mixed+Anhydride+and+Its+Application+to+Large-Ring+Lactonization&doi=10.1246%2Fbcsj.52.1989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid esterification by mixed anhydride and its application to large-ring lactonization</span></div><div class="casAuthors">Inanaga, Junji; Hirata, Kuniko; Saeki, Hiroko; Katsuki, Tsutomu; Yamaguchi, Masaru</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Chemical Society of Japan</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1989-93</span>CODEN:
                <span class="NLM_cas:coden">BCSJA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2673</span>.
    </div><div class="casAbstract">A rapid and mild esterification method using carboxylic 2,4,6-trichlorobenzoic anhydrides in the presence of 4-(dimethylamino)pyridine was developed.  The method was also successfully applied to the synthesis of large-ring lactones, including DL-2,4,6-tridemethyl-3-deoxymethynolide (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwvGlZSKrReLVg90H21EOLACvtfcHk0lhmc3zQgbLZ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXltl2rt78%253D&md5=73880dc7e3aebc06844628a0e9ff6a68</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.52.1989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.52.1989%26sid%3Dliteratum%253Aachs%26aulast%3DInanaga%26aufirst%3DJ.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DSaeki%26aufirst%3DH.%26aulast%3DKatsuki%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DM.%26atitle%3DA%2520Rapid%2520Esterification%2520by%2520Means%2520of%2520Mixed%2520Anhydride%2520and%2520Its%2520Application%2520to%2520Large-Ring%2520Lactonization%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1979%26volume%3D52%26spage%3D1989%26epage%3D1993%26doi%3D10.1246%2Fbcsj.52.1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-L.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Characterization and Activity of New Phosphonate Dipeptides as Potential Inhibitors of VanX</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.10.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2Fj.bmcl.2011.10.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=22113110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=482-484&author=C.+Jiaauthor=K.-W.+Yangauthor=C.-C.+Liuauthor=L.+Fengauthor=J.-M.+Xiaoauthor=L.-S.+Zhouauthor=Y.-L.+Zhang&title=Synthesis%2C+Characterization+and+Activity+of+New+Phosphonate+Dipeptides+as+Potential+Inhibitors+of+VanX&doi=10.1016%2Fj.bmcl.2011.10.094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization and activity of new phosphonate dipeptides as potential inhibitors of VanX</span></div><div class="casAuthors">Jia, Chao; Yang, Ke-Wu; Liu, Cheng-Cheng; Feng, Lei; Xiao, Jian-Min; Zhou, Li-Sheng; Zhang, Yi-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">482-484</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">VanX, a Zn(II)-dependent D-Ala-D-Ala dipeptidase, is essential for vancomycin resistance in Enterococcus faecium.  The enzymic activity of VanX was previously found to be inhibited competitively by 2-{[(1-aminoethyl)(hydroxy) phosphoryl]oxy}propanoic acid.  Here we report the synthesis and characterization of seven phosphonate dipeptide analogs of D-Ala-D-Ala with various substituents, the activity evaluation indicated that six of these phosphonate analogs inhibit VanX with IC50 of 0.48-8.21 mM.  These data revealed a structure-activity relationship which is that the large substituent group on β-carbon resulted in low binding affinity of the phosphonate analog to VanX.  This information will be helpful to guide the design and synthesis of the tightly-binding inhibitors for VanX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9a3BvD2RYQLVg90H21EOLACvtfcHk0lhmc3zQgbLZ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVymug%253D%253D&md5=3625bbfc09d5a815315edbf03675a78c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.094%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DK.-W.%26aulast%3DLiu%26aufirst%3DC.-C.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DJ.-M.%26aulast%3DZhou%26aufirst%3DL.-S.%26aulast%3DZhang%26aufirst%3DY.-L.%26atitle%3DSynthesis%252C%2520Characterization%2520and%2520Activity%2520of%2520New%2520Phosphonate%2520Dipeptides%2520as%2520Potential%2520Inhibitors%2520of%2520VanX%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D482%26epage%3D484%26doi%3D10.1016%2Fj.bmcl.2011.10.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapuis, J.-C.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic Agents. 571. Total Synthesis of Bacillistatin 2</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1021/np800607x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np800607x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVChtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=372-379&author=G.+R.+Pettitauthor=S.+Huauthor=J.+C.+Knightauthor=J.-C.+Chapuis&title=Antineoplastic+Agents.+571.+Total+Synthesis+of+Bacillistatin+2&doi=10.1021%2Fnp800607x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic Agents. 571. Total Synthesis of Bacillistatin 2</span></div><div class="casAuthors">Pettit, George R.; Hu, Shougang; Knight, John C.; Chapuis, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">372-379</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The cyclic peptide macrolactone/macrolactam bacillistatin 2 I is prepd. for the first time using a convergent route in 24 steps and 22.9% overall yield; the synthesis uses the Mitsunobu reactions of oligopeptides terminated with hydroxy acids with oligopeptides and a 2-methyl-6-nitrobenzoic acid anhydride-mediated macrolactonization reaction as the key steps.  I and intermediates and side products in its synthesis are tested for their anticancer activities in human cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJOCvETQNNRLVg90H21EOLACvtfcHk0lhmc3zQgbLZ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVChtbg%253D&md5=e51e11fefa7a04ca25aca208b669e687</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fnp800607x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp800607x%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DKnight%26aufirst%3DJ.%2BC.%26aulast%3DChapuis%26aufirst%3DJ.-C.%26atitle%3DAntineoplastic%2520Agents.%2520571.%2520Total%2520Synthesis%2520of%2520Bacillistatin%25202%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2009%26volume%3D72%26spage%3D372%26epage%3D379%26doi%3D10.1021%2Fnp800607x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glomb, M. A.</span></span> <span> </span><span class="NLM_article-title">Degradation of 1-Deoxy-d-erythro-hexo-2,3-diulose in the Presence of Lysine Leads to Formation of Carboxylic Acid Amides</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6458</span>– <span class="NLM_lpage">6464</span>, <span class="refDoi"> DOI: 10.1021/jf100334r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf100334r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=6458-6464&author=M.+Smudaauthor=M.+Voigtauthor=M.+A.+Glomb&title=Degradation+of+1-Deoxy-d-erythro-hexo-2%2C3-diulose+in+the+Presence+of+Lysine+Leads+to+Formation+of+Carboxylic+Acid+Amides&doi=10.1021%2Fjf100334r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Degradation of 1-Deoxy-D-erythro-hexo-2,3-diulose in the Presence of Lysine Leads to Formation of Carboxylic Acid Amides</span></div><div class="casAuthors">Smuda, Mareen; Voigt, Michael; Glomb, Marcus A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6458-6464</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel species of amides formed from degrdn. of one of the most important key intermediates in Maillard hexose chem.-1-deoxyhexo-2,3-diulose-was investigated.  In 1-deoxyhexo-2,3-diulose/Nα-t-BOC-lysine reaction mixts. four amides, Nε-acetyl lysine, Nε-formyl lysine, Nε-lactoyl lysine and Nε-glycerinyl lysine, were identified and their structures verified by authentic ref. stds.  Amides and corresponding carboxylic acids (acetic acid, formic acid, lactic acid and glyceric acid) accumulated over time.  Both Nε-lysine amides and carboxylic acids were thus detd. as stable Maillard end products.  Results of model incubations suggested the synthesis of amides to be mechanistically closely related to the formation of their corresponding carboxylic acids by β-dicarbonyl cleavage.  Due to the different chem. properties of all the compds. monitored, various anal. strategies had to be carried out (LC-MS2, GC-MS, GC-FID, enzymic detn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRT5jjS82mPrVg90H21EOLACvtfcHk0lhdFpLBlMTHdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSksLs%253D&md5=2e705fef5fb43ad59898f897ff3ee6f0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjf100334r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf100334r%26sid%3Dliteratum%253Aachs%26aulast%3DSmuda%26aufirst%3DM.%26aulast%3DVoigt%26aufirst%3DM.%26aulast%3DGlomb%26aufirst%3DM.%2BA.%26atitle%3DDegradation%2520of%25201-Deoxy-d-erythro-hexo-2%252C3-diulose%2520in%2520the%2520Presence%2520of%2520Lysine%2520Leads%2520to%2520Formation%2520of%2520Carboxylic%2520Acid%2520Amides%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2010%26volume%3D58%26spage%3D6458%26epage%3D6464%26doi%3D10.1021%2Fjf100334r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Au, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jwad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhadbhade, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, L.</span></span> <span> </span><span class="NLM_article-title">Scalable, Stereoselective Syntheses of α,β-Difluoro-γ-Amino Acids</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">3305</span>– <span class="NLM_lpage">3317</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2016.04.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2Fj.tet.2016.04.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslWkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=3305-3317&author=A.+R.+Patelauthor=X.-G.+Huauthor=A.+Lawerauthor=M.+I.+Ahmedauthor=C.+Auauthor=R.+Jwadauthor=J.+Trinhauthor=C.+Gonzalezauthor=E.+Hannahauthor=M.+M.+Bhadbhadeauthor=L.+Hunter&title=Scalable%2C+Stereoselective+Syntheses+of+%CE%B1%2C%CE%B2-Difluoro-%CE%B3-Amino+Acids&doi=10.1016%2Fj.tet.2016.04.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Scalable, stereoselective syntheses of α,β-difluoro-γ-amino acids</span></div><div class="casAuthors">Patel, Alpesh Ramanlal; Hu, Xiang-Guo; Lawer, Aggie; Ahmed, Md. Iqbal; Au, Catherine; Jwad, Rasha; Trinh, Johny; Gonzalez, Christina; Hannah, Elizabeth; Bhadbhade, Mohan M.; Hunter, Luke</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3305-3317</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Backbone-fluorinated gamma-amino acids are novel shape-controlled building blocks that have potential utility in a variety of biol. contexts.  However, their synthesis poses challenges in terms of chemo-, regio- and stereoselectivity, and this has proven to be the major bottleneck in the ongoing development of their various biol. applications.  To address this problem, several new synthetic strategies were investigated in this work.  This has led to the identification of new methods that are superior in terms of yield and stereocontrol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoROZ0ZiZzOMbVg90H21EOLACvtfcHk0lhdFpLBlMTHdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslWkt70%253D&md5=8d3dc6a87951d80c1168b2b6cb3fd0a5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2016.04.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2016.04.070%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%2BR.%26aulast%3DHu%26aufirst%3DX.-G.%26aulast%3DLawer%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DM.%2BI.%26aulast%3DAu%26aufirst%3DC.%26aulast%3DJwad%26aufirst%3DR.%26aulast%3DTrinh%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DC.%26aulast%3DHannah%26aufirst%3DE.%26aulast%3DBhadbhade%26aufirst%3DM.%2BM.%26aulast%3DHunter%26aufirst%3DL.%26atitle%3DScalable%252C%2520Stereoselective%2520Syntheses%2520of%2520%25CE%25B1%252C%25CE%25B2-Difluoro-%25CE%25B3-Amino%2520Acids%26jtitle%3DTetrahedron%26date%3D2016%26volume%3D72%26spage%3D3305%26epage%3D3317%26doi%3D10.1016%2Fj.tet.2016.04.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borhan, B.</span></span> <span> </span><span class="NLM_article-title">Prompt Determination of Absolute Configuration for Epoxy Alcohols via Exciton Chirality Protocol</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">16126</span>– <span class="NLM_lpage">16127</span>, <span class="refDoi"> DOI: 10.1021/ja805058t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja805058t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=16126-16127&author=X.+Liauthor=B.+Borhan&title=Prompt+Determination+of+Absolute+Configuration+for+Epoxy+Alcohols+via+Exciton+Chirality+Protocol&doi=10.1021%2Fja805058t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Prompt Determination of Absolute Configuration for Epoxy Alcohols via Exciton Chirality Protocol</span></div><div class="casAuthors">Li, Xiaoyong; Borhan, Babak</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">16126-16127</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A microscale protocol for detn. of abs. configurations of 2,3-epoxy alcs. is described.  2,3-Disubstituted (cis and trans), 2,2-disubstituted, 2,2,3-trisubstituted, and 2,3,3-trisubstituted epoxy alcs. rendered prominent ECCD signals upon complexing with a Lewis acidic porphyrin tweezer and consequently provide straightforward assignment of chirality for epoxy alcs.  This method proved to be rapid, simple, sensitive, and reliable for the class of mols. listed above.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb0BmDUX9r8rVg90H21EOLACvtfcHk0lhdFpLBlMTHdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGku7fM&md5=221ce1aa464930238ee7b3bdf9aaf04a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fja805058t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja805058t%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBorhan%26aufirst%3DB.%26atitle%3DPrompt%2520Determination%2520of%2520Absolute%2520Configuration%2520for%2520Epoxy%2520Alcohols%2520via%2520Exciton%2520Chirality%2520Protocol%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D16126%26epage%3D16127%26doi%3D10.1021%2Fja805058t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pastó, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pericàs, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riera, A.</span></span> <span> </span><span class="NLM_article-title">A Catalytic Asymmetric Synthesis of N-Boc-β-Methylphenylalanines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8425</span>– <span class="NLM_lpage">8431</span>, <span class="refDoi"> DOI: 10.1021/jo971178f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971178f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1CjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=8425-8431&author=M.+Past%C3%B3author=A.+Moyanoauthor=M.+A.+Peric%C3%A0sauthor=A.+Riera&title=A+Catalytic+Asymmetric+Synthesis+of+N-Boc-%CE%B2-Methylphenylalanines&doi=10.1021%2Fjo971178f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A Catalytic Asymmetric Synthesis of N-Boc-β-Methylphenylalanines</span></div><div class="casAuthors">Pasto, Mireia; Moyano, Albert; Pericas, Miquel A.; Riera, Antoni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8425-8431</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient, stereodivergent, and enantioselective synthesis of the syn and anti diastereomers of N-Boc-β-methylphenylalanine has been developed.  Starting from enantiomerically pure (2S,3S)-2,3-epoxy-3-phenyl-1-propanol, a three-step sequence, consisting of the oxidn. of the primary alc. up to the carboxyl stage, ring opening of the epoxy acid with Me2CuCNLi2, and esterification of the resulting hydroxy acid with Me iodide, leads to the hydroxy ester anti-I, which has been converted in a stereodivergent manner into both the (2S,3R) and the (2R,3R) diastereomers of N-Boc-β-methylphenylalanine, syn-II and anti-III, resp.  Activation of the secondary hydroxy group in anti-I as a mesylate, followed by nucleophilic displacement with sodium azide, hydrogenolysis with simultaneous protection of the amino group, and sapon. with LiOH, affords syn-II.  The same reaction sequence applied to syn-IV, obtained in turn by Mitsunobu reaction of anti-I with p-nitrobenzoic acid followed by the hydrolysis of the resulting p-nitrobenzoate, leads to anti-III.  Both products have been obtained with 99% enantiomeric excess.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq36Eoz9gFFg7Vg90H21EOLACvtfcHk0liSnFMwdOZuqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1CjtL4%253D&md5=f0c4865a7054e9b813872fb47dbf8da0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo971178f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971178f%26sid%3Dliteratum%253Aachs%26aulast%3DPast%25C3%25B3%26aufirst%3DM.%26aulast%3DMoyano%26aufirst%3DA.%26aulast%3DPeric%25C3%25A0s%26aufirst%3DM.%2BA.%26aulast%3DRiera%26aufirst%3DA.%26atitle%3DA%2520Catalytic%2520Asymmetric%2520Synthesis%2520of%2520N-Boc-%25CE%25B2-Methylphenylalanines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D8425%26epage%3D8431%26doi%3D10.1021%2Fjo971178f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomioka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozaki, H.</span></span> <span> </span><span class="NLM_article-title">Regio- and Stereoselective Ring Opening of Epoxy Alcohols with Organoaluminium Compounds Leading to 1,2-Diols</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3597</span>– <span class="NLM_lpage">3600</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)87680-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2FS0040-4039%2800%2987680-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaL3sXltlWhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1982&pages=3597-3600&author=T.+Suzukiauthor=H.+Saimotoauthor=H.+Tomiokaauthor=K.+Oshimaauthor=H.+Nozaki&title=Regio-+and+Stereoselective+Ring+Opening+of+Epoxy+Alcohols+with+Organoaluminium+Compounds+Leading+to+1%2C2-Diols&doi=10.1016%2FS0040-4039%2800%2987680-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Regio- and stereoselective ring opening of epoxy alcohols with organoaluminum compounds leading to 1,2-diols</span></div><div class="casAuthors">Suzuki, Toshifumi; Saimoto, Hiroyuki; Tomioka, Hiroki; Oshima, Koichiro; Nozaki, Hitosi</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">3597-600</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">Ring cleavage of epoxy alcs. with organoaluminum compds. introduced alkyl, alkynyl, or hydride regioselectively at the 3 position with inversion of configuration.  E.g., reaction of epoxide I with Me3Al in hexane at 0° for 30 min gave 94% diol II.  The reaction mechanism involves initial conversion of the OH group into Al alkoxide followed by coordination of the epoxy O to the Al and C-3-O bond cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorxaCjHwNy7rVg90H21EOLACvtfcHk0liSnFMwdOZuqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXltlWhsA%253D%253D&md5=7cbec96e1a09c8f5a6cc7e8e012935e3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2987680-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252987680-7%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DSaimoto%26aufirst%3DH.%26aulast%3DTomioka%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DNozaki%26aufirst%3DH.%26atitle%3DRegio-%2520and%2520Stereoselective%2520Ring%2520Opening%2520of%2520Epoxy%2520Alcohols%2520with%2520Organoaluminium%2520Compounds%2520Leading%2520to%25201%252C2-Diols%26jtitle%3DTetrahedron%2520Lett.%26date%3D1982%26volume%3D23%26spage%3D3597%26epage%3D3600%26doi%3D10.1016%2FS0040-4039%2800%2987680-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swern, D.</span></span> <span> </span><span class="NLM_article-title">Oxidation of Alcohols by “Activated” Dimethyl Sulfoxide. a Preparative, Steric and Mechanistic Study</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1651</span>– <span class="NLM_lpage">1660</span>, <span class="refDoi"> DOI: 10.1016/0040-4020(78)80197-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1016%2F0040-4020%2878%2980197-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaE1MXos1Cjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1978&pages=1651-1660&author=K.+Omuraauthor=D.+Swern&title=Oxidation+of+Alcohols+by+%E2%80%9CActivated%E2%80%9D+Dimethyl+Sulfoxide.+a+Preparative%2C+Steric+and+Mechanistic+Study&doi=10.1016%2F0040-4020%2878%2980197-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of alcohols by "activated" dimethyl sulfoxide.  A preparative steric and mechanistic study</span></div><div class="casAuthors">Omura, Kanji; Swern, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1651-60</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">The oxidn. of allylic and arom. alcs., cycloalkanols and alkanols with Me2SO activated by electrophiles to give carbonyl compds., was studied.  Paths for carbonyl and by-product formation are presented.  In general, yields of carbonyl compds. increased with increased steric hindrance in the alcs.  Steric effects of tertiary amines on the oxidns. were also studied.  With (COCl)2 as activator, yields of carbonyl compds. were generally >95%.  E.g., oxidn. of PhCH:CHCH2OH with Me2SO/(COCl)2 gave 100% PhCH:CHCHO.  High yields were also obtained using SOCl2 as activator.  ROCH2SMe [R = Me(CH2)9, Me(CH2)5CHMe, cyclohexyl, Ph(CH2)2, trans-PrCH:CHCH2] were prepd. (60-70%) by treatment of ROH with Me2SO/NEt3 contg. BF3.Et2O.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojfAH5e5aTWbVg90H21EOLACvtfcHk0liSnFMwdOZuqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXos1Cjtg%253D%253D&md5=b242305766e00a62b9220db412ca84ce</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0040-4020%2878%2980197-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4020%252878%252980197-5%26sid%3Dliteratum%253Aachs%26aulast%3DOmura%26aufirst%3DK.%26aulast%3DSwern%26aufirst%3DD.%26atitle%3DOxidation%2520of%2520Alcohols%2520by%2520%25E2%2580%259CActivated%25E2%2580%259D%2520Dimethyl%2520Sulfoxide.%2520a%2520Preparative%252C%2520Steric%2520and%2520Mechanistic%2520Study%26jtitle%3DTetrahedron%26date%3D1978%26volume%3D34%26spage%3D1651%26epage%3D1660%26doi%3D10.1016%2F0040-4020%2878%2980197-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span> <span> </span><span class="NLM_article-title">Synthetic Studies toward Verrucarol. 1. Synthesis of the AB Ring System</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4820</span>– <span class="NLM_lpage">4825</span>, <span class="refDoi"> DOI: 10.1021/jo01312a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01312a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaL3MXkslGhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=4820-4825&author=G.+A.+Krausauthor=B.+Roth&title=Synthetic+Studies+toward+Verrucarol.+1.+Synthesis+of+the+AB+Ring+System&doi=10.1021%2Fjo01312a003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic studies toward verrucarol.  1.  Synthesis of the AB ring system</span></div><div class="casAuthors">Kraus, George A.; Frazier, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4820-5</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The hydroxy ketone I, a synthon for verrucarol, was prepd. in 7.9% yield in 9 steps via the Diels-Alder adduct II (R = R1 = H) of isoprene and Me 2-oxo-2H-pyran-5-carboxylate (III).  Transformation of II (R = R1 = H) into the hydroxy lactone II (R = OH, R1 = Me) involved Me2CuLi addn., hydroxylation, and oxidn. with N-chlorosuccinimide.  Enol ether formation, redn. of the lactone and ester functions, and hydrolysis of the enol ether gave I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX8vamd2KLq7Vg90H21EOLACvtfcHk0lg9CZ_tFELc4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkslGhsA%253D%253D&md5=039aa698f645d2c1c8a247c8e666b07f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo01312a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01312a003%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DG.%2BA.%26aulast%3DRoth%26aufirst%3DB.%26atitle%3DSynthetic%2520Studies%2520toward%2520Verrucarol.%25201.%2520Synthesis%2520of%2520the%2520AB%2520Ring%2520System%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D4820%26epage%3D4825%26doi%3D10.1021%2Fjo01312a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taschner, M. J.</span></span> <span> </span><span class="NLM_article-title">Model Studies for the Synthesis of Quassinoids. 1. Construction of the BCE Ring System</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1176</span>, <span class="refDoi"> DOI: 10.1021/jo01294a058</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01294a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaL3cXhs1Cis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=1175-1176&author=G.+A.+Krausauthor=M.+J.+Taschner&title=Model+Studies+for+the+Synthesis+of+Quassinoids.+1.+Construction+of+the+BCE+Ring+System&doi=10.1021%2Fjo01294a058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Model studies for the synthesis of quassinoids.  1.  Construction of the BCE ring system</span></div><div class="casAuthors">Kraus, George A.; Taschner, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1175-6</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The synthesis of a key intermediate I for the prepn. of quassimarin (II) is described.  The BC ring system is constructed using a Diels-Alder reaction involving the in situ generated carbomethoxybenzoquinone.  The E ring is introduced by a selenoetherification reaction.  The trans diaxial diol unit can be constructed by intramol. epoxide opening.  Attempts to open the epoxide with external nucleophiles failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXJGvgihSziLVg90H21EOLACvtfcHk0lg9CZ_tFELc4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhs1Cis70%253D&md5=9202fa3b893c40e56d1700545f3a3a3d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo01294a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01294a058%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DG.%2BA.%26aulast%3DTaschner%26aufirst%3DM.%2BJ.%26atitle%3DModel%2520Studies%2520for%2520the%2520Synthesis%2520of%2520Quassinoids.%25201.%2520Construction%2520of%2520the%2520BCE%2520Ring%2520System%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D1175%26epage%3D1176%26doi%3D10.1021%2Fjo01294a058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abiko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masamune, S.</span></span> <span> </span><span class="NLM_article-title">The Anti-Selective Boron-Mediated Asymmetric Aldol Reaction of Carboxylic Esters</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">2586</span>– <span class="NLM_lpage">2587</span>, <span class="refDoi"> DOI: 10.1021/ja963754f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja963754f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaK2sXitFSrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=2586-2587&author=A.+Abikoauthor=J.+Liuauthor=S.+Masamune&title=The+Anti-Selective+Boron-Mediated+Asymmetric+Aldol+Reaction+of+Carboxylic+Esters&doi=10.1021%2Fja963754f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The Anti-Selective Boron-Mediated Asymmetric Aldol Reaction of Carboxylic Esters</span></div><div class="casAuthors">Abiko, Atsushi; Liu, Ji-Feng; Masamune, Satoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2586-2587</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A highly efficient, reliable method for the diastereo- and enantioselective construction of the anti-3-hydroxy-2-methylcarbonyl system has been devised using 2-[benzyl(mesitylenesulfonyl)amino]-1-phenylpropyl propionate (I), which is readily derived from norephedrine.  The boron-mediated aldol reaction (dicyclohexylboron triflate and triethylamine) of I proceeded with excellent anti-selectivity (anti:syn >98:2) and diastereofacial selectivity for anti-isomers (>95:5).  The ease of the operation and the mildness of the boron aldol reaction render this aldol method truly practical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGNWl1_jyoQ7Vg90H21EOLACvtfcHk0lg9CZ_tFELc4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitFSrtLg%253D&md5=772b991a8905de20b6e80a70143b2a51</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja963754f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja963754f%26sid%3Dliteratum%253Aachs%26aulast%3DAbiko%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMasamune%26aufirst%3DS.%26atitle%3DThe%2520Anti-Selective%2520Boron-Mediated%2520Asymmetric%2520Aldol%2520Reaction%2520of%2520Carboxylic%2520Esters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D2586%26epage%3D2587%26doi%3D10.1021%2Fja963754f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, L. A.</span></span> <span> </span><span class="NLM_article-title">1-Hydroxy-7-Azabenzotriazole. An Efficient Peptide Coupling Additive</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4398</span>, <span class="refDoi"> DOI: 10.1021/ja00063a082</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00063a082" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaK3sXkslejurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1993&pages=4397-4398&author=L.+A.+Carpino&title=1-Hydroxy-7-Azabenzotriazole.+An+Efficient+Peptide+Coupling+Additive&doi=10.1021%2Fja00063a082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive</span></div><div class="casAuthors">Carpino, Louis A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4397-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The title compd. (HOAt) (I), the 7-aza analog of the well-known, currently most-often preferred peptide coupling additive 1-hydroxybenzotriazole (HOBt), speeds up the coupling process and reduces racemization relative to HOBt.  In addn., HOAt signals completion of the reaction by a color change.  Uronium salts incorporating HOAt in place of HOBt show similar advantages.  These reagents are more effective than HOBt analogs for hindered systems.  Racemization is reduced 25-50% over that obsd. with HOBt for a series of model peptide couplings.  The isomeric 4-aza-1-hydroxybenzotriazole also speeds up the coupling process, but it does not show the racemization inhibition shown by HOAt, thus suggesting the importance of neighboring group effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbpCTFVq8bzbVg90H21EOLACvtfcHk0lhwFzu_M-bA2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkslejurc%253D&md5=39c0adaddc5e2dd1c15032ad524f3b88</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja00063a082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00063a082%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DL.%2BA.%26atitle%3D1-Hydroxy-7-Azabenzotriazole.%2520An%2520Efficient%2520Peptide%2520Coupling%2520Additive%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1993%26volume%3D115%26spage%3D4397%26epage%3D4398%26doi%3D10.1021%2Fja00063a082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariyama, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of (2R, 3S, 4S)-4-Amino-3-Hydroxy-2-Methyl-5-(3-Pyridyl)Pentanoic Acid Present in Antibiotic Pyridomycin</span>. <i>Bull. Chem. Soc. Jpn.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2081</span>– <span class="NLM_lpage">2083</span>, <span class="refDoi"> DOI: 10.1246/bcsj.48.2081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1246%2Fbcsj.48.2081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaE2MXlsVOltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1975&pages=2081-2083&author=M.+Kinoshitaauthor=S.+Mariyama&title=Synthesis+of+%282R%2C+3S%2C+4S%29-4-Amino-3-Hydroxy-2-Methyl-5-%283-Pyridyl%29Pentanoic+Acid+Present+in+Antibiotic+Pyridomycin&doi=10.1246%2Fbcsj.48.2081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (2R,3S,4S)-4-amino-3-hydroxy-2-methyl-5-(3-pyridyl)pentanoic acid present in antibiotic pyridomycin</span></div><div class="casAuthors">Kinoshita, Mitsuhiro; Mariyama, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Chemical Society of Japan</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2081-3</span>CODEN:
                <span class="NLM_cas:coden">BCSJA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2673</span>.
    </div><div class="casAbstract">(2R,3S,4S)-4-amino-3-hydroxy-2-methyl-5-(3-pyridyl)pentanoic acid (I) was prepd. from II by hydrolysis and oxidn. with periodate-bromine in aq. HOAc.  5,6-Anhydro-1,2-O-isopropylidene-3-C-methyl-α-D-allofuranose (III) was prepd. from 3-deoxy-1,2;5,6-di-O-isopropylidene-3-C-methyl-α-D-allofuranose.  Regiospecific introduction of 3-pyridyl group to the C-6 of III was effected by 3-pyridyllithium and the product was converted to II by SN2 substitution reaction of the 5-mesylate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3r8kR052Q5rVg90H21EOLACvtfcHk0lhwFzu_M-bA2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXlsVOltbg%253D&md5=c4bb19cc2a9af823f47f37c6d18dd4ce</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.48.2081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.48.2081%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DM.%26aulast%3DMariyama%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520%25282R%252C%25203S%252C%25204S%2529-4-Amino-3-Hydroxy-2-Methyl-5-%25283-Pyridyl%2529Pentanoic%2520Acid%2520Present%2520in%2520Antibiotic%2520Pyridomycin%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1975%26volume%3D48%26spage%3D2081%26epage%3D2083%26doi%3D10.1246%2Fbcsj.48.2081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neises, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steglich, W.</span></span> <span> </span><span class="NLM_article-title">Simple Method for the Esterification of Carboxylic Acids</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1002/anie.197805221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1002%2Fanie.197805221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1978&pages=522-524&author=B.+Neisesauthor=W.+Steglich&title=Simple+Method+for+the+Esterification+of+Carboxylic+Acids&doi=10.1002%2Fanie.197805221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fanie.197805221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.197805221%26sid%3Dliteratum%253Aachs%26aulast%3DNeises%26aufirst%3DB.%26aulast%3DSteglich%26aufirst%3DW.%26atitle%3DSimple%2520Method%2520for%2520the%2520Esterification%2520of%2520Carboxylic%2520Acids%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1978%26volume%3D17%26spage%3D522%26epage%3D524%26doi%3D10.1002%2Fanie.197805221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portaels, F.</span></span> <span> </span><span class="NLM_article-title">Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium Tuberculosis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2720</span>– <span class="NLM_lpage">2722</span>, <span class="refDoi"> DOI: 10.1128/AAC.46.8.2720-2722.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1128%2FAAC.46.8.2720-2722.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=12121966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFGiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=2720-2722&author=J.-C.+Palominoauthor=A.+Martinauthor=M.+Camachoauthor=H.+Guerraauthor=J.+Swingsauthor=F.+Portaels&title=Resazurin+Microtiter+Assay+Plate%3A+Simple+and+Inexpensive+Method+for+Detection+of+Drug+Resistance+in+Mycobacterium+Tuberculosis&doi=10.1128%2FAAC.46.8.2720-2722.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis</span></div><div class="casAuthors">Palomino, Juan-Carlos; Martin, Anandi; Camacho, Mirtha; Guerra, Humberto; Swings, Jean; Portaels, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2720-2722</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A method for detecting multidrug-resistant Mycobacterium tuberculosis by using a redn. of resazurin is described.  Eighty clin. isolates were evaluated against isoniazid and rifampin; results at 7 days were compared with those of the proportion method.  Specificity and sensitivity were excellent.  The method is simple, inexpensive, and rapid and might be used with other antituberculosis drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCEstIM6doRbVg90H21EOLACvtfcHk0lhwFzu_M-bA2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFGiu7w%253D&md5=555848714bd1528e6a8eb913b5971c9a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.8.2720-2722.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.8.2720-2722.2002%26sid%3Dliteratum%253Aachs%26aulast%3DPalomino%26aufirst%3DJ.-C.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DCamacho%26aufirst%3DM.%26aulast%3DGuerra%26aufirst%3DH.%26aulast%3DSwings%26aufirst%3DJ.%26aulast%3DPortaels%26aufirst%3DF.%26atitle%3DResazurin%2520Microtiter%2520Assay%2520Plate%253A%2520Simple%2520and%2520Inexpensive%2520Method%2520for%2520Detection%2520of%2520Drug%2520Resistance%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D2720%26epage%3D2722%26doi%3D10.1128%2FAAC.46.8.2720-2722.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houben, E. N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geurtsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Punder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wever, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piersma, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daffé, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appelmelk, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitter, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Wel1, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, P. J.</span></span> <span> </span><span class="NLM_article-title">Direct Visualization by Cryo-EM of the Mycobacterial Capsular Layer: A Labile Structure Containing ESX-1-Secreted Proteins</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1000794</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1000794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1371%2Fjournal.ppat.1000794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=20221442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A280%3ADC%252BC3c7nsFSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&author=M.+Saniauthor=E.+N.+G.+Houbenauthor=J.+Geurtsenauthor=J.+Piersonauthor=K.+de+Punderauthor=M.+van+Zonauthor=B.+Weverauthor=S.+R.+Piersmaauthor=C.+R.+Jim%C3%A9nezauthor=M.+Daff%C3%A9author=B.+J.+Appelmelkauthor=W.+Bitterauthor=N.+van+der%0AWel1author=P.+J.+Peters&title=Direct+Visualization+by+Cryo-EM+of+the+Mycobacterial+Capsular+Layer%3A+A+Labile+Structure+Containing+ESX-1-Secreted+Proteins&doi=10.1371%2Fjournal.ppat.1000794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins</span></div><div class="casAuthors">Sani Musa; Houben Edith N G; Geurtsen Jeroen; Pierson Jason; de Punder Karin; van Zon Maaike; Wever Brigitte; Piersma Sander R; Jimenez Connie R; Daffe Mamadou; Appelmelk Ben J; Bitter Wilbert; van der Wel Nicole; Peters Peter J</div><div class="citationInfo"><span class="NLM_cas:title">PLoS pathogens</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1000794</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The cell envelope of mycobacteria, a group of Gram positive bacteria, is composed of a plasma membrane and a Gram-negative-like outer membrane containing mycolic acids.  In addition, the surface of the mycobacteria is coated with an ill-characterized layer of extractable, non-covalently linked glycans, lipids and proteins, collectively known as the capsule, whose occurrence is a matter of debate.  By using plunge freezing cryo-electron microscopy technique, we were able to show that pathogenic mycobacteria produce a thick capsule, only present when the cells were grown under unperturbed conditions and easily removed by mild detergents.  This detergent-labile capsule layer contains arabinomannan, alpha-glucan and oligomannosyl-capped glycolipids.  Further immunogenic and proteomic analyses revealed that Mycobacterium marinum capsule contains high amounts of proteins that are secreted via the ESX-1 pathway.  Finally, cell infection experiments demonstrated the importance of the capsule for binding to cells and dampening of pro-inflammatory cytokine response.  Together, these results show a direct visualization of the mycobacterial capsular layer as a labile structure that contains ESX-1-secreted proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4xIZFY6FAWr9KldV63DuefW6udTcc2earH8Gn5cxs-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7nsFSkug%253D%253D&md5=0610ea5e56b6df489d1ff191169a60f5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1000794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1000794%26sid%3Dliteratum%253Aachs%26aulast%3DSani%26aufirst%3DM.%26aulast%3DHouben%26aufirst%3DE.%2BN.%2BG.%26aulast%3DGeurtsen%26aufirst%3DJ.%26aulast%3DPierson%26aufirst%3DJ.%26aulast%3Dde%2BPunder%26aufirst%3DK.%26aulast%3Dvan%2BZon%26aufirst%3DM.%26aulast%3DWever%26aufirst%3DB.%26aulast%3DPiersma%26aufirst%3DS.%2BR.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DC.%2BR.%26aulast%3DDaff%25C3%25A9%26aufirst%3DM.%26aulast%3DAppelmelk%26aufirst%3DB.%2BJ.%26aulast%3DBitter%26aufirst%3DW.%26aulast%3Dvan%2Bder%2BWel1%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DP.%2BJ.%26atitle%3DDirect%2520Visualization%2520by%2520Cryo-EM%2520of%2520the%2520Mycobacterial%2520Capsular%2520Layer%253A%2520A%2520Labile%2520Structure%2520Containing%2520ESX-1-Secreted%2520Proteins%26jtitle%3DPLoS%2520Pathog.%26date%3D2010%26volume%3D6%26doi%3D10.1371%2Fjournal.ppat.1000794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Massengo-Tiassé, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronan, J. E.</span></span> <span> </span><span class="NLM_article-title">Diversity in Enoyl-Acyl Carrier Protein Reductases</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1507</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1007/s00018-009-8704-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1007%2Fs00018-009-8704-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=19151923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnslyltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1507-1517&author=R.+P.+Massengo-Tiass%C3%A9author=J.+E.+Cronan&title=Diversity+in+Enoyl-Acyl+Carrier+Protein+Reductases&doi=10.1007%2Fs00018-009-8704-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Diversity in enoyl-acyl carrier protein reductases</span></div><div class="casAuthors">Massengo-Tiasse, R. P.; Cronan, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1507-1517</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  The enoyl-acyl carrier protein reductase (ENR) is the last enzyme in the fatty acid elongation cycle.  Unlike most enzymes in this essential pathway, ENR displays an unusual diversity among organisms.  The growing interest in ENRs is mainly due to the fact that a variety of both synthetic and natural antibacterial compds. are shown to specifically target their activity.  The primary anti-tuberculosis drug, isoniazid, and the broadly used antibacterial compd., triclosan, both target this enzyme.  In this review, the diversity of ENRs, and their inhibitors are discussed in the light of current research progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokuNowzqaKvLVg90H21EOLACvtfcHk0lgizO0MVbCuhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnslyltb0%253D&md5=d81da4c7b92cc18a09901870f1189df8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-8704-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-8704-7%26sid%3Dliteratum%253Aachs%26aulast%3DMassengo-Tiass%25C3%25A9%26aufirst%3DR.%2BP.%26aulast%3DCronan%26aufirst%3DJ.%2BE.%26atitle%3DDiversity%2520in%2520Enoyl-Acyl%2520Carrier%2520Protein%2520Reductases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26spage%3D1507%26epage%3D1517%26doi%3D10.1007%2Fs00018-009-8704-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubnau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quemard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Um, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lisle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, W. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">InhA, a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium Tuberculosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>263</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.1126/science.8284673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1126%2Fscience.8284673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=8284673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFylt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=227-230&author=A.+Banerjeeauthor=E.+Dubnauauthor=A.+Quemardauthor=V.+Balasubramanianauthor=K.+S.+Umauthor=T.+Wilsonauthor=D.+Collinsauthor=G.+de+Lisleauthor=W.+R.+Jacobs&title=InhA%2C+a+Gene+Encoding+a+Target+for+Isoniazid+and+Ethionamide+in+Mycobacterium+Tuberculosis&doi=10.1126%2Fscience.8284673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis</span></div><div class="casAuthors">Banerjee, Asesh; Dubnau, Eugenie; Quemard, Annaik; Balasubramanian, V.; Um, Kyung Sun; Wilson, Theresa; Collins, Des; de Lisle, Geoffrey; Jacobs, William, R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue">5144</span>),
    <span class="NLM_cas:pages">227-30</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Isoniazid (isonicotinic acid hydrazide, INH) is one of the most widely used antituberculosis drugs, yet its precise target of action on Mycobacterium tuberculosis is unknown.  A missense mutation within the mycobacterial inhA gene was shown to confer resistance to both INH and ethionamide (ETH) in M. smegmatis and in M. bovis.  The wild-type inhA gene also conferred INH and ETH resistance when transferred on a multicopy plasmid vector to M. smegmatis and M. bovis BCG.  The InhA protein shows a significant sequence conservation with the Escherichia coli enzyme EnvM, and cell-free assays indicate that it may be involved in mycolic acid biosynthesis.  These results suggest that InhA is likely a primary target of action for INH and ETH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUYkDS4hfHFrVg90H21EOLACvtfcHk0lgizO0MVbCuhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFylt7c%253D&md5=12f3eabbca02009180332c1e65db8c15</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1126%2Fscience.8284673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8284673%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DDubnau%26aufirst%3DE.%26aulast%3DQuemard%26aufirst%3DA.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DUm%26aufirst%3DK.%2BS.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DD.%26aulast%3Dde%2BLisle%26aufirst%3DG.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26atitle%3DInhA%252C%2520a%2520Gene%2520Encoding%2520a%2520Target%2520for%2520Isoniazid%2520and%2520Ethionamide%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D227%26epage%3D230%26doi%3D10.1126%2Fscience.8284673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilchèze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salfinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heifets, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazbon, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alland, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, W. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Overexpression of InhA, but Not KasA, Confers Resistance to Isoniazid and Ethionamide in Mycobacterium Smegmatis, M. bovis BCG and M. Tuberculosis</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2002.03162.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=10.1046%2Fj.1365-2958.2002.03162.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=12406221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADC%252BD38XosVartrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=453-466&author=M.+H.+Larsenauthor=C.+Vilch%C3%A8zeauthor=L.+Kremerauthor=G.+S.+Besraauthor=L.+Parsonsauthor=M.+Salfingerauthor=L.+Heifetsauthor=M.+H.+Hazbonauthor=D.+Allandauthor=J.+C.+Sacchettiniauthor=W.+R.+Jacobs&title=Overexpression+of+InhA%2C+but+Not+KasA%2C+Confers+Resistance+to+Isoniazid+and+Ethionamide+in+Mycobacterium+Smegmatis%2C+M.+bovis+BCG+and+M.+Tuberculosis&doi=10.1046%2Fj.1365-2958.2002.03162.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis</span></div><div class="casAuthors">Larsen, Michelle H.; Vilcheze, Catherine; Kremer, Laurent; Besra, Gurdyal S.; Parsons, Linda; Salfinger, Max; Heifets, Leonid; Hazbon, Manzour H.; Alland, David; Sacchettini, James C.; Jacobs, William R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">x453-466</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The inhA and kasA genes of Mycobacterium tuberculosis have each been proposed to encode the primary target of the antibiotic isoniazid (INH).  Previous studies investigating whether overexpressed inhA or kasA could confer resistance to INH yielded disparate results.  In this work, multicopy plasmids expressing either inhA or kasA genes were transformed into M. smegmatis, M. bovis BCG and three different M. tuberculosis strains.  The resulting transformants, as well as previously published M. tuberculosis strains with multicopy inhA or kasAB plasmids, were tested for their resistance to INH, ethionamide (ETH) or thiolactomycin (TLM).  Mycobacteria contg. inhA plasmids uniformly exhibited 20-fold or greater increased resistance to INH and 10-fold or greater increased resistance to ETH.  In contrast, the kasA plasmid conferred no increased resistance to INH or ETH in any of the five strains, but it did confer resistance to thiolactomycin, a known KasA inhibitor.  INH is known to increase the expression of kasA in INH-susceptible M. tuberculosis strains.  Using mol. beacons, quantified inhA and kasA mRNA levels showed that increased inhA mRNA levels correlated with INH resistance, whereas kasA mRNA levels did not.  In summary, anal. of strains harboring inhA or kasA plasmids yielded the same conclusion: overexpressed inhA, but not kasA, confers INH and ETH resistance to M. smegmatis, M. bovis BCG and M. tuberculosis.  Therefore, InhA is the primary target of action of INH and ETH in all three species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1zb4K7kRTF7Vg90H21EOLACvtfcHk0lgnw7hvT2U2Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosVartrw%253D&md5=422c40b60fbf6d5b8fb564f7009d82ec</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2002.03162.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2002.03162.x%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DM.%2BH.%26aulast%3DVilch%25C3%25A8ze%26aufirst%3DC.%26aulast%3DKremer%26aufirst%3DL.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DParsons%26aufirst%3DL.%26aulast%3DSalfinger%26aufirst%3DM.%26aulast%3DHeifets%26aufirst%3DL.%26aulast%3DHazbon%26aufirst%3DM.%2BH.%26aulast%3DAlland%26aufirst%3DD.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26atitle%3DOverexpression%2520of%2520InhA%252C%2520but%2520Not%2520KasA%252C%2520Confers%2520Resistance%2520to%2520Isoniazid%2520and%2520Ethionamide%2520in%2520Mycobacterium%2520Smegmatis%252C%2520M.%2520bovis%2520BCG%2520and%2520M.%2520Tuberculosis%26jtitle%3DMol.%2520Microbiol.%26date%3D2002%26volume%3D46%26spage%3D453%26epage%3D466%26doi%3D10.1046%2Fj.1365-2958.2002.03162.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunder, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masamune, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">Catalytic Asymmetric Epoxidation and Kinetic Resolution: Modified Procedures Including in Situ Derivatization</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">5765</span>– <span class="NLM_lpage">5780</span>, <span class="refDoi"> DOI: 10.1021/ja00253a032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00253a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;key=1%3ACAS%3A528%3ADyaL2sXltlemu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1987&pages=5765-5780&author=Y.+Gaoauthor=R.+M.+Hansonauthor=J.+M.+Klunderauthor=S.+Y.+Koauthor=H.+Masamuneauthor=K.+B.+Sharpless&title=Catalytic+Asymmetric+Epoxidation+and+Kinetic+Resolution%3A+Modified+Procedures+Including+in+Situ+Derivatization&doi=10.1021%2Fja00253a032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic asymmetric epoxidation and kinetic resolution: modified procedures including in situ derivatization</span></div><div class="casAuthors">Gao, Yun; Klunder, Janice M.; Hanson, Robert M.; Masamune, Hiroko; Ko, Soo Y.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5765-80</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The use of 3A or 4A mol. sieves (zeolites) substantially increases the scope of the Ti(IV)-catalyzed asym. epoxidn. of primary allylic alcs.  High conversions (>95%) and enantioselectivities (90-95%) are obtained.  The epoxidns. of 20 primary alcs. are described, and the kinetic resoln. of 4 secondary alcs. is also carried out.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb1HGdyJEcirVg90H21EOLACvtfcHk0lgnw7hvT2U2Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXltlemu7w%253D&md5=0f720a2212642b9f747e05dca6b9ba58</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fja00253a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00253a032%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DHanson%26aufirst%3DR.%2BM.%26aulast%3DKlunder%26aufirst%3DJ.%2BM.%26aulast%3DKo%26aufirst%3DS.%2BY.%26aulast%3DMasamune%26aufirst%3DH.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DCatalytic%2520Asymmetric%2520Epoxidation%2520and%2520Kinetic%2520Resolution%253A%2520Modified%2520Procedures%2520Including%2520in%2520Situ%2520Derivatization%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1987%26volume%3D109%26spage%3D5765%26epage%3D5780%26doi%3D10.1021%2Fja00253a032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i112"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01457">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_60577"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01457?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01457</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental protocols for the synthesis of acid <b>29</b> (including copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra of acid <b>29</b> and all intermediates); <sup>1</sup>H and <sup>13</sup>C NMR spectra of final products and intermediates; HPLC traces for all final products, except <b>28e</b>; MIC values of compounds <b>1</b>, <b>2</b>, <b>28c</b>, <b>28e</b>, and <b>35</b> in the absence of Tween 80; and X-ray crystal structures of bis-<i>epi</i>-<b>23</b> and <b>26c</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of all new compounds and associated biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_001.pdf">jm9b01457_si_001.pdf (17.09 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01457/suppl_file/jm9b01457_si_002.csv">jm9b01457_si_002.csv (9.87 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01457&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-3%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01457%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01457" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a9f403f5d3d0c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
